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Abstract 
  
Part I: Characterization and crystallization trials of ancient ferredoxins and Pyrococcus 
furiosus ferredoxin 
  
Ferredoxins are iron-sulfur proteins that are believed to have evolved during the very early 
stages of evolution. The first part of this dissertation primarily concerns reconstruction and 
characterization of a ferredoxin which is believed to be the Last Common Ancestor (LCA) of 
todays ferredoxins and a ferredoxin traced even further back to the origin of iron-sulfur 
proteins (Ori-ISP). The sequences of these ferredoxins have previously been determined 
based on phylogenetic analysis and a theory concerning co-evolution of amino acids and the 
genetic code. Ori-ISP only contains 23 amino acid residues and has been argued to be at least 
3.5 billion years old. Ori-ISP and LCA ferredoxin constitute model systems for gaining 
further knowledge about cluster-protein interactions in extant ferredoxins as well as in 
relation to the origin of life and early evolution. 
In vitro iron-sulfur cluster reconstitution into the fusion protein Ub-Ori-ISP (Ub for ubiquitin) 
was performed using different iron sources under strict anaerobic conditions. The reaction 
products were purified and analysed. When Fe(III) was used, two species were obtained; a 
monomeric [4Fe-4S]2+ protein and a dimeric protein possibly containing one or two [3Fe-
4S]1+ clusters or two different cluster types. However, when Fe(II) was used, two monomeric 
species were obtained. The dominating species was a [4Fe-4S]1+ protein and a protein 
containing the oxidized cluster, [4Fe-4S]2+, was also obtained. Attempts to crystallize holo-
Ub-Ori-ISP were not successful. 
A Ub protease was expressed in E. coli cells and a purification procedure was developed. A 
method for proteolytic cleavage of the fusion protein, Ub-Ori-ISP, and simultaneous cluster 
reconstitution into Ori-ISP was developed. Using Fe(III) as the iron source yielded results 
comparable to cluster reconstitution into Ub-Ori-ISP. 
Two approaches for obtaining LCA were investigated. In the first approach holo-Ub-LCA 
ferredoxin was expressed in E. coli cells, purified, Ub was cleaved off in vitro and holo-LCA 
ferredoxin was then further purified. In the second approach holo-LCA ferredoxin was 
purified directly from E. coli cells co-expressing holo-Ub-LCA and a Ub protease. The yields 
of holo-LCA ferredoxin from the two methods were comparable, but very low. The second 
method is preferable since it was less time-consuming. It was found that holo-LCA ferredoxin 
contained at least one [4Fe-4S]2+ cluster.  
It was finally attempted to crystallize the [4Fe-4S]2+ ferredoxin from the hyperthermophilic 
archaeon Pyrococcus furiosus under strict anaerobic conditions. Crystals in the form of 
needles were obtained. However, they were too small for diffraction experiments. The 
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crystallization conditions were difficult to optimize and the temperature appeared to be an 
important parameter for crystal formation. 
 
Part II: Mycobacterium tuberculosis dCTPdeaminase:dUTPase: Structural implications 
for inhibition and mechanism of hydrolysis 
 
The second part of this dissertation concerns crystallization and structure determination of 
Mycobacterium tuberculosis dCTP deaminase:dUTPase. The bifunctional enzyme, dCTP 
deaminase:dUTPase, is involved in the biosynthesis of the nucleotide, dTTP, and it catalyses 
the conversion of dCTP to dUMP. It belongs to a family of enzymes also including the 
monofunctional enzymes; dCTP deaminase and dUTPase. Studying these enzymes will 
provide knowledge on the evolutionary relations of the members of this family. Since the 
bifunctional enzyme is not found in eukaryotes it could be considered a possible drug target in 
the treatment of e.g. tuberculosis. 
dTTP acts as an inhibitor of the enzyme, which was crystallized as the enzyme-dTTP complex 
and as the apo-enzyme and data were collected to 2.0 Å and 2.4 Å, respectively. Each crystal 
structure was solved using molecular replacement. The enzyme was also crystallized in the 
presence of the substrate analogue, α,β-imido dUTP, and data was collected to 3.0 Å. 
However, the quality of the obtained model was poor and α,β-imido dUTP did not appear in 
the model. 
Comparing the structures of the apo-enzyme and enzyme-dTTP complex, major differences 
were apparent. Upon binding of dTTP in the active site, the otherwise disordered C-terminal 
arranges as a lid covering the active site. As a result of structural changes in the active site 
induced by the methyl group bound to C5 of the thymine moiety of dTTP, the enzyme adapts 
to an inactive conformation. dTTP is not hydrolysed due to the absence of a water molecule 
otherwise hydrogen-bonded to O2 of the α-phosphoryl. The inhibition mode of dTTP has 
been inferred; this gives new insight into the reaction mechanism of bifunctional dCTP 
deaminase:dUTPases as well as monofunctional dUTPases. 
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Del I: Karakterisering og krystallisationsforsøg af oldgamle ferredoxiner og Pyrococcus 
furiosus ferredoxin  
 
Ferredoxiner tilhører klassen jern-svovl proteiner og menes at være opstået under den tidlige 
evolution. Den første del af denne afhandling omhandler primært rekonstruktion og 
karakterisering af to oldgamle ferredoxiner; LCA ferredoxin (”Last Common Ancestor 
ferredoxin”, sidste fælles forfader ferredoxin) og Ori-ISP (”Origin of Iron-Sulfur Proteins”, 
ophav til jern-svovl proteiner). Sekvenserne for disse ferredoxiner er tidligere blevet udledt; 
LCA ferredoxin baseret på fylogenetisk analyse og Ori-ISP baseret på LCA ferredoxin-
sekvensen og en teori vedrørende samtidig udvikling af aminosyrer og den genetiske kode. 
Ori-ISP indeholder kun 23 aminosyrer og hævdes at være mindst 3,5 milliarder år gammel. 
Ori-ISP og LCA ferredoxin udgør modelsystemer til at opnå mere viden om vekselvirkninger 
mellem jern-svovl-klynge og protein i nutidige ferredoxiner såvel som i relation til livets 
oprindelse og tidlig evolution.  
Jern-svovl-klyngerekonstruktion i fusionsproteinet Ub-Ori-ISP (Ub for ubiquitin) blev udført 
in vitro med forskellige jernkilder under strengt anaerobe betingelser. Reaktionsprodukterne 
blev oprenset og analyseret. Med Fe(III) som jernkilde blev der opnået to specier; et 
monomert [4Fe-4S]2+ protein og et dimert protein indeholdende en eller to [3Fe-4S]1+ klynger 
eller to forskellige klyngetyper. Når Fe(II) blev brugt, blev der opnået to monomere specier. 
Den dominerende specie var et [4Fe-4S]1+ protein, og et protein indeholdende den oxiderede 
klynge, [4Fe-4S]2+, blev også opnået. Forsøg på at krystallisere holo-Ub-Ori-ISP gav ikke 
nogen brugbare resultater. 
En Ub protease blev udtrykt i E. coli celler og en oprensningsprocedure udarbejdet. Endvidere 
blev en metode til at udføre proteolytisk kløvning af fusionsproteinet, Ub-Ori-ISP, og 
samtidig klyngerekonstruktion i Ori-ISP udarbejdet. Med Fe(III) som jernkilde var de 
opnåede resultater sammenlignelige med klyngerekonstruktion i Ub-Ori-ISP. 
To fremgangsmåder til at opnå LCA ferredoxin blev undersøgt. I den første fremgangsmåde 
blev holo-Ub-LCA ferredoxin udtrykt i E. coli celler, oprenset, fusionsproteinet blev kløvet af 
in vitro og holo-LCA ferredoxin blev videre oprenset. I den anden fremgangsmåde blev holo-
LCA ferredoxin oprenset direkte fra E. coli celler, der på samme tid udtrykte holo-Ub-LCA 
ferredoxin og en Ub protease. Udbyttet af LCA ferredoxin fra de to metoder var 
sammenligneligt, men meget lavt. Sidstnævnte metode er at fortrække, idet den er hurtigere. 
Holo-LCA ferredoxin indeholdt mindst en [4Fe-4S]2+ klynge. 
Det blev endelig forsøgt at krystallisere [4Fe-4S]2+ ferredoxin fra den hypertermofile archaea 
Pyrococcus furiosus under strengt anaerobe betingelser. Krystaller i form af nåle blev opnået, 
 v
Dansk resumé 
 vi
men de var for små til diffraktionseksperimenter. Krystallisationsbetingelserne var svære at 
optimere, og temperaturen synes at være en vigtig parameter for krystaldannelse.  
 
Del II: Mycobacterium tuberculosis dCTPdeaminase:dUTPase: Strukturelle implika-
tioner for hæmning og hydrolysemekanisme  
 
Den anden del af denne afhandling omhandler krystallisation og strukturbestemmelse af 
Mycobacterium tuberculosis dCTPdeaminase:dUTPase. Det bifunktionelle enzym, dCTP 
deaminase:dUTPase, er involveret i reaktionsvejen til dannelse af nukleotidet, dTTP, og det 
katalyserer omdannelsen af dCTP til dUMP. Det tilhører en familie af enzymer, som også 
inkluderer de monofunktionelle enzymer; dCTP deaminase og dUTPase. Studier af disse 
enzymer vil tilvejebringe viden om de evolutionære sammenhænge blandt medlemmerne af 
denne familie. Idet det bifunktionelle enzym ikke findes i eukaryoter, kan det betragtes som et 
muligt medicinsk mål i behandlingen af f.eks. tuberkulose. 
dTTP fungerer som hæmmer for enzymet, der blev krystalliseret som enzym-dTTP kompleks 
og som apo-enzym. Data blev opsamlet til henholdsvis 2,0 Å og 2,4 Å. Hver krystalstruktur 
blev løst vha. molecular replacement. Enzymet blev også ko-krystalliseret med det 
substratlignende molekyle, α,β-imido dUTP, og data blev opsamlet til 3,0 Å. Kvaliteten af 
modellen var dårlig, og α,β-imido dUTP kunne ikke bygges i elektrontætheden. 
Ved sammenligning af strukturerne for apo-enzymet og enzym-dTTP komplekset var store 
forskelle synlige. Når dTTP bindes i det aktive center, danner den ellers uordnede C-terminal 
et låg, der dækker det aktive center. Som et resultat af strukturelle ændringer i det aktive 
center forsaget af methyl gruppen bundet til C5 af thymin delen i dTTP indtager enzymet en 
inaktiv konformation. dTTP hydrolyseres ikke pga. fraværet af et vandmolekyle, der ellers er 
hydrogenbundet til O2 fra α-fosforyl. dTTPs strukturelle hæmning af enzymet har givet ny 
indsigt i reaktionsmekanismen for de bifunktionelle dCTP deaminase:dUTPaser såvel som for 
de monofunktionelle dUTPaser.   
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List of abbreviations 
 
Amp Ampicillin 
asu Asymmetric unit  
AU Absorbance unit 
Bis-Tris propane 1,3-bis(tris(hydroxymethyl)methylamino)propane 
C. acidiurici Clostridium acidiurici  
Cam  Chloroamphenicol 
CT  Central trunk 
CV Column volume 
Da Dalton  
D. gigas Desulfovibrio gigas 
DNA Deoxyribonucleic acid 
DTT Dithiothreitol 
E. coli Escherichia coli 
EIAV Equine infectious anaemia virus  
EPR  Electron paramagnetic resonance 
ESRF European Synchrotron Radiation Facility  
FeS  Iron-sulfur 
FIV  Feline immunodeficiency virus  
f-Met  N-formylmethionine  
HEPES  4-(2-Hydroxyethyl)piperazine-1-ethanesulfonic acid 
HPLC High performance liquid chromatography 
IBS Institute of Structural Biology (Grenoble, France)  
IPTG Isopropyl-β-D-thiogalactopyranoside 
Kan  Kanamycin sulfate 
LB Luria Broth 
LCA Last Common Ancestor 
LMCT Ligand-to-metal-charge-transfer 
milli-q 18.2 MΩcm QPAK Milli-Q water (Millipore) 
M. jannaschii Methanocaldococcus jannaschii  
MPD  2-methyl-2,4-pentanediol 
M. tuberculosis Mycobacterium tuberculosis 
MWCO Molecular weight cut off 
NTSB 2-nitro-5-(thiosulfo)-benzoate 
OD600 Optical density at 600 nm 
Ori-ISP Origin of Iron-Sulfur Proteins 
 vii
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 viii
PEG  Polyethylene glycol 
P. furiosus Pyrococcus furiosus  
pI Isoelectric point 
RCC  Reductive citrate cycle  
rmsd Root mean square deviation 
RNA Ribonucleic acid 
RPC  Reductive pentose phosphate cycle  
rpm Revolutions per minute 
S Spin 
SDS-PAGE Sodium dodecyl sulfate polyacrylaminde gel electrophoresis 
Sec Selenocysteine 
SHE  Standard hydrogen electrode 
S. typhimurium Salmonella typhimurium 
TB Terrific Broth 
Tris Tris(hydroxymethyl)-aminoethane 
tRNA Transfer RNA 
Ub Ubiquitin 
Ub-LCA Protein fusion of Ub and LCA 
Ub-Ori-ISP Protein fusion of Ub and Ori-ISP  
UBP Ubiquitin specific proteases 
UCH Ubiquitin C-terminal hydrolase 
UV-vis Ultraviolet-visible 
YUH1 Yeast ubiquitin hydrolase  
 
The twenty common amino acids are abbreviated according to the standard three-letter or one-
letter abbreviations. 
Common abbreviations for nucleotides and nucleosides have been used. 
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Chapter one 
 
 
 
1 Introduction 
The first part of this dissertation primarily concerns reconstruction and characterization of an 
iron-sulfur protein, which is believed to be more than 3.5 billion years old. The protein in 
question has been named the Origin of Iron-Sulfur Proteins (Ori-ISP) and it is believed to be 
the evolutionary origin of ferredoxins (a class of iron-sulfur proteins). Reconstruction and 
preliminary characterization of a Last Common Ancestor (LCA) ferredoxin and crystalli-
zation trials of the [4Fe-4S] ferredoxin from Pyrococcus furiosus are also presented. The goal 
of this project was characterization and working towards crystallizing these proteins for 
crystal structure determination. 
Based on phylogenetic comparisons of ferredoxins, the sequence of the LCA ferredoxin was 
previously derived by B. K. Davis (2002). Based on a theory of amino acid and genetic code 
evolution (Davis, 1999), LCA ferredoxin was traced even further back and the sequence of a 
pro-ferredoxin consisting of 23 amino acids, Ori-ISP, was deduced by Davis (2002). An 
understanding of Ori-ISP and its chemical and biophysical properties might aid in defining 
criteria for the origin of biological life on Earth. Ori-ISP and LCA ferredoxin can further be 
viewed as model systems for studying interactions between the iron-sulfur cluster and the 
protein moiety.  
I worked on Ori-ISP during my M.Sc. studies (Christophersen, 2004) and developed a 
purification scheme for the sulfite-protected apo-protein and a procedure for performing in 
vitro iron-sulfur cluster reconstitution into the fusion protein Ub-Ori-ISP (Ub for ubiquitin). 
This Ph.D. thesis presents further characterization of Ori-ISP. 
 
1.1 Outline of part I 
In contemporary life, iron-sulfur proteins constitute one of the most widespread classes of 
metalloproteins. They are found in all living organisms and are believed to have evolved 
during the very early stages of evolution. Iron-sulfur proteins show remarkable structural and 
functional diversity. Their biological functions range from electron transfer, redox and non-
redox catalysis to iron- and superoxide-sensing and gene regulation. Chapter 2 gives a brief 
overview on iron-sulfur proteins; emphasis is put on the ferredoxins since the characterised 
proteins belong to this class of iron-sulfur proteins. 
How life evolved has puzzled mankind for many years, and an outline of the prevalent 
theories on this subject is presented in chapter 3. The main focus is put on a theory formulated 
by B. K. Davis (1999). This theory assumes an autotrophic origin of life which originated on 
mineral surfaces situated at hydrothermal vents. It suggests that coded amino acids originated 
from components of the central metabolism and that they co-evolved with the genetic code. 
How the sequences of LCA ferredoxin and Ori-ISP were derived is also presented. 
 - 3 -
Part I                                                                                                                          Introduction 
 - 4 -
An introduction to the experimental work is presented in chapter 4. Amongst others the 
anaerobic techniques employed are described. Chapters 5 to 11 constitute an outline of the 
experimental work and the obtained results. Chapter 5 presents the optimized schemes for 
expressing Ub-Ori-ISP in E. coli cells and purification of the sulfite-protected protein.  
Chapter 6 presents cluster re-constitution into Ub-Ori-ISP and high performance liquid 
chromatographic purification of the reaction products using Ar/N2 flushing for obtaining 
anaerobic conditions. The stabilities of the purified products were tested under various 
conditions. Electron paramagnetic resonance and Mössbauer spectroscopic measurements 
were performed on some of the obtained products. In chapter 7 anaerobic chambers were used 
for preparation and purification of holo-Ub-Ori-ISP. Products obtained were analysed by 
ultraviolet-visible (UV-vis) spectrophotometry and analytical gel filtration. A method for 
obtaining hydrolytic cleavage of the Ub-Ori-ISP fusion protein and cluster reconstitution into 
Ori-ISP followed by purification is presented. Chapter 8 presents crystallization trials of holo-
Ub-Ori-ISP. 
Ori-ISP as well as LCA ferredoxin were expressed and purified as ubiquitin fusions; Ub-Ori-
ISP and Ub-LCA ferredoxin. A ubiquitin hydrolase is necessary for cleavage of these fusions. 
Chapter 9 presents expression and purification of yeast ubiquitin hydrolase (YUH1). Cleavage 
experiments on Ub-Ori-ISP and Ub-LCA ferredoxin are presented. 
Chapter 10 presents expression, purification and initial characterization of Ub-LCA and LCA 
ferredoxin. Chapter 11 presents crystallization trials of the [4Fe-4S] ferredoxin from 
Pyrococcus furiosus.  
Finally, Chapter 12 offers an overall conclusion of the experimental work and gives an 
outlook discussing further projects based on the results presented in this thesis. 
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Chapter two 
 
 
 
2 Iron-sulfur proteins 
 
2.1 Introduction to iron-sulfur proteins 
Iron-sulfur (FeS) proteins constitute a large class of metalloproteins that occur in all life forms 
ranging from archaea and bacteria to plants and animals. FeS proteins were not discovered 
until the early 1960s and today hundreds of proteins and enzymes belonging to this class of 
proteins have been characterized, the number is still steadily rising (Beinert, 2000; Bian and 
Cowan, 1999; Imsande, 1999; Johnson,1998; Sticht and Rösch, 1998). 
The presence of FeS proteins in ancient organisms and the versatility of the metal center in 
biological as well as inorganic systems have led to the hypothesis that these proteins evolved 
during the very early stages of evolution (Imsande, 1999; Meyer, 2008; Rao and Holm, 2004; 
Sticht and Rösch, 1998).  
All FeS proteins contain one or more iron ions, and all (except the rubredoxins) also contain 
inorganic acid-labile sulfide. The iron ions and the inorganic sulfide constitute the iron-sulfur 
cluster (FeS cluster), where the iron ions are most frequently coordinated to the protein 
moiety via cysteinyl sulfurs (Bentrop et al., 2001; Bertini et al., 2007). However, histidine 
and aspartate have also been observed as naturally occurring ligands (Moulis et al., 1996). 
The most common types of FeS clusters are shown in figure 2.1. With only a few exceptions, 
each of the iron ions in these clusters is surrounded by four sulfur ions in a distorted 
tetrahedral geometry. This small coordination number is enforced by steric requirements of 
the large sulfur ions, and an important consequence of this is that the iron ions exclusively 
occur in a high-spin configuration (Bertini et al., 2007; Cotton et al., 1995).  
FeS proteins show remarkable structural and functional diversity. Nature has not only created 
the cluster types shown in figure 2.1 but more sophisticated variants such as the hybrid cluster 
(Cooper et al., 2000) and the P-cluster and MoFe cofactor of nitrogenase (Einsle et al., 2002) 
have been characterized. The majority of the FeS clusters are involved in electron transfer, 
and they play an essential role in photosynthesis, cell respiration and nitrogen fixation. 
However, FeS clusters have many other functions. They have been recognized as sites for 
redox and non-redox catalysis and all-structural functions have also been documented. FeS 
proteins can serve as sensors of iron, dioxygen and superoxide, and they have also been found 
to play a role in gene regulation (Beinert et al., 1997; Bentrop et al., 2001; Bian and Cowan, 
1999; Flint and Allen, 1996).  
FeS proteins have characteristic brown colours due to ligand-to-metal-charge-transfer 
(LMCT) (Cotton et al., 1995) and many of them are sensitive towards dioxygen. Electron 
paramagnetic resonance (EPR) spectroscopy and Mössbauer spectroscopy are methods that 
have been extensively used in inferring FeS cluster compositions and electron localization/ 
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delocalization patterns (Mouesca and Lamotte 1998; Noodleman, 1995; Schünemann and 
Winkler, 1999). 
This chapter focuses on the ferredoxins (a class of FeS proteins) since the proteins analysed in 
chapters 6 to 11 belong to this class. These small and very acidic proteins exclusively function 
in electron transport. 
 
 A B C
 
 
 
 
 
 
Figure 2.1 The most common cluster types. Iron and inorganic sulfide are shown as bonded spheres in 
orange and yellow, respectively. Cysteine ligands are shown as sticks; sulfur is yellow while carbon is green. 
A) The [2Fe-2S] cluster exemplified by the [2Fe-2S] ferredoxin isolated from Anabaena species strain PCC 
7120 (PDB ID: 1FXA, Rypniewski et al., 1991). B) The [3Fe-4S] cluster of ferredoxin II from Desulfovibrio 
gigas (PDB ID: 1FXD, Kissinger et al., 1991). C) The structure of the [4Fe-4S] cluster exemplified by 
Bacillus thermoproteolyticus [4Fe-4S] ferredoxin (PDB ID: 1IQZ, Fukuyama et al., 2002). The figure was 
prepared with PyMOL (DeLano W. L., 2002). 
 
 
 
 
 
 
 
2.2 [2Fe-2S] ferredoxins 
Ferredoxins containing a binuclear FeS cluster (includes two iron and two inorganic sulfide 
ions) have molecular weights from 11 to 14 kDa. The cluster-geometry can be described as 
two tetrahedral FeS4 units sharing an edge (figure 2.1 A) (Bertini et al., 2007; Zanetti et al., 
2001). 
The [2Fe-2S] ferredoxins can be subdivided in three groups: the plant-type, the adrenodoxin-
type and the Clostridium-type (Zanetti et al., 2001). The plant-type ferredoxins are found in 
plants, algae and cyanobacteria, where they serve as terminal electron acceptors to 
photosystem I and as electron carriers in other metabolic pathways (nitrogen fixation and 
sulfite reduction). They are monomers and the cluster binding motif is Cys-x4-Cys-x2-Cys-xn-
Cys (Bentrop et al., 2001; Zanetti et al., 2001). The adrenodoxin-type ferredoxins occur in 
oxygenase systems and they serve as electron donors to cytochrome P450-monooxygenases 
or to bacterial hydroxylation systems. They are monomers but contain an interaction domain 
in the structure, which is not found in the plant-type ferredoxins. The cluster binding motif is 
Cys-x5/3-Cys-x2-Cys-xn-Cys (Zanetti et al., 2001). The Clostridium-type ferredoxins are found 
only in bacteria, and they are homo-dimers with one [2Fe-2S] cluster per monomer. The 
distribution of the coordinating cysteine residues in the amino acid sequence differs for the 
members of this group (Zanetti et al., 2001). The structure of the plant- and adrenodoxin type 
[2Fe-2S] ferredoxins is characterized by a four-stranded anti-parallel β-sheet covered by an α-
helix. This core is surrounded by two short β-strands, an α-helix and a short C-terminal helical 
turn. The FeS-cluster is located near the surface and is protected by a long loop harbouring 
three of the coordinating cysteines (Meyer, 2008; Zanetti et al., 2001). 
The cluster can exist in two oxidation states, [2Fe-2S]1+/2+, and the reduction potential lies in 
the range -400 to -100 mV vs. SHE (standard hydrogen electrode). Proteins containing the 
 - 6 -
Part I                                                                                                               Iron-sulfur proteins 
oxidized form often display characteristic UV-vis absorptions at about 330, 420, 460 and  
550 nm (Zanetti et al., 2001). Molar absorptivities of [2Fe-2S]2+ ferredoxins are 
approximately 10 mM-1·cm-1 at 420 nm (Zanetti et al., 2001). Several examples of UV-vis 
spectra of proteins containing [2Fe-2S] clusters can be found in the literature (e.g. Chatelet 
and Meyer, 1999; Martínez-Espinosa et al., 2003, Pan et al., 2003) (these spectra are used for 
comparisons in chapters 6 and 7). 
The [2Fe-2S]2+ cluster contains two Fe3+ and the spin for each iron is S = 5/2. These spins are 
antiparallel and antiferromagnetically coupled with a resulting spin of S = 0, rendering the 
oxidized state EPR silent (Beinert, 2000; Beinert et al.,1997). The colour of the protein fades 
upon reduction. Mössbauer spectroscopy has shown that the “extra” electron in the [2Fe-2S]1+ 
cluster is localized on one of the two iron ions. This means that the cluster contains a valence-
localized Fe2+-site and a valence-localized Fe3+-site. The spins of the two sites are  
S = 2 and S = 5/2 respectively. The local spins couple antiferromagnetically to give a resultant 
spin of S = ½. This form of the protein is recognizable by EPR (Beinert, 2000; Beinert et 
al.,1997; Mouesca and Lamotte 1998).  
 
2.3 Ferredoxins containing cuboidal iron-sulfur clusters 
Ferredoxins containing cuboidal clusters are found in various bacteria. This group includes 
ferredoxins containing one or two [4Fe-4S] clusters, a single [3Fe-4S] cluster or ferredoxins 
containing one [3Fe-4S] and one [4Fe-4S] cluster (Sticht and Rösch, 1998). The two cluster 
types are shown in figure 2.1 B and C. 
 
2.3.1 Monocluster ferredoxins 
Monocluster ferredoxins contain either a [3Fe-4S] or a [4Fe-4S] cluster in the active site. 
These proteins often include about 55 to 60 amino acids. The overall fold is conserved and 
they contain two α-helices and two anti-parallel β-sheets. The placement of the coordinating 
cysteine residues in the amino acid sequence is also conserved; Cys-x2-Cys-x2-Cys-xn-Cys-
Pro. The [4Fe-4S] cluster coordinates to all four cysteines while the [3Fe-4S] cluster does not 
coordinate to the second cysteine. Most of these ferredoxins also contain two extra cysteines 
which constitute a disulfide bridge (Fukuyama, 2001; Moura et al., 2001; Sticht and Rösch, 
1998).  
As a result of the conserved fold the two cluster types are interconvertible under certain 
conditions. An example is ferredoxins from Desulfovibrio gigas (D. gigas). Ferredoxin I and  
ferredoxin II have the same amino acid sequence, but they contain a [4Fe-4S] and a [3Fe-4S] 
cluster, respectively (Fukuyama, 2001; Moura et al., 2001). Non-cysteine coordination to 
cuboidal clusters has also been observed in several proteins. An example is ferredoxin from 
Pyrococcus furiosus (P. furiosus) (section 2.5) where the second cysteine in the binding 
sequence has been exchanged with an aspartic acid residue. In this case, the carboxylate group 
coordinates to the FeS cluster. Cluster interconversion between the [4Fe-4S] and the [3Fe-4S] 
cluster also occurs (Brereton et al., 1998). 
Both cluster types can exist in two oxidation states, [4Fe-4S]1+/2+ and [3Fe-4S]0/1+. The 
reduction potential falls in the range -650 to -250 mV vs. SHE for the [4Fe-4S] cluster, and  
-145 to -100 mV vs. SHE for the [3Fe-4S] cluster (Fukuyama, 2001; Moura et al., 2001; 
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Sticht and Rösch, 1998). The [4Fe-4S] ferredoxins show a characteristic broad UV-vis 
absorption band at ca. 390 nm (Fukuyama, 2001) while the [3Fe-4S] proteins show an 
absorption band at about 410 nm (Brereton et al., 1998; Moura et al., 2001). These proteins 
have molar absorptivities of ca. 16 to 17 mM-1·cm-1 at their respective absorption maxima 
(Brereton et al., 1998; Fukuyama, 2001; Moura et al., 2001). The UV-vis absorption spectra 
of the P. furiosus ferredoxin containing a [4Fe-4S]2+ or a [3Fe-4S]1+ cluster are shown in 
figure 2.2.  
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  Figure 2.2 UV-vis absorption spectra of oxidized ferredoxins from P. furiosus. A) A [4Fe-4S]2+ cluster is 
present in the ferredoxin. An absorption maximum at 390 nm is evident. B) A [3Fe-4S]1+ cluster is present in 
the ferredoxin. An absorption maximum at 408 nm is observed. 
 
 
 
Mössbauer spectroscopy has shown that the [3Fe-4S]1+ cluster contains three equivalent Fe3+. 
Each iron has a formal spin of S = 5/2, but the spins couple antiferromagnetically to form an  
S = ½ and the cluster is EPR active. The [3Fe-4S]0 cluster formally contains one Fe2+ and two 
Fe3+. Mössbauer spectroscopy has shown that the cluster contains one Fe3+ and two Fe2.5+, 
which means that the “extra” electron is delocalized between two of the three iron ions. The 
formal spin of the Fe3+ and the delocalized Fe2.5+Fe2.5+ pair is S = 5/2 and S = 9/2, 
respectively. These spins couple antiferromagnetically to form an S = 2 state (Beinert, 2000; 
Beinert et al.,1997; Moura et al., 2001).  
The [4Fe-4S]2+ cluster formally contains two Fe2+ and two Fe3+. Mössbauer spectroscopy has 
shown that two mixed valence pairs (2 × Fe2.5+Fe2.5+) are formed, each pair having a spin of  
S = 9/2. These spins are then antiferromagnetically coupled resulting in an EPR silent cluster. 
The [4Fe-4S]1+ cluster formally contains three Fe2+ and one Fe3+. In this case a mixed-valence 
pair (Fe2.5+Fe2.5+) and a ferrous pair (Fe2+Fe2+) are formed which are ferromagnetically 
coupled to spins of S = 9/2 and S = 4, respectively. The mixed-valence pair and the ferrous 
pair are then antiferromagnetically coupled resulting in a spin of S = ½ (Beinert, 2000; 
Beinert et al.,1997).  
 
2.3.2 Dicluster ferredoxins 
Dicluster ferredoxins contain a core structure characterized by a two-fold symmetrical 
arrangement of the two clusters in a (βαβ)2 fold (Bentrop et al., 2001; Meyer, 2008). 
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Dicluster ferredoxins containing two [4Fe-4S]1+/2+ clusters primarily occur in anaerobic 
bacteria, especially in clostridial species. The primary sequence of these proteins contains 
about 55 to 60 amino acid residues. In the primary sequence the motif, Cys-x2-Cys-x2-Cys-x3-
Cys-Pro, occurs twice, but these cysteines do not constitute the cluster binding motif. In 
ferredoxin from Clostridium acidiurici (C. acidiurici), the N-terminal cluster (center I) is 
coordinated to Cys-8, Cys-11, Cys-14 and Cys-47, while the C-terminal cluster (center II) is 
coordinated to Cys-18, Cys-37, Cys-40 and Cys-43. Therefore, center I and center II have the 
binding motifs Cys-x2-Cys-x2-Cys-xn-Cys and Cys-xn-Cys-x2-Cys-x2-Cys, respectively. The 
reduction potential for center I and center II is ca. -400 mV and -660 mV vs. SHE, 
respectively (Sieker and Adman, 2001). 
Ferredoxins containing one [3Fe-4S]0/1+ and one [4Fe-4S]1+/2+ cluster are thermo- and air-
stable and can be handled aerobically for extended periods of time. In some of these proteins 
the [3Fe-4S]0 cluster can be converted to the [4Fe-4S]2+ cluster by insertion of Fe2+ in vitro. 
The primary sequence of these proteins contains about 60 to 110 amino acid residues. The 
placement of the [3Fe-4S]-coordinating cysteine residues in the amino acid sequence is Cys-
x5/7-Cys-xn-Cys, while the placement of the [4Fe-4S]-coordinating cysteine residues is Cys-
xn-Cys-x2-Cys-x2-Cys. The reduction potentials are in the range -150 to -450 mV vs. SHE for 
the [3Fe-4S]0/1+ cluster and -400 to -650 mV for the [4Fe-4S]1+/2+ cluster (Stout, 2001). 
 
2.3.3 Evolution of ferredoxins containing cuboidal clusters 
A very large number of ferredoxins have been characterized, and the structural and sequential 
evidence gathered support the hypothesis that all ferredoxins containing cuboidal clusters 
originate from a common ancestor (Fukuyama, 2001; Meyer, 2008) (section 3.3).  
The most widely accepted model assumes that all extant ferredoxins containing cuboidal 
clusters originate from an ancestral dicluster (2 × [4Fe-4S]) ferredoxin, which in turn had 
originated from gene duplication of a sequence encoding a short peptide. Extant dicluster 
ferredoxins then originated from insertion of C- or N-terminal extensions and Zn binding 
segments. The dicluster ferredoxins containing 55 residues constitute the core structure of this 
group (see section 2.3.2) and are believed to be very closely related to the ancestral 
ferredoxin. Extant monocluster ferredoxins originated from mutations of the cysteines 
coordinating the second cluster; in some cases a disulfide bridge was the result and in other 
cases the cysteines were all lost. Insertions of short peptide segments have also occurred 
(Fukuyama, 2001; Meyer, 2008; Sticht and Rösch, 1998). A crude sketch of the evolutionary 
events is presented in figure 2.3.   
 
2.4 Core structure analysis of ferredoxins containing cuboidal clusters 
To investigate structure-function properties and the properties of the residues in the close 
vicinity of the FeS-cluster, peptide-based model systems have been applied.  
The Ori-ISP and LCA ferredoxin characterized in this project constitute one such model 
system in relation to evolution of ferredoxins containing cuboidal clusters. Cluster 
reconstitution into Ori-ISP is examined in chapters 6 and 7. 
Cluster reconstitutions into peptide-based models have previously been accomplished and two 
such model systems are described in this section. 
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 Gene duplication 
 
 Ancestral  
 2 × [4Fe-4S]  
 ferredoxin 
55 residues  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2.4.1 Desulfovibrio gigas mini-ferredoxin 
Sow et al. (1996) designed a mini-ferredoxin based on the structure and sequence of D. gigas 
ferredoxin II (58 amino acid residues). The model consisted of 31 residues and was made up 
of residues 3 to 17 and 43 to 56 joined via two residues (Thr and Lys) obtained from a 6-
residue loop in trypsin. It was found that the cluster reconstituted mini-ferredoxin had roughly 
retained the properties from the native ferredoxin, but that it was less stable, suggesting that 
the entire peptide chain is involved in stabilizing the holo-protein (Sow et al., 1996).  
 
2.4.2 Ferredoxin maquettes 
A prototype ferredoxin maquette (figure 2.4) containing 16 amino acid residues based on a 
consensus sequence of bacterial [4Fe-4S] ferredoxins was generated to probe the ligand and 
non-coordinating residue requirements for [4Fe-4S] cluster binding (Gibney et al., 1996; 
Mulholland et al., 1998). Upon cluster reconstitution the ferredoxin maquettte was found to 
be monomeric and to contain a [4Fe-4S] cluster. From mutational analysis it was found that 
three cysteines were necessary for formation of a monomeric species containing a [4Fe-4S] 
Ancestral  
[4Fe-4S] 
ferredoxin 
Loss of second 
cluster  
(2FDN) 
C-terminal 
extension N-terminal 
Disulfide  No 
disulfide  
extension  
and Zn bond 
bond 
(2FGO) 
(1VJW) 
(1IQZ) (1XER) 
Figure 2.3 Crude sketch of evolution of ferredoxins containing cuboidal clusters. The figure was modified 
from Fukuyama (2001) and Meyer (2008).  Ferredoxin structures were obtained from: Thermotoga maritima 
(PDB ID: 1VJW, Macedo-Ribeiro et al., 1996), Bacillus thermoproteolyticus (PDB ID: 1IQZ, Fukuyama et 
al., 2002), Sulfolobus tokodaii (PDB  ID: 1XER, Fujii et al., 1996), Pseudomonas aeruginosa (PDB ID: 
2FGO, Giastas et al., 2006) and C. acidiurici (PDB ID: 2FDN, Dauter et al., 1998). Structures are shown in 
ribbon and α-helices and β-sheets are shown in red and yellow, respectively. Metal centers are shown as 
spheres; iron is orange, sulfur is yellow and zinc is grey. The structures were prepared with PyMOL (DeLano 
W. L., 2002). 
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cluster. Further it was found that the fourth cysteine was of particular importance for cluster 
binding (shown in pink in figure 2.4). Mutating all residues, except the cysteines, into 
glycines resulted in practically no formation of holo-protein, which shows that not only are 
the cysteines important, but the “core” sequence is of equal importance (Gibney et al., 1996; 
Mulholland et al., 1998). The minimum number of residues required to yield [4Fe-4S] cluster 
reconstitution was found to be the seven residues in the stretch including the three central 
cysteines (underlined in figure 2.4) (Mulholland et al., 1999). Requirements for the non-
cysteine residues in this seven residue peptide were analysed. It was found that isoleucine at 
the second or at the sixth position (while the remaining non-cysteine residues were mutated to 
glycine) resulted in cluster formation. Sequence analysis of 510 native [4Fe-4S] proteins 
revealed that Ile was the most frequent residue at the second position of the seven residue 
peptide while Gly was most often encountered at positions three and five while the sixth 
position was rather tolerant of all 20 amino acids, Ala being the most frequent (Mulholland et 
al., 1999). 
 NH2-KLCEGGCIACGACGGW-CONH2
 
 Figure 2.4 Sequence of ferredoxin maquette. Cysteines are shown in bold. A central seven residue peptide 
sequence constituting minimum requirements for cluster formation is underlined. The fourth cysteine in the 
sequence is of particular importance and shown in pink. 
 
 
 
2.5 Pyrococcus furiosus ferredoxin 
The hyperthermophilic archaeon P. furiosus lives under extreme conditions and has a growth 
optimum at 100ºC. The organism was originally isolated from geothermally heated marine 
volcanic sediments (Fiala and Stetter, 1986). It is a strict anaerobic heterotroph, which grows 
on carbohydrates and utilizes a modified Embden-Meyerhoff pathway for glycolysis (Kengen 
et al., 1996).  
A single [4Fe-4S] ferredoxin has been purified from P. furiosus (Aono et al., 1989) and it was 
found to act as an electron carrier protein in the glycolysis. It functions as electron acceptor 
for glyceraldehyde-3-phosphate oxidoreductase and pyruvate oxidoreductase and as electron 
donor for a transmembrane multi-subunit hydrogenase complex (Silva et al., 2000). The  
[4Fe-4S] ferredoxin consists of 66 residues and has a molecular weigh of 7.5 kDa including 
the FeS cluster (Conover et al., 1990). As for the common ferredoxins the cluster exists in 
two oxidation states, [4Fe-4S]1+/2+. This ferredoxin is highly thermostable and remains 
unaffected after 12 hours of incubation at 95 ºC (Aono et al., 1989). However, the [4Fe-4S] 
cluster can be converted to a [3Fe-4S] cluster upon oxidation e.g. by oxygen (Conover et al., 
1990). The cluster binding motif differs from common [4Fe-4S] ferredoxins (see section 
2.3.1) since the second Cys is replaced by Asp, which has been shown to coordinate the 
cluster (Calzolai et al., 1995). Upon oxidation to the [3Fe-4S] cluster it is the iron coordinated 
by Asp which is lost (Conover et al., 1990). UV-vis spectra of both forms are shown in figure 
2.2.  
The high stability of the ferredoxin along with the lability of the iron coordinated by Asp has 
rendered the ferredoxin an outstanding model system for studies of heterometallic clusters 
[M3Fe-4S], where M most often is an element of the first transition series (Conover et al., 
1990b; Fawcett et al., 1998; Finnegan et al., 1995; Fu et al., 1994; Staples et al., 1997). 
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The protein contains a disulfide bridge which, like the [4Fe-4S] cluster, is redox active. This 
yields four redox states for the protein (Gorst et al., 1995). The disulfide bond is further found 
in two conformations; a left-handed and a right-handed spiral conformation (Sham et al., 
2002). The ferredoxin has been reported to be both a monomer (Conover et al., 1990) and a 
dimer (Hasan et al., 2002), this is elaborated and discussed in chapter 11. The crystal structure 
of the ferredoxin containing a [3Fe-4S] cluster has been solved (figure 2.5 A and B), which 
revealed a β-sheet interaction between two monomers supporting the suggestion that the 
ferredoxin could in fact be a functional dimer (Nielsen et al., 2004). The overall fold is that of 
the family (section 2.3.1). The crystal structure of the D14C [4Fe-4S] variant has also been 
solved (Johannesen et al., in preparation). The overall structure is similar to the structure of 
the native protein except for the difference in clusters (figure 2.5 C). The mutant ferredoxin 
further contained two molecules in the asymmetric unit; one generating a dimer when 
imposing crystallographic symmetry and the other generating a monomer. Crystallization of 
the native [4Fe-4S] ferredoxin is the subject of chapter 11. Solving the structure of the [4Fe-
4S] native form will provide a detailed knowledge on Asp coordination and on structural and 
geometric differences of cluster and peptide chain enforced by the Cys/Asp-14 ligand. 
 
A  
 
 
 
 
 
 
 
 
 
 
 D14C  B CAsp-14  mutant 
 
 
 
 
 
 
 
 
Figure 2.5 Crystal structures of P. furiosus ferredoxin. A) Structure of the [3Fe-4S] ferredoxin (PDB ID: 
1SJ1, Nielsen et al., 2004). The protein is a dimer in the asymmetric unit. The two monomers are connected 
via a β-sheet interaction. The monomers are shown in ribbon view in pink and green. The five cysteines 
present in the protein are shown as sticks and the FeS cluster of each monomer is shown as bonded spheres; 
iron is orange while sulfur is yellow. Asp-14, which coordinates the fourth iron in the [4Fe-4S] form, is also 
shown. Two conformations of the disulfide bond are evident. B) Close-up of the cluster in A. C) Close-up 
(same point of view as in B) of the [4Fe-4S] cluster of the D14C mutant (PDB ID: 2Z8Q, Johannessen et al., 
in preparation). The protein is shown in cyan. The figure was prepared with PyMOL (DeLano W.L., 2002). 
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Chapter three 
 
 
 
3 On the origin of life, evolution of the genetic code and 
ancient ferredoxins 
How did life evolve? This question has always concerned the human race. How the 
chemosphere of early Earth was transformed to a biosphere is the key to understand the origin 
of life and to search for extraterrestrial life or life signatures. 
Several theories and ideas on this subject have been put forward and extensive amounts of 
literature can be found on this subject. In this section the two most prevalent theories are 
presented; the prebiotic soup model and the autotrophic origin of live. A theory concerning 
co-evolution of amino acids and the genetic code (Davis, 1999) is also presented. Based on 
this latter theory and a phylogenetic analysis of ferredoxins the sequences of a Last Common 
Ancestor (LCA) ferredoxin and a pro-ferredoxin (Ori-ISP) have been deduced, and Ori-ISP 
have been dated back billions of years (Davis, 2002). 
 
3.1 The origin of life 
 
3.1.1 Early Earth 
Radioactive dating indicates that Earth was formed about 4.6 billion years ago. Due to 
impacts of objects large enough to exterminate life on Earth today, the surface was very hot 
(500-1000ºC) for about half a billion years. According to geochemical estimations, Earth had 
cooled to about 100ºC, 3.9 billion years ago, giving rise to the formation of H2O(l), which is 
essential for the formation of life. Alternating evaporation/condensation processes must have 
led to forceful atmospheric phenomena such as electrical discharges and storms. The Earth 
was constantly irradiated by ultraviolet light since the ozone layer did not exist at that time 
and volcanic eruptions were frequent (Campbell and Farrel, 2003; Nisbet and Sleep, 2001; 
Orgel, 1998; Rode, 1999; Sleep et al., 1989).  
The atmosphere on early Earth was very different from the one we know today and it has 
probably gone through several stages before reaching its current composition. It is generally 
believed that the atmosphere was composed of NH3, H2S, CO, CO2, CH4, N2, H2, H2O(g) and 
H2O(l). However there is no agreement on the relative amounts of these compounds 
(Campbell and Farrel, 2003). The atmosphere of early Earth has been postulated to be 
everything from strongly reducing to slightly oxidizing (Berry, 2002; Edwards, 1998; 
Kasting, 1993; Orgel 1998).  
The oldest known cell-like structures are 3.5 billion years old fossils located in minerals. This 
means that only a few hundred million years were available for the evolution of mono-cellular 
structures from simple inorganic compounds (Furnes et al., 2004; van Zuilen et al., 2002). 
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3.1.2 The prebiotic soup model 
In the 1920s, A. I. Oparin (1938) and J. B. S. Haldane (1929) proposed that lightning could 
cause the molecules of the primordial reducing atmosphere to react and form simple organic 
compounds. These reactions were experimentally demonstrated by S. Miller in 1953 (Miller, 
1953). He simulated the effects of lightning in the primordial atmosphere, subjecting a 
mixture of NH3(g), CH4(g), H2(g) and H2O(l) to electric discharges in a refluxing system for 
about a week. The resulting solution contained simple organic compounds like formaldehyde 
and hydrogen cyanide and several naturally occurring amino acids. These experiments were 
repeated under varying conditions (different compositions of the reducing “atmosphere”, and 
ultraviolet radiation) leading to other molecules like nucleic bases and sugars (Campbell and 
Farrel, 2003; Orgel, 1998; Voet and Voet, 2003). These experiments were widely accepted as 
a heterotrophic model for synthesis of the bio-monomers needed for the creation of proteins 
and RNA. According to this model, the oceans slowly attained the consistency of a thin 
primordial soup of bio-monomers, which then somehow would react to create polypeptides 
and polynucleotides (Orgel, 1998; Voet and Voet, 2003).  
A variant of the heterotrophic model assumes that the organic molecules of the primordial 
soup were delivered to earth by meteorites that bombarded Earth after it was formed (Orgel, 
1998; Rode, 1999). 
 
3.1.3 An autotrophic origin of life 
An autotrophic (self-sustaining) origin of life would not be dependent on global conditions, 
but on local. Supporters of an autotrophic origin of life believe that life began on mineral 
surfaces. These surfaces were able to arrange primitive catalysts and substrates in simple 
arrays, and via a mineral-linked energy transduction mechanism, the first metabolic pathways 
were created (Edwards, 1998). Iron sulfide minerals, especially pyrite (FeS2), have been 
considered as possible sites for primordial processes. Pyrite has a positively charged surface 
which is capable of binding not only inorganic anions, but also organic molecules containing 
anionic groups e.g. carboxylate and thiolate (Wächtershäuser, 1992).  
G. Wächtershaüser (1990 and 1992) has proposed that life began chemoautotrophically on 
pyrite surfaces situated at hydrothermal vents and he has suggested an archaic reductive 
citrate cycle to be the origin of metabolism and bio-molecules. He suggested that the energy 
for reduction of CO2 (CO2 being the precursor molecule of bio-molecules) and for driving this 
cycle was the oxidative formation of FeS2 from FeS and H2S/HS-. According to 
Wächtershaüser’s theory, complex metabolic cycles self-organized on mineral surfaces and 
the products did not escape the surface. The reactions suggested by Wächtershäuser may be 
thermodynamically possible, but the thermodynamic calculations have been exposed to some 
critique (Kalapos, 2007) and the reactions have never been experimentally proved. Studies on 
CO2 fixation and reaction on mineral surfaces have been carried out. The outcome of these 
studies was, that the reactions are highly unlikely due to large overpotentials involved in the 
fixation of CO2, which means that further energy was necessary to carry out these reactions 
(Tributsch et al., 2003).   
Wächtershaüser has modified his original ideas to concern CO instead of CO2 
(Wächtershäuser, 2006). It was found that co-precipitated NiS and FeS could convert CO and 
CH3SH into the thioester CH3COSCH3, which then hydrolysed to CH3COOH. If the solution 
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was added a catalytic amount of selenium, CH3SH and CH3COOH were formed from CO and 
H2S alone. NiS, FeS, CO and H2S are found in the exhaust of hydrothermal vents. Therefore 
the above mentioned reactions can be considered to have participated in a chemoautotrophic 
origin of life (Huber and Wächtershäuser, 1997). Experiments have also shown that amino 
acids can form peptide bonds by activation with CO in the presence of NiS and FeS, and that 
a CO driven degradation of the peptides simultaneously proceeds, resulting in a peptide cycle. 
The ability of a primordial organism to recycle its components is necessary, otherwise 
functionless peptides would become a sink for valuable amino acids (Huber and 
Wächtershäuser, 1998; Huber et al., 2003). The formations of α-hydroxy and α-amino-acids 
by CO fixation on catalytic transition metal precipitates have also been shown (Huber and 
Wächtershauser, 2006). 
A variation of the pyrite theory is proposed by M. R. Edwards (1998) who has suggested that 
life could have originated on pyrite but that the origin was photoautotrophic. Studies of the 
photo-electrochemical behaviour of pyrite show that this mineral has photoelectric properties. 
Light absorbed by this mineral generates photocurrents and photo-potentials across the pyrite-
liquid interface. If pyrite is put in contact with an Fe2+/3+ electrolyte, it can convert light into 
photo-electrochemical energy (Tributsch, 2003). Edwards suggests that photoelectrons could 
have been used to reduce compounds in ancestral pathways (Edwards, 1998). 
 
3.1.4 Self-replicating systems 
Living systems/organisms have the ability to self-replicate. However, knowledge on the 
evolution of a self-replicating system is very limited (Orgel, 1998).  
A discovery which has had deep implications for this discussion is that RNA is capable of 
catalyzing its own formation. This has led many scientists to believe that life originated from 
an “RNA world” in which RNA molecules functioned both as genetic material and as 
catalysts (de Lucreazia et al., 2007). This system somehow evolved to a point when it was 
able to encode the synthesis of proteins, which are more effective catalysts. And at an even 
later stage, DNA took over as the genetic material (Campbell and Farrell, 2003). This 
hypothesis does not explain how the nucleotides of RNA originated and how they were able 
to polymerize. Polymerization could have proceeded on clay minerals. It has been found that 
montmorillonite, which is positively charged clay that is believed to have been plentiful on 
early Earth, is able to catalyze the formation of short RNA molecules (Orgel, 1998). It has 
also been proposed, that RNA was not the first genetic material, but that a simpler replicating 
system preceded RNA (Orgel, 1998). It has further been suggested that life appeared when 
different systems, some involved in metabolic cycles and others involved in replication, 
combined and entered into some sort of symbiotic process (Campbell and Farrell, 2003). 
 
3.1.5 Membranes and cells 
Lipid membranes are characteristic of extant life and they play a crucial role in energy 
metabolism of cells. How these cell boundaries arose and what their constituents were, is 
unknown (Berry, 2002). It has been proposed that cell membranes emerged very early in 
evolution. Several researchers think that the formation of macromolecules would have been 
assisted or even dependent on the compartmentalization that membranes would provide 
(Berry, 2002). 
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The main constituent of extant biomembranes is phospholipids, but the spontaneous formation 
of these under primordial conditions is not likely. Organic matter from meteorites have been 
found to form vesicles in water, which indicate that other molecules may have been suitable 
for the formation of these membranes. One theory says that the origin of the first cells was 
related to formation of cell membranes from terpenoids (Berry, 2002). 
Minerals could have functioned as primordial cells. Hydrothermally formed iron sulfide 
chimneys (hydrothermal vents) have been found to be “three-dimensional cells” and not just 
two-dimensional surfaces. These minerals contain inner compartments which are incom-
pletely separated from one another by membrane like sheaths of iron sulfide precipitate. One 
could imagine that life began inside these structures and that reactions could have been 
catalyzed on the iron sulfide surfaces (Martin and Russel, 2003). 
 
3.2 Amino acid synthesis and evolution of the genetic code 
B. K. Davis, who is a supporter of Wächtershaüsers theory, has proposed that primordial 
amino acid synthesis took place on mineral surfaces and that the genetic code evolved 
simultaneously (Davis, 1999). In this section the main aspects of Davis’ theory are presented. 
 
3.2.1 Primordial amino acid synthesis 
According to Davis’ theory, coded amino acids originate from branch reactions at various 
points in central metabolism. The components from which the amino acids originate include 
sugar derivatives and small carboxylated molecules. Under the anaerobic conditions that were 
found on early Earth, these compounds constituted the reductive citrate cycle (RCC), the 
reductive pentose phosphate cycle (RPC) and the central trunk (CT) that links these two 
cycles (figure 3.1). The RCC and RPC are autocatalytic CO2 fixing cycles and they are 
believed to have taken place on mineral surfaces. The energy necessary for the reactions was 
obtained from a coupling of the endergonic reduction of CO2 to the exergonic formation of 
pyrite. These reactions are based on ideas proposed by Wächtershäuser (1990 and 1992) and 
the correctness of these is questionable (section 3.1.3). 
The RCC, RPC and CT contributed to the formation of coded amino acids (Davis, 1999). The 
number of amino acids originating from each system was used to identify which part of 
central metabolism that was first linked to protein synthesis and formation of the genetic code. 
The more a system contributes, the earlier in evolution it was involved in amino acid 
synthesis. The number of reactions in the biosynthetic pathway needed to synthesize an amino 
acid gives a hint to when that particular amino acid was formed. If an amino acid requires a 
large number of reaction steps it was formed at a late stage in evolution. Based on the above 
assumptions, the RCC was seen as the first cycle linked to protein synthesis (elaborated 
below). When counting the path length for the formation of an amino acid, no addition was 
made to the path length for the distance between components in the same cycle because these 
cycles predate protein synthesis. RCC was the first cycle and therefore it forms the basis of 
counting. The RPC is a distinct cycle and it is linked to the RCC via the CT, consequently two 
steps are added to amino acids synthesized from RPC components and one step is added to 
amino acids synthesized from the CT (figure 3.1) (Davis, 1999). 
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Figure 3.1 Biosynthetic pathways for amino acids. Coded amino acids originate from components of central 
metabolism; RCC, RPC and CT. Reprinted from Davis (1999) with permission from Elsevier Limited. The 
reader is referred to the original literature for details and abbreviations concerning these cycles. 
 
Twenty α-amino acids (including selenocysteine, Sec) and one imino acid constitute the 
proteins of archeons and eukaryotes. Bacteria contain an additional amino acid; N-
formylmethionine (f-Met). All 21 amino acids occur in all life forms, because they were 
incorporated into proteins before divergence from the Last Common Ancestor (LCA). 
 
Table 3.1: Each amino acid originates from a component of central metabolism. The amino acids form six 
families and each family has a different precursor. The CT and RPC share Phe, Tyr and Trp but in counting 
the stage of addition to the genetic code, they are credited to the RPC (Davis, 1999). 
Metabolic cycle RCC CT CT/RPC RPC 
Precursor 
molecule 
Oxalo acetate α-keto-
gluterate 
Pyruvate Phospho-
glycerate 
Phosphoenolpyruvate + 
ribose-5-phosphate 
Ribose -5- 
phosphate 
Amino acid Asp    Asn 
Thr     Ile 
Met    f-Met 
Lys 
Glu 
Gln 
Pro 
Arg 
Ala 
Val 
Leu 
Ser 
Gly 
Cys 
Sec 
Phe 
Tyr 
Trp 
His 
 
The amino acids form six families, and each family has a different precursor in central 
metabolism (table 3.1). 13 common amino acids and f-Met, originate from components of the 
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RCC. Six common amino acids and Sec originate from two components of the CT, and four 
amino acids originate from two components of the RPC (table 3.1). As the source of the 
highest number of amino acid combined with the shortest path lengths of amino acid 
synthesis, the RCC is considered to have had the longest association with protein synthesis. 
Hence, the RPC has had the shortest association with protein synthesis (Davis, 1999). 
As stated above, the time of entry of each amino acid into the code is estimated from the 
number of reactions in its biosynthetic pathway. This number of reactions is therefore equal to 
the stage where a particular amino acid entered the genetic code, presented in table 3.2.  
No amino acids were added to the genetic code at stage 3, 8 and 12. If one compares the path 
length of amino acid synthesis and the properties of the side chain, a pattern emerges (table 
3.2). The first amino acids to enter the code were acidic or hydrophilic (stage 1 and 2); their 
side chains being carboxylate or amide groups. The next amino acids to enter the code (stage 
4-7) display side chains of increasing hydrophobicity. And the last amino acids to enter the 
code (stage 9-14) display basic or aromatic side chains (Davis, 1999).  
Path length analysis has also been applied to the synthesis of small amphipathic molecules, 
fatty acids, and phospholipids. Their formation is placed about 10 reactions (stage 10) from 
the RCC, giving rise to the formation of cells (Davis, 1999). 
 
Table 3.2: The stage in evolution when each amino acid was added to the code. The colours indicate: acidic, 
hydrophilic, hydrophobic, basic and aromatic amino acids. 
Stage 1 2 3 4 5 6 7 8 9 10 11 12 13 14 
Amino 
acid 
Asp 
Glu 
 
Asn 
Gln 
 Ala 
Pro 
Ser 
Val 
Cys 
Gly 
Thr Leu 
Ile 
Met 
 Arg Lys Phe 
Tyr 
 His Trp 
 
3.2.2 Evolution of the genetic code 
According to Davis (1999), the genetic code and amino acid synthesis co-evolved and this 
evolution was divided into three stages. Biosynthetically related amino acids often have 
related codons and a detailed examination of these relationships assisted in reconstruction of 
codon evolution. Davis has based codon assignment on the biosynthetic pathways of amino 
acid synthesis and tRNA phylogeny in extreme thermophiles and related archaean species. 
Consequently, the first part of the theory (section 3.2.1) supports the second part of the theory 
and vice versa (the main conclusions are described here) (Davis, 1999). 
The genetic code evolved during several millions of years from including only a few codons 
to include all 64 codons. In the first stage of code evolution four sets of codons (a total of 16) 
constituted the genetic code. These codons coded for stage 1 and 2 amino acids (table 3.2). As 
only one fourth of all codons were assigned, mutations to unreadable codons often occurred. 
The second stage of code evolution comprised amino acids synthesized from stage 4 to 7. 
During this stage, the size of the code grew rapidly to include all 64 codons, and the number 
of coded amino acids increased from 4 to 14. Expansion of the code decreased the risk of 
mutation to an unassigned codon and chain termination (Davis, 1999). In the first two stages 
residues included in the genetic code captured unassigned codons. In the third stage (the post-
expansion phase), incoming amino acids (synthesized from stage 9 to 14) needed to capture 
already assigned codons. These amino acids were basic or aromatic residues (table 3.2). 
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Capture of an already assigned codon required that the advantages contributed by an incoming 
amino acid exceed the cost of replacing the outgoing amino acid. The outgoing amino acid 
was already present in proteins, and changing this amino acid could change or destroy the 
function of a particular protein. Codon-reassignments that took place in the third stage led to 
the formation of the basic code, presently existing in animal mitochondria (Davis, 1999). 
Changes that affected single codons were further made in the basic code and these completed 
the formation of the standard code (the code of extant organisms). The standard code is not 
“frozen”, and variant codes have formed after the divergence of archaea, bacteria and 
eukarya. This means that the genetic code continues to evolve (Davis, 1999). 
The evolution of the genetic code and formation of living organisms took place within a few 
hundred million years. According to Davis, the code evolved in about 20 million years, which 
is almost instantaneous on a geological time scale. This result is based on tRNA divergence 
rates and error rates in RNA replication.  
 
3.3 Ancient ferredoxins 
This section provides an outline of how Davis (2002) deduced the sequences of Ori-ISP and 
LCA ferredoxin. Based on phylogenetic studies on ferredoxins, the sequence of LCA 
ferredoxin was constructed. The LCA ferredoxin was traced further back to a stage 5 protein 
that contained 23 amino acid residues; Ori-ISP (Davis, 2002). 
From a completed study on ten different proteins and enzymes from more than 800 
phylogenetic distinct sources, which included proteins like ferredoxins, reverse transcriptases, 
topoisomerases and ribonucleotide reductases, it was found that ferredoxins could be traced 
the furthest back in time. As a consequence of this study, Ori-ISP is believed to be the oldest 
known protein (it had the earliest residue profile).   
 
3.3.1 Phylogenetic analysis of ferredoxin 
To obtain sequences of ferredoxins, a representative of this class of proteins was chosen: 
Clostridium pasteurianum (C. pasteurianum) ferredoxin. It contains 55 amino acid residues 
and two [4Fe-4S] clusters (Davis, 2002). 
A sequence homology search was performed, and 82 sequences were obtained. 60 sequences 
came from bacteria, while the remaining sequences came from archaea. The sequence identity 
with residues in the aligned reference sequence was between 29 and 89 percent. Based on 
these sequences, the phylogenetic trees of archaea and bacteria were constructed using the 
Neighbour-Joining method (Davis, 2002). 
 
3.3.2 The Last Common Ancestor ferredoxin 
Based on the phylogenetic analyses, ancestral sequences for ferredoxins from archaea and 
bacteria were constructed; each sequence contained 55 amino acid residues (figure 3.2). 29 of 
the 55 sites in the ancestral ferredoxin from archaea were resolved to a single amino acid. 
Doublets were found at four sites, and 22 sites were resolved to three or more amino acids. 
The ancestral ferredoxin from bacteria was resolved to 32, 10 and 13 sites with one, two and 
three or more amino acid residues, respectively. A closer look at the sequences revealed that 
each sequence consisted of two almost identical 23-residue segments (residue 1-23 and 30-
 - 19 -
Part I                       On the origin of life, evolution of the genetic code and ancient ferredoxins 
 
52), which indicated that a duplication of “a first” primary structure took place (section 2.3.3). 
These two segments were separated by six residues (24-29) and each sequence had a C-
terminal “tail” consisting of three residues (53-55) (Davis, 2002). The sequences depicted in 
figure 3.2 were even further resolved when taking the 23-residue repeat into account. The 
resolved sequences are shown in figure 3.3. 
10 20 30 40 50 
10 20 30 40 50 
Figure 3.2 Ancestral sequences for ferredoxins from archaea and bacteria. Underlined amino acids are 
conserved between the two domains. Each box indicates one amino acid resolved to five or more residues 
(the sequences are not aligned). Reprinted from Davis (2002) with permission from Elsevier Limited. 
 
Because a stage 10 amino acid (Lys) was conserved at one site in the 23-residue repeat, the 
duplication that must have occurred, could not have happened prior to stage 10 in evolution of 
the genetic code. Figure 3.3 shows how the two ancestral ferredoxin sequences arose from the 
sequence of a Last Common Ancestor ferredoxin (LCA ferredoxin). The amino acid sequence 
of the LCA ferredoxin was determined from the sequence of the two ancestral ferredoxins 
using a minimum of nucleotide mutations. Seven single and two double-base changes were 
needed to link the LCA ferredoxin and bacterial ferredoxin, and three single and four double-
base changes were needed to link the LCA and archaean ferredoxin. In both cases a total of 
eleven base changes were necessary, placing bacteria and archaea equally far from the LCA. 
The majority of these mutations took place in the N-terminal of the internal repeat (Davis, 
2002). Due to the high similarity with extant dicluster ferredoxins, LCA ferredoxin most 
likely share their fold and properties (section 2.3.2). 
Chapter 10 presents expression, initial purification and characterization of LCA ferredoxin. 
 
3.3.3 Ori-ISP 
The LCA ferredoxin was traced even further back by Davis (2002). By removing the central 
6-residue insert and the 3-residue C-terminal “tail”, a protein containing 46 amino acids was 
obtained. This protein contained two identical 23-residue segments. Prior to duplication, the 
protein contained these 23 amino acids. This was a stage 10 protein (figure 3.3). Evidence of 
an earlier protein was found in the sequence, because early amino acids were dominant. 
Amino acids synthesized at stage 5 or earlier, accounted for 87 % of the residues in the stage 
10 protein, but in extant ferredoxin this percentage was found to be only 73. Three amino 
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acids in the stage 10 protein were post-stage 5 amino acids; Ile (stage 7) at sites 9 and 23 and 
Lys (stage 10) at site 7 (Davis, 2002).  
To reconstruct a stage 5 protein, these three amino acids had to be replaced by stage 5 or 
earlier amino acids. The codons specifying Lys (AAR, R = purines) can be changed to Glu 
codons (GAR) following a first base A:G substitution. In the ancestral sequence for bacteria, 
Glu occurred at site 36 (equivalent to site 7). Consequently Glu was placed at site 7 in the 
stage 5 protein. The codons specifying Ile (AUY and AUA, Y = pyrimidines) can be changed 
to Val codons (GUY and GUA) following a first base A:G substitution. In the ancestral 
sequence for archaea, Val occured at site 38 (equivalent to site 9). Consequently Val was 
placed at site 9 in the stage 5 protein. Val was also placed at site 23; it did however not occur 
in ancestral sequences at site 23 or 52, but in their descendants. These substitutions created 
the stage 5 protein, Ori-ISP (figure 3.3) (Davis, 2002).  
Stage 5 protein, Ori-ISP 
Stage 10 protein 
LCA ferredoxin 
Bacterial ancestral ferredoxin Archea ancestral ferredoxin 
 
 Figure 3.3 Evolution of ferredoxins in prokaryotes. The oldest known protein, Ori-ISP, was formed at stage 
5 in the evolution of the genetic code. Three G to A transitions in the gene coding for Ori-ISP, led to the 
formation of a stage 10 protein. The gene was then somehow duplicated. A central 6-residue segment and a 
C-terminal 3-residue segment were inserted creating a LCA ferredoxin. After formation of the LCA, 
divergence of species occurred. Seven single and two double-base changes formed ancestral bacteria 
ferredoxin and three single and four double-base changes formed ancestral archaea ferredoxin. Re-printed 
from Davis (2002) with permission (Elsevier Limited).  
 
 
 
 
 
 
3.3.4 Properties of Ori-ISP 
The sequence of Ori-ISP is shown in figure 3.4 and it consists of 23 amino acids (the 
molecular weight is 2266 Da). The protein contains eight different amino acids; Val, Asp, 
Glu, Cys, Gly, Ala, Asn and Pro. Ori-ISP has a highly acidic N-terminal while the C-terminal 
contains polar and non-polar residues indicating that these have had different functions. The 
C-terminal contains four cysteines at site 8, 11, 14 and 18, which might have coordinated a 
[4Fe-4S] cluster that could have functioned as an electron transport center. The iron and 
sulfide needed for cluster formation could have originated from pyrite/hydrothermal vents. 
The N-terminal region could have anchored Ori-ISP to (positively charged) surfaces.  
Since Ori-ISP is a stage 5 protein, it originated prior to the formation of cells, which 
according to Davis did not take place until stage 10 in evolution. Geological findings 
conclude that cellular organisms were present 3.5 billion years ago (section 3.1.1), which 
mean that Ori-ISP is at least this old. 
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VDVDEEECVGCGACVNVCPVGAV  
 
 Figure 3.4 The sequence of Ori-ISP. Red indicates acidic amino acids and cysteines are highlighted in bold. 
 
The proposed sequence of Ori-ISP provides support for the chemoautotrophic model for the 
origin of life, and the early amino acid residue profile found in the LCA ferredoxin supports 
Davis’ theory on evolution of the genetic code (Davis, 2002). 
Chapters 6 to 8 concerns cluster reconstitution, purification and characterization of Ori-ISP. 
 
3.3.5 Ori-ISP models 
Model structures for Ori-ISP have been predicted by Kasper P. Jensen (Post doc at 
Department of Chemistry, DTU) and they are presented here with his permission.  
C. pasteurianum ferredoxin (see section 3.3.1) was used to generate the models. The first 23 
residues from the sequence of this ferredoxin align with Ori-ISP to a sequence identity of  
43 % (the four cysteines are conserved) and the structure (PDB ID: 1CLF, Bertini et al., 
1995) was used as a template for generating two models. Upon creation of the models, 
residues of this stretch were mutated to the corresponding Ori-ISP residues (Thompson, 
2004), hydrogens were added and the structure was geometry optimized with the UFF force 
field (Rappe, 1992). Two possibilities for cluster coordination were considered as constraints 
during formation of the models; an open and a closed form. In the open form only the first 
three cysteines in the sequence were forced to coordinate a [4Fe-4S] cluster (this coordination 
mode derives directly from the template). In the closed form the fourth cysteine was forced to 
coordinate the unsaturated iron ion. The calculated models are shown in figure 3.5. These 
models show great differences due to the different cluster coordination modes. It might be 
envisaged that the two forms are both present in solution and that an equilibrium exists. The 
open form provides the possibility of dimerization and this is further discussed in chapter 7. 
 
 A B
 
 
 
 
 
 
 
 
 
Figure 3.5 Models of Ori-ISP. A) The open conformation. The first three cysteines in the sequence 
coordinate the [4Fe-4S] cluster. B) The closed conformation. All four cysteines coordinate the [4Fe-4S] 
cluster. The models are shown in ribbon view. The side chains of the four cysteines and the five acidic 
residues are shown as sticks while the clusters are shown as spheres. Carbon, sulfur, oxygen and iron are 
shown in green, yellow, red and orange, respectively. The figure was prepared with PyMOL (DeLano W. L., 
2002). 
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Chapter four 
 
 
 
4 Introduction to the experimental work  
This chapter presents an overview of some of the experimental techniques and 
instrumentation used throughout the project. Further, the Escherichia coli (E. coli) strains 
used for expressing the proteins and enzymes of interest are introduced.   
 
4.1 Inert gas flushing techniques 
Two different approaches to obtain anaerobic conditions were applied: constant Ar/N2 
flushing or anaerobic chambers (section 4.2). 
One approach to remove oxygen from purification buffers and vessels was to keep a constant 
flow of Ar or N2 to flush out O2. This was accomplished using the system shown in figure  
4.1 A. Glass vessels were fitted with Suba seal rubber septa. Teflon tubings were inserted 
through the rubber septa via stainless steel tubes. Ar or N2 was used to deoxygenate solutions 
or vessels. Ar/N2 was bubbled into buffer solutions using a moderate gas flow for one hour 
(per 100 ml) prior to application. Glass vessels used for reactions were flushed prior to use. 
Syringes were purged with N2, or Ar several times prior to use. In the case of protein 
solutions, the gas stream was kept above the surface, because direct flushing will cause the 
proteins to denature. Columns were equilibrated and run using deoxygenated buffers. When 
high performance liquid chromatography (HPLC) was employed buffers were kept in closed 
vessels and a constant slight over-pressure or constant flushing using Ar or N2 was applied 
during purification (figure 4.1 B). 
 
 A B
 
 
 
 
 
 
 
 
 
 
 
Figure 4.1 The system used for obtaining oxygen-free conditions through Ar/N2 flushing. A) Glass vessels 
were fitted with Suba seal rubber septa and flushing was performed via Teflon tubings. B) During HPLC 
purifications buffers were kept in closed vessels and a slight overpressure or constant flushing was applied. 
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4.2 Anaerobic chambers 
During my 10-weeks stay at Institute of Structural Biology (IBS, Grenoble, France), I had the 
opportunity to perform protein purification and protein crystallization experiments inside 
anaerobic chambers. These chambers along with working procedures and techniques used at 
IBS are described in section 4.2.1. Upon returning home an anaerobic chamber was equipped 
to perform protein purification and protein crystallization based on the observations I had 
made in France. This chamber is described in section 4.2.2. 
 
4.2.1 Anaerobic chambers at Institute of Structural Biology 
Two anaerobic chambers (both fabricated by Jacomex) were available. One chamber was 
employed for protein purification while the other was utilized for protein crystallization 
(figures 4.2 and 4.3). The working gas consisted of N2 which contained ca. 3 % H2. Chambers 
were supplied with a steady flow of gas to ensure a constant slight overpressure of < 5 mbar 
(pressure sensors were installed). Excess gas was removed by an oil safety valve. Both 
chambers were equipped with Cu-catalysts for removal of oxygen (Cu + ½O2 → CuO). 
Constant circulation of the gas through the catalyst was performed to ensure continuous 
removal of oxygen. Regeneration of the catalyst was performed with H2 (H2 + CuO → H2O + 
Cu). The composition of the working gas allowed continuous regeneration of the catalysts at 
room temperature. Gas was supplied via copper tubing from large tanks situated outside the 
building. Both chambers were equipped with an oxygen sensor and a refrigerating unit for 
maintaining the temperature at 20 ± 1ºC. A small and a large vacuum antechamber was 
 
 
Vacuum 
antechambers 
Control unit, catalyst and vacuum pump  
Oil safety valve 
Oxygen sensor  Inlet for  Cooling and circulation  catalyst and readout  
 
 
 
 HPLC  
system  
 
 
 
 
 
 
Cooling   device 
 
 
 
 
Figure 4.2 Anaerobic chamber used for protein purification (picture presented with permission from IBS). 
 - 24 -
Part I                                                                                 Introduction to the experimental work  
 
embedded in the side of each chamber and connected to a vacuum pump. The chambers were 
equipped with common laboratory equipment (e.g. magnetic stirrers and small table 
centrifuges) and equipment necessary for performing protein purification and crystallization. 
 
 Inlet for  Cooling and circulation 
Catalyst catalyst  Oil safety valve 
Vacuum 
antechambers Cooling 
device 
Control unit Vacuum pump Pedals for zoom control 
Pressure  
regulator 
Oxygen  
analyser 
Hygrostat 
Lightbox mounted on  
a laboratory jack 
Microscope with  
motorized zoom 
Temperature 
control 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.3 Anaerobic chamber used for protein crystallization (pictures presented with permission from 
IBS).  
 
4.2.1.1 The anaerobic chamber for protein purification 
The anaerobic chamber used for protein purification (figure 4.2) had an approximate volume 
of 1.5 m3. 2 pairs of gloves were mounted on the front plate. One glove was mounted on the 
back panel of the chamber. The small and large vacuum antechambers had volumes of 3 L 
and 100 L, respectively. The oxygen concentration measured varied from 6 to 8 ppm. The 
chamber was equipped with an HPLC system (ÄKTAFPLCTM), and a small refrigerator unit 
(approximately 25 × 25 × 30 cm). Valves for obtaining vacuum for degassing buffers 
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(connected to a water aspirator on the outside of the chamber) and compressed gas for ultra 
filtration (connected via cobber tubing to the inlet gas) were embedded in the back panel.  
 
4.2.1.2 The anaerobic chamber for protein crystallization 
The anaerobic chamber used for protein crystallization was constructed of two side-connected 
units each having a volume of 0.85 m3 (figure 4.3). Each unit was equipped with one pair of 
gloves on the front and on the back plates (total of four pairs). The small and large vacuum 
antechambers had volumes of 2 L and 36 L, respectively. The oxygen concentration measured 
was below 2 ppm. A humidity control system consisting of a hygrostat connected to a water 
heating bath had been installed to maintain a relative humidity of at least 40 %. The chamber 
was equipped with an alarm system; if an oxygen concentration above 10 ppm was measured 
an audible alarm would be activated and oxygen concentrations above 100 ppm would trigger 
automatic flushing of the box with nitrogen. A microscope (figure 4.3) consisting of an 
internal part and an external part was mounted in the box. The internal part consisted of a 
light-box mounted underneath a transparent plate and placed on top of laboratory jack; this 
was used for focus adjustment. The external part consisted of a microscope (Leica, Wild 
M3Z) mounted in one of the front plates. This was equipped with motorized zoom control 
operated by two foot pedals, enabling full control of the microscope when working inside the 
chamber.   
 
4.2.1.3 Procedures and equipment  
As a precaution the vacuum antechambers were kept evacuated at all times when not in use. 
 
Importing equipment and liquids into the chambers 
All equipment and solutions required inside the chambers had to enter through the vacuum 
antechambers. Liquids had to enter via tightly closed flasks or containers to avoid 
evaporation. Containers had to be almost completely filled with liquid (leaving only as little 
air as possible inside the container) to avoid letting high amounts of O2 inside. For each 
antechamber two rounds of evacuation had been found to be adequate to ensure depletion of 
O2 prior to importing objects. One round of evacuation contained three steps; (i) complete 
evacuation of the chamber, (ii) when full vacuum was obtained the chamber was left 
evacuated for a certain period of time (explained below), (iii) the chamber was then filled 
with the working gas. When only importing a few objects (e.g. a box of pipette tips or a few 
flasks of buffers) the evacuation period, step (ii), should be 1 min when using the small 
antechamber and 5 min when using the large antechamber. When importing larger quantities, 
especially plastic ware (oxygen dissolves in plastic), then the evacuation period in one of the 
evacuation rounds should be at least two hours and preferably over night. When importing 
objects in this way no change in the oxygen concentration inside the chambers was measured.  
 
Deoxygenating buffers and crystallization solutions  
Buffers and crystallization solutions were not deoxygenated prior to entering the chambers. 
All solutions were deoxygenated by flushing with the inside gas using fish tank pumps. This 
was done by flushing through disposable pipette tips or serological pipettes connected to the 
pump via rubber tubing. Buffers used for HPLC purifications were further degassed by 
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evacuation (see section 4.2.1.1). Deoxygenation of buffers or solutions caused an unavoidable 
increase in the oxygen concentration (less than 2 ppm) depending on the volume of solution 
and the volume of air imported in the containers. 
 
Crystallization set up 
Crystallization set up was difficult when working with the large size gloves and therefore the 
sitting drop vapour diffusion method using crystal tape for sealing or the hanging drop vapour 
diffusion method using crystallization plates with screw caps were most often used. 
 
Anaerobic flash cooling of crystals 
To ensure that proteins crystallized under anaerobic conditions would not be damaged by 
mounting and flash cooling under aerobic conditions, a system for flash cooling crystals under 
anaerobic conditions had been developed. The rationale along with the system is described by 
Vernède and Fontecilla-Camps (1999). Here, a short introduction is presented along with an 
introduction to the updated equipment (unpublished).  
The system was based on flash cooling of crystals in liquid propane instead of the commonly 
used liquid nitrogen. The cryogenic agent had to be brought inside the anaerobic chamber via 
the small vacuum antechamber. Propane (Tm = 85.5 K, Tb = 231.1 K) can be solidified by 
liquid nitrogen (Tb = 77.4 K) and then imported into the anaerobic chamber.  
Gaseous propane was solidified in an aluminium container cooled in a nitrogen bath (figure 
4.4 A). The container was then transferred to a polystyrene insulator (figure 4.4 B and C) and 
a cap-holder was placed on top. The equipment was then imported into the chamber (getting 
the propane through the small vacuum antechamber took about 3 min). When using the 
equipment described here (figure 4.4) and by Vernède and Fontecilla-Camps (1999), the 
propane had liquefied after approximately 4 min and after approximately 7 min the 
temperature had risen to 130 K. Only a very short time frame is therefore adequate for 
transferring a crystal from the crystallization drop or a soaking solution to the liquid propane. 
When the propane had liquefied, the collected crystal was plunged into the liquid propane and 
immediately the piece of equipment was taken out of the chamber. The cap could then be 
transferred to liquid nitrogen for storage of the crystal mounted in the loop. The system shown 
in figure 4.4 was adapted to magnetic caps and wands from Hampton Research (CrystalWand 
Magnetic and CrystalCap Magnetic) while the system described by Vernède and Fontecilla-
Camps (1999) was adapted to cryoloops and caps made in-house.  
 
4.2.2 Preparing an anaerobic chamber for protein purification and 
crystallization 
The anaerobic chamber available in our own laboratories was a LabStar 50 (MBraun) having 
an approximate volume of 0.8 m3. The chamber was equipped with a single H2O/O2 purifier 
unit. O2 and H2O sensors were not connected to the system. The chamber was equipped with a 
vacuum antechamber (approximate 74 L) connected to a vacuum pump. The working gas 
consisted of pure nitrogen supplied via copper tubing from 50 L high pressure gas flasks. A 
slight overpressure of < 5 mbar was applied and controlled via electro-pneumatic valves 
connected to the working gas inlet and the vacuum pump. Constant circulation of the gas 
through the purifier unit was performed to ensure continuous removal of oxygen. The purifier 
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unit could be regenerated through a regenerating cycle including heating and exposure to 
reformer gas (10 % H2 and 90 % N2). 
 
A Solid propane 
Aluminium 
container 
Liquid 
nitrogen 
B 
 
 
 
 
 
 
 
The chamber was equipped with an inside power supply so that several electrical instruments 
could be operated inside the chamber at the same time. The power cable had been cast in 
epoxy in an inside/outside connector device. To allow outside operation of instruments and 
data storage by computers, USB-cables were cast in epoxy in an inside/outside connecter 
device. The chamber was further equipped with an HPLC system (ÄKTAprimeTM plus), a 
spectrophotometer (NanoDrop ND-1000, NanoDrop Technologies), a magnetic stirrer and a 
small table centrifuge. No temperature control unit was connected to the chamber and it was 
found that during operation of the system the temperature would vary from approximately 22 
to 32ºC primarily depending on the use of the electrical instruments (due to heat generation) 
and the temperature inside the laboratory (no air-conditioning system was installed).    
 
CPolystyrene insulation unit 
 
Aluminium  
container  
Cap holder 
Figure 4.4 Equipment for anaerobic flash cooling of crystals. A) Propane was solidified in an aluminium 
container (ø 20 mm) immersed in a liquid nitrogen bath. B) The container for transferring solid propane into 
the anaerobic chamber and flash cooling crystals consists of three parts; a polystyrene insulator unit placed in 
a stainless steel cylinder (ø 40 mm), the aluminium container for solid/liquid propane and a cap holder. 
C) The assembled parts shown in panel B. The aluminium container is placed in the insulator and the cap 
holder is mounted on top (pictures presented with permission from IBS). 
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Figure 4.5 Anaerobic chamber used for protein purification and crystallization.  
 
During operation of the anaerobic chamber, procedures for importing equipment and liquids 
into the chamber and deoxygenating buffers and crystallization solutions were adopted from 
those learned during my stay at Institute of Structural Biology (section 4.2.1.3). 
Deoxygenated solutions could not be degassed and the HPLC system was therefore operated 
with a flow restrictor (to avoid evolution of gas in the columns). Ultrafiltration was 
accomplished using a Vivacell 20 or 70 pressure cells (Sartorius Stedim), which could be 
sealed inside the chamber and then exported out of the chamber. Pressure could be applied to 
the cell under anaerobic conditions using pure nitrogen, and the cell could be imported though 
the vacuum antechamber after or during ultrafiltration. Since no humidity control system was 
present, solutions were kept in tightly closed containers when not in use. 
During crystallization trials, set up could easily be performed inside the chamber but the 
crystallization drops could not be examined since no microscope was embedded in the front 
panel. It was therefore necessary to export plates from the chamber and then examine the 
drops under a microscope outside the chamber. When using screw cap plates (EasyXtal Tool 
plates from Qiagen) it was found that the plates could be re-imported into the chamber 
through the vacuum antechamber without damaging the drops. Since the plates were only kept 
outside the chamber for a short period of time, I believe that oxygen penetration is minimal. 
This offers a cheap alternative to embedding a microscope in the front plate. However, 
anaerobic seeding and flash cooling of crystals are rendered impossible.  
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4.3 Chromatographic media and HPLC systems 
The pre-packed columns and column materials (table 4.1) used for protein purification 
throughout this project were purchased from Amersham Biosciences (GE Healthcare). 
 
Table 4.1 Pre-packed columns and column materials  
Pre-packed columns A Column material Specifications 
 Source 30Q Anion-exchange 
Resource Q 6 ml Source 15Q Anion-exchange 
Resource Q 1 ml Source 15Q Anion-exchange 
HiLoad 16/10 Q Sepharose High 
Performance 
Q Sepharose High Performance Anion exchange 
HiPrep 16/10 ANX Sepharose 
Fast Flow 
ANX Sepharose Fast Flow Anion exchange 
 Q Sepharose Fast Flow Anion-exchange 
HiLoad 16/60 Superdex 75 prep 
grade 
Superdex 75 High resolution fractionation 
31/13 Superdex 75 HR Superdex 75 High resolution fractionation 
30/10 Superdex 75 HR Superdex 75 High resolution fractionation 
PD-10 Desalting Sephadex G-25 Medium Group separation 
 Sephadex G-10 Group separation 
HisTrap HP 5 ml Ni Sepharose High Performance Immobilized metal ion affinity 
A: The dimensions, x/y, of some of the columns are given, x is the inner diameter of the column in mm and y 
is the height of the column in cm.  
 
Purification experiments were either performed by gravity (for group separation and when a 
15/2 Q Sepharose Fast Flow column was employed, chapters 6 to 8) or by HPLC. Three 
HPLC systems were employed, all purchased from Amersham Biosciences (GE Healthcare): 
ÄKTAFPLCTM, ÄKTAprimeTM plus and ÄKTATM purifier 100.    
 
4.4 Iron-sulfur cluster types inferred from ultraviolet-visible spectro-
photometry 
Throughout chapters 6 to 11, UV-vis spectrophotometry was used to aid in detecting the 
presence of FeS clusters in the given proteins and inferring the type of cluster present. UV-vis 
spectrophotometry is insufficient in itself since it measures the total absorbance of a given 
solution, and it cannot stand alone in inferring the composition of a sample (Skoog et al., 
1996).  
If a sample contains a component with two or more different cluster types or several 
components with different cluster types, the different cluster types cannot be inferred from the 
UV-vis spectrum. If however a purified species with a measured UV-vis spectrum is 
identified to be of a certain composition using other spectroscopic methods (e.g. EPR and 
Mössbauer spectroscopy), the UV-vis spectrum can be used as a fast method to establish 
whether another sample contains the same purified species. 
UV-vis spectra recorded of different purified FeS proteins known to contain the same cluster 
type may differ slightly since the absorbance is a consequence of LMCT (Cotton et al., 1995) 
and the difference in energy levels are affected by the geometry of the cluster and ligands 
(Cotton et al., 1995). Therefore, if a recorded spectrum of a given purified FeS protein is very 
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similar to a spectrum of a known FeS protein, it indicates but not verifies that your protein 
contains the same cluster type.  
UV-vis spectrophotometry was also used for concentration determinations applying Beers 
law, when molar absorptivities are known or calculated at a certain wavelength.  
UV-vis spectra were recorded either on a HP8453 (Hewlett Packard) diode-array 
spectrophotometer or on a NanoDrop ND-1000 spectrophotometer (NanoDrop Technologies). 
Unless otherwise stated, UV-vis spectra were recorded by the HP8453 diode-array 
spectrophotometer. 
 
4.5 Ubiquitin fusion technology 
Expression of recombinant proteins fused to ubiquitin (Ub) is a commonly used approach to 
obtain high yield expression and increased solubility of both peptides and large protein. 
Further, it can be combined with in vivo as well as in vitro cleavage (section 4.6) of the fusion 
tag (Butt et al., 1989; Gohara et al., 1999; Pilon et al., 1997; Varshavsky, 2000).  
Ub is a highly conserved protein consisting of 76 amino acids, and it is found in eukaryotic 
cells (Vijay-Kumar et al., 1987), where it functions in the pathway for targeting proteins for 
degradation by the proteasome (Wilkinson, 2000). In the fusion proteins considered in this 
project, yeast (Saccharomyces ceravisiae) Ub (Wilkinson et al., 1986) was used. Yeast Ub 
has a molecular weight of 8557 Da. It contains eleven basic residues, eleven acidic residues 
and one aromatic residue and has a calculated pI of 6.6 (calculated using the ExPASy 
Proteomics Server, Bjellqvist et al., 1993 and 1994). 
 
4.6 Ubiquitin hydrolases  
The Ub fusion system was used for production of Ori-ISP and LCA ferredoxin. To fully study 
the properties of these proteins it is necessary to cleave off the Ub-fusion. This can be 
accomplished by the aid of ubiquitin hydrolases. 
Ubiquitin hydrolases comprise a large family of enzymes that are able to hydrolyse Ub 
fusions having the general sequence Ub1-72-Leu73-Arg74-Gly75-Gly75-X, where X is the protein 
or peptide fused to Ub. The enzymes cleave specifically at the peptide bond following the 
Arg-Gly-Gly sequence. Most of these enzymes are cysteine hydrolases that hydrolyse their 
substrates via nucleophilic attack by a Cys-SH/His-imidazole catalytic diad (Case et al., 
2006). 
Yeast ubiquitin hydrolase (YUH1) belongs to the UCH (ubiquitin C-terminal hydrolase) 
family, which is comprised of low molecular weight enzymes. The UCHs hydrolyse short 
peptides or small thioester-, ester- and amide-linked adducts fused at the C-terminal of 
ubiquitin. YUH1 consist of 236 amino acid residues and has a molecular weight of 26.4 kDa 
(Case et al., 2006; Miller et al., 1989; Sakamoto et al., 1999). The Ub/YUH1 system has 
previously been used to prepare short peptides in E. coli (Khono et al., 1998; Miller et al., 
1989). YUH1 was used to perform in vitro cleavage of Ub-Ori-ISP and Ub-LCA ferredoxin.  
The ubiquitin specific proteases (UBPs) are larger than the UCHs and vary in molecular mass 
from 50 to 300 kDa. The UBPs hydrolyse Ub-fusions when Ub is linked to proteins or other 
Ub molecules (Case et al., 2006; Sakamoto et al., 1999). UBP1 from yeast consists of 809 
amino acid residues and has an approximate molecular weight of 93 kDa (Tobias and 
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Varshavsky, 1991). UBP1 was co-expressed with Ub-LCA ferredoxin to produce LCA 
ferredoxin in E. coli cells. 
 
4.7 Strains used for expression of recombinant proteins and enzymes 
The particular expression systems used for expression of both native and fusion proteins were 
based on the pET and pACYC vectors and the E. coli BL21(DE3) expression strain. This 
expression system employs the T7 RNA polymerase gene under the control of the lacUV5 
promoter/operator and is therefore inducible by isopropyl-β-D-thiogalactopyranoside (IPTG) 
(Gohara et al., 1999; Studier et al., 1990; Sweet 2003). Five different strains expressing the 
proteins and enzymes of interest have been constructed by other members of our research 
group (table 4.2). 
 
Table 4.2 Strains expressing proteins and enzymes 
Strain 
number 
Vector construct The expressed protein(s) E. coli strain Selection 
marker 
HC496 pET26b-Ub-Ori-ISP Fusion protein, Ub-Ori-ISP BL21 (DE3) 30 Kan A 
HC298 pET3a-PfFd Native, P. furiosus  [4Fe-4S] ferredoxin BL21 (DE3) 100 Amp B 
HC1269 pET26b-Ub-LCA Fusion protein, Ub-LCA ferredoxin BL21 (DE3) 30 Kan A 
HC1419 pET26b-Ub-LCA/ 
pACYC184-UBP1 
Fusion protein, Ub-LCA ferredoxin 
Native, UBP1 
BL21 (DE3) 30 Kan A 
20 Cam C 
HC1434 pET26-YUH1-His6 His-tagged, YUH1-His6 BL21 (DE3) 30 Kan A 
A: 30 μg kanamycin sulfate pr millilitre of culture. B: 100 μg ampicillin pr millilitre of culture.  
C: 20 μg chloroamphenicol pr millilitre of culture. 
 
4.8 Chemicals and SDS-PAGE 
All chemicals applied were of analytical grade. Water used throughout the experiments was 
18.2 MΩcm QPAK Milli-Q (Millipore), abbreviated milli-q.  
Samples that were to be analysed by sodium dodecyl sulfate polyacrylaminde gel 
electrophoresis (SDS-PAGE) were collected throughout the experiments and stored in 
Eppendorf tubes at -20ºC until further use. Precast gels from Bio-RAD (16,5% Tris-
Tricine/Peptide) were used in combination with polypeptide SDS-PAGE molecular weight 
standards. SDS-PAGE was performed according to the instructions from the manufacturer of 
the gel. 
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Chapter five 
 
 
 
5 Purification of sulfonated Ub-Ori-ISP 
This chapter presents the optimized procedures for cultivation of cells expressing the fusion 
protein, Ub-Ori-ISP, and purification of the sulfonated apo-protein. The originally developed 
procedures are described in my M.Sc. thesis (Christophersen, 2004). Crystallization of the 
sulfonated apo-protein is also presented. 
Ori-ISP is expressed as a fusion protein (Ub-Ori-ISP) due to the small size (23 residues) and 
the lack of aromatic and basic residues, which renders it difficult to visualize by SDS-PAGE 
and UV-vis spectrophotometric analysis. Since Ub contains a tyrosine and basic residues 
(section 4.5), Ub-Ori-ISP (10806 Da) is detectable by SDS-PAGE (stained with Coomassie 
blue G-250) and UV-vis spectrophotometry (Compton and Jones, 1985; Pace et al., 1995).  
It was previously attempted to purify holo-Ub-Ori-ISP produced in vivo however, this was not 
possible due to breakdown of the holo-protein. Therefore a different method was applied. The 
first step was to sulfonate the free cysteines of the apo-protein and purify the sulfonated 
protein (11126 Da) (Christophersen, 2004). Sulfonation of the free cysteines is performed to 
prevent formation of inter- and intra-molecular disulfide bonds and oxygenated species during 
purification. In the sulfonation reaction, the cysteinyl thiolates are bound to sulfite (- CH2 - S - 
SO3-) rendering the protein stable for handling under aerobic conditions. Sulfonation of 
cysteinyl thiolates and di-sulfide bonds can be achieved by treating the protein with 2-nitro-5-
(thiosulfo)-benzoate (NTSB), a denaturing agent (e.g. urea) and excess sulfite (Sow, 1997; 
Creighton, 1989). In the second step, the holo-protein was then obtained from the sulfonated 
apo-protein by de-protecting the sulfonated cysteines using a reducing agent and then 
performing in vitro iron-sulfur cluster reconstitution (Christophersen, 2004) (chapters 6 and 
7). 
 
5.1 Modifications to previously used protocols 
The original method for cultivation of Ub-Ori-ISP producing cells gave a very low yield (ca. 
5 mg/L cell culture) and this was traced to the cultivation protocol. It was found that the yield 
of protein was highly dependent on the optical density at 600 nm (OD600) at the time of 
induction with IPTG and the length of the induction period (results not shown). The optimal 
conditions were found to be an OD600 between 1.2 and 1.5 at the time of induction and an 
induction period of 2 hours.  
In the protocol for sulfonation and purification of apo-Ub-Ori-ISP, changes to the original 
protocols were also applied. An ultrafiltration step was introduced after the sulfonation 
reaction. Optimization of this step was performed by Laboratory Technician student, Ditte 
Skibstrup, under my supervision (results not shown). The first HPLC purification step was 
modified from including a one-step gradient (in the original procedure) to a two-step gradient.     
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5.2 Experimental 
 
5.2.1 Cultivation of cells expressing Ub-Ori-ISP 
This procedure is for cultivating 12 times 650 ml cell cultures. Cells from the HC496 glycerol 
stock were plated on an agar plate containing LB/30 Kan (37 g/L Luria Broth agar, 30 μg/ml 
kanamycin sulphate) and incubated overnight (16 hours) at 37ºC. Two single colonies were 
used to each inoculate 50 ml TB/30 Kan (45 g/L Terrific Broth, 0.4 % v/v glycerol, 30 μg/ml 
kanamycin sulphate) in 300 ml triple baffled shake flasks and incubated at 37ºC with shaking 
(250 rpm) until an OD600 of 0.6 to 1.0 was obtained. The pre-cultures were stored at 4ºC 
overnight. The cells of the two pre-cultures were then sedimented (centrifuged at 4ºC and 
2300 g for 10 min) and supernatants discarded. The two cell portions were each re-suspended 
in 50 ml fresh TB/30 Kan. 6.5 ml portions, which were used to inoculate the large scale 
cultures, were transferred to each of twelve 2 L triple baffled shake flasks containing 650 ml 
TB/30 Kan. The cultures were incubated at 30ºC with shaking (250 rpm) until the OD600 was 
between 1.2 and 1.5. Then protein expression was induced by addition of IPTG (200 mM 
stock solution) to a final concentration of 0.1 mM, and the incubation was continued with 
shaking (250 rpm) for 2 hours at 30ºC. The cells were harvested by centrifugation at 3000 g 
and 4ºC for 15 min. The supernatants were discarded and each of the 12 portions of cells were 
re-suspended in 25 ml cold (4ºC) 20 mM Tris/HCl pH 8.0 (Tris(hydroxymethyl)-
aminoethane, pH adjusted with 1 M HCl) and transferred to cold 50 ml polypropylene tubes. 
The cells were sedimented by centrifugation (3000 g, 4ºC, 15 min) and the supernatants 
discarded. The cells were kept at -80ºC for storage. 
 
5.2.2 Sulfonation and purification of Ub-Ori-ISP 
An overview of sulfonation and purification is presented in figure 5.1. 
 
5.2.2.1 Sulfonation of Ub-Ori-ISP  
Six portions of harvested cells (cells from 3.9 litres of culture, total volume of cells, ca.  
45 ml) were thawed at 4ºC and re-suspended in cold sulfite-containing buffer (11.3 g of 
Na2SO3 dissolved in 165 ml 20 mM Tris/HCl pH 8.0). The cells were lysed by sonication 
(Satorius Labsonic P at 80 % amplitude) in three intervals of 30 seconds. The solutions were 
kept on ice at all times and allowed to cool between each sonication burst. The crude lysate 
was centrifuged at 24800 g for 40 minutes at 4ºC. The yellowish brown supernatant was 
decanted, and the pellet discarded. 36 g urea was dissolved in the supernatant (gently stirring) 
after which 40 ml 400 mM NTSB was added and the volume was adjusted to ca. 300 ml using 
20 mM Tris/HCl pH 8.0 (final concentrations of sulfite, urea and NTSB: 0.3 M, 2 M and  
0.05 M, respectively). The resulting orange solution was stirred gently for 3.5 hours at room 
temperature, and stirring was continued overnight at 4ºC. The now yellow solution was 
centrifuged at 24800 g for 40 minutes at 4ºC, the yellow supernatant decanted, and the pellet 
discarded. The supernatant was diluted ca. 3.5 times using 20 mM Tris/HCl pH 8.0 and the 
volume reduced (at 4ºC) to below 80 ml using the Vivaflow 50 filtering system (Sartorius 
Stedim) equipped with six 10.000 MWCO (molecular weight cut off) membranes. Dilution 
followed by reduction of the volume was continued (three times) until the conductivity of the 
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solution was below 5 mS/cm. The protein extract solution was centrifuged (24800 g, 40 min, 
4ºC) and the supernatant kept for purification of sulfonated Ub-Ori-ISP. 
 
 
Lysis of Ub-Ori-ISP containing cells, centrifugation and sulfonation 
reaction in supernatant by addition of sulfite, urea and NTSB  
 
Reaction over night  
 Centrifugation and ultrafiltration of supernatant 
succeeded by a second centrifugation 
 
 
 
 Capture of protein by anion-exchange 
(50/8 Q Sepharose Fast Flow column)  
 
 Intermediate purification by gel filtration 
(HiLoad 16/60 Superdex 75 prep grade column)  
 
 
Polishing by high resolution anion-exchange 
(16/10 Source 30Q column)  
 
 
Figure 5.1 Flowchart of sulfonation, ultrafiltration and the subsequent three-step purification of Ub-Ori-ISP. 
 
5.2.2.2 Purification of sulfonated Ub-Ori-ISP 
The protein extract containing the sulfonated Ub-Ori-ISP (corresponding to protein from 12 
portions of cells, section 5.2.1, and twice the amount sulfonated in section 5.2.2.1) was loaded 
onto a 50/8 Q Sepharose Fast Flow column equilibrated with 20 mM Tris/HCl pH 8.0. The 
protein was purified by HPLC (ÄKTATM purifier 100) and eluted (linear flow rate:  
1.3 cm/min) using a stepwise gradient, 0.22 M NaCl in 2 CV (column volume) and 0.45 M 
NaCl in 4 CV. Fractions were collected and the total volume reduced to ca. 20 ml. The buffer 
was changed to 20 mM Tris/HCl, 0.15 M NaCl pH 8.0 by ultrafiltration using a stirred 
Amicon cell with a YM3 membrane. Ub-Ori-ISP was further purified on a HiLoad 16/60 
Superdex 75 prep grade column equilibrated with 20 mM Tris/HCl pH 8.0, 0.15 M NaCl. The 
protein sample was filtered (0.45 μm) then loaded onto the column (a maximum of 4 ml was 
loaded for each run), and fractions were collected upon elution with the same buffer (linear 
flow rate: 0.2 cm/min). Ub-Ori-ISP was further purified on a 16/10 Source 30Q column 
equilibrated with 20 mM Tris/HCl pH 8.0, 0.05 M NaCl. Fractions collected from the gel 
filtration step were filtered (0.45 μm) and diluted three times with 20 mM Tris/HCl pH 8.0 
before loading onto the column. The protein was eluted (linear flow rate: 1.2 cm/min) using a 
linear gradient, 0.15 M to 0.4 M NaCl in 10 CV. The volume of the collected fractions was 
reduced to ca. 15 ml and the buffer was changed to 0.1 M NH4HCO3 by ultrafiltration using a 
stirred Amicon cell with a YM3 membrane (Millipore). The amount of protein was 
determined by UV-vis spectrophotometry (using a molar absorptivity of 1490 M-1·cm-1 at  
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280 nm, Pace et al., 1995) and the solution was then freeze-dried. The freeze-dried protein 
was weighed and the percentage of remaining salt was determined. The protein was kept at  
-20ºC for storage. The purity of the protein was tested by SDS-PAGE.  
 
5.2.3 Analytical gel filtration of sulfonated and purified Ub-Ori-ISP 
Freeze-dried, sulfonated Ub-Ori-ISP was dissolved in 20 mM Tris/HCl, 0.15 M NaCl pH 8.0 
to a final concentration of 5 mg/ml and analysed by analytical gel filtration. The sample was 
filtered (0.45 μm) and 250 μl was loaded onto a 20 mM Tris/HCl, 0.15 M NaCl pH 8.0 
equilibrated 31/13 Superdex 75 HR column. Protein was eluted using the same buffer with a 
linear flow rate of 0.3 ml/min. 
 
5.2.4 Crystallization of sulfonated Ub-Ori-ISP 
Freeze-dried, sulfonated Ub-Ori-ISP was dissolved in 20 mM Tris/HCl, pH 8.0 and washed 
three times with the same buffer (using a stirred Amicon cell with a YM3 membrane). The 
solution was up-concentrated, filtered (0.22 μm) and the concentration was determined to be  
17.9 mg/ml. The protein was kept at -20 ºC for storage.  
Initial screening for crystallization conditions were performed using The Solubility Tool Kit 
(Molecular Dimensions). The hanging drop vapour diffusion method was applied and the 
drop (2 μl of protein solution mixed with 2 μl of reservoir solution) was equilibrated over  
500 μl of reservoir solution at room temperature. 
Micro crystals appeared when using ammonium citrate pH 9 as precipitant. Conditions for 
crystal growth were optimized by testing precipitant concentration versus pH and also testing 
addition of small volumes of PEG (polyethylene glycol) 4000 (experiments are not shown). 
Diffracting properties of some of the obtained crystals were tested at MaxLab (Lund, Sweden) 
beamline 9-11-3 and at European Synchrotron Radition Facility (ESRF) (Grenoble, France) 
beamline ID14-3.  
 
5.3 Results and discussion 
 
5.3.1 Cultivation of cells, sulfonation reaction and purification 
The yield of cells (section 5.2.1) was about 5 to 10 ml cells per 650 ml of culture. The cells 
had a light brownish colour. Re-suspension of cells in buffer followed by cell lysis and 
centrifugation (section 5.2.2.1) yielded a light yellowish brown supernatant. Upon addition of 
the yellow NTSB, the supernatant turned bright orange indicating progress of sulfonation 
reaction. The orange colour is attributed to a bi-product (2-nitro-5-thiobenzoate) of the 
reaction (Sow, 1997 and Creighton, 1989). During ultrafiltration precipitation was observed 
which is probably due to the removal of the denaturing agent (urea), causing some protein to 
precipitate. Only protein from six portions of cells could be sulfonated in one batch, since 
ultrafiltration of a batch of this size took about 8 hours and it was not possible to leave the 
filtration to proceed overnight unattended.  
The precipitation was removed by centrifugation prior to purifying the protein. Two batches 
of sulfonated protein (corresponding to protein from 12 portions of cells, section 5.2.1) was 
loaded onto the 50/8 Q Sepharose Fast Flow column and Ub-Ori-ISP was captured as 
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described (section 5.2.2.2) (figure 5.2). Sulfonated Ub-Ori-ISP was further purified by gel 
filtration (on a 16/60 Superdex 75 prep grade column) (figure 5.3). 5 to 6 runs loading a 
maximum of 4 ml in each run were necessary for purifying protein corresponding to 12 
portions. Otherwise the column would be overloaded and the viscosity of the sample too high 
for optimal separation. The protein was finally purified by high-resolution anion-exchange in 
6 runs on a 16/10 Source 30Q column (figure 5.4). The identity of the purified product as 
sulfonated Ub-Ori-ISP has previously been verified by mass spectrometry (Christophersen, 
2004). The purity of the product was tested by SDS-PAGE (figure 5.5 lane 1) and two bands  
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Figure 5.2 Chromatogram for purification of sulfonated Ub-Ori-ISP on 50/8 Q Sepharose Fast flow column. 
The collected fraction is indicated with a black box. The blue and the red lines indicate the absorbances at 
236 nm and 280 nm, respectively. The brown and the green lines indicate the conductivity and the NaCl 
gradient, respectively. The concentration of NaCl can be read from the conductivity axis employing the unit 
10-2 M. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Elution volume  
 Figure 5.3 Chromatogram for purification of sulfonated Ub-Ori-ISP on 16/60 Superdex 75 prep grade 
column. The collected fraction is indicated with a black box. The blue and the red lines indicate the 
absorbances at 236 nm and 280 nm, respectively. 
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were apparent. The dominating band is known to be Ub-Ori-ISP (Christophersen, 2004) and 
the minor band is believed to be non-denatured, dimerized Ub-Ori-ISP. When re-purifying the 
protein by gel filtration, no secondary peak was observed from the chromatogram and SDS-
PAGE yielded the same result (results not shown). 
Including the ultrafiltration step in the purification strategy (see section 5.2.2.2) has had a 
great impact on the individual purification steps as compared to previously (Christophersen, 
2004). When purifying protein from 12 portions of cells, the number of runs on the 50/8 Q 
Sepharose Fast flow column have been reduced from 4 to 1 and the number of runs on the 
16/10 Source 30Q column have been reduced from 10 to 6. This has decreased buffer 
consumption and the time spent purifying the protein has been reduced from 9 to 7 working 
days. The yield of the Ub-Ori-ISP has also improved markedly from about 5 mg/L cell culture 
to 30 to 40 mg/L cell culture containing 5 to 30 % salt. 
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 Figure 5.4 Chromatogram for purification of sulfonated Ub-Ori-ISP on 16/10 Source 30Q column. The 
collected fraction is indicated with a black box. The blue and the red lines indicate the absorbances at 236 nm 
and 280 nm, respectively. The brown and the green lines indicate the conductivity and the NaCl gradient, 
respectively. The concentration of NaCl can be read from the conductivity axis employing the unit 10-2 M. 
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Figure 5.5 Purity of freeze-dried Ub-Ori-ISP tested by SDS-PAGE. Lane 1: 6 μl of an 8 mg/ml solution 
containing freeze-dried Ub-Ori-ISP dissolved in 20 mM Tris/HCl pH 8. Lane 2: Marker (1 μl). 
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5.3.2 Analytical gel filtration of sulfonated and purified Ub-Ori-ISP 
The chromatogram from the analytical gel filtration (section 5.2.3) is shown in figure 5.6. One 
major peak eluted at 11.6 ml. In front of this peak a very small shoulder (ca. 10.5 ml) was 
observed. A minor peak at 12.9 ml was also observed. Since the SDS-PAGE results (figure 
5.5) gave essentially only one band, the shoulder and the minor peak are also believed to be 
sulfonated Ub-Ori-ISP. The dominating peak at 11.6 ml is probably a dimer form, while the 
minor peak at 12.9 ml is a monomeric form. Protein found in the shoulder was attributed to 
polymeric forms. Chapter 7 presents thorough discussion of the presence of monomers and 
dimers. It is interesting that Ub-Ori-ISP seems to be present as a dimer in solution since no 
record has been found in the literature of wild-type ubiquitin acting as a dimer. Ubiquitin 
participates in the pathway for targeting proteins for degradation by the proteasome. Proteins 
are marked with chains of ubiquitin and then recognised by the proteasome. In these chains 
ubiquitin monomers are bound together by covalent bonds and are therefore not dimers, 
trimers or polymers in the traditional sense (Jackson, 2006; Fang and Weissman, 2004; 
Wilkinson, 2000). However, upon analysis of fragments of human ubiquitin it was found that 
a fragment encompassing residues 1 to 51 was able to dimerise (Bolton et al., 2001). It is 
therefore likely that the fusion of Ub to Ori-ISP induces dimerisation. This could be due to 
structural changes of ubiquitin or the presence of Ori-ISP. 
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 Figure 5.6 Chromatogram for analytical gel filtration obtained when analysing sulfonated and purified Ub-
Ori-ISP. The blue and the red lines indicate the absorbance at 236 nm and 280 nm, respectively.  
 
5.3.3 Crystallization of sulfonated Ub-Ori-ISP 
To gain knowledge on the crystallization properties of Ub-Ori-ISP, crystallization of the 
sulfonated apo-protein was attempted. It was hoped that conditions for crystallization of the 
apo-protein could be modified and used to obtain crystals of the holo-protein. 
Crystallization trials were carried out and conditions optimized for growth of regular, three-
dimensional single crystals (section 5.2.4). Figure 5.7 shows some of the obtained crystals. 
Cubic shaped crystals were formed in tri-ammonium citrate in the concentration range 1.4 M 
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to 1.5 M and in the pH range 6.5 to 8.5. When PEG 4000 was added (0.5 % to 1.0 %) larger 
crystals were obtained. Diffraction properties of some of the crystals were tested. At MaxLab 
only diffraction from the largest crystals could be measured. However, these were extremely 
poor (diffraction limits about 15 Å). At the ESRF, diffraction to ca. 7 Å was obtained. 
Annealing the crystals had no effect on the diffracting properties. No further attempts were 
made to optimize the diffraction properties. The poor diffraction properties are believed to be 
due to disorder in the fusion protein either originating from flexibility in the Ori-ISP part of 
the molecule or at the junction of the two proteins. It is hoped that formation of the holo-
protein will inhibit possible flexibility, and hereby produce better diffracting crystals. Another 
possibility is to cleave off the ubiquitin part of the molecule and then crystallize holo-Ori-ISP 
(discussed further in chapter 8). 
 
 CA B 
  
 
 
 
 
~ 100 μm ~ 90 μm ~ 120 μm 
 
 
 
Figure 5.7 Pictures showing some of the obtained crystals. A) Crystals were grown from 1.4 M tri-
ammonium citrate pH 7.8, 1 % PEG 4000. B) Crystals were grown from 1.5 M tri-ammonium citrate pH 6.5. 
C) Crystals were grown from 1.4 M tri-ammonium citrate pH 7.8, 0.75 % PEG 4000. 
 
5.4 Conclusion 
The cultivation procedure of cells expressing Ub-Ori-ISP and the purification procedure for 
sulfonated Ub-Ori-ISP have been optimized. This has resulted in an increased yield of 
purified protein from ca. 5 mg/L cell culture to 30 to 40 mg/L and a reduction of time 
consumption from 9 to 7 days in the purification procedure. Analytical gel filtration has 
shown the protein to be a dimer in solution. The sulfonated, purified protein was crystallized; 
however, the obtained crystals diffracted poorly and this was believed to be due to flexibility 
of the Ori-ISP part of the fusion protein. 
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Chapter six 
 
 
 
6 Iron-sulfur cluster reconstitution of Ub-Ori-ISP followed 
by purification 
 
This chapter provides a presentation of the experimental work and results obtained when 
performing in vitro iron-sulfur cluster reconstitution of Ub-Ori-ISP followed by purification 
using Ar/N2 flushing (section 4.1) for obtaining anaerobic conditions. 
In vitro FeS cluster reconstitution was first accomplished in 1966 by Malkin and Rabinowitz, 
and since then, their method has been modified and optimized. Much literature is found on 
this subject, and all methods in which the FeS cluster reconstruction progresses in situ have in 
common the presence of iron ions, sulfide and thiols (reducing agent) as necessary 
components for the reconstitution to occur (Coghlan and Vickery, 1991; Hong and 
Rabinowitz, 1970; Mulholland et al., 1998; Ollagnier et al., 1999; Pierrel et al., 2003). 
The procedure used for cluster reconstitution in Ub-Ori-ISP has been developed and 
optimized by the writer (Christophersen, 2004) and was based on previous procedures for 
cluster reconstitution in ferredoxins (Sow, 1997). In this procedure FeCl3 was used as the iron 
source for cluster reconstitution. After reconstitution the protein solution was desalted on a 
PD-10 column and purified on a 15/2 Q Sepharose Fast Flow column. Further purification of 
the product was attempted on a 1 ml Resource Q column, but total breakdown of the holo-
protein was observed (Christophersen, 2004).   
In this chapter, the outcome of performing cluster reconstitution using different iron sources 
followed by purification either by gravity or by HPLC is described. Further, purification was 
performed with or without glycerol in the purification buffers when purification was 
performed by HPLC. The stability of the obtained product has been tested under various 
conditions. 
 
6.1 Experimental  
 
6.1.1 Cluster reconstitution reaction and desalting 
13.6 mg freeze-dried sulfite-protected Ub-Ori-ISP (chapter 5) was weighed out in a round 
bottomed flask and dissolved in 1.9 ml 100 mM Tris/HCl pH 8.5. 200 μl 0.12 M dithiothreitol 
(DTT) solution (20-fold molar excess, DTT was dissolved in 100 mM Tris/HCl pH 8.5) was 
added to the protein solution followed by incubation for 1.5 hours with gentle stirring. Then, 
200 μl freshly prepared 50 mM iron solution (8-fold molar excess) was added to the protein 
solution. The iron source was either NH4Fe(III)(SO4)2·12H2O, (NH4)2Fe(II)(SO4)2·6H2O or 
FeCl3 dissolved in milli-q water or metallic iron dissolved in sulphuric acid (section 6.1.1.1). 
Right after addition of the iron solution, 200 μl freshly prepared 50 mM Na2S·9H2O solution 
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(8-fold molar excess, dissolved in milli-q water) was added drop wise over a period of 
approximately two minutes. The resultant solution was incubated for one hour with gentle 
stirring, after which desalting on a PD-10 column (by gravity) into either 20 mM Tris/HCl, 
0.15 M NaCl pH 8.0 or 20 mM Tris/HCl, 0.15 M NaCl, 20 % glycerol pH 8.0 was carried out. 
The protein was further purified either by gravity on a 15/2 Q Sepharose Fast Flow column 
(section 6.1.2) or by HPLC purification on a 10/5 Source 30Q column (section 6.1.3). Cluster 
reconstitution, desalting and purification were carried out at room temperature while all 
obtained products were kept on ice. Figure 6.1 presents a flow chart of the cluster 
reconstitution and purification. 
  
Dissolution of freeze-dried sulfite-protected Ub-Ori-ISP in 
buffer followed by addition of 20-fold molar excess of DTT   
 
 
Reaction for 1.5 hours 
 Addition of iron (8-fold molar excess), the iron source 
is either iron-salts or dissolved metallic iron powder  
 
 
 
 Addition of sulfide (8-fold molar excess) 
 
 Reaction for 1 hour 
Desalting on PD-10 column 
Purification on 15/2 Q Sepharose Fast 
Flow column using a stepwise gradient 
HPLC purification on a 10/5 Source 30Q 
column using a continuous gradient  
  
 
 
 
 
 
 
 
 
 Figure 6.1 Flowchart of cluster reconstitution reaction into Ub-Ori-ISP and subsequent desalting and 
purification of reaction products.  
 
6.1.1.1 Dissolution of iron powder in sulphuric acid 
Dissolution of metallic iron powder was carried out as described (Jørgensen, 2003). 685 μl  
1.4 M H2SO4 was added to 13.4 mg of metallic iron powder (H+ is in 8-fold molar excess) and 
incubated for 18 hours at 65ºC. This was not carried out under anaerobic conditions. NaOH 
was added to the solution (5-fold molar excess compared to iron, from 1 M stock solution) to 
avoid overloading the buffer capacity of the protein solution (section 6.1.1). Then, the iron 
concentration was adjusted to 50 mM with milli-q water to obtain the wanted concentration 
(see section 6.1.1). After dilution the pH was < 1. An iron solution prepared as stated was 
determined (Nørgaard, 2006) to contain ca. 80 % Fe2+ and 20 % Fe3+. The iron powder was 
either 57Fe or common iron powder (containing natural isotope distribution). 
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6.1.2 Purification on a 15/2 Q Sepharose Fast Flow column 
Protein desalted into 20 mM Tris/HCl, 0.15 M NaCl pH 8.0 (section 6.1.1) was diluted with 
20 mM Tris/HCl pH 8.0 to a final NaCl concentration of 0.1 M and loaded onto a 15/2 Q 
Sepharose Fast Flow column (by gravity) equilibrated with 20 mM Tris/HCl, 0.1 M NaCl pH 
8.0. After washing with 2 CV 20 mM Tris/HCl, 0.1 M NaCl pH 8.0, the protein was eluted 
with 20 mM Tris/HCl, 0.5 M NaCl pH 8.0. Fractions were collected and UV-vis spectra 
recorded.  
 
6.1.2.1 Experiments with product obtained from purification by gravity 
Several experiments were carried out to test the stability of the product obtained from the Q 
Sepharose Fast Flow column and to identify stabilising conditions. The effects of temperature, 
dilution, buffer, NaCl, glycerol, citrate and reducing agents were tested. Some of the 
experiments are outlined below. In all experiments (NH4)2Fe(II)(SO4)2·6H2O was used as the 
iron source for the cluster reconstitution reaction and protein eluted in the main fraction from 
the anion-exchange was used. UV-vis spectra were recorded throughout the experiments. All 
stock solutions were freshly prepared. 
 
1. A sample was diluted 2.5 times with the elution buffer and left undisturbed in the 
cuvette in air and at room temperature for 3 hours.  
2. A sample was diluted 12.5 times with 20 mM Tris/HCl pH 8.0 (final salt concentration 
of 0.04 M) and kept at room temperature for 3 hours.  
3. A sample was diluted 12.5 times with milli-q water (final buffer concentration of 
1.6 mM and final salt concentration of 0.04 M), kept at room temperature for 3 hours.  
4. A sample was diluted 12.5 times with elution buffer and kept at room temperature for 3 
hours.  
5. A sample was diluted 12.5 times with elution buffer and kept at 37ºC for 3 hours.  
6. A sample was diluted 12.5 times with 20 mM Tris/HCl pH 8.0 (final salt concentration 
of 0.04 M) and tri-sodiumcitrate (C6H5Na3O7·2H2O, 100 mM stock solution) was added 
to a final concentration of 2.7 mM (100 times molar excess). The sample was kept at 
room temperature for 16 hours.  
7. Same as experiment 2 however, the sample was kept at 0ºC for 48 hours. 
8. Same as experiment 3 however, the sample was kept at 0ºC for 48 hours. 
9. Same as experiment 4 however, the sample was kept at 0ºC for 48 hours. 
10. A sample was diluted 12.5 times with 20 mM Tris/HCl, 5 % glycerol pH 8.0 (final salt 
and glycerol concentrations: 0.04 M and 4.6 %, respectively), kept at 0ºC for 24 hours. 
11. A sample was diluted 12.5 times with 20 mM Tris/HCl, 10 % glycerol pH 8.0 (final salt 
and glycerol concentrations: 0.04 M and 9 %, respectively), kept at 0ºC for 48 hours. 
12. A sample was diluted 12.5 times with 20 mM Tris/HCl, 20 % glycerol pH 8.0 (final salt 
and glycerol concentrations: 0.04 M and 18 %, respectively), kept at 0ºC for 48 hours.  
13. A sample was diluted 12.5 times with 20 mM Tris/HCl, 30 % glycerol pH 8.0 (final salt 
and glycerol concentrations: 0.04 M and 28 %, respectively), kept at 0ºC for 48 hours.  
14. A sample was diluted 12.5 times with 20 mM Tris/HCl, 40 % glycerol pH 8.0 (final salt 
and glycerol concentrations: 0.04 M and 37 %, respectively), kept at 0ºC for 48 hours. 
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15. An undiluted sample was frozen at -20ºC for 14 hours. The sample was sealed under 
anaerobic conditions and then transferred to the freezer. The sample was removed from 
the freezer, and then thawed under argon. UV-vis spectra were recorded before and 
after freezing.  
16. A sample was diluted 2 times with 20 mM Tris/HCl, 40 % glycerol pH 8.0 (to a final 
salt concentration of 0.25 M, and a final glycerol concentration of 20 %). It was frozen 
at -20ºC for 24 hours and then thawed as described above. UV-vis spectra were 
recorded before and after freezing.  
17. An undiluted sample was left at 0ºC for 72 hours. 
18. An undiluted sample was left at room temperature for 72 hours. 
19. A sample diluted 10 times with elution buffer was kept at 0ºC for 72 hours. 
20. 50 times molar excess Na2S2O4 (0.5 M stock solution, final concentration of 10 mM) 
was added to an undiluted sample and left at 0ºC for 72 hours. 
21. 50 times molar excess Na2S2O4 (0.5 M stock solution, final concentration of 1mM) was 
added to a sample diluted 10 times with elution buffer and left at 0ºC for 72 hours. 
22. 20 times molar excess DTT (0.5 M stock solution, final concentration of 0.4 mM) was 
added to a sample diluted 10 times with elution buffer and left at 0ºC for 72 hours. 
 
6.1.3 HPLC purification on a 10/5 Source 30Q column 
If the protein was desalted into buffer containing 20 % glycerol (section 6.1.1), buffers used 
for further purification also contained 20 % glycerol. This is indicated in the following 
description with ± 20 % glycerol. Purification was performed an ÄKTATM purifier 100 HPLC 
system capable of measuring absorption at three wavelengths.  
Protein exchanged into 20 mM Tris/HCl, 0.15 M NaCl pH 8.0 (± 20 % glycerol) was diluted 
with 20 mM Tris/HCl pH 8.0 (± 20 % glycerol) to a final NaCl concentration of 0.1 M and 
loaded onto a 10/5 Source 30Q column equilibrated with 20 mM Tris/HCl, 0.1 M NaCl pH 
8.0 (± 20 % glycerol). After washing with 2 CV 20 mM Tris/HCl, 0.1 M NaCl pH 8.0 (± 20 
% glycerol), the protein was eluted using a linear gradient, 0.10 M to 0.45 M NaCl in 20 CV 
and a linear flow rate of 2.6 cm/min. Fractions were collected and UV-vis spectra recorded.  
It was tested if the obtained product could be re-purified. Product obtained when using 
(NH4)2Fe(II)(SO4)2·6H2O as an iron source and purification buffers containing glycerol was 
diluted to ca. 0.1 M NaCl using 20 mM Tris/HCl, 20 % glycerol pH 8.0 and purified as 
described above.  
 
6.1.3.1 Experiments with product obtained from purification by HPLC 
Experiments were carried out on holo-protein obtained when cluster reconstitution reaction 
was performed using FeCl3 as iron source and in the absence of glycerol in the purifications 
buffers. UV-vis spectra were recorded throughout the experiments and some of the 
experiments are outlined below. 
 
23. To a sample containing undiluted protein, iron ((NH4)2Fe(II)(SO4)2·6H2O, 10 mM stock 
solution, final concentration of 0.2 mM) and cysteine (cysteine·H2O·HCl, 0.05 M stock 
solution adjusted to pH 7.5 with 1 M NaOH, final concentration of 0.9 mM) were added 
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in 12 and 50 times molar excess, respectively. The sample was left at room temperature 
for 35 minutes. 
24. Control sample for experiment 1. Same conditions as in experiment 1 but with no 
protein in the sample. Instead an equal volume of 20 mM Tris/HCl pH 8.0, 0.5 M NaCl 
was used. 
25. An undiluted sample was frozen at -20ºC for two weeks and then thawed as described 
in section 6.1.2.1. UV-vis spectra were recorded before and after freezing. 
 
6.1.4 Preparation of holo-protein for EPR and Mössbauer spectroscopic 
analyses 
This part of the project was carried out in collaboration with M.Sc. student, Hanne Nørgaard. 
The procedure for cluster reconstitution is described in section 6.1.1 using 82 mg of protein (6 
times 13.6 mg) dissolved in the reaction buffer to a concentration of 7.2 mg/ml. As 
previously, DTT was added in 20-fold molar excess (0.3 M stock solution) and iron and 
sulfide were both added in 8-fold molar excess (100 mM stock solutions). Dissolved 57Fe 
(section 6.1.1.1) was used as the iron source and the product from the cluster reconstitution 
reaction was purified in buffers containing 20 % glycerol. Anion-exchange was performed on 
a 16/5 Source 30Q column under the same conditions as described in section 6.1.3. The main 
fraction was split into three portions. The first portion was concentrated without addition of 
any reducing agent while a 25-fold and a 100-fold excess of Na2S2O4 (200 mM stock 
solution) were added to the second and third portions, respectively, prior to concentration of 
the samples. Samples were concentrated using a Vivacell 70 cell equipped with a 5000 
molecular weight cut off (MWCO) membrane.  From each of the three solutions, aliquots 
were taken for EPR and Mössbauer spectroscopic measurements. Samples for Mössbauer 
spectroscopic measurements were transferred to polymethylmethacrylate sample holders and 
then frozen in liquid nitrogen. Samples for EPR spectroscopic measurements were transferred 
to EPR tubes and frozen by immersing the tubes into isopentane cooled in a dry ice/ethanol 
bath. The EPR tubes were transferred to liquid nitrogen and stored herein.  
The active iron species in Mössbauer spectroscopy is the isotope 57Fe which has a nuclear 
spin of I = ½. When using 57Fe in EPR samples, the nuclear spin causes broadening of the 
measured signal (Nørgaard, 2006). EPR and Mössbauer measurements were performed and 
analysed by Hanne Nørgaard (Nørgaard, 2006).  
 
6.2 Results 
 
6.2.1 Cluster reconstitution and desalting 
In the cluster reconstitution procedure (section 6.1.1), sulfite-protected Ub-Ori-ISP was first 
de-protected with DTT. If Fe3+ was used as the iron source, the solution turned dark reddish 
brown upon addition (figure 6.2 A). If Fe2+ was used as the iron source, the solution turned 
yellowish brown upon addition. Independent on the iron source, the colour of the solution 
changed to dark blackish brown upon addition of sulfide (figure 6.2 B).  
In the desalting step, the column turned brown upon loading of the protein (figure 6.2 C) 
solution and a dark brown fraction was collected upon elution. After elution the column 
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sometimes appeared almost clean (almost no coloured species seen on the column) while at 
other times the column was dark grey. Also, sometimes a broad pink band was seen on the 
column, and on the top of the column, a green precipitate remained (figure 6.2 D).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.2 Reconstitution and purification of holo-Ub-Ori-ISP. A) Upon addition of FeCl3 to the solution of 
sulfite de-protected Ub-Ori-ISP, the solution turned reddish brown. B) When sulfide was added, the solution 
turned dark blackish brown. C) Upon loading the solution onto the PD-10 column, a broad brown band 
appeared. D) After elution, a broad pink band was sometimes observed on the column, and a green 
precipitate remained on top. E) When the desalted solution was loaded to the Q Sepharose Fast Flow column, 
a narrow blackish brown band appeared on the column. F) Upon elution, a dark brown band moved down the 
column. G) The brown band was collected in one main fraction. 
 
 
 
 
 
 
6.2.2 Purification on Q Sepharose Fast Flow column 
When loading the protein sample onto the Q Sepharose Fast Flow column a dark narrow 
blackish brown band appeared at the top of the column (figure 6.2 E). Upon elution a dark 
broad band moved down the column (figure 6.2 F) and was collected in a primary fraction 
(dark brown, figure 6.2 G) and a few secondary fractions (tail end of the band). The dark 
brown colour is consistent with the colour of iron-sulfur proteins (section 2.1). Only the 
primary fraction was used for further experiments. After elution a black band remained at the 
top of the column and the column had a grey colour, which could be removed when the 
column was washed with 1 M HCl.  
Typical UV-vis spectra of the primary fractions obtained when using ferrous or ferric iron 
sources are shown in figure 6.3. In both spectra an absorption maximum at ca. 280 nm, a 
shoulder at ca. 310 nm and a shoulder or an absorption maximum at ca. 390 nm can be seen.  
The yield of the reaction under different conditions was calculated based on an assumed 
molar absorptivity of 17 mM-1·cm-1 at 390 nm (Brereton et al., 1999; Conover et al., 1990). 
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The yield of the reaction was found in the primary fraction to vary from 30 % to 50 % and in 
the secondary fractions to vary from 2 % to 10 %. A total yield of ca. 40 % to 55 % was 
obtained. 
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6.2.2.1 Experiments with product obtained from purification by gravity 
 
Short term stability (experiments 1 to 5) 
Experiments 1 to 5 (section 6.1.2.1) explored the short term stability of the obtained product 
at different conditions. In figure 6.4 A the spectrum of a sample exposed to air at room 
temperature (experiment 1) was recorded over a period of three hours. Within the first 80 
minutes the shoulder at 310 nm was unchanged while a minor flattening of the shoulder at 
390 nm was observed. A marked increase of the absorption above 450 nm was observed. 
After 110 minutes almost all characteristics had disappeared and after 180 minutes they were 
all gone. Figure 6.4 B shows the spectrum of a sample diluted in 20 mM Tris/HCl pH 8.0 and 
kept under anaerobic conditions at room temperature (experiment 2) over a period of three 
hours. Unlike in the previous experiment, the shoulders at 310 nm and 390 nm were 
preserved. However, a slight decrease in absorbance was observed throughout the spectrum. 
The results of experiments 3 to 5 are not shown since they resembled the results obtained 
from experiment 2.   
 
 
e(II)
300605 Fe(III)Shoulder, 310 nm 
Figure 6.3 UV-vis spectra of reconstituted Ub-Ori-ISP. Spectra are those of main fractions (diluted 12.5 
times with elution buffer) obtained from purification on Q Sepharose Fast Flow column. They were obtained 
when using (NH4)2Fe(II)(SO4)2·6H2O or FeCl3 as iron source and shown in black and red, respectively.  
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Figure 6.4 Short term stability of holo-Ub-Ori-ISP obtained from purification on Q Sepharose Fast Flow 
column. Results from experiment 1 and 2 (section 6.1.2.1) are shown in A and B, respectively. UV-vis 
spectra were recorded over a period of three hours as indicated in both panels. A) A sample diluted with 
elution buffer was exposed to air. B) A sample diluted with elution buffer was kept under anaerobic 
conditions. 
 
 
 
 
 
Effect of citrate exposure (experiment 6) 
Experiment 6 (section 6.1.2.1) explored the stability of the holo-protein in the presence of 
citrate. From the UV-vis spectra (figure 6.5) it is seen that the shoulder at 310 nm turned into 
a distinct absorption maximum within three hours, and after 16 hours it became the 
dominating feature of the spectrum with a maximum at ca. 330 nm. At the same time the 
absorption maximum at 390 nm shifted to higher wavelengths and decreased in intensity. 
After 16 hours an absorption maximum at about 420 nm and a shoulder at about 465 nm were 
observed.   
 
Stability upon dilution and effect of glycerol (experiments 7 to 14) 
Experiments 7 to 14 (section 6.1.2.1, results shown in figure 6.6) explored the stability of the 
holo-protein at 0ºC when diluted with either milli-q water, 20 mM Tris/HCl pH 8.0, elution 
buffer or 20 mM Tris/HCl pH 8.0 containing different concentrations of glycerol (5 % - 40 %) 
over a period of 48 hours (experiment 10 only 24 hours). The general trend in all the 
experiments was that the absorbance decreased over time and that the absorption maximum at 
390 nm was reduced to a shoulder. In experiment 14 (40 % glycerol in dilution buffer, figure 
6.6 H) the distinctive features disappeared after 24 hours and in experiment 7 (dilution with 
20 mM Tris/HCl pH 8.0, figure 6.6 A) the features were reduced to very faint shoulders. 
Experiment 12 (20 % glycerol in dilution buffer, figure 6.6 F) showed the slowest decrease in 
absorbance. 
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 Figure 6.5 Results of experiment 6 (section 6.1.2.1). Tri-sodium citrate was added to a diluted sample 
obtained from purification on Q Sepharose Fast Flow column and UV-vis spectra were recorded throughout a 
time period of 16 hours. 
 
 
 
 
Stability upon freezing and thawing (experiment 15 and 16) 
Experiment 15 and 16 (section 6.1.2.1, results shown in figure 6.7) explored the stability of 
the holo-protein upon freezing followed by thawing. Figure 6.7 A shows that when an 
undiluted sample was frozen for 14 hours and then thawed a decrease in absorption was 
observed below 550 nm. Also, the absorption maximum at 390 nm was reduced to a flat 
shoulder. Figure 6.7 B shows that freezing a sample in 20 % glycerol caused a slight shift in 
the shoulder at 310 nm to about 325 nm. The maximum at 390 nm shifted to a shoulder at  
410 nm while the absorbance above 450 nm increased. 
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(Figure 6.6: figure legend found on the next page) 
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 Figure 6.6 Stability of diluted samples kept at 0ºC from purification on Q Sepharose Fast Flow column. The 
results of experiment 7 to 14 (section 6.1.2.1) are shown in panels A to H. Black spectra were recorded just 
after dilution, red spectra were recorded after 24 hours while green spectra were recorded after 48 hours. The 
feature at 360 nm is an instrument artefact. A) Experiment 7; protein solution was diluted with 20 mM 
Tris/HCl pH 8.0. B) Experiment 8; protein solution was diluted with milli-q water. C) Experiment 9; protein 
solution was diluted with elution buffer. D) Experiment 10; protein solution was diluted with 20 mM 
Tris/HCl, 5 % glycerol pH 8.0. E) Experiment 11; protein solution was diluted with 20 mM Tris/HCl, 10 % 
glycerol pH 8.0. F) Experiment 12; protein solution was diluted with 20 mM Tris/HCl, 20 % glycerol pH 8.0. 
G) Experiment 13; protein solution was diluted with 20 mM Tris/HCl, 30 % glycerol pH 8.0. H) Experiment 
14; protein solution was diluted with 20 mM Tris/HCl, 40 % glycerol pH 8.0. 
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Figure 6.7 Stability of the product obtained from purification on Q Sepharose Fast Flow column upon 
freezing under different conditions. The results from experiments 15 and 16 (see section 6.1.2.1 for details) 
are shown in panels A and B, respectively. The black spectra were recorded prior to freezing the samples 
while the red spectra were recorded after thawing the samples. In experiment 15 an aliquot was diluted 12.5 
times prior to recording a spectrum, while in experiment 16 the aliquot was diluted 5 times.  
 
Effects of temperature and dilution (experiments 17 to 19) 
Experiments 17 to 19 (section 6.1.2.1, results shown in figure 6.8) explored the stability of 
undiluted samples left at 0ºC and at room temperature, respectively, versus a diluted sample 
left at 0ºC. In all experiments a flattening of the peaks was observed, the absorption maximum 
at 390 nm was reduced to a faint shoulder. In the experiment (19) leaving a diluted sample on 
ice the characteristics had almost disappeared after 48 hours, which was also the case when an 
undiluted sample was left at room temperature (experiment 18). In the experiment with an 
undiluted sample left at 0ºC (experiment 17) the characteristics were still present after 72 
hours. 
 
Effects of reducing agents (experiments 20 to 22) 
Experiment 20 to 22 (section 6.1.2.1, results shown in figure 6.9) explored the effect of a 
reducing agent on the holo-protein. When dithionite was added to a diluted or undiluted 
sample (figure 6.9 A and B), the characteristic features in the spectra disappeared just after 
addition and then returned. However, the absorption at 390 nm was a shoulder. This effect 
was more pronounced in the undiluted sample (experiment 20), where the characteristics were 
still present after 72 hours while they had disappeared for the diluted sample. In the undiluted 
sample an absorption maximum observed at about 315 nm can be assigned to the dithionite 
radical (Mayhew, 1978). Upon addition of DTT to a diluted sample, all characteristics 
disappeared and they did not return (figure 6.9 C). 
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 Figure 6.8 Stability of undiluted samples left at 0ºC (A) and at room temperature (B), respectively, versus a 
diluted sample left at 0ºC (C). Results of experiments 17 to 19 are shown in panels A to C. UV-vis spectra 
were recorded over a period of 72 hours as indicated in the figure. In experiment 17 and 18 an aliquot was 
taken out and diluted 10 times prior to recording a spectrum. 
 
 
 
 
 
6.2.3 HPLC purification on a 10/5 Source 30Q column 
Observations made during HPLC protein purification were comparable to those made using 
the Q Sepharose Fast Flow column (see section 6.2.2). The chromatograms obtained using 
different iron sources and purification buffers with or without glycerol are presented in figure 
6.10. In all chromatograms a main peak is observed followed by tailing. However, the size 
and resolution of the main peak compared to the tailing and minor peaks differ markedly.  
FeCl3, NH4Fe(III)(SO4)2·12H2O and (NH4)2Fe(II)(SO4)2·6H2O were tested as iron sources 
without glycerol in the purification buffers. Chromatograms for the purifications are shown in 
figure 6.10 A to C and the main peaks eluted from 19.5 mS/cm to 21.0 mS/cm. UV-vis 
spectra corresponding to main peak fractions are presented in figure 6.11 A to C. Two 
absorption maxima at about 320 nm and 420 nm, respectively, are present in the three spectra; 
the exact positions differ in each spectrum. Also, a slight shoulder at about 460 nm is 
apparent. 
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Figure 6.9 Reduction of samples from purification on Q Sepharose Fast Flow column. The results from 
experiments 20 to 22 (see section 6.1.2.1 for details) are shown in panels A to C. A) Reduction of an 
undiluted sample with dithionite. Prior to recording a spectrum an aliquot was diluted 10 times. B) Reduction 
of a diluted sample with dithionite. C) Reduction of a diluted sample with DTT.  
 
 
 
 
 
 
FeCl3, (NH4)2Fe(II)(SO4)2·6H2O, 57Fe powder and common iron powder were tested as iron 
sources with glycerol in the purification buffers. Chromatograms for the purifications are 
shown in figure 6.10 D to G and the main peaks eluted from 13.0 to 14.0 mS/cm (glycerol 
reduces the conductivity of a solution). When iron-powder was used the UV-vis spectra of 
main fractions (figure 6.11 F and G) resembled those obtained from purification on the Q 
Sepharose Fast Flow column (sections 6.1.2 and 6.2.2 and figure 6.3). A maximum at 390 nm 
was present when 57Fe-powder was used and a shoulder at about 400 nm was observed when 
common Fe-powder was used. The UV-vis spectra obtained when glycerol was present in 
purification buffers and FeCl3 or (NH4)2Fe(II)(SO4)2·6H2O was used (figure 6.11 D and E), 
resembled those obtained when no glycerol was used (figure 6.11 A to C). 
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 (Figure 6.10: figure legend found on page 56) 
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Figure 6.10 Chromatograms for purification on a 10/5 Source 30Q column of holo-protein obtained under 
different conditions. In each chromatogram the collected fraction is indicated with a black box and the 
conductivity at maximum absorption at 280 nm is also presented. The blue, red and pink lines indicate the 
absorbances at 236 nm, 280 nm, and 390 nm, respectively. The brown and the green lines indicate the 
conductivity and the NaCl gradient, respectively. The concentration of NaCl can be read from the 
conductivity axis employing the unit 10-2 M. 
G 
A) FeCl3 was used as iron source and no glycerol was added to the purification buffers. 
13.4 mS/cm 
B) NH4Fe(III)(SO4)2·12H2O was used as iron source and no glycerol was added to purification buffers. 
Iron source: Fe-powder 
C) (NH4)2Fe(II)(SO4)2·6H2O was used as iron source and no glycerol was added to purification buffers. 
 
Glycerol: present 
D) FeCl3 was used as iron source and glycerol was added to the purification buffers. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
14.0 mS/cm 
E) (NH4)2Fe(II)(SO4)2·6H2O was used as iron source and glycerol was added to purification buffers. 
Iron source: 57Fe-powder 
F) Dissolved Fe-powder was used as iron source and glycerol was added to purification buffers. Twice the 
amount of protein used in A to E was purified. 
 
Glycerol: present 
G) Dissolved 57Fe-powder was used as iron source and glycerol was added to purification buffers. Same 
amount of protein as in F was purified. 
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(Figure 6.11: figure legend found on the next page) 
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Figure 6.11 UV-vis spectra of main fractions collected from purification of holo-protein on 10/5 Source 30Q 
column (see figure 6.10). In each spectrum absorption maxima are indicated. Numbering of the spectra 
corresponds to the numbering of the chromatograms in figure 6.10 from which the analysed fractions 
originated. In F, the fraction was diluted two times prior to recording the spectrum 
A) FeCl3 was used as iron source and no glycerol was added to the purification buffers. 
B) NH4Fe(III)(SO4)2·12H2O was used as iron source and no glycerol was added to purification buffers. 
C) (NH4)2Fe(II)(SO4)2·6H2O was used as iron source and no glycerol was added to purification buffers. 
D) FeCl3 was used as iron source and glycerol was added to the purification buffers. 
E) (NH4)2Fe(II)(SO4)2·6H2O was used as iron source and glycerol was added to purification buffers. 
F) Dissolved Fe-powder was used as iron source and glycerol was added to purification buffers. Twice the 
amount of protein used in A to E was purified. 
G) Dissolved 57Fe-powder was used as iron source and glycerol was added to purification buffers. Same 
amount of protein as in F was purified. 
 
 
The chromatogram obtained from re-purification of one of the main-peak fractions (section 
6.1.3) is shown in figure 6.12. Only this one re-purification was performed. One main peak 
was observed followed by tailing and the absorption was very low compared to the original 
chromatogram (from which the re-purified fraction was obtained) (figure 6.10 E). UV-vis 
spectra were recorded however, only absorption at about 280 nm was apparent from the 
spectra (results not shown) even though the chromatogram indicated weak absorption at  
390 nm. 
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 Figure 6.12 Chromatogram for re-purification on a 10/5 Source 30 Q column of purified holo-protein (figure 
6.10 E) obtained using (NH4)2Fe(II)(SO4)2·6H2O as the iron source and glycerol in purification buffers. The 
blue, red and pink lines indicate the absorbances at 236 nm, 280 nm, and 390 nm, respectively. The brown 
and the green lines indicate the conductivity and the NaCl gradient, respectively. The concentration of NaCl 
can be read from the conductivity axis employing the unit 10-2 M. 
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6.2.3.1 Experiments with product obtained from purification by HPLC 
The results obtained from experiment 23 and 24 (section 6.1.3.1) are shown in figure 6.13. 
Addition of cysteine and Fe2+ to the protein solution (experiment 23), caused a shift in the 
absorption maximum at 414 nm to 385 nm, while the maximum at 313 nm disappeared. The 
absorption maximum at 280 nm remained but the absorbance increased. The absorbance 
above ca. 400 nm decreased. In the control experiment (24), upon mixing Fe2+ and cysteine, 
slight shoulders at ca. 290 nm and 350 nm as well as a broad peak at ca. 500 nm were 
observed. However, the absorbance was very low compared to when holo-protein was 
present.   
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Figure 6.13 Effect of addition of cysteine and ferrous iron to purified holo-protein. The results of experiment 
23 and 24 is shown in A and B, respectively. A) UV-vis spectra recorded before and 35 minutes after 
addition of cysteine and ferrous iron to purified holo-protein. B) UV-vis spectrum obtained from control 
experiment. 
 
 
 
 
The result of experiment 25 is shown in figure 6.14. Upon freezing the protein and thawing 
two weeks after, the absorption maximum at 414 nm disappeared and the maximum at  
313 nm had been reduced to a shoulder. The absorbance below ca. 400 nm had increased 
markedly.  
 
 
 
 
 
 
 
 
 
 
 
 Figure 6.14 Effect of freezing a purified protein sample for two weeks. The result of experiment 25 is shown 
in the figure. A UV-vis spectrum was recorded before and after freezing the sample. 
414 nm 
313 nm 
0.05
0.25
0.45
0.65
0.85
1.05
250 350 450 550 650
Wavelength / nm
Ab
so
ra
nc
e 
/ A
U
Experiment 25 
before
after
 - 59 -
Part I                          Iron-sulfur cluster reconstitution of Ub-Ori-ISP followed by purification 
6.2.4 EPR and Mössbauer analyses of holo-protein 
The chromatogram obtained from purification of sample to be used for EPR and Mössbauer 
spectroscopic measurements (see section 6.1.4) is shown in figure 6.15. One main peak was 
observed followed by a little tailing and poorly resolved minor peaks. In front of the main 
peak a minor peak was present with tailing in front of the peak. This peak did not show 
absorption at 390 nm. The UV-vis spectrum recorded of the main peak is shown in figure  
6.16 A. Absorption maxima were observed at ca. 280 nm and at 390 nm and a shoulder was 
present at ca. 310 nm. UV-vis spectra were also recorded of the minor peaks following the 
main peak (not shown) and the spectra very closely resembled that of the main fraction. The 
yield of the reaction and purification was ca. 45 % (calculated for the main peak as described 
in section 6.2.2). 
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Figure 6.15 Chromatogram for purification of holo-protein for preparation of EPR and Mössbauer samples. 
In the chromatogram the collected fraction is indicated with a black box and the conductivity at maximum 
absorption at 280 nm is also presented. The blue, red and pink lines indicate the absorbances at 236 nm, 
280 nm, and 390 nm, respectively. The brown and the green lines indicate the conductivity and the NaCl 
gradient, respectively. The concentration of NaCl can be read from the conductivity axis employing the unit 
10-2 M. 
 
From the main peak three samples were prepared for EPR and Mössbauer spectroscopic 
measurements (section 6.1.4 and table 6.1). The UV-vis spectra of the samples are shown in 
figure 6.16 B. From the spectra of sample 1 and 2 it is seen that the absorption maximum 
found previously at 390 nm (figure 6.16 A) had been reduced to a shoulder and the 
absorbance above 450 nm had increased. The spectrum of sample 3 on the other hand 
resembled the spectrum of the main fraction (figure 6.16 A). 
The EPR spectra are not shown since the recorded signals were very weak and could not be 
convincingly assigned to any compounds. The Mössbauer results obtained from sample 1 and 
2 are not shown since they could not be unambiguously interpreted. The Mössbauer spectrum 
of sample 3 obtained at 6 K is shown in figure 6.17 along with simulated spectra of 
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adventitious Fe2+ and a [4Fe-4S]2+ cluster and the sum of the fits. These results indicate that 
95.3 % of the 57Fe was found as [4Fe-4S]2+ clusters while 4.7 % was found as adventitiously 
bound Fe2+. A detailed interpretation of the EPR and Mössbauer results has been presented 
elsewhere (Nørgaard, 2006). 
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Figure 6.16 UV-vis spectra of purified holo-protein and samples prepared for EPR and Mössbauer 
spectroscopic measurements. A) UV-vis spectrum of the main fraction obtained upon purification. The 
fraction was diluted five times prior to recording the spectrum. B) UV-vis spectra of the EPR and Mössbauer 
samples (see table 6.1). The samples were diluted 10 times prior to recording the spectra. 
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Figure 6.17 Mössbauer spectrum of sample 3. The dots correspond to the measured spectrum. The red and 
blue curves are fits of adventitious bound Fe(II), 4.7%, and simulated [4Fe-4S]2+ cluster, 95.3%, respectively. 
These are offset 0.01 on the y-axis. The pink curve is the sum of fits. The figure was prepared by Hanne 
Nørgaard and printed with permission. 
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Table 6.1 Overview of EPR and Mössbauer samples 
Sample Protein concentration* / mM Molar excess dithionite added prior 
to concentration 
1 0.39 - 
2 0.47 25 
3 0.51 100 
* The concentration was determined by measuring the absorbance at 390 nm and assuming a molar absorbtivity 
at this wavelength of 17 mM-1·cm-1   
 
6.3 Discussion 
In all experiments a brown coloured protein solution was obtained when performing cluster 
reconstitution reaction follow by purification, which indicates the formation of FeS-clusters. 
A general trend was observed in all experiments, namely that the intensity of the brown 
colour faded and turned into a blackish brown colour over time. This is probably due to 
cluster breakdown and formation of iron sulfide. However, no visible precipitation was 
formed. 
When performing desalting after cluster reconstitution the appearance of the column differed 
from experiment to experiment (section 6.2.1). The pink band and the green precipitation are 
probably due to formation of Fe-DTT complexes, while the grey species are from 
precipitations of iron sulfide. No relation could be established between the state of the column 
after elution and the iron source.  
 
6.3.1 Holo-protein obtained form purification by gravity  
After purification on the Q Sepharose Fast Flow column a black band remained on the 
column and the column material had turned grey. These grey or black species can be assigned 
to some form iron sulfide. However, one would expect these species to have been removed 
during the desalting step unless they are part of some polymer material or “bound” to the 
protein. The massive colouring of the column material may also to a minor extent be due to 
breakdown of the holo-protein during purification because of exposure to residual oxygen 
(further discussed in chapter 7). 
The UV-vis spectra of the purified products (figure 6.3) clearly resemble spectra of [4Fe-4S] 
ferredoxins (chapter 2 figure 2.2) since a maximum or a very distinct shoulder is present at 
390 nm. The absorption at 280 nm can be assigned to a tyrosine residue found in the ubiquitin 
part of the Ub-Ori-ISP protein (section 4.5). However, disulfide bonds also absorbs in this 
part of the UV-vis spectrum (Pace et al., 1995). 
The overall yield of the reaction varied from ca. 40 % to ca. 55 % independent on iron source. 
This might be explained by varying degree of oxygen exposure. The method used for keeping 
anaerobic conditions (Ar/N2 flushing, section 4.1) is not 100 % efficient in keeping out 
oxygen and the concentration of oxygen in the reaction flask etc. probably varied from 
experiment to experiment. 
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6.3.1.1 Experiments with product obtained from purification by gravity 
 
Short term stability (experiments 1 to 5) 
The obtained product is very sensitive towards dioxygen and when exposed to air, the 
spectrum of a diluted sample lost all characteristic features within a period of three hours 
(experiment 1, section 6.1.2.1 and figure 6.4 A). The dilution and temperature can be ruled 
out as being major contributing factor, since samples diluted with milli-q water, 20 mM 
Tris/HCl pH 8.0 or elution buffer, kept at the same temperature or at 37ºC over the same time 
period under anaerobic conditions, remained stable (experiment 2-5, section 6.1.2.1 and figure 
6.4 B). The breakdown progress is interesting (see figure 6.4 A) since an increase in 
absorption above 450 nm is seen before the shoulder at 390 nm disappears. No other cluster 
types could be distinguished from the UV-vis spectra during breakdown. One could envisage 
cluster breakdown taking place in a series of oxidation reactions e.g. the oxidation of the 
[4Fe-4S]2+ cluster to a [3Fe-4S]1+ cluster and its subsequent conversion to the [2Fe-2S]2+ 
cluster. This may still happen, but undetectable by UV-vis spectrophotometry. The stability of 
the obtained product at least for a short period of time (at least three hours) in various 
solutions and in the temperature interval 0ºC to 37ºC is a necessity for analysing the 
composition and properties of the obtained product. 
 
Effect of citrate exposure (experiment 6) 
The sulfonated apo-protein was crystallized using a citrate salt (section 5.2.4) as precipitant 
and it was hoped that these conditions could be applied and further optimized for 
crystallization of the holo-protein. Therefore, the effect of adding citrate to holo-protein was 
investigated (experiment 6, section 6.1.2.1). As seen in figure 6.5 a major change of the UV-
vis spectrum was observed (see section 6.2.2.1 for a description). The resultant spectrum 
resembles spectra of the [3Fe-4S]1+ or [2Fe-2S]2+ ferredoxins (see sections 2.2 and 2.3), 
showing absorption maxima at 330 nm, 420 nm and a shoulder at ca. 465 nm. The [3Fe-4S]1+ 
ferredoxin from P. furiosus has an absorption maximum at 408 nm (figure 2.2 B) while the 
[2Fe-2S]2+ ferredoxin from A. vinelandii has absorption maxima at 330 nm, 420 nm, 460 nm 
and 550 nm (Chatelet and Meyer, 1999). The observed absorption maxima fits closely to the 
[2Fe-2S]2+-ferredoxin while the UV-vis spectrum above 400 nm resembles more closely the 
UV-vis spectrum of a [3Fe-4S]1+ ferredoxin. Citrate may act as an iron scavenger and here it 
appears to facilitate cluster conversion from a [4Fe-4S]2+ cluster to possibly a [2Fe-2S]2+ or a 
[3Fe-4S]1+ cluster or a mixture of clusters. Therefore, citrate salts should not be applied as 
precipitants for holo-protein during crystallization experiments since it induces cluster 
breakdown.  
 
Stability upon dilution and effect of glycerol (experiments 7 to 14) 
The stability of the product at 0ºC diluted with different solutions (milli-q water, 20 mM 
Tris/HCl pH 8.0, elution buffer or 20 mM Tris/HCl pH 8.0 containing 5 to 40 % glycerol) was 
investigated over a period of 48 hours (experiment 7 to 14, section 6.1.2.1 and figure 6.6). 
Glycerol was added since it is commonly used to keep proteins and enzymes stable in solution 
or during freezing. In all cases, a drop in absorbance was seen. When 20 mM Tris/HCl, 20 % 
glycerol pH 8.0 was used to dilute the sample, the least drop in absorbance was observed 
 - 63 -
Part I                          Iron-sulfur cluster reconstitution of Ub-Ori-ISP followed by purification 
(figure 6.6 F) and the maximum at 390 nm had not been reduced to a shoulder or completely 
disappeared as in the other cases. Based on the results of experiments 7 to 14 it can be 
concluded that adding 20 % glycerol to the holo-protein has a stabilizing effect. It was 
therefore decided to add 20 % glycerol to the purification buffer in some of the HPLC 
purification procedures (see section 6.1.3). It is interesting to note that the sample diluted with 
milli-q water appears to be more stable than the sample diluted with 20 mM Tris/HCl pH 8.0. 
One would expect the protein to be more stable in a buffered solution unless the buffer itself 
takes part in protein breakdown. However, this rapid breakdown is not seen in the remaining 
UV-vis spectra (figure 6.6, except when 40 % glycerol was added). The only obvious 
explanation is that this sample was somehow exposed to a higher degree of oxygen.  
 
Stability upon freezing and thawing (experiment 15 and 16) 
The stability of the holo-protein upon freezing was investigated (experiment 15 and 16, 
section 6.1.2.1 and figure 6.7). The results indicate massive cluster degradation. It can 
therefore be concluded that even though glycerol appear to have a stabilizing effect on the 
protein in solution (see above) it does not have a similar effect upon freezing the protein 
hence freezing of the holo-protein should be avoided. The UV-vis spectra recorded after 
freezing of the samples in the two experiments do have some differences (each spectrum is 
described in section 6.2.2.1). When no glycerol was added (experiment 15) the absorbance 
below 550 nm decreased and when glycerol was added the absorbance above 450 nm 
increased. However, the spectra are similar and the difference in absorbance after thawing 
might be due to different absorption properties of the breakdown products. 
 
Effects of temperature and dilution (experiments 17 to 19) 
The results obtained from experiment 17 to 19 (section 6.1.2.1 and figure 6.8) clearly indicate 
that an undiluted sample left at 0ºC is more stable than a diluted sample left at 0ºC or an 
undiluted sample left at room temperature. It is expected that degradation will take place at a 
higher rate when the temperature is high. The diluted solution and the solution left at room 
temperature were transferred to new vessels prior to starting the experiments hereby possibly 
introducing small amounts of oxygen in the process, while the undiluted solution left at 0ºC 
was left in the original vessel. This might have affected the outcome of the experiments, 
which could explain why the diluted sample degraded much faster than the undiluted (both 
left at 0ºC).  
 
Effects of reducing agents (experiments 20 to 22) 
Addition of dithionite to a diluted or undiluted sample (experiment 20 and 21, section 6.1.1.2 
and figure 6.9 A and B) immediately reduced the holo-protein as seen from the recorded UV-
vis spectra since the feature at 390 nm disappeared. After 24 hours the feature at 390 nm 
returned indicating the holo-protein had been re-oxidized. The feature was however present as 
a shoulder indicating slight degradation. Degradation within 24 hours was also observed in 
the previous experiments. Right after addition of DTT to a diluted sample (experiment 22, 
section 6.1.1.2 and figure 6.9 C), the feature found at 390 nm was still present, which 
indicates that the holo-protein had not been reduced. DTT may not be powerful enough for 
reduction of holo-Ub-Ori-ISP or the reaction is very slow. After 24 hours however, all 
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features associated with the presence of holo-protein had disappeared and they did not return. 
DTT is able to form complexes with iron and one could therefore envisage DTT acting as an 
iron scavenger. When citrate was added to holo-protein, the UV-vis spectrum changed and 
resembled more those of [3Fe-4S] or [2Fe-2S] ferredoxins. However, here total degradation 
was observed.  
 
6.3.2 HPLC purification on a 10/5 Source 30Q column 
As observed previously (section 6.3.1) a black/grey band assigned to some form of iron 
sulfide remained on the column after purification.  
 
6.3.2.1 The obtained products 
The chromatograms obtained upon purification of holo-protein on the Source 30Q column 
(section 6.1.3 and figure 6.10) show great differences (section 6.2.3).  
 
(NH4)2Fe(II)(SO4)2·6H2O, FeCl3 and NH4Fe(III)(SO4)2·12H2O as iron sources 
In the absence of glycerol in purification buffers the best resolved main peak was found using 
FeCl3 as the iron source. When using NH4Fe(III)(SO4)2·12H2O or (NH4)2Fe(II)(SO4)2·6H2O 
the main peak was very poorly resolved (figure 6.10 A to C). It appears that the differences 
are independent on the oxidation state of iron but dependent on counter-ions since poorly 
resolved peaks were obtained using iron compounds containing sulphate and ammonium. 
Sulphate was however present when using iron powder as the iron source (see below), hence 
ruled out as the cause. The difference in elution patterns could arise from different species 
present. However, upon comparing the UV-vis spectra of the main fractions (figure 6.11 A to 
C) they appear very similar, only a slight difference in the exact position of the absorption 
maxima is evident. These spectra are comparable to the spectrum obtained when treating 
(what appears to be) a [4Fe-4S]2+-cluster containing protein with citrate (experiment 6 section 
6.1.2.1 and figure 6.5). It appears that the main fraction contains holo-protein containing 
oxidized forms of [2Fe-2S] or [3Fe-4S] or a mixture (argument found in section 6.3.1.1). 
However, these two cluster types would not be expected to elute simultaneously due to their 
overall charge difference of 1.  
When glycerol was present in purification buffers and FeCl3 was used as the iron source, the 
obtained chromatogram showed a less resolved main peak compared to when glycerol was 
absent (comparison of figure 6.10 A and D). The opposite was the case when 
(NH4)2Fe(II)(SO4)2·6H2O was used as the iron source since glycerol in purification buffers 
provided a better resolved main peak (comparison of figure 6.10 C and E). The effect of 
glycerol is therefore inconclusive. UV-vis spectra of the main fractions are comparable in the 
presence and absence of glycerol (compare panels in figure 6.11 A to E). Components of the 
main fractions are discussed above. 
 
Fe-powder as iron source 
It was decided to use glycerol in purification buffers when using iron powder as the iron 
source since the dissolved iron contained about 80 % Fe2+ (section 6.1.1.1), and glycerol 
appeared to improve the chromatogram when Fe2+ was used as the iron source (see above). 
When iron powder was used as iron source the best results were observed (figure 6.10 F and 
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G) since the resolution of the main peak had markedly improved compared to the previous 
experiments (compare panels F and G to panels A to E in figure 6.10). The UV-vis spectra of 
the main fractions shown in figure 6.11 F and G resemble those of [4Fe-4S]2+ ferredoxins. 
When 57Fe was used, the closest resemblance was observed (absorption maximum at 390 nm). 
Iron powder was dissolved using sulphuric acid and consequently sulphate was present during 
cluster reconstitution. However, no ammonium ions were present (which was the case for the 
other Fe(II) source). When iron powder was used, twice the amount of protein was purified, 
and it may be a combination of the iron source and the amount of protein loaded onto the 
column or either of the two, which are responsible for the improved resolution and the 
difference in the obtained UV-vis spectra. This is further discussed below. 
 
Cluster types and degradation 
Since the product obtained when purifying the reconstituted protein on the Source 30Q 
column appeared to contain a [4Fe-4S]2+ cluster when using iron powder as iron source (see 
above), it can be envisaged that the majority of the observed products from HPLC purification 
were in fact breakdown products of a [4Fe-4S] specie. [2Fe-2S]2+ and [3Fe-4S]1+ contain only 
Fe3+ contrary to [4Fe-4S]2+ and have been observed to be oxidative breakdown products of 
[4Fe-4S] clusters (Crack et al., 2004; Khoroshilova et al., 1997; Leal et al., 2004; Liu et al., 
2000; Tilley et al., 2001). The time the holo-protein spent on the column was longer during 
HPLC purification (compared to purification by gravity) and it may therefore have been 
exposed to higher amounts of oxygen which leads to oxidative breakdown. The products 
obtained from purification on the Q Sepharose Fast Flow column did in fact appear to be a 
[4Fe-4S]2+ protein independent on the iron source (section 6.3.1). Buffer exiting the HPLC 
when anaerobic conditions were applied was shown to contain about 0.5 mg/L dissolved 
oxygen (results not shown). It can be anticipated that the concentration of oxygen might vary 
depending on the conditions of the system. If this is the case, the difference in oxygen 
concentration might be responsible for the differences observed in the chromatograms and 
UV-vis spectra (figure 6.10 and 6.11) and not the iron source or glycerol. When loading e.g. a 
double amount of protein onto the column, it is likely that a smaller percentage of oxidative 
breakdown will occur and it is therefore more likely to get a better resolution in the 
chromatogram and a UV-vis spectrum of a [4Fe-4S]-cluster containing protein.  
The results obtained when using glycerol in purification buffers indicate that holo-protein 
containing a [4Fe-4S]2+ cluster eluted at a slightly higher conductivity than what appeared to 
be a [2Fe-2S]2+ or a [3Fe-4S]1+ protein (figures 6.10 and 6.11). Since the [4Fe-4S]2+ cluster 
and [2Fe-2S]2+ cluster have the same net charge holo-protein containing these clusters are 
expected to elute at approximately the same conductivity, while protein containing a  [3Fe-
4S]1+ cluster is expected to elute at a higher conductivity (anion-exchange) due to the less 
positive charge ( Δ  = 1). The fact that only a slight variation in the elution point of the main 
fraction was observed favours the [2Fe-2S]2+ cluster as the product of degradation. Another 
possibility could be formation of monomers, dimers etc. since the elution would be expected 
to be dependent on the degree of polymerization. 
As discussed above, differences in the position of the elution point (measured conductivity) of 
the main peak is evident which may indicate the presence of different species. However in 
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most cases the shape of the main peak is symmetrical, which indicates that only one species is 
present in the fraction corresponding to this particular peak, or that this peak contains several 
species with the same surface charge distribution under the given conditions. The tailing in 
front of or after the main peak and poorly resolved peaks indicate either breakdown of holo-
protein during purification, presence of multiple species or slightly differing conformations of 
species. Since cluster reconstitution was performed using purified protein, all peaks can be 
assigned to different forms of the protein. Different conformations are imaginable since the 
cluster formation was performed under unnatural conditions compared to the “cluster 
formation machinery” found in living organisms (Frazzon and Dean, 2003; Lill and 
Mühlenhoff, 2005). 
However, most likely the major differences seen in the chromatograms and the poorly 
resolved peaks are due to breakdown caused by oxygen. 
The yields of the reactions were not calculated since in most of the cases it was difficult to 
assign the obtained products to a certain cluster species and different species have different 
molar absorptivities (see chapter 2). 
 
6.3.2.2 Re-purification of the obtained product  
When comparing the chromatograms shown in figure 6.10 E and 6.12 it is clear that re-
purification of holo-protein found in the main peak (figure 6.10 E) was not possible under the 
given conditions (section 6.1.3). When attempting to re-purify the protein, very weak 
absorbance was observed from the chromatogram (figure 6.12) and tailing and several peaks 
were observed indicating breakdown of the holo-protein. UV-vis spectra of fractions 
corresponding to the peaks revealed absence of holo-protein. Degradation is most likely 
caused by oxygen as discussed in section 6.3.2.1. Re-purification was only performed this one 
time and it was performed on a poorly resolved main peak. However, it is still believed that 
breakdown would also have been observed had re-purification been carried out on well 
resolved main peaks. Therefore it appears that re-purification with an acceptable yield is not 
possible under the given conditions. 
 
6.3.2.3 Experiments with product obtained from purification by HPLC 
When adding cysteine and Fe2+ to the obtained product (experiment 23, section 6.1.3.1 and 
figure 6.13) the UV-vis spectrum was seen to undergo a striking change (described in section 
6.2.3.1) from what looks like a [2Fe-2S]2+/[3Fe-4S]1+ protein to a [4Fe-4S]2+ protein with an 
absorption maximum at 385 nm. From the control experiment, no indication of an absorption 
maximum in this region was evident, indicating the change had happened to the cluster of the 
protein. It is however very likely that this newly formed cluster is coordinated by the 
“external” cysteine and not cysteine from the protein. The cluster re-arrangement could also 
be achieved using cysteine alone but when DTT and iron was used no change was observed 
(results not shown), supporting the above stated assumption. It was attempted to desalt the 
protein solution (results not shown), but the UV-vis spectrum of the product was comparable 
to the spectrum obtained prior to addition of Fe2+ and cysteine indicating breakdown of the 
obtained product. Cluster re-arrangement is not an uncommon phenomenon. In biotin 
synthase from E. coli two [2Fe-2S]2+ clusters can be transformed into a [4Fe-4S]2+ cluster by 
reduction (Duin et al., 1997). 
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When freezing the obtained product (experiment 25, section 6.1.3.1 and figure 6.14) 
degradation of the holo-protein was observed as previously seen (section 6.3.1.1). 
 
6.3.3 EPR and Mössbauer analyses on holo-protein 
The holo-protein obtained from HPLC purification for EPR and Mössbauer spectroscopic 
analyses (sections 6.1.4 and 6.2.4) very closely resembled [4Fe-4S]2+ ferredoxins since 
absorption at 390 nm was observed from the UV-vis spectrum (figure 6.16 A).  
Three samples were prepared for measurements (see section 6.1.4 and table 6.1). The samples 
to which no dithionite and 25-fold molar excess of dithionite was added prior to up-
concentration (sample 1 and 2, respectively) did appear to be partly broken down as evident 
from the UV-vis spectra (figure 6.16 B) since only a shoulder and no absorption maximum 
was present at 390 nm. The sample to which 100-fold molar excess of dithionite was added 
prior to concentration looked like the spectrum recorded prior to addition of dithionite and up-
concentration. It is very likely that that the holo-protein found in this sample contained a  
[4Fe-4S]2+ cluster in the active site. It appears that adding 25-molar excess of dithionite did 
not reduce the protein or keep it from breakdown during concentration. This is probably due 
to oxygen exposure. When 100-fold molar excess of dithionite was added, the protein was 
kept from breakdown. However, the amount of dithionite was apparently not enough to 
reduce the protein (or keep it reduced). Extra dithionite should probably have been added after 
up-concentration of the protein to keep it reduced since it has been shown that the protein can 
be reduced by dithionite (section 6.3.1.1). 
The EPR results of the three samples showed only very weak signals which could not be 
assigned to any compounds, only a very small amount of adventitious ferric iron could be 
assigned in all spectra. This however indicates that no paramagnetic species were present in 
any of the samples hence excluding the presence of [3Fe-4S]1+, [4Fe-4S]1+, [4Fe-4S]3+ and  
[2Fe-2S]1+ (chapter 2). 
The Mössbauer results of samples 1 and 2 could not be unambiguously interpreted since they 
appeared to contain multiple cluster types which could not be simulated to fit the spectra. The 
Mössbauer results of sample 3 on the other hand could be fitted to contain 4.7 % of the iron as 
adventitiously bound ferrous iron and 95.3 % as present in [4Fe-4S]2+ clusters.  
EPR and Mössbauer results were interpreted by Hanne Nørgaard and thoroughly discussed 
elsewhere (Nørgaard, 2006). 
The results very strongly suggest that holo-protein present in sample 3 contained a [4Fe-4S]2+ 
cluster in the active site (see figure 6.16 B for the corresponding UV-vis spectrum with an 
absorption maximum at 390 nm and a shoulder at about 310 nm). The results indicate that 
holo-protein obtained when purifying the protein on the Q Sepharose Fast Flow column most 
likely contained a [4Fe-4S]2+ cluster in the active site (figure 6.3). The products obtained 
when using iron powder as iron source and performing HPLC purification were also 
dominated by a [4Fe-4S]2+ cluster in the active site (figure 6.10 F and G). 
 
6.3.4 Fusion protein 
The protein was purified as a fusion with ubiquitin since it provides a means of identifying the 
protein throughout purification (chapter 5). It is however possible that the presence of 
ubiquitin interferes with the formation of holo-protein and affects the properties of the holo-
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protein. Therefore, the fusion should be removed when investigating the intrinsic properties of 
holo-Ori-ISP.  
 
6.4 Conclusion 
From UV-vis spectrophotometric analyses, reconstituted protein purified on a Q Sepharose 
Fast Flow column appear to contain a [4Fe-4S]2+ cluster in the active site irrespective of the 
iron source used. It was not possible to purify the reconstituted protein by HPLC unless the 
ion-exchange by gravity was omitted. Depending on the conditions of cluster reconstitution 
and purification, different cluster types ([2Fe-2S]2+ / [3Fe-4S]1+ or [4Fe-4S]2+) appeared to be 
present in the active site of the purified holo-protein. 
The holo-protein is very sensitive towards oxygen and it is only stable for a short while (less 
than 24 hours) under anaerobic conditions and 0ºC before breakdown was apparent. To 
preserve the protein it should be left undisturbed after purification (undiluted) and at 0ºC 
under anaerobic conditions. Freezing and thawing of the holo-protein resulted in degradation. 
Re-purification of the obtained product was not possible due to degradation. Glycerol 
appeared to have a stabilizing effect on the holo-protein, but the results were not conclusive. 
Reduction of holo-protein was achieved by dithionite, however, DTT appeared to break down 
the holo-protein. Cluster conversions from a [4Fe-4S] cluster to a [2Fe-2S] / [3Fe-4S] cluster 
and vice versa appeared to take place by addition of citrate and cysteine, respectively.  
Mössbauer spectroscopy identified a [4Fe-4S]2+ cluster to be the absolute dominating species 
in one sample. Since this sample had a UV-vis spectrum with an absorption maximum at  
390 nm and a shoulder at about 310 nm, it was concluded that other samples having 
comparable UV-vis spectra contained a [4Fe-4S]2+ cluster as the dominant cluster type in the 
active site. 
Since oxygen appears to be a parameter which is difficult to exclude and control using Ar/N2 
flushing for obtaining anaerobic conditions, the results obtained in this chapter are to some 
degree flawed. Residual oxygen has to be controlled since the holo-protein is extremely 
sensitive towards it, hence continual work on this protein should be carried out under strictly 
controlled conditions in an anaerobic chamber. 
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Chapter seven 
 
 
 
7 Reconstitution and purification of Ub-Ori-ISP and Ori-
ISP in anaerobic chambers 
The results obtained in chapter 6 strongly indicate that further work on holo-Ub-Ori-ISP 
should be carried out in a strictly controlled environment depleted of oxygen. 
This chapter describes experimental work and results obtained when performing cluster 
reconstitution and purification in anaerobic chambers. The experiments described were 
carried out during a 10-week stay at IBS (Grenoble, France) and in our own laboratories. The 
anaerobic chamber used for the experiments in France contained 6-8 ppm oxygen, while the 
concentration in the chamber used in our own laboratories was not determined. Further 
information on the anaerobic chambers is found in chapter 4. All experiments were carried out 
at room temperature, and samples were left at room temperature unless otherwise stated. 
Three experiments were performed using FeCl3 as the iron source for cluster reconstitution 
into Ub-Ori-ISP. Two identical experiments were performed in France to test reproducibility. 
A third experiment was performed in Denmark to test reproducibility in a different anaerobic 
chamber with an unknown oxygen concentration prior to performing cluster reconstitution 
into Ori-ISP in experiment 4. One experiment (experiment 5) was performed using 
(NH4)2Fe(II)(SO4)2·6H2O as the iron source for cluster reconstitution into Ub-Ori-ISP. This 
experiment was performed in France. 
In each of the five experiments described in this chapter, parallel anion-exchange purifications 
were carried out on a 15/2 Q Sepharose Fast Flow column and a 10/5 Source 30Q column, 
respectively. This was done to test differences in the obtained products under the same 
conditions. 
 
7.1 Experimental 
HPLC purifications were carried out on an ÄKTAFPLCTM system in France and on an 
ÄKTAprimeTM plus system in Denmark. Both systems were capable of measuring the 
absorbance at 280 nm. No glycerol was added to any of the purification buffers due to the 
inconclusive results in chapter 6. All experimental work was carried out inside the anaerobic 
chamber except UV-vis spectrophotometric recordings on the diode array spectrophotometer. 
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7.1.1 Cluster reconstitution and purification using FeCl3 as the iron source 
 
7.1.1.1 Cluster reconstitution into Ub-Ori-ISP and purification 
 
Experiment 1 and 2 (performed in France) 
Experiment 1 and 2 were identical and in each experiment cluster reconstitution was 
performed as described in section 6.1.1. However, 34.0 mg protein was used and dissolved in 
reaction buffer to a concentration of 7.4 mg/ml. DTT was added in 20-fold molar excess (0.3 
M stock solution) and iron and sulfide were both added in 8-fold molar excess (0.12 M stock 
solutions). After cluster reconstitution the protein solution was divided into two portions and 
each was desalted into 20 mM Tris/HCl, 0.15 M NaCl pH 8.0 as described in section 6.1.1. 
Holo-protein from both solutions was further purified by anion-exchange. One portion was 
purified on a 15/2 Q Sepharose Fast Flow column (by gravity) as described in section 6.1.2. 
The other solution was purified on a 10/5 Source 30Q column (by HPLC) as described in 
section 6.1.3, but with the gradient extended to 0.6 M NaCl (28.6 CV). Fractions collected 
from each of the two anion-exchange purifications were analysed by UV-vis spectrophoto-
metry and by analytical gel filtration on a 20 mM Tris/HCl, 0.15 M NaCl pH 8.0 equilibrated 
10/30 Superdex 75 HR column (by HPLC). 50 μl samples were loaded onto the column and 
eluted using the same buffer (linear flow rate: 0.6 cm/min). Fractions were collected and UV-
vis spectra recorded. Figure 7.1 presents a flow chart of the cluster reconstitution and 
purification. 
 
Experiment 3 (performed in Denmark) 
Experiment 1 (see above) was repeated. However, 27.2 mg protein dissolved in reaction 
buffer to a concentration of 6.0 mg/ml was used. During the purification of the obtained 
protein on the Q Sepharose Fast Flow column (section 6.1.2) a second elution step was 
introduced, namely elution with 20 mM Tris/HCl, 1.0 M NaCl. Analytical gel filtration was 
performed on a 13/31 Superdex 75 HR column with 500 μl aliquots of sample (linear flow 
rate: 0.3 cm/min). Some fractions were re-analysed on the analytical gel filtration column. 
 
7.1.1.2 Cluster reconstitution into Ori-ISP and purification 
One experiment was carried out performing cluster reconstitution into Ori-ISP (experiment 4) 
using the optimized conditions for Ub-Ori-ISP (section 6.1.1). However, the reaction time for 
de-protection was raised from 1.5 to 22 hours (section 9.4.2). The rationale was to de-protect 
the cysteines and perform simultaneous proteolytic cleavage (by the enzyme YUH1) of the 
Ub-fusion. Since the cleavage was to take place in the reaction mixture the amount of YUH1 
necessary for cleavage under the given conditions was optimized (section 9.3.3). After 
cleavage and de-protection of the cysteines cluster reconstitution was to be carried out leaving 
YUH1 and ubiquitin in the reaction mixture. During anion-exchange YUH1 and ubiquitin 
could be separated from holo-Ori-ISP due to differences in total charge and surface charge 
distributions. 
27.2 mg freeze-dried Ub-Ori-ISP was dissolved in 4.3 ml 100 mM Tris/HCl pH 8.5. 200 μl 
0.25 M DTT solution (20-fold molar excess) was added to the protein solution followed by 
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189 μl of YUH1 solution (17.7 mg/ml, the molar ratio Ub-Ori-ISP:YUH1 was 20:1). The 
solution was incubated for 22 hours with gentle stirring. Then, 200 μl freshly prepared  
0.10 M FeCl3 solution (8-fold molar excess) was added to the protein solution followed by 
200 μl freshly prepared 0.10 M Na2S·9H2O solution (8-fold molar excess). The resultant 
solution was incubated for one hour with gentle stirring (see section 6.1.1 for further details 
on cluster reconstitution). The solution was split into two portions and each was further 
purified as described in section 7.1.1.1. However, desalting was carried out on two 15/8 
Sephadex G-10 columns (by gravity). When purifying the first portion on the Q Sepharose 
Fast Flow column (section 7.1.1.1 and 6.1.2) a second elution step was included, namely 
elution with 20 mM Tris/HCl, 1.5 M NaCl. When purifying the second portion on the 10/5 
Source 30Q column (section 7.1.1.1 and 6.1.3), the gradient was extended to 1.0 M NaCl  
(43 CV). Fractions collected from each of the two anion-exchange purifications were further 
separately analysed by analytical gel-filtration on a 20 mM Tris/HCl, 0.15 M NaCl pH 8.0 
equilibrated 13/31 Superdex 75 HR column (by HPLC). 500 μl samples were loaded onto the 
column and eluted using the same buffer (linear flow rate: 0.3 cm/min). This analysis was 
carried out right after anion-exchange and again after a period of 24 hours. Fractions were 
collected and UV-vis spectra recorded. An overview of the cluster reconstitution and 
purification is presented in figure 7.2.  
 
Dissolution of freeze-dried sulfite-protected Ub-Ori-ISP in buffer 
followed by addition of 20 fold molar excess DTT 
Reaction for 1.5 hours 
 
Addition of iron (8 fold molar excess) followed 
by addition of sulfide (8 fold molar excess) 
Reaction for 1 hour 
 
Reaction product was 
split into two portions 
 
Desalting on PD-10 column Desalting on PD-10 column 
Purification on 15/2 Q Sepharose Fast 
Flow column functioning by gravity 
using a stepwise gradient 
HPLC purification on a 10/5 Source 30 Q 
column using a continuous gradient  
Analytical gel filtration on 10/30 
Superdex 75 HR column 
Analytical gel filtration on 10/30 
Superdex 75 HR column 
 
 Figure 7.1 Flowchart of cluster reconstitution reaction into Ub-Ori-ISP followed by splitting of the solution 
into two portions and subsequent parallel desalting and purification of reaction products.  
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7.1.2 Cluster reconstitution into Ub-Ori-ISP and purification using Fe(II) as 
the iron source 
Experiment 5 was performed in France and cluster reconstitution and purification was carried 
out as described in section 7.1.1.1 (experiment 1 and 2). However, (NH4)2Fe(II)(SO4)2·6H2O 
was used as the iron source. 
 
7.1.3 Stability of holo-protein purified by gravity  
Holo-protein obtained from purification on the Q Sepharose Fast Flow column (section 
7.1.1.1, experiment 1 and 2) was up-concentrated to approximately 70 mg/ml using a 
Microcon YM-3 centrifugal filter unit. The holo-protein was stored at 4ºC and the stability 
was measured by recording a UV-vis spectrum of the obtained product over a period of 49 
days. 
 
Dissolution of freeze-dried sulfite-protected Ub-Ori-ISP in buffer 
followed by addition of DTT and YUH1 
Reaction for 22 hours 
 
Addition of Fe3+ followed by addition of sulfide 
Reaction for 1 hour 
 
Reaction product was 
split into two portions 
 
Desalting on 15/8 Sephadex 
G-10 column 
Desalting on 15/8 Sephadex 
G-10 column 
Purification on 15/2 Q Sepharose Fast 
Flow column functioning by gravity 
using a stepwise gradient 
HPLC purification on a 10/5 Source 30Q 
column using a continuous gradient  
Analytical gel filtration on 13/31 
Superdex 75 HR column 
Analytical gel filtration on 13/31 
Superdex 75 HR column 
 Figure 7.2 Flowchart of proteolytic cleavage of Ub-Ori-ISP, cluster reconstitution reaction into Ori-ISP 
followed by splitting of the solution into two portions and subsequent parallel desalting and purification of 
reaction products. 
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7.2 Results and discussion 
 
7.2.1 General comments on cluster reconstitution and desalting 
Observations made during cluster reconstitution and desalting in this chapter are comparable 
to those made previously (section 6.2.1). This indicates that oxygen was not the determining 
factor when different coloured by-products and differing amounts of by-products were 
observed. Other parameters such as the batch from which apo-protein originated, the speed of 
which iron and sulfide were added, the iron source, the temperature in the reaction mixture 
and the reaction time may be important parameters. Even though experiments were carried 
out in the exact same manner, there are still minor differences since they are not automated. 
When using (NH4)2Fe(II)(SO4)2·6H2O as the iron source inside the anaerobic chamber 
(section 7.1.2), the colour of the reaction mixture was not nearly as intense as using the same 
iron source outside the anaerobic chamber or Fe3+ in general (section 6.2.1). When adding 
Fe2+ to a reducing solution in a non-oxidizing environment it is difficult to imagine oxidized 
FeS-cluster forms being synthesized (further discussed in section 7.2.5). Reduced forms are 
more faintly coloured than the oxidized forms (chapter 2) and this is probably the reason for 
the faintly coloured solution. 
 
7.2.2 General comments on anion-exchange and analytical gel filtration 
When performing anion-exchange purifications the observations made were comparable to 
those observed previously (section 6.2.2 and 6.2.3). However, when eluting the holo-protein 
from the Q Sepharose Fast Flow column larger broadening of the band was observed. When 
eluting the protein from the Source 30Q column, two bands were observed. In the following 
description (sections 7.2.3 and 7.2.4) all fractions had a brown colour unless otherwise stated. 
As observed in chapter 6, anion-exchange columns had a black band at the top and a greyish 
colour after elution of holo-protein which could be assigned to some form of iron sulfide (see 
section 6.3.1 for further discussion). This is expected since iron and sulfide were both added 
in molar excesses. In all five experiments (section 7.1.1 and 7.1.2) fractions collected from 
anion-exchange were analysed by analytical gel filtration. Two different analytical gel 
filtration columns were used.  
When using the 10/30 Superdex 75 HR column (experiments 1, 2 and 5) main peaks were 
found to elute at two positions, namely ca. 10.9 ml and ca. 12.4 ml. When using the 13/31 
Superdex 75 HR column in experiment 3, main peaks were also found at two positions, ca. 
11.7 ml and 12.8 ml (comparable to those in experiments 1, 2 and 5). In experiment 4 the 
13/31 Superdex 75 HR column was also used and main peaks at two positions were also 
found. However, these were found at higher volumes since the ubiquitin fusion was cleaved 
off. In each of the five experiments, the protein present in the main peaks eluting at the lowest 
volume are considered dimeric, while the protein present in the main peaks eluting at the 
highest volume are considered monomeric. These assumptions are substantiated in  
section 7.2.7. 
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7.2.3 Purification of holo-protein when FeCl3 was used as the iron source 
 
7.2.3.1 Purification of holo-Ub-Ori-ISP 
 
Experiment 1 
The chromatogram obtained from the HPLC purification on the Source 30Q column is 
presented in figure 7.3. A minor peak eluted with a maximum absorbance at 24.7 mS/cm 
(Source fraction 1) and a major peak eluted from 37 to 46 mS/cm (Source fraction 2). Small 
and poorly resolved peaks were also observed between these two peaks.  
Source fraction 1 eluted at a somewhat higher conductivity than the main peak observed 
previously (figure 6.10 A to C) when performing purification outside the anaerobic chamber 
(chapter 6). The UV-vis spectrum of Source fraction 1 (figure 7.4 A black spectrum) reveals a 
[4Fe-4S]2+ cluster to be present in the protein (absorption maximum at 390 nm, see section 
6.3.3). Therefore, this peak corresponds to the previously observed main peaks (see sections 
6.2.3 and 6.3.2). Source fraction 2, which was the major peak in the chromatogram, has not 
previously been observed. The UV-vis spectrum of this fraction (figure 7.4 A, red spectrum) 
resembles those of [3Fe-4S]1+ ferredoxins (absorption maximum at 408 nm, figure 2.2 B). 
This is in agreement with electrostatic considerations since a [3Fe-4S]1+ cluster containing 
protein would be expected to elute at a higher conductivity than a corresponding [4Fe-4S]2+ 
cluster containing protein.  
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Elution volume  
 Figure 7.3 Chromatogram for purification of holo-Ub-Ori-ISP on the Source 30Q column in experiment 1, 
when using FeCl3 as the iron source. The red line indicates the absorbance at 280 nm. The brown and the 
green lines indicate the conductivity and the NaCl gradient, respectively. The concentration of NaCl can be 
read from the conductivity axis employing the unit 10-2 M. Collected fractions are indicated with black boxes 
and the conductivity at maximum absorption is also presented. 
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Figure 7.4 UV-vis spectra of main fractions from anion-exchange in experiment 1. A) Spectra obtained from 
fractions from purification on Source 30Q column. Source fraction 2 was diluted 5 times (with 20 mM 
Tris/HCl pH 8.0) prior to recording the spectrum. B) Spectra obtained from fractions from purification on Q 
Sepharose Fast Flow column. Both fractions were diluted 50 times (with 20 mM Tris/HCl pH 8.0) prior to 
recording the spectra. Maxima and shoulders (sh) are indicated with arrows.   
 
 
 
 
 
An experiment where the holo-protein was purified on a Q Sepharose Fast Flow column (by 
gravity) and eluted in one step was performed. Two main fractions (FF fractions 1 and 2) 
were collected and from the UV-vis spectra shown in figure 7.4 B, FF fraction 1 is seen to be 
comparable to Source fraction 1 while FF fraction 2 is comparable to Source fraction 2. 
Prior to analytical gel filtration, Source fractions 1 and 2 were concentrated ca. 20 and 5 
times, respectively, and FF fractions 1 and 2 were both concentrated ca. 5 times 
(concentration was performed using a stirred Amicon cell equipped with a YM3 membrane). 
The four chromatograms obtained from the analytical gel filtrations on each of the four 
collected fractions are presented in figure 7.5. From the purifications of Source fractions 1 
and 2 and FF fraction 2, one main peak along with one or two minor peak were observed 
while two similarly sized peaks were observed from purification of FF fraction 1. Minor 
peaks are difficult to observe in the figure due to the scale on the y-axis. The elution volume 
at maximum absorption of each of the peaks is presented in table 7.1 and UV-vis spectra 
corresponding to the main peaks are presented in figure 7.6 (absorption maxima and shoulders 
are indicated in the figure). 
Source fraction 1, gave one main peak (12.5 ml) and a minor peak (10.9 ml) in the 
chromatogram (figure 7.5, red line). This strongly indicates that Source fraction 1 contains a 
monomer. The UV-vis spectrum of the main peak (figure 7.6 A, black spectrum) is slightly 
different from the spectrum recorded prior to the analysis (figure 7.4 A, black spectrum) since 
maxima at 308 nm and 403 nm are now observed. This spectrum indicates the presence of a 
[3Fe-4S]1+ cluster or a mixture of clusters, which could have been formed due to oxidative 
breakdown of the [4Fe-4S]2+ cluster either prior to or during the analysis (discussed in section 
7.2.8). The chromatogram for Source fraction 2 (figure 7.5, green line), shows main peak at 
10.9 ml indicating the presence of a dimer. However, a minor peak corresponding to a 
monomer (12.4 ml) is also present. The UV-vis spectrum of the main peak (figure 7.6 A, red 
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spectrum) resembles the spectrum recorded prior to performing the analysis (figure 7.4 A, red 
spectrum) however, no absorption maxima are evident. 
In summary Source fraction 1 appears to be a monomer containing a [4Fe-4S]2+ cluster while 
Source fraction 2 appears to be a dimer containing one or two [3Fe-4S]1+ clusters or a 
combination of two cluster types. 
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Figure 7.5 Chromatograms for analytical gel filtrations in experiment 1 obtained when analysing fractions 
collected from anion-exchange. Absorption was measured at 280 nm. Red, green, blue and brown lines 
indicate overlaid chromatograms for Source fraction 1, Source fraction 2, FF fraction 1 and FF fraction 2, 
respectively.   
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Figure 7.6 UV-vis spectra of fractions corresponding to peaks observed when performing analytical gel 
filtration in experiment 1. A) Source fractions 1 and 2. B) FF fractions 1 and 2. Maxima and shoulders (sh) 
are indicated.   
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The chromatogram of FF fraction 1 (figure 7.5, blue line), showed two equally sized main 
peaks (10.9 ml and 12.4 ml) indicating the presence of both a dimer and a monomer. The UV-
vis spectrum of the monomer peak (figure 7.6 B, red spectrum) resembles a [4Fe-4S]2+ 
ferredoxin while the UV-vis spectrum of the dimer (figure 7.6 B, black spectrum) resembles 
that of a [3Fe-4S]1+ ferredoxin (see figure 2.2). FF fraction 2 (figure 7.5, brown line) gave one 
main peak at 10.9 ml indicating the presence of a dimer and a minor peak (12.5 ml) 
corresponding to a monomer. The UV-vis spectrum of the main peak (figure 7.6 B, green 
spectrum) resembles the spectrum recorded prior to performing the analysis (figure 7.4 B, red 
spectrum). 
When eluting the holo-protein from the Q Sepharose Fast Flow column, all was eluted in one 
step and collected in two fractions. Therefore FF fraction 1 contains holo-protein 
corresponding to Source fractions 1 and 2 (monomer and dimer) while FF fraction 2 contains 
holo-protein corresponding to Source fraction 2 (dimer). 
  
Table 7.1 Elution points of peaks observed in chromatograms obtained from analytical gel filtration. 
Experiment Fractions analysed 
by gel filtration 
Point of elution presented in ml. Corresponding peaks from different 
chromatograms are presented in the same columns. The magnitude of each 
peak is presented in parenthesis (main, minor) 
Source fraction 1  10.9 (minor) 12.5 (main)   
Source fraction 2 10.0 (minor) 10.9 (main) 12.4 (minor)   
FF fraction 1  10.9 (main) 12.4 (main)   
1 a 
FF fraction 2  10.9 (main) 12.5 (minor)   
Source fraction 1 10.1 (minor) 10.9 (main) 12.4 (main)   
Source fraction 2 10.0 (minor) 10.9 (main) 12.5 (minor)   
2 a 
FF fraction 1  10.9 (minor) 12.4 (main)   
Source fraction 1  10.9 (minor) 12.5 (main)   
Source fraction 2  11.0 (minor) 12.4 (main)   
FF fraction 1 10.1 (minor) 10.9 (minor) 12.2 (main)   
5 a 
FF fraction 2  shoulder 12.3 (main)   
Source fraction 1  shoulder 12.7 (main)   
Source fraction 2 10.7 (minor) 11.6 (main) 12.8 (minor)   
FF fraction 1  tailing 12.8 (main)   
FF fraction 2  11.7 (main) 13.0 (minor)   
Source fraction 1,  
12.7 ml (main) 
10.7 (minor) 11.4 (main) 12.9 (minor)   
3 b 
Source fraction 2,  
11.8 ml (main) 
Shoulder 11.5 (main) 12.8 (minor)   
Source fraction 1    shoulder 14.4 (main) 
Source fraction 1, 
24 hours 
   13.1 (main) 14.4 (main) 
Source fraction 2    13.2 (main) Shoulder 
FF fraction 1  11.3(YUH1)  shoulder 14.5 (main) 
4 b 
FF fraction 2    13.3 (main) shoulder 
a The 10/30 Superdex 75 HR column was used 
b The 13/31 Superdex 75 HR column was used 
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Experiment 2  
Experiment 2 was a repetition of experiment 1 to test reproducibility of the results. The 
chromatogram obtained when purifying the reconstituted protein on the Source 30Q column 
(figure 7.7) contains two main peaks. The major peak eluted with a maximum absorption at 
23.9 mS/cm (Source fraction 1) and a minor peak eluted at 41.8 mS/cm (Source fraction 2). 
Some small and poorly resolved peaks were observed between these two peaks. UV-vis 
spectra of the two fractions are shown in figure 7.8 A. The two main peaks are comparable to 
the peaks investigated in experiment 1 (Source fractions 1 and 2). However, here the first 
peak is the dominating peak. Even though experiment 1 and 2 were carried out in the same 
way, this major difference is seen in the chromatograms. The reasons for this discrepancy 
might be those discussed in section 7.2.1. As observed in experiment 1, Source fraction 1 
(figure 7.8 A, black spectrum) contains a [4Fe-4S]2+ protein (absorption maximum at 390 nm) 
while the UV-vis spectrum of Source fraction 2 (figure 7.8 A, red spectrum) resembles that of 
a [3Fe-4S]1+ ferredoxin (weak absorption maximum at 402 nm) or a mixture of clusters.  
An experiment purifying holo-protein on a Q Sepharose Fast Flow column (by gravity) was 
performed and the holo-protein was eluted in one step (section 7.1.1.1). One main fraction 
was collected, FF fraction 1, and from the UV-vis spectra shown in figure 7.8 B, it is seen to 
be comparable to Source fraction 1. 
Prior to performing analytical gel filtration, Source fractions 1 and 2 were concentrated ca. 10 
and 15 times, respectively, and FF fraction 1 was concentrated ca. 5 times (concentration was 
performed using a stirred Amicon cell equipped with a YM3 membrane). The three 
chromatograms obtained from the analytical gel filtrations are presented in figure 7.9. The 
elution volume at maximum absorption of each of the peaks is presented in table 7.1 and UV-
vis spectra corresponding to the main peaks are presented in figure 7.10. 
For Source fraction 1 (figure 7.9, red line), two main peaks were observed at 10.9 ml and  
12.4 ml, respectively, along with a minor peak at 10.1 ml in the chromatogram. This indicates 
that Source fraction 1 contains monomer, dimer and a small amount of polymer, which was 
not the case in experiment 1 (see above). The multiple components might be due to oxidative 
breakdown prior to analysis or during analysis or it might be due to conversion between 
monomer and dimer (further discussed in section 7.2.8). UV-vis spectra of the main fractions 
reveal that the monomer fraction (12.4 ml) appears to contain a [4Fe-4S]2+ protein (figure 
7.10 A red spectrum, absorption maximum at 390 nm) while the cluster type for the dimer 
fraction is difficult to infer (10.9 ml, figure 7.10 A black spectrum). However, the UV-vis 
spectrum is comparable to that of Source fraction 2 (figure 7.8 A, red spectrum). Source 
fraction 2 (figure 7.9 green line) gave one main peak at 10.9 ml, indicating the presence of a 
dimer, and a minor peak (12.4 ml) indicating a monomer, as well as a peak at 10.0 ml 
indicating a polymer form. The UV-vis spectrum of the main peak (figure 7.10 A, blue 
spectrum) resembles the spectrum recorded prior to performing the analysis (figure 7.8 A, red 
spectrum). The UV-vis spectrum of the polymer form (10.0 ml, figure 7.10 A, green 
spectrum) differs slightly since it has a maximum at 306 nm and the holo-protein 
corresponding to this peak probably contains multiple cluster types. 
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Figure 7.7 Chromatogram for purification of holo-Ub-Ori-ISP on the Source 30Q column in experiment 2, 
when using FeCl3 as the iron source. The red line indicates the absorbance at 280 nm. The brown and the 
green lines indicate the conductivity and the NaCl gradient, respectively. The concentration of NaCl can be 
read from the conductivity axis employing the unit 10-2 M. Collected fractions are indicated with black boxes 
and the conductivity at maximum absorption is also presented. 
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 Figure 7.8 UV-vis spectra of main fractions from anion-exchange in experiment 2. A) Fractions from 
purification on Source 30Q column. Both fractions were diluted 5 times (with 20 mM Tris/HCl pH 8.0) prior 
to recording the spectra. B) Fraction collected when performing purification on Q Sepharose Fast Flow 
column. The fraction was diluted 20 times (with 20 mM Tris/HCl pH 8.0) prior to recording the spectrum. 
Maxima and shoulders (sh) are indicated.   
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Figure 7.9 Chromatograms for analytical gel filtrations in experiment 2 obtained when analysing fractions 
collected from anion-exchange. Absorption was measured at 280 nm. Red, green and blue lines indicate 
overlaid chromatograms for Source fraction 1, Source fraction 2, and FF fraction, respectively.   
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Figure 7.10 UV-vis spectra of fractions corresponding to peaks observed when performing analytical gel 
filtration in experiment 2. A) Source fractions 1 and 2. Fractions were three times diluted (with 20 mM 
Tris/HCl pH 8.0) prior to recording the spectra except for Source fraction 2, 10.0 ml (minor), which was 
undiluted. B) FF fractions 1. FF fraction 1, 12.4 ml (main) was three times diluted (with 20 mM Tris/HCl pH 
8.0). Maxima and shoulders (sh) are indicated.   
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FF fraction 1, gave one main peak at 12.4 ml (figure 7.9, blue line) indicating the presence of 
a monomer. A minor peak was observed at 10.9 ml indicating the presence of a dimer. UV-vis 
spectra of both of these peaks (figure 7.10 B) closely resemble the spectrum recorded prior to 
performing the analysis (figure 7.8 B), indicating the presence of a [4Fe-4S]2+ cluster 
(absorption maximum at 390 nm). When eluting the holo-protein from the Q Sepharose Fast 
Flow column, the holo-protein was eluted in one step and therefore FF fraction 1 contains 
holo-protein corresponding to Source fraction 1, and holo-protein corresponding to Source 
fraction 2 was probably eluted in minor fractions (tailing) that were not analysed. It is 
interesting to note that FF fraction 1 is more homogenous than Source fraction 1 (as judged by 
analytical gel filtration), which was not the case in experiment 1. This might be due to 
breakdown or conversion as discussed in section 7.2.8.   
 
Experiment 3  
Since experimental work was now carried out in an anaerobic chamber in our own laboratory 
and since no oxygen sensor was present, experiment 1 carried out in France was repeated to 
test reproducibility prior to performing cluster re-constitution into Ori-ISP.  
Throughout this experiment the nano-drop UV-vis spectrophotometer (see section 4.4) was 
employed since this was present inside the anaerobic chamber. This resulted in poor spectra 
rendering it impossible to determine exact absorption maxima. 
The chromatogram obtained when purifying the reconstituted protein on the Source 30Q 
column is presented in figure 7.11. Two main peaks eluted at 22.7 mS/cm (Source fraction 1) 
and 30.8 mS/cm (Source fraction 2), respectively. Some small and poorly resolved peaks were 
also observed between these two peaks. It is seen that the gradient was too short and only the 
first part of Source fraction 2 was collected. The UV-vis spectra recorded of Source fractions 
1 and 2 are of quite poor quality (figure 7.12 A) which makes it difficult to distinguish any 
particular cluster types. The chromatogram is comparable to the chromatograms obtained in 
experiment 1 and 2 (figures 7.3 and 7.7) however, the two main fractions are found to elute at 
somewhat lower conductivities. This might be due to a higher temperature of the anaerobic 
chamber (see section 4.2). The size of the two main peaks are somewhat comparable (Source 
fraction 2 being the dominating peak), which was not the case previously (figures 7.3 and 7.7) 
since Source fraction 2 dominated in experiment 1 while Source fraction 1 dominated in 
experiment 2. The chromatogram obtained in this experiment can be regarded as being 
something in between the chromatograms obtained in experiment 1 and 2. Even though these 
three experiments were carried out in the same way, differences in the chromatograms are 
apparent. Oxygen can be ruled out as the main contributor and reasons for these differences 
might be those discussed in section 7.2.1.  
An experiment where the holo-protein was purified on a Q Sepharose Fast Flow column (by 
gravity) was performed and the holo-protein was eluted in two steps. One fraction was eluted 
using 0.5 M NaCl, FF fraction 1, and one fraction was eluted using 1.0 M NaCl, FF fraction 2. 
The UV-vis spectra of these fractions are shown in figure 7.12 B. The quality of the spectra is 
quite poor. However, FF fractions 1 and 2 have absorption maxima at about 395 nm and 390 
nm, respectively, indicating that both fractions contain a [4Fe-4S]2+ protein. 
Prior to performing analytical gel filtration, Source fractions 1 and 2 were both concentrated 
ca. 10 times while FF fractions 1 and 2 were not (concentration was performed using Vivacell 
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70 equipped with a 5000 Da MWCO membrane). The four chromatograms obtained from the 
analytical gel filtrations are presented in figure 7.13. From each chromatogram one main peak 
was apparent however, shoulders or minor peaks were also present as indicated in table 7.1. 
UV-vis spectra corresponding to the main peaks are not presented since they resemble those 
seen in figure 7.12 A. As seen previously (in experiment 1 and 2) holo-protein eluted at two 
positions, namely ca. 11.6 ml and ca. 12.8 ml (see table 7.1). These positions are different 
from what was previously observed (see table 7.1) since analytical gel filtration was 
performed on a different column. Elution at ca. 11.6 ml is corresponds to a dimeric compound 
while elution at ca. 12.8 ml is corresponds to a monomeric compound (discussed in section 
7.2.7). 
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Figure 7.11 Chromatogram for purification of holo-Ub-Ori-ISP on the Source 30Q column in experiment 3, 
when using FeCl3 as the iron source. The red line indicates the absorbance at 280 nm. The brown and the 
green lines indicate the conductivity and the NaCl gradient, respectively. The concentration of NaCl can be 
read from the conductivity axis employing the unit 10-2 M. Collected fractions are indicated with black boxes 
and the conductivity at maximum absorption is also presented. 
 
 
 
 
 
Analytical gel filtrations on Source fraction 1 and FF fraction 1 are comparable and both gave 
one main peak (monomer) eluting at 12.7 ml and 12.8 ml, respectively (figure 7.13, red and 
blue lines). Analytical gel filtrations on Source fraction 2 and FF fraction 2 are also 
comparable and both gave one main peak (dimer) eluting at 11.6 ml and 11.7 ml, respectively 
(figure 7.13, green and brown lines). These observations are in agreement with those made in 
experiment 1 and 2. 
The main peaks observed in the chromatograms when analysing Source fractions 1 and 2 
(figure 7.13) by gel filtration were collected and re-purified by analytical gel filtration to test 
whether the species formed were stable or not. The result of re-purifying Source fraction 1, 
main peak (12.7 ml, monomer), is shown in figure 7.14 A. It is seen that the one peak 
observed previously has turned into three poorly resolved peaks (the dimer peak is now 
dominating) and broadening in the region 8 to 10 ml. This indicates breakdown, resulting in 
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formation of dimers and polymers. This might have taken place prior to analysis or during 
analysis (further discussed in section 7.2.8). When re-analysing Source fraction 2, main peak 
(11.7 ml), the resulting chromatogram (figure 7.14 B) shows formation of shoulders on both 
sides of the main peak which either indicates breakdown or slight conversion of dimer to 
monomer and polymer (further discussed in section 7.2.8).  
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Figure 7.12 UV-vis spectra of main fractions from anion-exchange in experiment 3. A) Fractions from 
purification on Source 30Q column. The spectra are too poor to determine exact absorption maxima. B) 
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Figure 7.13 Chromatograms for analytical gel filtrations obtained when analysing fractions collected from 
anion-exchange in experiment 3. Absorption was measured at 280 nm. Red, green, blue and brown lines 
indicate overlaid chromatograms for Source fraction 1, Source fraction 2, FF fraction 1 and FF fraction 2, 
respectively.   
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Figure 7.14 Chromatograms obtained when re-analysing main peak fractions obtained from analytical gel 
filtrations. A) Source fraction 1, 12.7 ml (main) obtained from analytical gel filtration was re-purified. B) 
Source fraction 2, 11.8 ml (main) obtained from analytical gel filtration was re-purified.  
 
 
 
7.2.3.2 Purification of holo-Ori-ISP  
After performing proteolytic cleavage on Ub-Ori-ISP using the protease YUH1 (see section 
7.1.1.2, experiment 4) the composition of the solution was analysed by SDS-PAGE to test the 
extent of cleavage, which was found to be complete (results not shown). Cluster 
reconstitution was then performed into Ori-ISP. The observations made during cluster 
reconstitution and desalting were comparable to those made previously (section 7.2.1). Also 
when performing anion-exchange purifications the observations made were comparable to 
those observed previously (7.2.3.1). However, the holo-protein was found to elute at higher 
conductivities as would be expected. 
The chromatogram obtained from the HPLC purification is presented in figure 7.15. A small 
peak (uncoloured) eluted at 29.0 mS/cm and it was assigned to YUH1 due to the position of 
the peak and UV-vis spectrophotometric analysis revealed only apo-protein (results not 
shown). Ubiquitin did not bind to the column (results not shown). A larger peak followed by 
tailing eluted at 36.5 mS/cm (Source fraction 1). The tailing could indicate slow breakdown 
during purification or presence of multiple species. The dominating peak eluted at 72.1 
mS/cm (Source fraction 2). The chromatogram differs from those previously obtained (see 
section 7.2.3.1) since comparable coloured fractions elute at much higher conductivities in 
this experiment. The elution at higher conductivities is a result of a change in overall charge 
and charge distribution upon cleavage of the Ub-fusion. UV-vis spectra of Source fractions 1 
and 2 recorded right after purification and after 24 hours are shown in figure 7.16 (absorption 
maxima and shoulders are outlined in the figure). These spectra reveal that Ub is no longer 
part of the molecules since no distinct absorption is seen at 280 nm however, what was 
previously seen to be a shoulder at 310 nm has now turned into a maximum in the same 
region. Source fraction 1 and Source fraction 2 are comparable to fractions obtained 
previously named the same way (section 7.2.3.1). The spectrum of Source fraction 1 shows 
that the fraction most likely contains a [4Fe-4S]2+ protein (figure 7.16 A, shoulder at 390 nm) 
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while the spectrum of Source fraction 2 (figure 7.16 B, shoulder at 400 nm) resembles more 
closely the spectra previously suggested to contain [3Fe-4S]1+ or different cluster types 
(section 7.2.3.1). After 24 hours the spectrum of Source fraction 1 changed (figure 7.16 A), 
the maximum at 305 nm shifted to 310 nm and flattening of the spectrum was evident. It 
appears that breakdown has happened. No marked changes were observed in Source fraction 
2 within the same period (figure 7.16 B).  
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Figure 7.15 Chromatogram for purification of holo-Ori-ISP on the Source 30Q column in experiment 4. The 
red line indicates the absorbance at 280 nm. The brown and the green lines indicate the conductivity and the 
NaCl gradient, respectively. The concentration of NaCl can be read from the conductivity axis employing the 
unit 10-2 M. Collected fractions are indicated with black boxes and the conductivity at maximum absorption 
is also presented. 
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Figure 7.16 UV-vis spectra of fractions from anion-exchange on Source 30Q column in experiment 4. 
Spectra were recorded right after elution and 24 hours later. A) Source fraction 1. B) Source fraction 2, 
diluted ca. three times prior to recording the spectra. Maxima and shoulders (sh) are indicated. 
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Figure 7.17 UV-vis spectra of fractions from anion-exchange on the Q Sepharose Fast Flow column in 
experiment 4. Spectra were recorded right after elution and 24 hours later. A) FF fraction 1. B, FF fraction 2. 
Fractions 1 and 2 were diluted ca. three and five times, respectively, prior to recording the spectra. Maxima 
and shoulders (sh) are indicated. 
 
An experiment where the holo-protein was purified on a Q Sepharose Fast Flow column (by 
gravity) was performed and the holo-protein was eluted in two steps. One fraction was eluted 
using 0.5 M NaCl, FF fraction 1, and one fraction was eluted using 1.5 M NaCl, FF fraction 2. 
The UV-vis spectra of these fractions are shown in figure 7.17. FF fraction 1 is comparable to 
Source fraction 1 (figure 7.16 A, containing a [4Fe-4S]2+ protein, shoulder at 390 nm). 
However, a maximum at ca. 280 nm shows that YUH1 is found in the fraction (this is because 
of the stepwise elution). FF fraction 2 is comparable to Source fraction 2 (figure 7.16 B, 
indicating the presence of [3Fe-4S]1+ or multiple cluster types, shoulder at 400 nm). No 
changes were observed in the UV-vis spectra (figure 7.17) over a 24 hour period for both 
fractions.  
It was tested whether the obtained holo-protein could be concentrated using a 3000 MWCO 
membrane. However, this was not possible since the holo-protein passed through. 
Analytical gel filtration was performed on the four collected fractions right after preparation 
(figure 7.18) and again after 24 hours, and as seen previously (sections 7.2.1.2 and 7.3.2), 
holo-protein was found to elute at two positions, namely ca. 13.2 ml and ca. 14.4 ml (see table 
7.1). These positions are different from those observed previously on the same column.  This 
is because ubiquitin is no longer part of the molecules. Elution at ca. 13.2 ml corresponds to a 
dimeric protein while elution at ca. 14.4 ml is corresponds to a monomeric protein (discussed 
in section 7.2.7). 
Analytical gel filtrations on Source fraction 1 and FF fraction 1 both gave main peak 
(monomer) eluting at 14.4 ml and 14.5 ml, respectively (figure 7.18, red and blue lines). A 
minor peak at 11.4 ml was also observed when analysing FF fraction 1, which is assigned to 
YUH1. Analytical gel filtrations on Source fraction 2 and FF fraction 2 also both resulted in 
one main peak (dimer) eluting at 13.2 ml and 13.3 ml, respectively (figure 7.18, green and 
brown lines). Shoulders were seen to be present for all the main peaks. The observations made 
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in this experiment are in agreement with those made previously when using FeCl3 as the iron 
source (see section 7.2.3.1). The main peak observed when analysing FF fraction 2 is very 
broad and the top of the peak appears rounded. This could indicate multiple components with 
comparable sizes. 
When analysing the four fractions again (by analytical gel filtration) 24 hours later, no 
changes were observed for Source fraction 2 and FF fractions 1 and 2. However, analysis of 
Source fraction 1 revealed two similarly sized main peaks in the chromatogram (figure 7.19) 
indicating the presence of monomer and dimer. Changes were already apparent from the UV-
vis spectrum recorded prior to the analysis (see above and figure 7.16 A). This change is 
probably due to breakdown (discussed in section 7.2.8).  
Figure 7.20 shows UV-vis spectra of the main peak fractions obtained by analytical gel 
filtration. The spectra of Source fraction 2 and FF fraction 2 main peaks (blue and cyan) are 
comparable to spectra obtained prior to the analysis (figures 7.16 B and 7.17 B). Spectra of 
Source fraction 1 and FF fraction 1 main peaks (black, red, green and pink) are comparable 
however, they differ from spectra recorded prior to the analysis (figures 7.16 A and 7.17 A). 
They now resemble more closely those of [2Fe-2S] or [3Fe-4S] ferredoxins (see section 
6.3.1.1 for a discussion of a comparable spectrum, figure 6.5). The observed changes in the 
spectra are probably due to breakdown of the cluster of the holo-protein from one cluster type 
to another during the analyses (discussed in section 7.2.8). These results show that the dimeric 
protein is more stable than the monomeric protein. This could be attributed to the assumed 
overall lower oxidation state of the monomeric compound, which can easily be oxidized by 
trace amounts of oxygen (further discussed in section 7.2.8). Further, the dimeric protein 
might provide better protection of the cluster from the surroundings.  
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 Figure 7.18 Chromatograms for analytical gel filtrations obtained when analysing fractions collected from 
anion-exchange in experiment 4. Absorption was measured at 280 nm. Red, green, blue and brown lines 
indicate overlaid chromatograms for Source fraction 1, Source fraction 2, FF fraction 1 and FF fraction 2, 
respectively.   
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 Figure 7.19 Chromatograms for analytical gel filtrations of Source fraction 1 collected from anion-exchange 
in experiment 4. The analysis was carried out just after obtaining the fraction 1 (red line) and 24 hours after 
obtaining the fraction (blue line). Absorption was measured at 280 nm.  
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 Figure 7.20 UV-vis spectra of fractions corresponding to main peaks observed when performing analytical 
gel filtrations in experiment 4. Maxima and shoulders (sh) are indicated.   
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7.2.4 Purification of holo-Ub-Ori-ISP using Fe(II) as the iron source 
In experiment 5, (NH4)2Fe(II)(SO4)2·6H2O was used as iron source and differences observed 
during cluster reconstitution are explained and discussed in sections 7.2.1 and 7.2.5. The 
chromatogram obtained when purifying the reconstituted protein on the Source 30Q column 
(figure 7.21) differs from those obtained in experiment 1 to 3 (figures 7.3, 7.7 and 7.11). A 
minor peak (uncoloured) eluted at 20.1 mS/cm and from UV-vis spectrophotometric analysis 
this peak was found to contain apo-protein (results not shown). A small poorly resolved peak 
eluted at 25.1 mS/cm (Source fraction 1) and a major peak eluted at 36.6 mS/cm (Source 
fraction 2). UV-vis spectra of the two fractions recorded right after elution and after 24 hours 
are shown in figure 7.22. Source fraction 1 is comparable to Source fraction 1’s from the 
previous experiments (section 7.2.3) and the UV-vis spectrum (figure 7.22 A) shows that this 
fraction very likely contains [4Fe-4S]2+ protein (shoulder at 390 nm). Source fraction 2 is not 
comparable to Source fraction 2’s from the previous experiments due to the earlier elution. 
The obtained UV-vis spectra are also not comparable. Just after preparation no distinct cluster 
types can be inferred (figure 7.22 B), but after 24 hours the protein appears to contain a  
[4Fe-4S]2+ cluster (shoulder at 390 nm, figure 7.22 B). This strongly suggests that Source 
fraction 2 contained reduced holo-protein (containing a [4Fe-4S]1+cluster) right after elution. 
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 Figure 7.21 Chromatogram for purification of holo-Ub-Ori-ISP on the Source 30Q column in experiment 5, 
when using (NH4)2Fe(II)(SO4)2·6H2O as the iron source. The red line indicates the absorbance at 280 nm. 
The brown and the green lines indicate the conductivity and the NaCl gradient, respectively. The 
concentration of NaCl can be read from the conductivity axis employing the unit 10-2 M. Collected fractions 
are indicated with black boxes and the conductivity at maximum absorption is also presented. 
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 Figure 7.22 UV-vis spectra of fractions from anion-exchange on Source 30Q column in experiment 5. 
Spectra were recorded right after elution and 24 hours later. A Source fraction 1. B) Source fraction 2. When 
recording the spectrum after 24 hours the fraction was diluted two times. No distinct absorption maxima are 
present, but shoulders (sh) are presented in the figures.   
 
 
 
 
An experiment where the holo-protein was purified on a Q Sepharose Fast Flow column (by 
gravity) was performed and the holo-protein was eluted in one step. Two main fractions were 
collected (FF fractions 1 and 2). The UV-vis spectrum of FF fraction 1 (figure 7.23 A) is 
dominated by apo-protein (absorption at 280 nm) and no distinct cluster types can be inferred. 
From the UV-vis spectrum of FF fraction 2 (figure 7.23 B), it is also difficult to infer any 
particular cluster types and leaving the sample for 24 hours at room temperature did not 
change the spectrum as was the case for Source fraction 2. 
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Figure 7.23 UV-vis spectra of fractions from anion-exchange on Q Sepharose Fast Flow column in 
experiment 5. Spectra were recorded right after elution and 24 hours later. All spectra were recorded on ca. 
ten times diluted samples. A FF fraction 1. B) FF fraction 2. No distinct absorption maxima are present but 
shoulders (sh) are presented in the figures.   
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Prior to performing analytical gel filtration, Source fractions 1 and 2 were concentrated ca. 20 
and 10 times, respectively, and FF fractions 1 and 2 were concentrated ca. 10 and 5 times, 
respectively (concentration was performed using a stirred Amicon cell equipped with a YM3 
membrane).  
The four chromatograms obtained from the analytical gel filtrations are presented in figure 
7.24. One main peak was observed in all four chromatograms (varying from 12.2 ml to  
12.5 ml) indicating they were all dominated by monomeric species. However, tailing (FF 
fraction 2), minor resolved peaks (FF fraction 1) or very small peaks (Source fractions 1 and 
2) were found to elute prior to the main peak. The elution volume at maximum absorption of 
each of the peaks is presented in table 7.1 and UV-vis spectra corresponding to the main 
peaks are presented in figure 7.25. 
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 Figure 7.24 Chromatograms for analytical gel filtrations in experiment 5 obtained when analysing fractions 
collected from anion-exchange. Absorption was measured at 280 nm. Red, green, blue and brown lines 
indicate overlaid chromatograms for Source fraction 1, Source fraction 2, FF fraction 1 and FF fraction 2, 
respectively.   
 
 
 
 
For Source fraction 1, the UV-vis spectrum of the main peak (figure 7.25, blue spectrum) is 
different compared to the spectrum recorded prior to the analysis (figure 7.22 A). It is difficult 
to infer any particular cluster type. However, the spectrum is comparable to those previously 
inferred to be dominated by [3Fe-4S]1+ protein or multiple cluster types (see section 7.2.3). 
This probably indicates breakdown (discussed in section 7.2.8). Source fraction 2 gave a main 
fraction with the UV-vis spectrum resembling a [4Fe-4S]2+ protein (figure 7.25, pink 
spectrum, maximum at 390 nm). For FF fraction 1, the main peak is seen to contain what 
appears to be a [4Fe-4S]2+ protein (figure 7.25, red spectrum, shoulder at 390 nm), but apo-
protein is still a dominating factor in the spectrum (absorption at 280 nm). The minor peak 
(10.1 ml) is dominated by apo-protein as seen from the UV-vis spectrum (figure 7.25, black 
spectrum, absorption at 280 nm). However, some coloured species were also apparent, but 
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cannot be resolved. The UV-vis spectrum of the main peak for FF fraction 2 after analysis 
(figure 7.25, green spectrum) is different compared to the spectrum recorded prior to the 
analysis (figure 7.23 B). A maximum is now apparent at 385 nm, strongly indicating the 
presence of a [4Fe-4S]2+ protein. This probably means that FF fraction 2 did in fact contain 
reduced protein (containing a [4Fe-4S]1+ cluster) just like Source fraction 2. FF fraction 1 and 
Source fraction 1 are comparable. However, FF fraction 1 contains the apo-protein eluting 
prior to Source fraction 1. FF fraction 2 and Source fraction 2 are comparable. 
 
0
0.05
0.1
0.15
0.2
0.25
0.3
250 350 450 550 650
Wavelength / nm
Ab
so
rb
an
ce
 / 
AU
0
0.3
0.6
0.9
1.2
250 350 450 550 650
Wavelength / nm
Ab
so
rb
an
ce
 / 
AU
sh 310 nm, all three 
sh 310 nm, both 
390 nm 
sh 390 nm 
385 nm sh 400 nm 
 
 
 
 
 
FF fraction 1, 10.1 ml (minor) FF fraction 1, 12.2 ml (main) FF fraction 2, 12.3 ml (main)
 
Source fraction 1, 12.5 ml (main) Source fraction 2, 12.4 ml (main)
 
 Figure 7.25 UV-vis spectra of fractions corresponding to peaks observed when performing analytical gel 
filtration in experiment 5. Maxima and shoulders (sh) are indicated.     
 
7.2.5 Fe(II) versus Fe(III) as iron sources and reproducibility 
As discussed in sections 7.2.3 and 7.2.4 a great difference in the obtained chromatograms and 
the products was observed depending on the iron source. When an Fe(III) source was used, 
the products appeared to contain oxidized cluster forms ([4Fe-4S]2+ and [3Fe-4S]1+), and 
dimeric and monomeric compounds were obtained. The majority of the iron remained in the 
high oxidation state. When an Fe(II) source was used under the reducing conditions, it is quite 
difficult to obtain Fe(III), which is necessary for formation of common cluster types  
(chapter 2). However, the oxygen concentration inside the anaerobic chamber was 6-8 ppm 
(see section 4.2) which could contribute to formation of Fe(III). The major component 
obtained when purifying the protein was in fact found to be reduced monomeric holo-protein 
([4Fe-4S]1+), which was slowly oxidized. Using Fe(II), some apo-protein was also observed 
during purification, and it might be necessary to increase the time of reaction to gain higher 
yield of holo-protein. A super reduced [4Fe-4S]0 protein is highly unlikely to form under the 
given circumstances and has only been generated from clusters of higher oxidation states 
(Scott et al., 2005). 
Using FeCl3 as the iron source, three experiments were carried out performing cluster 
reconstitution into Ub-Ori-ISP followed by purification (sections 7.1.1.1 and 7.2.3.1). There 
were some discrepancies in the sizes of comparable peaks in the chromatograms obtained 
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from anion-exchange. However, the components found in comparable peaks were believed to 
be identical based on UV-vis spectrophotometric analysis and analytical gel filtrations. The 
experiments are therefore to some degree reproducible. However, unknown parameters do 
affect the ratio of produced species (see section 7.2.1). When using FeCl3 as the iron source, 
cluster reconstitution into Ori-ISP followed by purification was performed successfully. The 
experiment was repeated (results not shown) with a highly similar outcome showing that the 
experiment was reproducible. Only one experiment was performed using Fe(II) for 
performing cluster reconstitution into Ub-Ori-ISP.    
 
7.2.6 Stability of holo-protein purified by gravity  
The stability of holo-protein obtained when FeCl3 was used as iron source and the obtained 
holo-protein was purified on the Q Sepharose Fast Flow column was investigated (see section 
7.1.3) by recording UV-vis spectra over a period of 49 days. As seen from the UV-vis spectra 
in figure 7.26, the characteristics associated with a [4Fe-4S]2+ protein are preserved 
throughout the measuring period (shoulder at 310 nm and maximum at 390 nm), indicating 
that the [4Fe-4S]2+ protein is not degraded significantly. However, the absorption increases 
throughout the entire spectrum over time (a factor 2 within 49 days). One explanation could 
be formation of breakdown products increasing the background absorption. Another 
explanation could be up-concentration of the holo-protein due to evaporation. The sample had 
an approximate volume of 200 μl and was kept in an eppendorf tube at 4ºC. Since the sample 
was opened regularly evaporation could at least be part of the explanation.  
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 Figure 7.26 Stability of a concentrated sample of holo-protein obtained from purification on Q Sepharose 
fast Flow column. UV-vis spectra were recorded throughout a time period of 49 days. Prior to recording a 
spectrum an aliquot was diluted 200 times.  
 
 
 
Even though the characteristic features do not disappear, there is no guarantee that conversion 
between monomer, dimer or polymers and slight breakdown has not happened (see discussion 
section 7.2.8). It is not known whether the sample is homogeneous consisting of either 
monomer or dimer to begin with, since it was not analysed by analytical gel filtration. 
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The stability of the obtained product has however greatly improved in comparison to the 
results obtained in chapter 6, where the features were only present for a day or two and 
massive breakdown was apparent. 
 
7.2.7 Molecular weights of species obtained from analytical gel filtrations 
When performing analytical gel filtration on holo-protein purified by anion-exchange, main 
peaks were found to elute at two distinct positions (high and low molecular weight) when 
FeCl3 was used as an iron source (experiment 1 to 4). Using Fe(II) (experiment 5) produced 
only species of the lower molecular weight (see section 7.2.4 and table 7.1). The properties of 
the eluting compounds as monomers, dimers or polymers are discussed in this section.  
A calibration curve had not been determined for the analytical gel filtration column used for 
the experiments carried out in France (experiment 1, 2 and 5, 10/30 Superdex 75 HR column). 
However, a calibration curve was obtained (appendix A.1) for the column used in our own 
laboratory (experiment 3 and 4, 13/31 Superdex 75 HR column). Using this curve and the 
elution points, approximate molecular weights were determined for the eluting species in 
experiment 3 (see table 7.2). A monomeric or dimeric holo-Ub-Ori-ISP containing one  
[4Fe-4S] cluster per monomer would have molecular weights of ca. 11.2 kDa and 22.3 kDa, 
respectively. This indicates that the species which eluted at 11.6 ml and 12.7 ml are most 
likely to be trimeric and dimeric, respectively. Since no compounds are found to elute at 
higher volumes than at about 12.7 ml and YUH1 (27.2 kDa) is found to elute at 11.4 ml (see 
section 7.2.3.2), it is more likely that the species which eluted were dimeric (ca. 11.6 ml) and 
monomeric (12.7 ml). Elution at lower volumes is considered to be of polymeric forms.  
 
Table 7.2 Calculated molecular weights of species eluting from the 13/31 Superdex 75 HR column 
Point of elution (ml) 10.7 11.6 12.7 
Molecular weight (kDa) 44.2 31.4 20.0 
 
Since experiment 3 (using the 13/31 Superdex 75 HR column) is a repetition of experiment 1 
and 2 (using the 10/30 Superdex 75 HR column) the peaks observed using the 10/30 Superdex 
75 HR column were also considered to be of monomeric and dimeric species. 
Purified, sulfonated apo-protein has also been analysed on the analytical gel filtration column 
(section 5.3.2) and the main peak was found to elute at 11.6 ml (just like the dimeric holo-
protein) suggesting that the apo-protein is found as a dimer. However, a minor peak is also 
present at 12.9 ml, suggesting that monomer is also present. Since apo-protein appears to be 
present as both dimeric and monomeric forms, it is possible that the dimer/monomer forms of 
the holo-protein might be an effect of the ubiquitin part of the molecule and not the Ori-ISP 
part. To establish whether this is the case, ubiquitin should be cleaved off. When performing 
analytical gel filtration on holo-Ori-ISP main peaks at two positions were also found to be 
present, which proves that two differently sized species were formed and that this happened 
without the ubiquitin being part of the molecules. This suggests that the formation of 
monomer/dimer is independent on ubiquitin and the fact that apo-Ub-Ori-ISP most likely is a 
dimer does not appear to affect formation of holo-protein as a dimer or monomer.  
Massive conversion from monomer to dimer and not the other way around has been observed 
(sections 7.2.3 and 7.2.4). This has been observed with and without ubiquitin as part of the 
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molecule, which indicates that ubiquitin is not the main factor contributing to formation of 
dimers or polymers. It is much more likely that the protein takes these conformations as part 
of a breakdown mechanism (section 7.2.8). The protein originates from di-cluster ferredoxins 
(chapter 3) and it is very likely that it is this conformation it “tries” to adopt (see section 
7.2.9). 
 
7.2.8 Breakdown, cluster interconversion and monomer-dimer conversions 
As observed from the gel filtration analyses throughout this chapter, the cluster in the holo-
protein appear to either convert or break down to other cluster forms and monomeric holo-
protein appear to be able to convert to dimers. It is possible that equilibrium between different 
forms exists. It is also very likely, that these transformations happen as a consequence of 
breakdown, since no dimers were observed to transform into monomers to any noteworthy 
extent.  
Breakdown might happen as a series of steps where one cluster type is oxidized to another 
and so forth. Formation of dimers and polymers might also be a part of this mechanism. This 
is substantiated by the obtained results (see section 7.2.3 and 7.3.4) since the reduced  
[4Fe-4S] cluster was found as a monomer while the oxidized form was found primarily as a 
monomer with a small amount as dimer. At the same time what appeared to contain a  
[3Fe-4S]1+ cluster (an oxidized form) or a mixture of clusters was found to be a dimer.  
The most obvious reason for breakdown is oxygen, since no reducing agents were added to 
purification buffers and a small amount of oxygen was present in the anaerobic chamber  
(6-8 ppm in the chamber in France). When leaving a solution shielded from the surroundings 
this small amount of oxygen might only be slightly damaging. During purification on the 
other hand, the holo-protein is continuously exposed to fresh buffer containing small amounts 
of oxygen. This constant exposure might prove harmful to a very oxygen-sensitive protein. 
This could be why possible breakdown is seen during purification.  
Due to the very small size of Ori-ISP (only 23 amino acid residues) the FeS cluster is exposed 
and the protein moiety provides less protection against solubilised destructive or oxidizing 
species than in the larger FeS-protein, rendering it quite unstable. The small size probably 
prevents extensive secondary structure and hydrogen bonding, leaving the chain which is 
wrapped around the cluster quite flexible. 
During purification, interaction with the column material might also be detrimental. When 
performing anion-exchange it is imaginable that the interaction between the negatively 
charged protein and the positively charged groups of the media might be enough to rip the 
cluster and protein apart. This is however not the case when performing gel filtration since no 
interaction with the media should take place. If the holo-protein is to some extent unstable due 
to the small size (explained above) the stress of purification might still cause some 
breakdown. 
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7.2.9 Dimer conformations 
Models of Ori-ISP as a monomer containing a [4Fe-4S] cluster have been made previously, 
and they are presented in section 3.3.5.  
No models are available for holo-Ori-ISP as a dimer. One could however imagine two 
scenarios for the formation of a dimer containing two clusters; parallel and anti-parallel 
alignment of the two peptide chains (see figure 7.27). 
The parallel alignment would have to contain a disulfide bond for binding the two monomers 
together since the three remaining cysteines from each monomer would be expected to be 
coordinated to each their cluster (see figure 7.27 A). In this scenario the most likely cluster 
type to be coordinated would be a [3Fe-4S] cluster since only three cysteines are available for 
coordination. 
The anti-parallel alignment is a much more likely scenario. This is also the coordination mode 
that dicluster ferredoxins adopt (section 2.3.2). Tryptic cleaved apo-ferredoxin from  
C. acidiurici (holo-form contains two [4Fe-4S] clusters) was found to form a dimer identical 
to the native ferredoxin upon in vitro cluster reconstitution (evident from EPR spectroscopy, 
Orme-Johnson, 1973) indicating that the anti-parallel mode is the most likely to form. In the 
anti-parallel mode, the three first cysteines from monomer 1 and the fourth cysteinee from 
monomer 2 share in coordinating one cluster. At the same time the three first cysteines from 
monomer 2 and the fourth cysteine from monomer 1 share in coordinating the second cluster 
(see figure 7.27 B). This coordination mode would be able to accommodate each of the three 
common cluster types: [2Fe-2S], [3Fe-4S] and [4Fe-4S]. Accommodating a [3Fe-4S] cluster 
would mean that one of the cysteines in the sequence would not coordinate the cluster. In di-
cluster ferredoxins this would be comparable to the second cysteine in the sequence  
(section 2.3.2).  
Several scenarios for forming a dimeric protein containing only one cluster can be envisaged 
(not shown). These would have to contain free cysteines and/or disulfide bonds.  
 
 A B
Parallel  
N C 
Anti-parallel  
 N C 
S- S- S- S  
S- S- S- S- Cluster  Cluster Cluster 
 Cluster S- S- S- S- 
 S- S- S- S 
N C 
C N  
 
 Figure 7.27 Possible dimer conformations of holo-Ori-ISP. A) Example of parallel coordination of two 
clusters. B) Example of anti-parallel coordination of two clusters.  
 
 
A crude model for the anti-parallel scenario can be made by aligning two Ori-ISP peptides to 
the sequence of a dicluster ferredoxin with a known structure and then taking the structure and 
deleting all residues not superposed by Ori-ISP. Only looking at the backbone and 
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coordinating cysteines, yields a very rough picture of a possible coordination mode. This was 
done using the sequence and structure of C. acidiurici 2 × [4Fe-4S] ferredoxin (PDB ID: 
2FDN, Dauter et al., 1997). The structure was found by performing a blast search (National 
Center for Biotechnology Information, Altschul et al., 1990) of the Ori-ISP sequence against 
the PDB and thereafter search for 2 × [4Fe-4S] ferredoxins. The sequence alignment based on 
cysteines (performed by hand) is shown in figure 7.28 and the modified structure is shown in 
figure 7.29. From the sequence alignment it is seen that the sequences have 47.8 % sequence 
identity (calculated based on the 46 aligned residues). From this crude model it can be seen 
that the two N-terminals point in opposite directions. This means that this model is also 
plausible when ubiquitin is fused to Ori-ISP since the ubiquitin C-terminal is fused to the Ori-
ISP N-terminal. 
C C C C C C C CAYVINEA
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
IS GA EPE PVNAISSGDDRYVIDADT ID GA AGV PVDAPVQA 
C C C C C C C CVDVDEEE VG GA VNV PVGAV------VDVDEEE VG GA VNV PVGAV  
Figure 7.28 Sequence alignments of two Ori-ISP peptides with the sequence of C. acidiurici ferredoxin. The 
alignment was made by hand using the repeated cluster coordination cysteine pattern. The cysteines are 
underlined and identical residues are coloured green. 
Figure 7.29 Crude model for the anti-parallel dicluster Ori-ISP dimeric protein. The model was generated by 
first aligning two Ori-ISP peptide sequences with the sequence of C. acidiurici 2 × [4Fe-4S] ferredoxin (see 
figure 7.28). Residues from the ferredoxin not aligned with the Ori-ISP sequences were then deleted in the 
structure of the ferredoxin (PDB ID: 2FDN, Dauter et al., 1997). Here, residues 1 to 23 (corresponding to the 
first Ori-ISP monomer) are coloured green while residues 30 to 52 (corresponding to the second Ori-ISP 
monomer) are coloured cyan. N- and C-terminals of the two segments are coloured blue and red, 
respectively. The model is shown in ribbon view and only the side chains of the eight cysteines are shown. 
The two [4Fe-4S] clusters are shown in ball and sticks; sulphur is yellow while iron is orange. The figure was 
prepared with PyMOL (DeLano W. L., 2002). 
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7.3 Conclusion  
Cluster reconstitution and purification of holo-Ub-Ori-ISP was successfully carried out in 
anaerobic chambers and better resolved peaks and less tailing was observed when performing 
HPLC anion-exchange inside anaerobic chambers compared to previously obtained results 
(chapter 6). Further, a marked increase in stability of the obtained products was observed. The 
characteristics of holo-protein purified by gravity were found to be preserved for at least 49 
days as determined by UV-vis spectrophotometry.  
The obtained chromatograms were only reproducible to some degree since great differences 
in the sizes of comparable peaks were observed. Oxygen was ruled out as the determining 
factor and other determining factors have been discussed. The products obtained during 
reconstitution and purification do appear reproducible and the general trend of purification is 
that when FeCl3 was used as iron source, a monomeric [4Fe-4S]2+ protein was eluted at low 
conductivities while a dimeric [3Fe-4S]1+ protein or a protein containing two different clusters 
or multiple cluster types was found to elute at higher conductivities. When Fe(II) was used as 
the iron source, only monomeric compounds were obtained. [4Fe-4S]2+ protein was found to 
elute at low conductivity, while the reduced form, containing a [4Fe-4S]1+ cluster, was found 
to elute at a higher conductivity. 
Breakdown, oxidation of holo-protein and monomer to dimer conversions were observed in 
some cases when performing analytical gel filtration experiments. The primary reasons for 
this are believed to be the presence of trace amounts of oxygen or interaction with the column 
material. 
A preliminary experiment performing cluster reconstitution into Ori-ISP (the ubiquitin fusion 
was cleaved) using a slightly modified procedure for cluster reconstitution (using FeCl3 as the 
iron source) was found to be successful. The obtained products were comparable to those 
obtained for Ub-Ori-ISP, namely a monomeric [4Fe-4S]2+ protein and a dimeric protein 
containing [3Fe-4S]1+ clusters or different cluster types. 
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Chapter eight 
 
 
 
8 Initial crystallization trials of holo-Ub-Ori-ISP 
This chapter describes initial crystallization trials of holo-Ub-Ori-ISP. The experiments were 
carried out in the anaerobic chamber described in section 4.2.1.2.  
In the previous chapter, holo-protein eluting in Source fraction 1 and FF fraction 1 
(experiment 1 and 2, section 7.2.3.1) was found to contain a [4Fe-4S]2+ cluster. However, 
both fraction types could be highly homogeneous (containing mostly monomer) or in-
homogeneous (a mixture of monomer and dimer). Even though a completely homogeneous 
sample could not be attained, it was decided to set up initial crystallization trials. FeCl3 was 
used as iron source and holo-protein was purified by gravity, since this purification step is less 
time consuming than performing HPLC purification. Protein purified by gravity was found to 
be quite stable; the [4Fe-4S]2+cluster features were still present after 49 days (section 7.2.6). 
 
8.1 Experimental 
Cluster reconstitution was performed as described (section 6.1.1) using 34.0 mg freeze-dried 
protein (section 7.1.1.1). The protein was desalted and purified by anion-exchange (sections 
6.1.1 and 6.1.2). The obtained product was up-concentrated (Microcon YM-3 centrifugal 
filter) and stored at 4ºC. Using holo-protein concentrated to 75 mg/ml (concentration 
determination, section 6.2.2), initial screening was performed with Crystal Screen I and II 
(Hampton Research) and the pH Clear Suite (Qiagen). 96-well plates were set up with 
reservoir volumes of 100 μl and sitting drops of 1 μl protein solution and 1 μl reservoir 
solution. The vapour diffusion method was applied and plates were stored at 20ºC.  
From a second batch of holo-protein (100 mg/ml) experiments were carried out to optimize 
promising conditions using the hanging drop vapour diffusion method (appendix A.2).  
 
8.2 Results  
After setting up Crystal Screen I and II approximately half of the drops had lost their colour 
within a few days. In most of the remaining drops the colour turned blackish brown within the 
same period of time. No precipitation or crystalline material was observed in any of the 
coloured drops and no general trends could be inferred from the results. 
When setting up the pH Clear Suite, no precipitation was observed when using NaCl as 
precipitant. However, drops lost their colour at pH 4 and 5 which was also the case when PEG 
6000, MPD (2-methyl-2,4-pentanediol) and ammonium sulphate (0.8 and 1.6 M) was used. At 
high concentrations (20 or 30 %) PEG 6000 resulted in phase separation above pH 6 which 
further turned into black precipitation. 2.4 M ammonium sulphate resulted in blackish brown 
precipitation which turned grey within one week. 3.2 M ammonium sulphate resulted in 
precipitation at all examined pH values (4 to 9); the lower the pH the more blackish was the 
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brown precipitation. The precipitation observed was fluffy looking and not appearing to have 
“sharp edges”. 65 % MPD resulted in phase separation above pH 6. 
Using an increased holo-protein concentration, trials to optimise the ammonium sulphate 
conditions (appendix A.2) only resulted in clear drops. Trials to optimise the MPD conditions 
resulted in phase separation when 60 % MPD was used and fluffy precipitate when salts were 
added. A home made version of The Solubility Tool Kit (originally manufactured by 
Molecular Dimensions) (appendix A.2) only resulted in clear drops. 
 
8.3 Discussion 
No crystalline precipitation or crystals were obtained when using commercially available 
screens. The protein was found to break down (loss of colour and formation of black iron 
sulfide species) under most of the analysed conditions and when exposed to solutions having 
a pH of 5 or below. The only leads to follow (however not particularly convincing) were 
fluffy precipitation when using ammonium sulphate as precipitant or phase separation using 
MPD as precipitant. Trials to optimize these conditions did not yield any usable results.  
The sensitivity towards pH is expected since it is a general feature of FeS-proteins that the 
inorganic sulfide present in clusters is acid labile (section 2.1). 
The protein concentration used for setting up the experiments was quite high (75 mg/ml and 
100 mg/ml) and a too low protein concentration is therefore probably not the reason for the 
lack of coloured precipitation. One reason for not obtaining any usable results is breakdown 
of holo-protein when exposed to oxygen or precipitants inducing breakdown. The protein 
solution is probably not homogeneous (as discussed in chapter 7) and conversions between 
monomer and dimer forms or between different cluster types might also be problematic 
(discussed in section 7.2.8) when trying to crystallize the protein. If such conversions indeed 
do take place it is likely that they are dependent on protein concentration, salt concentration or 
other compounds present in solution and equilibria might shift as a consequence of the 
applied conditions for crystallization. Adventitiously bound iron (section 6.3.3) or iron sulfide 
(section 6.3.1) might also be a problem since these compounds are probably bound to the 
surface of the protein. These compounds may be difficult to remove or avoid since the FeS 
cluster was assembled in the protein by inorganic synthesis. It was previously seen that the 
sulfonated apo-protein could be crystallized using ammonium citrate (section 5.3.3). The 
[4Fe-4S] cluster present in holo-protein was found to convert to another cluster type (see 
section 6.3.1.1) when exposed to citrate, rendering the conditions found for crystallizing apo-
protein unsuitable for crystallization of the holo-protein. 
It may prove very difficult to crystallize the holo-protein. It could be advantageous to cleave 
off the Ub-fusion before further attempting to crystallize the holo-protein. 
 
8.4 Conclusion 
It was attempted to crystallize holo-Ub-Ori-ISP however, no crystals were obtained. This is 
believed to be due to either breakdown of holo-protein, an inhomogeneous sample or presence 
of adventitiously bound iron. 
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Chapter nine 
 
 
 
9 Purification of YUH1 and proteolytic cleavage of 
ubiquitin fusions 
This chapter describes the final procedures for cultivation of YUH1 expressing cells and 
purification of YUH1. The final optimization experiment on proteolytic cleavage of 
sulfonated Ub-Ori-ISP is also presented along with a preliminary experiment on Ub-LCA 
ferredoxin cleavage. 
YUH1 (section 4.6) has previously been expressed and purified (Kohno et al., 1998, Liu et 
al., 1989; Miller et al., 1989), however, it was decided to create new expression and 
purification protocols suitable for equipment present in our laboratories. 
Optimization of the cultivation procedure was performed by Laboratory Assistant, Stephanie 
Boy and Miriam G. Pedersen (project student) under my supervision, and it was based on in-
house procedures for cultivation of non-metalloenzymes. Initial purification trials were 
performed by Miriam G. Pedersen under my supervision.   
 
9.1 Considerations prior to development of the purification procedure 
It was decided to purify the enzyme at pH 7.0 since the enzyme contains a free cysteine in the 
active site. At this pH value the cysteine is most likely protonated (pKa 8.3) and less prone to 
oxidation by oxygen. Therefore thiol-containing reducing agents and EDTA were not added 
to purification buffers as described elsewhere (Kohno et al., 1998; Liu et al., 1989; Miller et 
al., 1989). Ubiquitin hydrolases purified in the absence of thiol-containing reducing agents 
have been found to be inactive. They can be activated by addition of e.g. DTT, although full 
activity has not been obtained (Duerksen-Huges et al., 1989). The enzyme should not be 
frozen during the purification procedure since repeated freeze-thaw cycles have been found to 
render ubiquitin hydrolases inactive. Activity loss has also been observed when the cleavage 
reaction proceeds at 25ºC compared to 37ºC (Duerksen-Huges et al., 1989). 
Even though the enzyme is expressed as His-tagged (YUH1-His6) the strategy was, that 
purification should be attempted by omitting purification on a His-binding column. It is a 
general experience of mine, that His-binding column materials that have been in contact with 
protein/enzyme extract (obtained from cells lysis) are tedious to clean and regenerate, while 
this is easily accomplished with anion-exchange materials.  
 
9.2 Considerations prior to performing proteolytic cleavage of Ub-Ori-ISP 
As described in section 7.1.1.2 proteolytic cleavage of sulfonated Ub-Ori-ISP and de-
protection of the sulfite-protected thiolate groups were intended to take place simultaneously. 
Since the de-protection reaction has already been optimized (Christophersen, 2004) the 
amount of YUH1 needed to perform proteolytic cleavage was tested under the following 
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conditions; 6 mg/ml Ub-Ori-ISP, 100 mM Tris/HCl pH 8.5, 10 mM DTT and room 
temperature. 
No record of a pH optimum for the proteolytic cleavage of Ub-fusions by YUH1 has been 
found however cleavage reactions at pH 8.0 and 7.5 have been performed (Kohno et al., 1998; 
Liu et al., 1989). pH optima for other ubiquitin hydrolases between pH 7.5 and 8.5 have been 
reported (data obtained from the Braunschweig Enzyme Database, Barthelmes et al., 2007). 
  
9.3 Experimental 
 
9.3.1 Cultivation of YUH1 expressing cells 
This procedure is for cultivation of 6 times 650 ml cell cultures. Cells from the HC1434 
glycerol stock were plated on an agar plate containing LB/30 Kan and incubated overnight 
(16 hours) at 30ºC. A single colony was used to inoculate 50 ml LB/30 Kan (25 g/L Luria 
Broth, 30 μg/ml kanamycin sulfate) poured into a 300 ml triple baffled shake flask and 
incubated at 37ºC with shaking (250 rpm) until an OD600 of 0.6 was obtained. The pre-culture 
was stored at 4ºC overnight. The cells were sedimented (centrifuged at 4ºC and 2300 g for  
10 min), the supernatant discarded and cells were re-suspended in 50 ml fresh LB/30 Kan.  
6.5 ml were transferred to each of six 2 L triple baffled shake flasks each containing 650 ml 
TB/30 Kan. The cultures were incubated at 30ºC with shaking (250 rpm) until the OD600 was 
0.6. Then protein expression was induced by addition of IPTG (200 mM stock solution) to a 
final concentration of 0.1 mM, and the incubation was continued with shaking (250 rpm) 
overnight (16 hours) at 30ºC. The cells were harvested by centrifugation at 3000 g and 4ºC for 
15 min. The supernatants were discarded and each of the six portions of cells were re-
suspended in 25 ml cold (4ºC) 20 mM Bis-Tris propane/HCl pH 7.0 (1,3-bis(tris-
(hydroxymethyl)methylamino)propane, pH adjusted with 1 M HCl) and transferred to 50 ml 
polypropylene tubes. The cells were sedimented by centrifugation (3000 g, 4ºC, 15min) and 
the supernatants discarded. The cells were kept at -80ºC for storage. 
 
9.3.2 Purification of YUH1 
2 portions of harvested cells (cells from 1.3 litres of culture, total volume of cells, ca. 8 ml) 
were thawed at 4ºC and re-suspended in cold (4ºC) 20 mM Bis-Tris propane/HCl pH 7.0 to a 
final volume of 80 ml. The cells were lysed by sonication (Satorius Labsonic P at 80 % 
amplitude) in three intervals of 30 seconds. The solutions were kept on ice at all times and 
allowed to cool between each sonication burst. The crude lysate was centrifuged at 24800 g 
for 40 minutes at 4ºC. The enzyme extract (supernatant) was decanted, and the pellet 
discarded.  
The enzyme was then purified by HPLC (ÄKTATM purifier 100) in a three-step purification 
procedure (anion-exchange → gel filtration → anion-exchange). The enzyme was kept on ice 
or at 4ºC between each purification step, which were all performed at room temperature. The 
extract was loaded onto a 20 mM Bis-Tris propane/HCl pH 7.0 equilibrated HiPrep 16/10 
ANX Sepharose Fast Flow column and eluted (linear flow rate: 0.8 cm/min) using a linear 
gradient, 0 M to 0.6 M NaCl in 15 CV, and fractions were collected. The buffer was changed 
to 20 mM Bis-Tris propane/HCl, 0.15 M NaCl pH 7.0 and the volume reduced to ca. 15 ml by 
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ultrafiltration using a stirred Amicon cell with a YM3 membrane. The enzyme sample was 
filtered (0.45 μm) and loaded onto a 20 mM Bis-Tris propane/HCl, 0.15 M NaCl pH 7.0 
equilibrated HiLoad 16/60 Superdex 75 prep grade column  (a maximum of 4 ml was loaded 
for each run) and fractions were collected upon elution with the same buffer (linear flow rate: 
0.2 cm/min). The enzyme was finally purified on a 20 mM Bis-Tris propane/HCl, 0.05 M 
NaCl pH 7.0 equilibrated 16/10 Source 30Q column. Fractions collected from the gel 
filtration step were filtered (0.45 μm) and diluted three times with 20 mM Bis-Tris 
propane/HCl pH 7.0 before loading onto the column. The protein was eluted (linear flow rate: 
1.2 cm/min) using a linear gradient, 0.15 M to 0.3 M NaCl in 10 CV, and fractions were 
collected. The buffer was changed to 20 mM Bis-Tris propane/HCl, pH 7.0 and the volume 
reduced to ca. 4 ml by ultrafiltration using a stirred Amicon cell with a YM3 membrane. The 
enzyme solution was diluted with glycerol to a final concentration of 50 % (w/v) for storage 
at -20ºC (the final buffer concentration was ca. 10 mM). The enzyme concentration and yield 
was determined by UV-visible spectrophotometric analysis (the molecular weight of the His6-
tagged enzyme was calculated to 27.2 kDa and the molar absorptivity was calculated to  
28 mM-1·cm-1, (ExPASy Proteomics Server; Gasteiger et al., 2005)) and the purity was tested 
by SDS-PAGE. 
  
9.3.3 Enzymatic cleavage of sulfonated Ub-Ori-ISP 
The progress of enzymatic cleavage of sulfonated Ub-Ori-ISP under the given conditions 
(section 9.2) was tested at two different concentrations of YUH1. The molar ratios of Ub-Ori-
ISP:YUH1 tested were 20:1 and 50:1. Two solutions were prepared and both solutions 
contained 6 mg/ml sulfonated Ub-Ori-ISP and 10 mM DTT dissolved in 100 mM Tris/HCl 
pH 8.5. The first solution furthermore contained 0.7 mg/ml YUH1, and the second solution 
contained 0.3 mg/ml YUH1. The cleavage experiments were performed at room temperature 
using Ar-flushing for obtaining anaerobic conditions (section 4.1) and progress was followed 
by taking out samples for SDS-PAGE analysis after 1, 2, 4 and 22 hours.   
 
9.3.4 Enzymatic cleavage of Ub-LCA ferredoxin 
A preliminary experiment on cleavage of Ub-LCA ferredoxin using YUH1 was performed. 
The progress of cleavage was tested at two different concentrations of YUH1. The molar 
ratios of Ub-LCA ferredoxin:YUH1 tested were 1:1 and 5:1. Two solutions were prepared, 
which contained 1.5 mg/ml purified Ub-LCA ferredoxin (chapter 10) and 4 mM DTT 
dissolved in 100 mM Tris/HCl pH 8.5 and 2.6 mg/ml or 0.6 mg/ml YUH1, respectively. The 
cleavage experiments were performed as described in section 9.3.3. 
 
9.4 Results and discussion 
 
9.4.1 Purification of YUH1 
The enzyme was purified using a three-step purification procedure (anion-exchange → gel 
filtration → anion-exchange, section 9.3.2). Enzyme extract from two portions of cells was 
loaded onto the HiPrep16/10 ANX Sepharose Fast Flow column and purified by anion-
exchange in the first step (figure 9.1). In the second step gel filtration (on a HiLoad 16/60 
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Superdex 75 prep grade column) was performed (figure 9.2). 4 runs with a maximum loading 
of 4 ml in each run were necessary for purification of protein from two portions of cells, 
otherwise the column was overloaded and the viscosity of the sample too high for optimal 
separation. The protein was finally purified by high-resolution anion-exchange on a 16/10 
Source 30Q column (figure 9.3). Again, 4 runs were necessary to ensure optimal conditions.  
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 Elution volume 
 
 Figure 9.1 Chromatogram for purification of YUH1 on the HiPrep 16/10 ANX Sepharose Fast Flow column. 
The collected fraction is indicated with a black box. The blue and the red lines indicate the absorbance at 
236 nm and 280 nm, respectively. The brown and the green lines indicate the conductivity and the NaCl 
gradient, respectively. The concentration of NaCl can be read from the conductivity axis employing the unit 
10-2 M. 
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Figure 9.2 Chromatogram for purification of YUH1 on the HiLoad 16/60 Superdex 75 prep grade column. 
The collected fraction is indicated with a black box. The blue and the red lines indicate the absorbance at 236 
nm and 280 nm, respectively. 
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The purity of the product was tested by SDS-PAGE (figure 9.4) and only one band was 
observed, which indicates a highly pure product. The yield of enzyme was calculated to  
150 mg/L cell culture, which is very high compared to yields obtained when purifying other 
proteins/enzymes in our laboratories (see chapters 5 and 10). 
The optimized purification procedure is a “small scale” procedure that takes three working 
days. Bearing in mind the high yield, the procedure should not be scaled for larger columns or 
other column materials until the effects of freezing and long-term storage on enzyme activity 
and stability have been examined. The effect of adding a reducing agent during purification 
on enzyme activity and stability should also be investigated. 
 
Figure 9.3 Chromatogram for purification of YUH1 on the 16/10 Source 30Q column. The collected fraction 
is indicated with a black box. The blue and the red lines indicate the absorbance at 236 nm and 280 nm, 
respectively. The brown and the green lines indicate the conductivity and the NaCl gradient, respectively. 
The concentration of NaCl can be read from the conductivity axis employing the unit 10-2 M. 
Figure 9.4 Purity of YUH1 tested by SDS-PAGE. Lane 1: Purified YUH1, 1 μl of a 17.6 mg/ml solution. 
Lane 2: Marker, 1 μl.  
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9.4.2 Enzymatic cleavage of sulfonated Ub-Ori-ISP 
The SDS-PAGE results obtained from proteolytic cleavage of sulfonated Ub-Ori-ISP is 
shown in figure 9.5. Cleavage reaction was performed with 20:1 and with 50:1 molar ratio of 
Ub-Ori-ISP:YUH1. It was observed that a ratio of 20:1 resulted in complete cleavage after 22 
hours (only the Ub band is visible, figure 9.5 lane 6). Cleavage was still incomplete after 4 
hours (Ub-ori-ISP and Ub bands visible, figure 9.5 lane 5). A ratio of 50:1 gave incomplete 
cleavage (figure 9.5 lane 7 to 10). However, only a very weak Ub-Ori-ISP band was left after 
22 hours (lane 10).   
 
 Ub-Ori-ISP:YUH1 Ub-Ori-ISP:YUH1 
               20:1               50:1 
 
 1 2 3 4 5 6 7 8 9 10 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Therefore a ratio of 20:1 and a cleavage and de-protection period of 22 hours should be used 
prior to performing cluster reconstitution into Ori-ISP (see section 7.1.1.2). In the cluster 
reconstitution procedure (chapters 6 and 7) the time period for de-protection of the sulfonated 
thiolate groups is 1.5 hours. Increasing this period might affect the outcome of cluster 
reconstitution but, the reaction is supposed to take place in a closed vessel under reducing 
conditions (DTT) inside an anaerobic chamber. Therefore it is unlikely that the free cysteines 
will become oxidised. It might however prove necessary to add extra DTT just prior cluster 
reconstitution. If a period of 1.5 hours is optimal for the de-protection reaction, then more 
YUH1 or a higher reaction temperature (see section 9.1) is necessary for the cleavage 
reaction. The effect of temperature on de-protection has not been investigated. The amount of 
YUH1 added should be kept as low as possible since it is not known how the presence of this 
enzyme affects the cluster reconstitution reaction. As YUH1 contains a His6-tag it may act as 
an iron scavenger. 
26.6  
17.0  
YUH1-His6,  
27.2 kDa 
kDa  
Apo-Ub-Ori-ISP,  
10.8 kDa 14.4  
6.5  Ub, 8.6 kDa 
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Figure 9.5 SDS-PAGE results showing the extent of Ub-Ori-ISP cleavage by YUH1. Lane 1: Marker, 1 μl. 
Lane 2: 4 μl of a solution containing 6 mg/ml un-cleaved sulfonated Ub-Ori-ISP. Lanes 3 to 6 show the 
extent of cleavage when the Ub-Ori-ISP:YUH1 molar ratio was 20:1. 4 μl samples were analysed 1, 2, 4 and 
22 hours after the reaction was initiated. Lanes 7 to 10 show the extent of cleavage when the Ub-Ori-
ISP:YUH1 molar ratio was 50:1. 4 μl samples were analysed 1, 2, 4 and 22 hours after the reaction was 
initiated. 
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9.4.3 Enzymatic cleavage of Ub-LCA ferredoxin 
Ub-LCA:YUH1 Ub-LCA ferredoxin:YUH1 
A B             5:1                               1:1 
1 2 1 2 3 
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Since a pH of 8.5 had proven successful in cleavage of Ub-Ori-ISP (section 9.3.3), the same 
pH was applied in the preliminary experiment of Ub-LCA ferredoxin cleavage (section 9.3.4). 
The DTT concentration was lowered from 10 mM to 4 mM in the reaction mixture since the 
effect of a high DTT concentration on the iron-sulfur clusters in LCA ferredoxin is not 
known. A lower protein concentration was also applied. Cleavage reaction was performed 
when the molar ratio of Ub-LCA ferredoxin:YUH1 was 1:1 and 5:1 and the SDS-PAGE 
results are presented in figure 9.6. The extend of cleavage was followed by the presence of Ub 
in the reaction mixture, since LCA ferredoxin is not visible from SDS-PAGE (chapter 10). 
With a ratio of 5:1 almost no cleavage was observed after 22 hours (only a very faint Ub band 
is visible, figure 9.6 A lane 3). When a ratio of 1:1 was used about 20 % was cleaved as 
judged by the intensity of the bands on the gel (Ub and Ub-LCA ferredoxin bands visible, 
figure 9.6 B, lanes 3 to 5). It appears that cleavage has stagnated after 2 hours since the 
intensity of comparable bands were about the same throughout the time period (2, 4 and 22 
hours). Stagnation and incomplete cleavage of Ub-fusions using YUH1 have previously been  
  
 
 
  
  
  
  
  
  
  
  
  
  
  
 
 
 
 
 
Figure 9.6 SDS-PAGE results showing the extent of Ub-LCA ferredoxin cleavage by YUH1. A) Shows the 
extent of cleavage when the Ub-LCA ferredoxin:YUH1 molar ratio was 5:1. Lanes 1 to 3: 4 μl samples were 
analysed 2, 4 and 22 hours after the reaction was initiated. Lane 4: Marker, 1 μl. B) Shows the extent of 
cleavage when the Ub-LCA ferredoxin:YUH1 molar ratio was 1:1. Lane 1: Marker, 1 μl. Lane 2: 4 μl of a 
solution containing 1.5 mg/ml un-cleaved Ub-LCA ferredoxin. Lanes 3 to 5: 4 μl samples were analysed 2, 4 
and 22 hours after the reaction was initiated. 
 
 
 
observed (Ub was fused to a peptide containing 38 amino acid residues) and was attributed to 
the presence of un-cleavable conformations of the Ub-fusion (Lui et al., 1989). YUH1 has 
also been found to be nearly inactive with larger fusions such as Ub-β-galactosidase (Miller et 
al., 1989). The high ratios (Ub-fusion:YUH1) used here have previously been necessary for 
complete cleavage of other Ub-fusions (Kohno et al., 1998). Therefore, the low percentage of 
cleavage using a high ratio is not surprising. It is however interesting that Ub-Ori-ISP was 
almost completely cleaved after 22 hours using a ratio of 50:1 (section 9.4.2). The most 
 - 109 -
Part I                                   Purification of YUH1 and proteolytic cleavage of ubiquitin fusions 
 - 110 -
obvious reason for this difference is that the size of the protein fused to ubiquitin plays a 
major role in the progress of the reaction. If the fusion is too big, then the reaction is hindered. 
It may be necessary to employ a UBP (see section 4.6) to obtain complete cleavage. The 
concentrations of DTT, the Ub-fusion and YUH1 may also be important for the progress of 
the reaction. It can be anticipated that a higher percentage of cleavage may be accomplished 
by raising the reaction temperature to 37ºC, lowering the pH to e.g. 8.0 or 7.5 (see section 9.1) 
or raising the concentration of the reactants. The effect of raising the temperature on LCA 
ferredoxin stability is not known. 
 
9.5 Conclusion 
A procedure for expression of YUH1 in E. coli cells has been prepared, and an optimized 
three-step small scale procedure for purification of YUH1 has been achieved. The final yield 
of purified enzyme was ca. 150 mg/L cell culture. 
Complete cleavage of sulfonated Ub-Ori-ISP using a Ub-Ori-ISP:YUH1 molar ration of 20:1 
was accomplished in a time period of 22 hours under the conditions used. 
Preliminary cleavage experiments were performed on Ub-LCA ferredoxin, however, the 
progress of cleavage was only about 20 % when a Ub-LCA ferredoxin:YUH1 molar ratio of 
1:1 was applied under the conditions used and hence the procedure should be further 
optimized.    
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Chapter ten 
 
 
 
10 Purification of Ub-LCA and LCA ferredoxin 
This chapter presents the cultivation of E. coli cells expressing Ub-LCA or LCA ferredoxin 
and small scale purification procedures for both proteins. A large scale purification procedure 
for Ub-LCA ferredoxin and experiments concerning cleavage of Ub-LCA ferredoxin on a 
large scale and purification of the reaction products are also presented. 
Two approaches for obtaining LCA ferredoxin are exploited in this chapter. One is to obtain 
Ub-LCA ferredoxin and then cleave off ubiquitin using the Ub-protease, YUH1. The other is 
to obtain LCA ferredoxin directly from cells co-expressing Ub-LCA ferredoxin and UBP1. 
The co-expression is hoped to yield LCA ferredoxin by proteolytic cleavage (ection 4.6). 
Strains expressing Ub-LCA ferredoxin were used since high yields are obtainable (section 
4.5). 
To perform characterization of LCA ferredoxin it is necessary at least at some point to obtain 
the ferredoxin without the Ub-fusion. Preliminary characterization can however be performed 
on the Ub-LCA ferredoxin since most methods for characterization of the protein and the FeS 
cluster(s) are assumed to be more or less independent on ubiquitin (UV-visible spectrophoto-
metry, EPR, Mössbauer and electrochemical measurements). Since it was not possible to 
obtain suitable crystals on the apo-Ub-Ori-ISP fusion protein (section 5.3.3) it may also prove 
difficult to obtain diffracting crystals on the Ub-LCA ferredoxin fusion protein. Therefore a 
method to obtain LCA ferredoxin is sought. 
The sequence of LCA ferredoxin was obtained from phylogenetic analyses of dicluster 
ferredoxins and it contains the cysteines necessary for coordination of two FeS clusters (see 
section 3.3.2). It is hoped that holo-LCA ferredoxin is obtainable directly from expression in 
E. coli cells (contrary to holo-Ub-Ori-ISP, chapter 5). Obtained holo-LCA and holo-Ub-LCA 
ferredoxin are further assumed to contain two FeS clusters.   
 
10.1 Experimental 
All purifications and cleavage experiments were performed anaerobically using either inert 
gas flushing or an anaerobic chamber (see sections 4.1 and 4.2.2). 
 
10.1.1 Cultivation of cells  
The cultivation protocol presented in this section was based on strategies previously 
developed in our laboratories for cultivation of cells expressing FeS proteins (Caspersen et 
al., 2000). The two strains used are HC1269 (selection marker: 30 μg/ml Kan), which 
expresses Ub-LCA ferredoxin, and HC1419 (selection markers: 30 μg/ml Kan and 20 μg/ml 
Cam), which co-expresses Ub-LCA ferredoxin and UBP1 (see section 4.7). 
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The following procedure is for cultivation of 6 times 650 ml cell cultures using either 
HC1269 or HC1419. Cells from the glycerol stock were plated on an LB agar plate containing 
the appropriate selection marker and incubated overnight at 37ºC. Two single colonies were 
used to each inoculate 50 ml TB media containing the appropriate selection marker. 
Incubation with shaking (250 rpm) in 300 ml triple baffled shake flasks was performed at 
37ºC until an OD600 of 0.6 to 1.0 was obtained. The pre-cultures were stored at 4ºC overnight. 
The cells of the two pre-cultures were then sedimented (centrifuged at 4ºC and 2300 g for  
10 min) and supernatants discarded. The two cell portions were each re-suspended in 23 ml 
fresh TB media containing the appropriate selection marker. 6.5 ml portions were transferred 
to six 2 L triple baffled shake flasks each containing 650 ml TB media (and the appropriate 
selection marker). The cultures were incubated at 30ºC with shaking (250 rpm) until the 
OD600 was 2.4. Protein expression was induced by addition of IPTG (200 mM stock solution) 
to a final concentration of 0.1 mM, and the incubation was continued with shaking (250 rpm) 
for 2 hours at 30ºC. The cells were harvested by centrifugation at 3000 g and 4ºC for 15 min. 
The supernatants were discarded and each of the six portions of cells was re-suspended in 25 
ml cold (4ºC) 20 mM Tris/HCl pH 8.0 and transferred to 50 ml polypropylene tubes. The cells 
were sedimented by centrifugation (3000 g, 4ºC, 15 min) and the supernatants discarded. The 
cells were kept at -80ºC for storage. 
 
10.1.2 Small scale purification of Ub-LCA and LCA ferredoxin 
Protein obtained from the two strains was purified by the following procedure using inert gas 
flushing for obtaining anaerobic conditions. Protein extract was prepared aerobically. 
3 portions of harvested cells (cells from 1.95 litres of culture, total volume of cells was ca.  
35 ml) were thawed at 4ºC and re-suspended in cold (4ºC) 20 mM Tris/HCl pH 8.0 to a final 
volume of 120 ml. Na2S2O4 was added to a final concentration of 2 mM (1 M stock solution, 
freshly prepared). The cells were lysed by sonication (Satorius Labsonic P at 80 % amplitude) 
in three intervals of 30 seconds. The solutions were kept on ice at all times and allowed to 
cool between each sonication burst. The crude lysate was centrifuged at 24800 g for  
40 minutes at 4ºC. The protein extract (supernatant) was decanted, and the pellet discarded. 
The protein was then purified by HPLC (ÄKTATM purifier 100) in a three-step purification 
procedure (figure 10.1). The protein was frozen (-20ºC) between each of the three purification 
steps, which were performed at room temperature. The protein extract was diluted (ca. 3 
times) with 20 mM Tris/HCl, 2 mM Na2S2O4 pH 8.0 to a conductivity below 5 mS/cm and 
loaded onto a 20 mM Tris/HCl, 2 mM Na2S2O4, 0.05 M NaCl pH 8.0 equilibrated HiLoad  
16/10 Q Sepharose High Performance column (linear flow rate: 0.6 cm/min). Protein was 
eluted using a linear gradient, 0.1 M to 0.6 M NaCl in 12.5 CV, and fractions were collected. 
For each of the collected fractions the buffer was changed to 20 mM Tris/HCl, 2 mM 
Na2S2O4, 0.15 M NaCl pH 8.0 and the volume reduced to ca. 4 ml by ultrafiltration using a 
stirred Amicon cell with a YM3 membrane. Each sample was filtered (0.45 μm) and loaded 
onto a 20 mM Tris/HCl, 2 mM Na2S2O4, 0.15 M NaCl pH 8.0 equilibrated HiLoad 16/60 
Superdex 75 prep grade column and fractions were collected upon elution with the same 
buffer (linear flow rate: 0.2 cm/min). Ub-LCA or LCA ferredoxin was finally purified on a  
20 mM Tris/HCl, 2 mM Na2S2O4, 0.05 M NaCl pH 8.0 equilibrated 16/10 Source 30Q 
column. Fractions collected from the gel filtration step were filtered (0.45 μm) and diluted 
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three times with 20 mM Tris/HCl, 2 mM Na2S2O4 pH 8.0 before loading onto the column. 
The protein was eluted (linear flow rate: 1.2 cm/min) using a linear gradient; 0.17 M to 0.35 
M NaCl in 12 CV (when purifying Ub-LCA ferredoxin) or 0.22 M to 0.40 M NaCl in 12 CV 
(when purifying LCA ferredoxin), and fractions were collected. The purity was tested by 
SDS-PAGE. The yield of protein was determined by UV-vis spectrophotometric analysis by 
assuming a molar absorptivity of 30.6 mM-1·cm-1 at 390 nm (this value is valid for C. 
acidiurici 2 × [4Fe-4S] ferredoxin (Lode et al., 1974)) and using molecular weights of holo-
Ub-LCA and holo-LCA ferredoxin calculated to 14.8 kDa (apo-form, 14.1 kDa) and 6.3 kDa 
(apo-form, 5.6 kDa), respectively.  
 
 Capture of protein by anion-exchange on HiLoad 16/10 Q Sepharose High Performance 
column (small scale protocol) or 50/7 Q Sepharose Fast Flow column (large scale protocol)   
 
Intermediate purification by gel filtration on HiLoad 
16/60 Superdex 75 prep grade column 
 
 
 
 
 
 
 
Polishing by high resolution anion-exchange on 
16/10 Source 30Q column  
 
 
Figure 10.1 Flowchart of the three-step purification procedure of Ub-LCA or LCA ferredoxin.  
 
10.1.3 Large scale purification of Ub-LCA ferredoxin 
The small scale purification procedure (section 10.1.2) was scaled up to allow purification of 
protein from 12 portions of Ub-LCA ferredoxin producing cells (HC1269, from 7.8 litres of 
culture). Protein extract was prepared as described, but the first purification column was 
replaced by a 50/7 Q Sepharose Fast Flow column (figure 10.1). The diluted protein extract 
was loaded onto the 20 mM Tris/HCl, 2 mM Na2S2O4, 0.05 M NaCl pH 8.0 equilibrated 
column (linear flow rate: 0.6 cm/min) and eluted using a linear gradient, 0.15 M to 0.45 M 
NaCl in 5 CV. The volume of the collected fraction was reduced to ca. 15 ml and the protein 
was further purified by gel filtration (a maximum of 4 ml was loaded for each run) and high 
resolution anion-exchange (section 10.1.2).   
 
10.1.4 Proteolytic cleavage of Ub-LCA ferredoxin 
Experiments described in this section were performed in an anaerobic chamber (section 4.2.2) 
and HPLC purifications were performed on an ÄKTAprimeTM plus system. Two cleavage 
experiments were performed. 
In the first experiment 22.6 mg purified Ub-LCA ferredoxin (in 10 ml 20 mM Tris/HCl,  
2 mM Na2S2O4 pH 8.0) and 3.0 ml 17.6 mg/ml YUH1 (ca. 10 mM Bis-Tris propane/HCl  
pH 7.0, 50 % (w/v) glycerol) were mixed and the buffer was changed to 100 mM Tris/HCl pH 
8.5 via ultrafiltration using a Vivacell 70 equipped with a 5000 MWCO membrane. The 
 - 113 -
Part I                                                                      Purification of Ub-LCA and LCA ferredoxin 
volume was adjusted to 5.0 ml and DTT was added (500 mM stock solution) to a final 
concentration of 8 mM. The final Ub-LCA ferredoxin and YUH1 concentrations were  
4.4 mg/ml and 13.2 mg/ml, respectively. The molar ratio of Ub-LCA ferredoxin:YUH1 was 
approximately 1:1. The solution was left with gentle stirring for 22 hours. The buffer was 
changed to 20 mM Tris/HCl, 20 mM imidazole, 0.5 M NaCl pH 7.5 using a Vivacell 20 
equipped with a 3000 MWCO membrane and the volume adjusted to 10 ml. The purification 
was carried out in 5 runs. In each run 2 ml of the solution was loaded onto a 20 mM Tris/HCl, 
20 mM imidazole, 0.5 M NaCl pH 7.5 equilibrated 5 ml HisTrap HP column (flow rate:  
2 ml/min), and the flow through and wash out containing LCA ferredoxin and un-cleaved Ub-
LCA ferredoxin was collected. YUH1 was eluted using 20 mM Tris/HCl, 0.5 M imidazole, 
0.5 M NaCl pH 7.5 and discarded. LCA and Ub-LCA ferredoxin were separated by anion-
exchange. The solution containing LCA and Ub-LCA ferredoxin was diluted five times with 
20 mM Tris/HCl pH 8.0 and loaded onto a 20 mM Tris/HCl, 0.05 M NaCl pH 8.0 equilibrated 
6 ml Resource Q column (flow rate: 4 ml/min). Proteins were eluted using a linear gradient,  
0.17 M to 0.5 M NaCl in 22 CV, and fractions were collected. 
In the second experiment 14 mg Ub-LCA ferredoxin (in 3.5 ml 20 mM Tris/HCl) and 3.0 ml 
17.6 mg/ml YUH1 (ca. 10 mM Bis-Tris propane/HCl pH 7.0, 50 % (w/v) glycerol) were 
mixed and the buffer was changed to 20 mM Tris/HCl, 0.15 M NaCl pH 8.0 via ultrafiltration 
using a Vivacell 70 equipped with a 5000 MWCO membrane. The volume was adjusted to 
2.5 ml and DTT was added (500 mM stock solution) to a final concentration of 20 mM. The 
final Ub-LCA ferredoxin and YUH1 concentrations were 5.6 mg/ml and 21.1 mg/ml, 
respectively. The molar ratio of Ub-LCA ferredoxin:YUH1 was approximately 1:2. The 
solution was left with gentle stirring for 22 hours. Purification was then performed as 
described above. 
Purified LCA ferredoxin from the two experiments was pooled, concentrated to 14.3 mg/ml 
and the buffer was changed to 20 mM Tris/HCl pH 8.0 via ultrafiltration using a Vivacell 20 
equipped with a 3000 MWCO membrane. The purity was tested by SDS-PAGE. 
 
10.1.5 Solubility tests of LCA ferredoxin  
To find the optimal concentration of LCA ferredoxin necessary for crystallization, The 
Solubility Tool Kit (Molecular Dimensions) was set up. This was performed in the anaerobic 
chamber (section 4.2.2) at room temperature. For each precipitant available, only the lowest 
and the highest concentrations were tested. When testing salts as precipitants, the pH was 
predetermined (pH 4.5 and 9.0) and when testing PEGs and MPD a pH of 5.5 was applied. 
The hanging drop vapour diffusion method was applied and each drop was equilibrated over 
500 μl of reservoir solution. Drops were set up using 1 μl of protein solution (14.3 mg/ml in 
20 mM Tris/HCl pH 8.0) and 1 μl of reservoir solution.   
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10.2 Results 
 
10.2.1 Expression and small scale purifications of LCA and Ub-LCA 
ferredoxin 
Independent on the strain (HC1269 or HC1419) used, the cells obtained from the cultivation 
(section 10.1.1) had a greenish brow colour and ca. 10 ml to 15 ml cell paste was obtained 
from 650 ml culture. The protein extract obtained from cell lysis had a yellowish brown 
colour. When performing SDS-PAGE on cells or cell extract (results not shown) no distinct 
bands were observed for either strain. 
 
10.2.1.1 Purification of Ub-LCA ferredoxin 
When the protein extract (obtained from HC1269) containing Ub-LCA ferredoxin was loaded 
onto the 16/10 Q Sepharose High Performance column a greenish brown band appeared close 
to the top of the column. Upon elution the brown band moved down the column and was 
collected in one fraction (figure 10.2). The maximum absorption of the peak corresponding to 
the brown band was observed at a conductivity of 22.9 mS/cm (measured at 390 nm). After 
elution the column had a greyish colour, and it was cleaned with 1 M acetic acid, 2 M NaCl 
and 1 M NaOH. The brown coloured protein was further purified by gel filtration (two runs as 
described in section 10.1.2) on the HiLoad 16/60 Superdex 75 prep grade column. Upon 
elution one brown band was observed moving down the column and collected in one fraction 
(figure 10.3). The maximum absorption of the peak corresponding to the brown band was 
observed at 72.0 ml (measured at 390 nm). The brown coloured protein was finally purified 
by high resolution anion-exchange on the 16/10 Source 30Q column. Again, one brown band 
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Figure 10.2 Chromatogram for purification of Ub-LCA ferredoxin obtained from HC1269 on the 16/10 Q 
Sepharose High Performance column. The collected fraction is indicated with a black box and the 
conductivity at maximum absorption (390 nm) is also indicated. The red and pink lines indicate the 
absorbance at 280 nm and 390 nm, respectively. The brown and the green lines indicate the conductivity and 
the NaCl gradient, respectively. The concentration of NaCl can be read from the conductivity axis employing 
the unit 10-2 M. 
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Figure 10.3 Chromatogram for purification of Ub-LCA ferredoxin obtained from HC1269 on the HiLoad 
16/60 Superdex 75 prep grade column. The collected fraction is indicated with a black box and the elution 
volume at maximum absorption (390 nm) is also indicated. The blue, the red and the pink lines indicate the 
absorbance at 236 nm, 280 nm and 390 nm, respectively. 
 
 
 
 
was observed upon elution and it was collected in one fraction (figure 10.4). The maximum 
absorption of the peak corresponding to the brown band was observed at a conductivity of 
22.7 mS/cm (measured at 390 nm). A UV-vis spectrum recorded of purified Ub-LCA 
ferredoxin is shown in figure 10.5 A. An absorption maximum at approximately 390 nm was 
evident. The purity of Ub-LCA ferredoxin was analysed by SDS-PAGE (figure 10.5 B). The 
yield was 2.7 mg/L cell culture.  
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Figure 10.4 Chromatogram for purification of Ub-LCA ferredoxin obtained from HC1269 on the 16/10 
Source 30Q column. The collected fraction is indicated with a black box and the conductivity at maximum 
absorption (390 nm) is also indicated. The blue, red and pink lines indicate the absorbance at 236 nm, 
280 nm and 390 nm, respectively. The brown and the green lines indicate the conductivity and the NaCl 
gradient, respectively. The concentration of NaCl can be read from the conductivity axis employing the unit 
10-2 M. 
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Figure 10.5 Identity of purified product from HC1269, Ub-LCA ferredoxin, analysed by UV-vis 
spectrophotometry and SDS-PAGE. A) UV-vis spectrum of purified Ub-LCA ferredoxin, a solution 
containing 0.4 mg/ml was diluted three times and the spectrum recorded. Absorption maximum at ca. 390 nm 
is indicated in the figure. B) SDS-PAGE results. Lane 1: 20 μl of a solution containing 0.4 mg/ml purified 
Ub-LCA ferredoxin. Lane 2: Marker, 1 μl.  
 
 
 
 
 
10.2.1.2 Purification of LCA ferredoxin 
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When the protein extract (obtained from HC1419) was loaded onto the 16/10 Q Sepharose 
High Performance column a greenish brown band appeared close to the top of the column, 
which was also the case when purifying protein from HC1269. However, upon elution the 
brown band split into two and each band was collected in one fraction (figure 10.6). The first 
brown band eluted was assigned to Ub-LCA ferredoxin (see section 10.3.1 for a discussion) 
and the maximum absorption of the peak was observed at a conductivity of 22.1 mS/cm  
 
  
  
  
  
  
  
  
  
  
  
  
  
  
 
 
 
 
Figure 10.6 Chromatogram for purification of Ub-LCA and LCA ferredoxin obtained from HC1419 on the 
16/10 Q Sepharose High Performance column. The collected fractions are indicated with black boxes and the 
conductivities at maximum absorption (390 nm) are also indicated. The red and pink lines indicate the 
absorbance at 280 nm and 390 nm, respectively. The brown and the green lines indicate the conductivity and 
the NaCl gradient, respectively. The concentration of NaCl can be read from the conductivity axis employing 
the unit 10-2 M. 
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(measured at 390 nm). The second brown band eluted was assigned to LCA ferredoxin (see 
section 10.3.1 for a discussion) and the maximum absorption of the peak was observed at a 
conductivity of 27.9 mS/cm (measured at 390 nm). Both were further purified by gel filtration 
on the HiLoad 16/60 Superdex 75 prep grade column. Upon elution one brown band was 
observed during each of the two purifications and it was collected in one fraction (figure 
10.7). Ub-LCA and LCA ferredoxin eluted at 71.5 ml and 78.2 ml, respectively (measured at 
390 nm). Both were purified by high resolution anion-exchange on the 16/10 Source 30Q 
column. Again, one brown band was observed upon elution in each of the purifications and it 
was collected in one fraction (figure 10.8). LCA and Ub-LCA ferredoxin eluted at  
23.5 mS/cm and 29.2 mS/cm, respectively (measured at 390 nm). The purities of LCA and 
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 Figure 10.7 Chromatograms for purification of Ub-LCA ferredoxin (A) and LCA ferredoxin (B) obtained 
from HC1419 on the HiLoad 16/60 Superdex 75 prep grade column. In each chromatogram the collected 
fraction is indicated with a black box and the elution volume at maximum absorption (390 nm) is also 
indicated. The blue, the red and the pink lines indicate the absorbance at 236 nm, 280 nm and 390 nm, 
respectively. 
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Ub-LCA ferredoxin were analysed by SDS-PAGE (figure 10.9). UV-vis spectra of purified 
LCA and Ub-LCA ferredoxin have an absorption maximum at approximately 390 nm (figure 
10.10). The yields of LCA and Ub-LCA ferredoxin were 0.3 mg/L cell culture and 1.6 mg/L 
cell culture, respectively.  
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Figure 10.8 Chromatograms for purification of Ub-LCA ferredoxin (A) and LCA ferredoxin (B) obtained 
from HC1419 on the 16/10 Source 30Q column. In each chromatogram the collected fraction is indicated 
with a black box and the conductivity at maximum absorption (390 nm) is also indicated. The blue, red and 
pink lines indicate the absorbance at 236 nm, 280 nm and 390 nm, respectively. The brown and the green 
lines indicate the conductivity and the NaCl gradient, respectively. The concentration of NaCl can be read 
from the conductivity axis employing the unit 10-2 M. 
 
10.2.2 Large scale purification of Ub-LCA ferredoxin 
Observations made during the large scale purification of Ub-LCA obtained from the HC1269 
strain were comparable to those observed from the small scale purification (section 10.2.1). 
Typical chromatograms obtained from the purification are shown in appendix A.3 along with 
purity analysis by SDS-PAGE. The yield of Ub-LCA ferredoxin was 1 to 2 mg/L cell culture.  
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Figure 10.9 Purity of LCA and Ub-LCA ferredoxin obtained from HC1419 tested by SDS-PAGE. Lane 1: 
20 μl of 1.8 mg/ml LCA ferredoxin. Lane 2: 5 μl of 6.4 mg/ml Ub-LCA ferredoxin. Lane 3: Marker, 1 μl. 
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 Figure 10.10 UV-vis spectra recorded of purified proteins obtained from HC1419. A) Purified Ub-LCA 
ferredoxin (0.2 mg/ml). B) Purified LCA ferredoxin (0.04 mg/ml). Maxima  and shoulders (sh) are indicated 
in the figures. 
 
 
 
10.2.3 Proteolytic cleavage of Ub-LCA ferredoxin 
Compared to the test experiment (section 9.3.4) some changes were made in the first cleavage 
reaction. The Ub-LCA ferredoxin concentration was raised from 1.5 to 4.4 mg/ml and the 
DTT concentration was doubled from 4 to 8 mM. During the cleavage reaction no visible 
changes happened and the brown colour of the solution was unchanged. After the 22 hours of 
reaction, the buffer of the reaction solution was changed and YUH1 was separated from LCA 
ferredoxin and un-cleaved Ub-LCA ferredoxin by passing the solution through a HisTrap 
column (figure 10.11). The brown coloured proteins were seen to pass straight through the 
column without binding while uncoloured compounds were seen to elute upon washing with 
0.5 M imidazole containing buffer. Ub-LCA and LCA ferredoxin were further purified by 
high-resolution anion-exchange (figure 10.12). The peak corresponding to Ub-LCA 
ferredoxin is dominating. Ub-LCA and LCA ferredoxin were collected separately. The UV-
vis spectrum of Ub-LCA ferredoxin was comparable to the one shown in figure 10.10 A while 
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the spectrum of LCA ferredoxin was comparable to the one shown in figure 10.10 B. The 
yield of LCA ferredoxin was 1.8 mg which corresponds to 19 % (on a molar basis) and the 
un-cleaved Ub-LCA ferredoxin recovered was 14.0 mg (62 %).   
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 Figure 10.11 Chromatogram for separation of Ub-LCA and LCA ferredoxin from YUH1 on the HisTrap 
column. The collected fraction is indicated with a black box. The red line indicates the absorption at 280 nm 
and the brown line indicates the conductivity. The green line indicates the gradient where 0 % corresponds to 
buffer containing 20 mM imidazole and 100 % corresponds to buffer containing 0.5 M imidazole. 
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Figure 10.12 Chromatogram for separation of Ub-LCA and LCA ferredoxin obtained from the first cleavage 
experiment on the 6 ml Resource Q column. The collected fractions are indicated with black boxes and the 
conductivities at maximum absorption (280 nm) are also indicated. The red line indicates the absorbance at 
280 nm. The brown and the green lines indicate the conductivity and the NaCl gradient, respectively. The 
concentration of NaCl can be read from the conductivity axis employing the unit 10-2 M. 
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Several changes were made in the second cleavage experiment. The DTT concentration was 
raised from 8 to 20 mM, the pH was lowered from 8.5 to 8.0 (also to include 0.15 M NaCl), 
the Ub-LCA ferredoxin concentration was raised from 4.4 mg/ml to 5.6 mg/ml and the molar 
ratio of Ub-LCA ferredoxin:YUH1 was raised from 1:1 to 1:2. Again, no visible changes 
happened during the cleavage reaction and separation of YUH1 from Ub-LCA and LCA 
ferredoxin was comparable to what was described above. Ub-LCA and LCA ferredoxin were 
separated by high-resolution anion-exchange (figure 10.13). Contrary to the previous 
separation (figure 10.12), the peaks corresponding to Ub-LCA and LCA ferredoxin were now 
comparable in size. The yield of LCA ferredoxin was 1.9 mg corresponding to 32 % (on a  
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Figure 10.13 Chromatogram for separation of Ub-LCA and LCA ferredoxin obtained from the second 
cleavage experiment on the 6 ml Resource Q column. The collected fractions are indicated with black boxes 
and the conductivities at maximum absorption (280 nm) are also indicated. The red line indicates the 
absorbance at 280 nm. The brown and the green lines indicate the conductivity and the NaCl gradient, 
respectively. The concentration of NaCl can be read from the conductivity axis employing the unit 10-2 M. 
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Figure 10.14 Purity of LCA ferredoxin obtained from cleavage reaction and recovered Ub-LCA ferredoxin 
tested by SDS-PAGE. Lane 1: 0.5 μl of 16.1 mg/ml Ub-LCA ferredoxin. Lane 2: 2 μl of 14.3 mg/ml LCA 
ferredoxin. Lane 3: 0.5 μl of 14.3 mg/ml LCA ferredoxin. Lane 4: Marker, 1 μl.  
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molar basis) and the un-cleaved Ub-LCA ferredoxin recovered was 5.5 mg (39 %). The total 
yield of LCA ferredoxin obtained from the first and second cleavage experiment was 0.1 and 
0.2 mg/L cell culture, respectively. LCA ferredoxin obtained from the two cleavage reactions 
was pooled and concentrated to 14.3 mg/ml. The purity of LCA and Ub-LCA ferredoxin was 
tested by SDS-PAGE (figure 10.14). Recovered Ub-LCA ferredoxin gave several bands on 
the SDS-PAGE in addition to the band assigned to Ub-LCA ferredoxin, while LCA 
ferredoxin gave one band at ca. 26 kDa and a faint band assigned to LCA ferredoxin. 
 
10.2.4 Solubility tests of LCA ferredoxin 
When testing salts as precipitants at pH 4.5 heavy precipitations were observed within a day 
even at the low salt concentration. Phase separations were also observed at high salt 
concentrations. When using sodium acetate, ammonium dihydrogen phosphate and 
ammonium citrate, denaturation and colour loss were observed within two weeks. 
When testing salts as precipitants at pH 9.0, no precipitation was observed when sodium 
acetate, magnesium sulfate and calcium chloride were used. With di-ammonium hydrogen 
phosphate and ammonium citrate, slight precipitation was observed at the low concentrations 
while heavy precipitation was evident at high concentrations. Ammonium sulfate resulted in 
heavy precipitation at high concentration while no precipitation was observed at low 
concentration. The drops in which heavy precipitation had been observed at high 
concentrations were then equilibrated over low concentration solutions. This resulted in 
dissolution of the precipitation obtained using ammonium sulfate and di-ammonium hydrogen 
phosphate while a marked reduction in the amount of precipitation was observed for 
ammonium citrate. 
PEGs and MPD were tested as precipitants at pH 5.5. PEG 400 resulted in precipitation after 
one week at high concentration while slight precipitation was observed at low concentration 
after four weeks. PEG 4000 and 8000 resulted in slight precipitation at low concentrations 
and moderate precipitation at high concentration within one week. MPD caused colour loss 
and denaturation. 
 
10.3 Discussion 
 
10.3.1 Small scale purifications of Ub-LCA and LCA ferredoxin 
It was first attempted to purify Ub-LCA ferredoxin since it is easily detectable by SDS-PAGE 
and this could prove advantageous if holo-protein was not formed in the E. coli cells. LCA 
ferredoxin is not expected to be easily detectible by SDS-PAGE (stained with Coomassie blue 
G-250) since it only contains two basic and no aromatic residues (figure 3.3) (Compton and 
Jones, 1985).  
Protein extract obtained from the two strains did not show any distinct bands for Ub-LCA 
ferredoxin or Ub when analysing the extract by SDS-PAGE. This shows that the Ub-LCA 
ferredoxin has not been highly over-expressed in any of the strains and the cultivation 
protocols should be optimized.   
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10.3.1.1 Purification of Ub-LCA ferredoxin  
When performing purification of Ub-LCA ferredoxin from HC1269, brown coloured protein 
was evident from the first purification step (section 10.2.1.1), which indicates the presence of 
an FeS protein. The brown coloured protein was purified and the identity verified by SDS-
PAGE analysis (figure 10.5 B) and UV-vis spectrophotometric analysis (figure 10.5 A). The 
dominating band on the SDS-PAGE was at ca. 14.4 kDa and apo/holo-Ub-LCA ferredoxin 
has a molecular weight of 14.8/14.1 kDa. A minor impurity was observed at ca. 20 kDa. This 
impurity may be removed by further optimization of the purification procedure. From the UV-
vis spectrum an absorption maximum at ca. 390 nm was observed (figure 10.5 A). This 
spectrum is very similar to the spectra obtained from holo-Ub-Ori-ISP (chapters 6 and 7), 
which were assigned to a [4Fe-4S]2+ protein. Therefore it can be said with great certainty that 
Ub-LCA ferredoxin contains at least one [4Fe-4S]2+ cluster. This proves that holo-Ub-LCA 
ferredoxin has been produced in E. coli cells. The yield of protein was however very low  
(2.7 mg/L cell culture) and the cultivation procedure should be optimized. 
 
10.3.1.2 Purification of LCA ferredoxin 
When purifying protein from HC1419 two peaks corresponding to the collected brown 
fractions were observed from the chromatogram for the first purification (figure 10.6). 
Comparing this chromatogram to the one obtained when purifying Ub-LCA ferredoxin from 
HC1269 (figure 10.2) it is evident that the peak at 22.1 mS/cm (figure 10.6) is comparable to 
the peak assigned to Ub-LCA ferredoxin eluting at 22.9 mS/cm (figure 10.2). The first peak 
was therefore assigned to Ub-LCA ferredoxin. The second peak at 27.9 mS/cm (figure 10.6) 
was assigned to LCA ferredoxin, since LCA ferredoxin is expected to elute at a higher 
conductivity due to the change in surface charge distribution. A shift in elution to higher 
conductivities was also observed when ubiquitin was cleaved off Ub-Ori-ISP (producing Ori-
ISP, chapter 7). Both of the brown coloured proteins were purified and their identity verified 
by SDS-PAGE analysis (figure 10.9) and UV-vis spectrophotometric analysis (figure 10.10). 
Analysing Ub-LCA ferredoxin by SDS-PAGE gave a result (figure 10.9 lane 2) which was 
highly similar to the result obtained when purifying Ub-LCA ferredoxin from HC1269 (figure 
10.5 B). Further, the UV-vis spectrum (figure 10.10 B) was almost identical to the one 
obtained from HC1269 Ub-LCA ferredoxin (figure 10.5 A). On SDS-PAGE (figure 10.9  
lane 1) LCA ferredoxin gave a dominating band at ca. 3 kDa. Compared to the amount 
loaded, this band is very faint, which was also expected. This provides a hint that it in fact is 
LCA ferredoxin (molecular weight of apo/holo-protein is 5.6/6.3 kDa) even though the band 
is found at quite a low molecular weight. It is however my experience that low molecular 
weight proteins and peptides often do possess odd properties when analysed by SDS-PAGE. 
To obtain an indisputable verification, LCA ferredoxin should be analysed by mass 
spectrometry. An impurity at ca. 14.4 kDa was observed in the gel which may be removed by 
further optimization of the purification procedure. The UV-vis spectrum supports the identity 
of LCA ferredoxin (figure 10.10 B) since no absorption maximum at 280 nm associated with 
aromatic residues are present. Distinct absorption maxima are present at approximately 305 
nm and 390 nm, which strongly indicate the presence of FeS clusters. The UV-vis spectrum is 
almost identical to the spectra obtained for holo-Ub-LCA ferredoxin (figure 10.10 A) except 
for the missing absorption at 280 nm. Purified LCA ferredoxin very likely contains one or two 
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[4Fe-4S]2+ clusters. The yield of protein was however very low; 0.3 mg LCA ferredoxin and 
1.6 mg Ub-LCA ferredoxin per litre of cell culture. This corresponds to that approximately  
30 % of holo-protein is found as holo-LCA ferredoxin (on a molar basis). Therefore the 
cultivation procedure should be optimized. 
In chapter 9 it was found that YUH1 was inefficient in cleaving Ub-LCA ferredoxin in vitro 
under the investigated conditions and based on the results presented in this chapter UBP1 also 
appears inefficient for in vivo cleavage of Ub-LCA ferredoxin. 
 
10.3.1.3 The strategy for obtaining LCA ferredoxin for further 
characterization 
From the HC1269 strain the yield of Ub-LCA ferredoxin was 2.7 mg/L cell culture. If all 
protein could be cleaved and retained this would result in a yield of LCA ferredoxin of  
1.1 mg/L cell culture. Initial cleavage experiments were performed (see chapter 9), and here it 
was observed that cleavage was about 20 % under the conditions used, which would result in 
a yield of 0.2 mg/L cell culture. This is lower than the LCA ferredoxin yield from the 
HC1419 strain (0.3 mg/L cell culture). Since complete cleavage of Ub-Ori-ISP was obtained 
using much less YUH1 (see chapter 9) it is believed that the conditions for Ub-LCA 
ferredoxin cleavage can be optimized further. As stated in the beginning of the chapter it is 
not necessary to cleave off Ub for preliminary characterization. Therefore it was decided to 
proceed with purification of Ub-LCA ferredoxin from the HC1269 strain and then perform 
cleavage of the purified Ub-fusion using YUH1. 
 
10.3.2 Large scale purification of Ub-LCA ferredoxin  
During the purification procedure it was observed from UV-vis spectrophotometric measure-
ments at 390 nm (results not shown) that about 50 % of the starting material was lost for each 
of the purification steps; gel filtration and high resolution anion-exchange. Normally, 
recovery is about 90 to 95 %, which accounts for some of the loss. As seen from the 
chromatograms (appendix A.3) the compound that is responsible for the absolute majority of 
absorption at 390 nm is Ub-LCA ferredoxin. Separation of coloured compounds cannot 
account for all of the remaining loss. Since the inert gas flushing was used for obtaining 
anaerobic conditions, complete removal of oxygen is not accomplished (see section 6.3.2.1). 
Breakdown due to oxidation may account for the remaining loss of protein since FeS proteins 
generally are oxygen sensitive (see chapter 2). The stability of Ub-LCA/LCA ferredoxin 
towards oxygen has not been examined. Therefore, it may be an advantage to perform 
purification inside an anaerobic chamber. The yield of the large scale purifications was found 
from 1 to 2 mg/L cell culture. This is lower than for the small scale purifications and may be 
attributed to the cultivation procedure and breakdown during purification. The same problems 
are expected when working with expression and purification of protein from the HC1419 
strain. 
The purity of the obtained product was analysed by SDS-PAGE (appendix A.3) and as seen 
previously (section 10.3.1) an impurity around 20 kDa is present. 
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10.3.3 Proteolytic cleavage of Ub-LCA ferredoxin 
 
10.3.3.1 Separation of reaction products from proteolytic cleavage 
Prior to proteolytic cleavage it was tested how the products of the reaction could be separated 
on analytical columns (these results are not shown). It was found that at pH 8.0 Ub-LCA and 
LCA ferredoxin were separable by anion-exchange (1 ml Resource Q column) (as previously 
shown, see section 10.3.1) and ubiquitin did not bind to the column. LCA ferredoxin and 
YUH1 eluted at the same conductivity rendering them inseparable by anion-exchange at this 
pH. Upon analytical gel filtration (13/31 Superdex 75 HR) it was found that YUH1 and LCA 
ferredoxin were separable but Ub-LCA ferredoxin and Ub could not be completely separated 
from LCA ferredoxin. YUH1 is equipped with a His6-tag (YUH1-His6) and it was found that 
the enzyme was able to completely bind to a 5 ml HisTrap HP column (10.6 mg, 20 mM 
Tris/HCl, 20 mM imidazole, 0.5 M NaCl pH 7.5). 
Based on the observations the following purification strategy was adopted: YUH1 should be 
removed from other products and reactants by purification on a HisTrap HP column and then 
LCA ferredoxin should be separated from Ub and Ub-LCA ferredoxin by anion-exchange.  
 
10.3.3.2 Cleavage followed by separation 
In the first cleavage reaction some changes to the preliminary cleavage experiments (section 
9.3.4) were made (section 10.2.3). The yields of the two procedures were similar. Therefore 
doubling the DTT concentration and tripling the Ub-LCA ferredoxin concentration did not 
seem to have any effect on the yields.   
In the second experiment several changes were made (see section 10.2.3). The yield of LCA 
ferredoxin increased from 19 % to 32 %. The dramatic change was also observed in the anion-
exchange chromatograms from each experiment (compare figures 10.12 and 10.13). Since 
several changes were made compared to the first experiment, it is difficult to single out one 
parameter responsible for the higher yield and it may be a combination of parameters. Since 
DTT and Ub-LCA ferredoxin concentrations did not seem to play any significant part as 
judged from the first experiment, the increased Ub-LCA ferredoxin:YUH1 molar ratio (from 
1:1 to 1:2) and the decrease in pH (from 8.5 to 8.0) may be responsible. It is necessary to 
further investigate the effects of pH and molar excess of YUH1. To increase the yield even 
further, it may be advantageous to increase the temperature of the reaction mixture to 37 ºC 
(see chapter 9). 
The purity of recovered Ub-LCA ferredoxin from the cleavage reaction was tested by SDS-
PAGE (figure 10.14 lane 1). As observed previously (section 10.3.1) the impurity at 20 kDa 
was still present and even more prominent. Impurities at 15 and 10 kDa had now become 
apparent. These impurities had probably been present prior to cleavage, but now they were 
visible since they had remained (accumulated) during purification while some of the Ub-LCA 
ferredoxin had been cleaved to LCA ferredoxin. 
The purity of LCA ferredoxin was also tested by SDS-PAGE (figure 10.14 lanes 2 and 3). 
Besides the faint band assigned to LCA ferredoxin, a dominating band at ca. 26 kD was 
present. This band was assigned to YUH1 (see chapter 9). Comparing the intensity of the 
band to gels containing known amounts of YUH1 (results not shown) a rough estimate of the 
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degree of contamination was ca. 10 to 15 % of the total mass. The presence of YUH1 must be 
a result of incomplete binding to the HisTrap HP column or that the column was overloaded. 
Purified YUH1 loaded in a comparable amount was however found to bind completely to the 
HisTrap HP column (section 10.3.3.1). The other compounds found in solution (Ub, LCA 
ferredoxin and uncleaved Ub-LCA ferredoxin) might induce incomplete binding. Since the 
cleavage reaction was incomplete it is imaginable that YUH1 could be in contact with Ub-
LCA ferredoxin, which may somehow hinder contact between the His6-tag and the column 
material. YUH1 and LCA ferredoxin can be separated by gel filtration (section 10.3.3.1). This 
would however require a third purification step and it may be better changing the strategy for 
separation of LCA ferredoxin from YUH1, Ub and Ub-LCA ferredoxin by skipping the 
HisTrap HP column and performing anion-exchange followed by gel filtration instead.  
 
10.3.4 Re-evaluation of the procedure for obtaining LCA ferredoxin 
The yield of LCA ferredoxin from the second cleavage experiment was low (ca. 30 %) and at 
least two purification steps are believed to be required (section 10.3.3.2) for optimal 
separation of products. The total yield of LCA ferredoxin from the procedure of first purifying 
Ub-LCA ferredoxin and then performing cleavage reactions and purifications was about  
0.2 mg/L cell culture. This is comparable to what was obtained when purifying LCA 
ferredoxin directly from the cell extract (0.3 mg/L, see section 10.2.1.2). At the same time a 
huge amount of YUH1 was used (4 mg per 1 mg Ub-LCA ferredoxin) which makes this 
procedure time-consuming and expensive.  
At present it seems more advantageous to return to the strategy of obtaining LCA ferredoxin 
directly from the E. coli cells (HC1419) and to optimize the cultivation procedure to yield 
more LCA ferredoxin. Alternatively, a new E. coli strain should be constructed which only 
expresses LCA ferredoxin. 
 
10.3.5 Solubility tests of LCA ferredoxin 
LCA ferredoxin was contaminated with YUH1 (see section 10.3.3.2) but since a very small 
amount was available it was decided not to further purify but instead test the concentration 
range for crystallization to be used for future experiments. 
The Solubility Tool Kit (Molecular Dimensions) was applied to test solubility properties of 
LCA ferredoxin. It applies the Hofmeister series for testing different salts (Collins, 2004; 
Riès-Kautt and Ducruix, 1997) and tests solubility at pH (4.5) < pI, pH (9.0) > pI and pH ≈ pI.  
Apo-LCA ferredoxin has a theoretical pI of 4.0 (calculated using the ExPASy Proteomics 
Server, Bjellqvist et al., 1993 and 1994) and therefore at pH 4.5 the holo-protein is very close 
to the pI. At pH ≈ pI the net charge of a protein is close to zero and the solubility is very low. 
This is also reflected by the results since at pH 4.5 massive precipitations occurred when 
using various salts as precipitants (section 10.2.4). The protein was also found to denature 
using certain precipitants, which may be due to a combination of the precipitant in question 
and the pH since the stability of LCA ferredoxin at various pH values has not been 
determined.  
At pH 9.0 ammonium sulfate, di-ammonium hydrogen phosphate and ammonium citrate 
yielded brown precipitation while sodium acetate, magnesium sulfate and calcium chloride 
did not yield any precipitation. This is in agreement with the Hofmeister series since the first 
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three precipitants are more powerful. The precipitation was either completely or to a high 
extent soluble which shows that the precipitation was crystalline and provides hopes for 
future crystallization.  
When using salts as precipitants the solubility is highly dependent on pH and the particular 
precipitant. It might be necessary to test the solubility and precipitation properties over a 
broad concentration interval e.g. from 5 to 20 mg/ml. 
When pH ≈ pI organic solvents such as PEGs and MPD are applied in The Solubility tool Kit. 
The lowest pH available is pH 5.5 which was used in the experiments. MPD resulted in 
denaturation of the protein. This may be a combined effect of pH and precipitant. Applying 
PEG 4000 and 8000 as precipitants, precipitation was observed at the low concentration 
within a week which might suggest that the protein concentration is too high. PEG 400 did 
not result in precipitation at the lowest concentration until four weeks had passed indicating 
the concentration might be close to optimal under the given conditions.  
Future crystallization experiments will probably include commercially available screens and it 
may be useful to test two or three different LCA ferredoxin concentrations. 
 
10.4 Conclusion 
Two approaches for obtaining holo-LCA ferredoxin have investigated: either directly from 
protein expressing cells (co-expression of Ub-LCA ferredoxin and UBP1) or from proteolytic 
cleavage of already purified Ub-LCA ferredoxin (from Ub-LCA expressing cells).  
Procedures for expression of holo-Ub-LCA and holo-LCA ferredoxin in E. coli cells have 
been prepared. The yield of each protein was very low and the procedures should be further 
optimized. 
Procedures for small scale purification of Ub-LCA and LCA ferredoxin along with a large 
scale procedure for purification of Ub-LCA ferredoxin have been developed. 
Proteolytic cleavage of Ub-LCA ferredoxin using YUH1 to obtain LCA ferredoxin has been 
partly optimized. However further optimization is required to improve the yield and to 
minimize YUH1 consumption. Separation of the reaction products has been examined and a 
purification strategy put forward. 
The yields of LCA ferredoxin obtained from the two approaches were comparable. However, 
obtaining LCA ferredoxin directly from protein expressing cells proved much less time 
consuming. 
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Chapter eleven 
 
 
 
11 Crystallization trials for Pyrococcus furiosus [4Fe-4S] 
ferredoxin 
This chapter describes trials to crystallize the [4Fe-4S]2+ ferredoxin from the hyperthermo-
philic archaeon P. furiosus (section 2.5). Crystal structures of the native [3Fe-4S] ferredoxin 
along with the mutant D14C [4Fe-4S] ferredoxin have already been solved (Nielsen et al., 
2004; Johannesen et al., in preparation). Earlier attempts to crystallize the native [4Fe-4S] 
ferredoxin in our research group (unpublished) have been unsuccessful. It was therefore 
decided to start from scratch and screen for crystallization conditions for the native [4Fe-4S] 
ferredoxin. Reasons as to why crystallization of the [4Fe-4S] ferredoxin appears to be difficult 
are also investigated. 
Expression and purification of P. furiosus ferredoxin were performed under aerobic 
conditions by Laboratory Assistant, Stephanie Boy and Managing Laboratory Technician, 
Lise-Lotte Jespersen in accordance to existing procedures described in in-house protocols. In 
all the presented crystallization trials the protein used was in 20 mM Tris/HCl pH 8.0 and 
stored at -20ºC or in liquid nitrogen. The concentration of holo-protein was calculated using a 
molar absorptivity of 17 mM-1·cm-1 at 390 nm (Conover et al., 1990). 
 
11.1 Experimental 
Aerobic screening was performed at the University of Copenhagen, Department of Chemistry 
(section 11.1.1), while anaerobic screening and initial optimization was performed at IBS 
(Grenoble, France) (section 11.1.2.1). Further optimization was performed in our own 
laboratories (11.1.2.2). 
  
11.1.1 Aerobic screening 
Protein purified under aerobic conditions was re-purified by HPLC (ÄKTATM purifier 100) 
using high resolution anion-exchange under anaerobic conditions using Ar-flushing. This was 
performed by loading the protein onto a 20 mM Tris/HCl pH 8.0 equilibrated 16/10 Source 
30Q column. The protein was eluted using a linear gradient from 0.15 M to 0.3 M NaCl in  
10 CV. The buffer was changed to 20 mM Tris/HCl pH 8.0 via ultrafiltration and up-
concentrated using a stirred Amicon cell equipped with a YM3 membrane. 
Initial crystallization screening was carried out under aerobic conditions using an Oryx 8 
robot system from Douglas Instruments at room temperature. Prior to set up, the protein 
solution was spun for 10 min at 10000 g. Three commercially available screens were 
employed, each containing 96 reagents: Index Screen (Hampton Research), JCSG+ Suite and 
PACT Suite (both from Quiagen). The sitting drop vapour diffusion technique was applied 
and the reservoir and total drop volumes were 100 μl and 0.3 μl, respectively. For each tested 
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condition, three drops were set up containing 25 %, 50 % and 75 % of protein solution, 
respectively. All three screens were set up using a protein stock of 14.5 mg/ml and all were 
stored at room temperature. The JCSG+ suite was also set up using a protein stock of  
45.0 mg/ml. Conditions for set up are presented in table 11.1. 
 
Table 11.1 Overview of aerobic screening. 
Screen Concentration of protein 
stock (mg/ml) 
Storage 
temperature 
Volume ratios of protein solution to 
reservoir solution 
Index Screen 14.5 Room temperature 1:3 1:1 3:1 
PACT Suite 14.5 Room temperature 1:3 1:1 3:1 
JCSG+ Suite 14.5 Room temperature 1:3 1:1 3:1 
JCSG+ Suite 45.0 Room temperature 1:3 1:1 3:1 
 
11.1.2 Crystallization trials performed under anaerobic conditions 
Protein purified under aerobic conditions was re-purified as described in section 11.1.1 in an 
anaerobic chamber (see section 4.2). Ultrafiltration was performed using either a stirred 
Amicon cell equipped with a YM3 membrane or a Vivacell 70 equipped with a 5000 MWCO 
membrane. HPLC purifications were carried out on an ÄKTAFPLCTM system in France and 
on an ÄKTAprimeTM plus system in Denmark. Prior to set up of crystallization experiments, 
the protein solution was filtered (0.22 μm, Ultrafree-MC, Millipore). 
 
11.1.2.1 Anaerobic screening and initial optimization  
Anaerobic screening and initial optimizations were performed (anaerobic chamber described 
in section 4.2.1) using a second batch of protein. Three commercially available screens were 
employed, each containing 96 reagents; Crystal Screen HT (Hampton Research), PEGs Suite 
and pH Clear Suite (both from Qiagen). The sitting drop vapour diffusion technique was 
applied and the reservoir volumes were 100 μl. The crystallization drops were set up using  
1 μl of protein solution and 1 μl of reservoir solution. A protein stock of 10.0 mg/ml was used 
and set up and storage was at 20 ± 1ºC. Crystal Screen I (Hampton Research) along with a 
home made version of the Solubility Tool Kit (originally manufactured by Molecular 
Dimension) at high pH (see appendix A.4 section A.4.1) was also set up using the hanging 
drop vapour diffusion technique. The reservoir volumes were 500 μl and each crystallization 
drop consisted of 1 μl of protein solution and 1 μl of reservoir solution. A protein stock of 
15.0 mg/ml was used and set up, and storage was at 20 ± 1ºC. 
During screening, crystals appeared and several experiments to optimize the crystallization 
conditions were performed. The conditions tested in these experiments are outlined in 
appendix A.4 section A.4.2. 
 
11.1.2.2 Further optimization 
Further optimizations were performed (anaerobic chamber described in section 4.2.2) using a 
third batch of protein. The conditions tested in these experiments are outlined in appendix A.4 
section A.4.3. For all the trials a protein stock of 23.5 mg/ml was used and set up and storage 
was at room temperature.  
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11.1.3 Monomer-dimer interconversion 
It has been reported that P. furiosus ferredoxin can be found as a monomer or dimer 
depending on ionic strength (Hasan et al., 2002). This was investigated by analytical gel 
filtration under aerobic conditions. These experiments were performed by Mette Jensen and 
Tina Vognsen (project students) under my supervision. 
The purified [4Fe-4S] ferredoxin (8.5 mg/ml, 20 mM Tris/HCl pH 8.0) was diluted 17 times 
with NaCl-containing buffer. Six different NaCl concentrations were tested. The dilution 
buffers were: 
 
1. 20 mM Tris/HCl, 0.15 M NaCl pH 8.0 
2. 20 mM Tris/HCl, 1.0 M NaCl pH 8.0 
3. 20 mM Tris/HCl, 2.0 M NaCl pH 8.0 
4. 20 mM Tris/HCl, 3.0 M NaCl pH 8.0 
5. 20 mM Na acetate 0.15 M NaCl pH 4.6 
6. 20 mM Na acetate 3.0 M NaCl pH 4.6 
 
The six solutions containing the diluted protein were incubated for 24 hours at 4ºC. Each 
solution was then analysed by analytical gel filtration at room temperature by HPLC 
(ÄKTATM purifier 100). 250 μl aliquots of sample (linear flow rate: 0.3 cm/min) were loaded 
onto a 13/31 Superdex 75 HR column equilibrated with the corresponding dilution buffer and 
protein was eluted with the same buffer.  
 
11.2 Results and discussion 
 
11.2.1 Aerobic screening 
It is known that upon oxidation the [4Fe-4S]2+ ferredoxin converts to the [3Fe-4S]1+ 
ferredoxin (section 2.5). This is a slow process that takes place as a consequence of exposure 
to air. Upon re-purification of aerobically purified [4Fe-4S]2+ ferredoxin that had been stored 
at -20ºC (section 11.1.2) it was found that approximately 10 % of the [4Fe-4S]2+ ferredoxin 
had been oxidized to [3Fe-4S]1+ ferredoxin (results not shown). It was also found that when 
the [4Fe-4S]2+ ferredoxin was exposed to air and the pH had been lowered to 4.6, the 
dominating species was the [3Fe-4S]1+ ferredoxin after one week of exposure (results not 
shown). This was evident from UV-vis spectrophotometric analysis since the absorption 
maximum had changed from 390 nm to 408 nm (figure 2.2). This is not surprising since iron-
sulfur clusters are acid labile (section 2.1).  
Even though slow oxidation was evident it was decided to perform rapid screening using an 
experimental set up performed by a robot. This was not possible to perform under anaerobic 
conditions. 
No crystals appeared in any of the tested conditions. However, brown crystalline precipitation 
appeared in many of the tested conditions. Denaturation was observed in some cases when the 
pH was below 5 and especially when phosphate was present. A general trend was that the 
lower the pH, the heavier the precipitation. P. furiosus apo-ferredoxin has a theoretical pI of 
3.9 (calculated using the ExPASy Proteomics Server, Bjellqvist et al., 1993 and 1994) and 
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therefore at low pH the net charge of the protein is close to zero hence the solubility is very 
low, which is reflected by the results. 
 
Index Screen 
It was found that ammonium sulphate and phosphate salts resulted in precipitation or phase 
separation. Sodium chloride gave precipitation when pH was below 4.5 and magnesium 
formate did not yield any precipitation. PEG 3350 without salts only resulted in slight 
precipitation below pH 5.5. PEG 3350 in combination with salts resulted in precipitation at 
almost all conditions tested. MPD resulted in phase separation. 
 
PACT Suite 
Testing pH values in the interval 4 to 9 using four different buffer systems at each tested pH 
value and at constant PEG 1500 concentration, gave precipitation when the SPG buffer 
(contains succinic acid, Na dihydrogen phosphate and glycine) and the PCB buffer (contains 
Na propionate, Na cacodylate and Bis-Tris propane) were used. When testing the effect of 
cations (chloride salts) at pH 5 to 8 at constant PEG 6000 concentration, it was found that 
ammonium, zinc, magnesium and calcium caused precipitation at all pH values while lithium 
and sodium only caused precipitation at pH 5. When testing the effects of various anions 
(sodium salts) at a constant PEG 3350 concentration and at pH values from 6.5 to 8.5 as well 
as without any buffer, it was found that citrate and malonate did not yield any precipitation 
while tartrate resulted in loss of colour indicating cluster degradation. Phosphate, sulphate, 
acetate, formate, nitrate, thiocyanate, iodide, bromide and fluoride resulted in precipitation. 
 
JCSG+ Suite 
The observations were comparable to those made from the Index Screen and The PACT Suite. 
The JCSG+ Suite screens conditions for which other proteins and enzymes have been 
successfully crystallized. It is difficult to draw any conclusions since no hits were found. 
 
11.2.2 Anaerobic screening  
Holo-protein purified under strict anaerobic conditions was re-purified and it was found that 
less than 0.5 % had converted to the [3Fe-4S]1+ ferredoxin at pH 8.0 (results not shown). 
Further, no conversion was evident after exposing the protein to pH 4.6 at room temperature 
for a period of four weeks as determined by UV-vis spectrophotometric analysis (results not 
shown). However, this only shows that the [4Fe-4S]2+ ferredoxin is the dominating species. 
Testing the Crystal Screen HT, the PEGs Suite and the pH Clear Suite using a protein stock of 
10.0 mg/ml gave only slight precipitation in few of the drops, and no crystals were observed. 
The results obtained were comparable to those observed during aerobic screening (section 
11.2.1). From the PEGs Suite, precipitation was only observed when PEG 3350 in 
combination with various salts was tested; calcium chloride, sodium thiocyanate, lithium 
nitrate, zinc/calcium/ammonium acetate, magnesium/ammonium sulfate, potassium/ 
ammonium phosphate and tri-lithium/di-ammonium citrate. From the pH Clear Suite, 
precipitation was only observed when ammonium sulphate was used as precipitant.  
Since only slight precipitation had appeared, it was decided to increase the concentration of 
the protein stock to 15.0 mg/ml and to set up Crystal Screen I and a home made version of the 
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Solubility Tool Kit (see appendix A.4 section A.4.1). Using the solubility tool kit, 
precipitation was observed when ammonium sulphate and ammonium citrate were used. 
However, no crystals were observed. From Crystal Screen I, precipitation was observed in 
approximately 75 % of the drops. After 10 days, needles appeared to grow from the 
precipitation of condition no. 47 (2.0 M ammonium sulphate, 0.1 M Na acetate pH 4.6). 
These needles grew to an approximate size of ca. 150 × 20 × 20 μm and they had a brown 
colour (see figure 11.1). The needles were present for almost four weeks and in this period of 
time the drop containing the needles was used for seeding purposes. However, within a period 
of two days the needles suddenly dissolved before the diffraction properties could be tested. 
When the needles dissolved, the drop had not been disturbed for two weeks. However, there 
had been problems with the thermostat. During the first three weeks of storage the 
temperature had been unstable ranging from 20 to 25ºC. at the time of dissolution the 
thermostat had been repaired and the temperature was at a constant 20 ± 1ºC. It is likely that 
the crystals were sensitive towards temperature. 
  
  
  
  
  
  
 
 
 
 
 
 
 
 
 
~ 150 μm  
 
 Figure 11.1 Needles observed during screening. The needles were observed when Crystal Screen I condition 
no. 47 (2.0 M ammonium sulphate, 0.1 M Na acetate pH 4.6) was applied. The drop was set up using 1 μl of 
reservoir solution and 1 μl of protein stock solution (15.0 mg/ml). The picture was taken a few days after the 
needles had appeared, when they were not fully grown.  
 
 
 
 
11.2.3 Initial optimization 
Optimization of the crystallization conditions (section 11.2.2) was attempted and the trials and 
observations of each condition are outlined in appendix A.4 section A.4.2.  
In the first trial the pH (Na acetate pH 4.0 to 6.0) was tested against the concentration of the 
precipitant (1.8 to 2.4 M ammonium sulphate), but no crystals were observed.  
The second trial was comparable to the first trial, but 2 % PEG 400 was added to the reservoir 
solution. In a few cases, seeding was also attempted. No crystals were obtained. Condition no. 
47 (Crystal Screen I) was tested again with and without addition of 2 % PEG 400, and with 
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and without seeding, using two protein concentrations (8 conditions). This resulted in small 
needles (figure 11.2) when no PEG was added irrespective of seeding and protein stock.  
In the third trial, the concentration of the buffer (50 mM to 150 mM Na acetate) was tested 
against pH (4.6, 5.0 and 6.0) at two ammonium sulphate concentrations (1.8 and 2.0 M) using 
two protein concentrations (15.0 and 20.0 mg/ml). In a few drops small needles were 
observed. This was generally observed using 100 mM Na acetate at pH 4.6 and a protein 
stock of 20.0 mg/ml. 
Trial 4 exploited the effect of using Additive Screen (Hampton Research, conditions 1 to 24) 
in combination with a precipitant solution consisting of 2.0 M ammonium sulphate and 0.1 M 
Na acetate pH 4.6. In eight of the tested conditions small needles were observed (appendix 
A.4 section A.4.2, trial 4). 
The large needles observed during screening (section 11.2.2) could not be reproduced. 
However, small needles were observed several times during the attempts to optimize the 
crystallization conditions. 
 
 
 
 
 
 
 
 
 
~ 50 μm  
 
 Figure 11.2 Example of the brown needles observed during initial optimization of the crystallization 
conditions.  
 
11.2.4 Further optimization 
Further optimization was attempted using a new batch of protein at a higher concentration 
(23.5 mg/ml). The trials and observations of each condition are outlined in appendix A.4 
section A.4.3.  
Since a new protein batch was used, the buffer pH (Na acetate pH 4.0 to 6.0) was tested 
against the concentration of the precipitant (1.6 to 2.4 M ammonium sulphate) again (trial 5). 
Needles appeared independent on the protein to precipitant volume ratio when the precipitant 
concentration was 1.6 M and the pH was 4.0. However, the largest needles appeared at the 
lowest protein to precipitant volume ratio (figure 11.3 A). It was decided not to lower the pH 
further since the FeS cluster is acid labile, but to test the precipitant concentration in the range 
from 1.2 M to 2.0 M at pH 4.0 and 4.6 and also test an even lower protein to precipitant 
volume ratio (trial 6). Needles only appeared at pH 4.0 in the precipitant concentration range; 
1.4 to 1.6 M. 
Since needles had been observed when The Additive Screen had been applied (section 
11.2.3), it was decided to test seven different salts at pH 4.6 using two different precipitant 
concentrations; 1.8 and 2.0 M (trial 7). Li2SO4 resulted in needles at both precipitant 
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concentrations (figure 11.3 B). At 1.8 M needles were only observed at the low protein to 
precipitant volume ratio. (NH4)H2PO4 and ZnCl2 resulted in needles when the precipitant 
concentration was 2.0 M and the protein to precipitant volume ratio was low. It was decided 
to test the effect of Li2SO4 and (NH4)H2PO4 at pH 4.0 and 4.6 in the precipitant concentration 
interval 1.2 M to 2.2 M (trial 8). At pH 4.0 Li2SO4 resulted in needles at a precipitation 
concentrations of 1.2 M and 1.4 M (figure 11.3 C). At pH 4.6 needles were observed at 1.8 M. 
At pH 4.0 (NH4)H2PO4 resulted in needles at a precipitation concentration from 1.2 M to  
1.6 M. At pH 4.6 needles were observed at 1.8 M.   
 
A B C 
 
Figure 11.3 Examples of the brown needles observed during optimization of the crystallization conditions. In 
each of the panels the largest needles are approximately 80 μm long. A) The reservoir solution contained 
1.6 M (NH4)2SO4 and 0.1 M Na acetate/HCl pH 4.0. The drop was set up using 1 μl protein solution 
(23.5 mg/ml) and 2 μl reservoir solution. B) The reservoir solution contained 2.0 M (NH4)2SO4, 0.1 M 
Na acetate/HCl pH 4.6 and 200 mM Li2SO4. The drop was set up using 1 μl protein solution (23.5 mg/ml) 
and 2 μl reservoir solution. C) The reservoir solution contained 1.2 M (NH4)2SO4, 0.1 M Na acetate/HCl pH 
4.0 and 200 mM Li2SO4. The drop was set up using 1.5 μl of protein (23.5 mg/ml) and reservoir solutions. 
  
 
 
 
 
 
 
Due to the small size of the needles obtained during optimization, the diffraction properties 
were not tested. The needles were only found in drops containing moderate to heavy 
precipitation and in all cases they seemed to grow from the precipitation. The large single 
needles observed during screening (section 11.2.2) were not reproduced. 
Precipitant concentration at which needles appear have been found but conditions should be 
further optimized to gain larger, single needles or three dimensional crystals suitable for 
diffraction experiments. Since the pH of the precipitant was low (pH 4.0 or 4.6) this might 
have caused partial degradation of the [4Fe-4S] cluster to a [3Fe-4S] cluster. It was attempted 
to dissolve the precipitation and needles in a few drops and then record the UV-vis spectrum 
to gain insight into cluster composition, but the obtained spectrum could not be convincingly 
interpreted (results not shown).  
 
11.2.5 Monomer-dimer interconversion 
It has been reported that a monomer/dimer equilibrium exists as a function of ionic strength 
for P. furiosus ferredoxin (Hasan et al., 2002). At a low ionic strength (below 0.35 M NaCl, 
pH 7.8) the protein was predominantly found as a dimer, while at high ionic strengths (above  
 - 135 -
Part I                                     Crystallization trials for Pyrococcus furiosus [4Fe-4S] ferredoxin 
 
0.35 M NaCl, pH 7.8) the protein was present as a monomer. These observations were based 
on analytical gel filtrations since the elution volume of the protein was found to increase with 
increasing salt concentration compared to those of a reference protein (cytrochrome c) (Hasan 
et al., 2002). 
If a monomer/dimer equilibrium exists, this may greatly affect the crystallization properties 
since salts in various concentrations are often used as precipitants. Further, during 
equilibration of the crystallization drop, the compounds are up-concentrated which raises the 
ionic strength of the drop. If the protein in the crystallization drop is not homogeneous, then 
crystallization may prove impossible. 
It was decided to verify the suggested monomer/dimer equilibrium by performing analytical 
gel filtration of P. furiosus [4Fe-4S] ferredoxin at different NaCl concentrations and pH 
values (section 11.1.3). 
Figure 11.4 shows the obtained chromatograms when pH 8.0 was employed. It was observed 
that the elution volume increased with increasing NaCl concentrations signifying a decrease 
in size. Figure 11.5 presents a plot of the elution volume as a function of the NaCl 
concentration at the two tested pH values (4.6 and 8.0). At a given salt concentration the 
elution volume was highest at pH 4.6, again signifying a decrease of size. 
Empirical considerations suggest that if a monomer/dimer equilibrium was present, then one 
would expect to see elution about two distinct elution volumes. One would also expect to see 
tailing from the elution point of one species toward the elution point of the other species or 
perhaps even two peaks if a salt concentration resulting in close to equal amounts of monomer 
and dimer was applied. However, this was not observed.   
When performing gel filtration, the separation is affected by size and shape of the proteins. 
The radius of the molecule is not just determined by the amino acids constituting the protein, 
but also on the solvation shell/ionic radius of the protein. Therefore it is the hydrodynamic 
radius/volume, which in part determines the elution properties during gel filtration (Barth et 
al., 1998).  
The hydrodynamic radius of a given protein is highly dependent on the physicochemical 
properties of the solvent such as pH and ionic strength. It depends on the effective net charge 
of the protein (Piaggio et al., 2002). It was found that the lower the charge of a particular 
protein, the lower was the resulting hydrodynamic radius. Further, when the ionic strength of 
a solution was increased (by adding a salt), then the resulting hydrodynamic radius decreased 
(Piaggio et al., 2002). The obtained results from the P. furiosus ferredoxin (figures 11.4 and 
11.5) fit the above stated observations. The ferredoxin is highly acidic and at pH 8.0 it has a 
high negative charge. At pH 4.6 the charge is low since the pH is close to pI of the protein 
(section 11.2.1). 
Based on the results, it is unlikely that a monomer/dimer equilibrium exists. It is more likely 
that the changes observed in the elution volume when varying pH and salt concentration are 
due to changes of the hydrodynamic radius of the protein. The observations suggest that the 
ferredoxin is found merely as a dimer or merely as a monomer, but based on the elution 
profile it is difficult to establish whether the ferredoxin is in fact a dimer or a monomer. 
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 Figure 11.4 Chromatograms for analytical gel filtrations obtained when analysing elution of P. furiosus 
[4Fe-4S] ferredoxin at pH 8.0 (20 mM Tris/HCl) at various concentrations of NaCl. Absorption was 
measured at 390 nm. The blue, red, brown and green lines indicate overlaid chromatograms when 0.15 M, 
1.0 M, 2.0 M and 3.0 M NaCl was applied, respectively. 
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 Figure 11.5 Elution volumes of P. furiosus [4Fe-4S] ferredoxin measured during analytical gel filtrations 
when different concentrations of NaCl were added to the elution buffer. Elution volumes were measured at 
two pH values: 4.6 (red) and 8.0 (blue). The elution buffers were 20 mM Tris/HCl pH 8.0 and 20 mM Na 
acetate/HCl pH 4.6. 
 
 
 
 
11.2.6 Comments on crystallization 
Based on the results it is clear that future crystallization trials should be carried out under 
strict anaerobic conditions due to oxidation of the FeS cluster. It appears to be quite a difficult 
task to obtain suitable crystals of the [4Fe-4S]2+ ferredoxin even though anaerobic conditions 
were applied. One reason may be cluster degradation from a [4Fe-4S] to a [3Fe-4S] cluster 
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due to trace amounts of oxygen or low pH. Another reason however might be a monomer-
dimer interconversion as discussed in section 11.2.5. Even though crystals (needles) have 
been obtained crystallization conditions are difficult to optimize and it appears that 
temperature plays an important role in the process of growing crystals. 
 
11.3 Conclusion 
It has been attempted to crystallize the [4Fe-4S]2+ ferredoxin from P. furiosus. Crystals in the 
form of needles have been obtained and further optimization should be performed to gain 
crystals suitable for diffraction experiments. Reasons as to why the ferredoxin is difficult to 
crystallize have been discussed. 
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Chapter twelve 
 
 
 
12 Concluding remarks and outlook 
The first part of this thesis concerns the origin of life and iron-sulfur proteins. Three proteins 
have been investigated. Two of the proteins (Ori-ISP and LCA ferredoxin) originate from 
phylogenetic analysis of ferredoxins (Davis, 2002) and a theory concerning co-evolution of 
amino acids and the genetic code (Davis, 1999). The third protein is a [4Fe-4S] ferredoxin 
that originates from the hyperthermophilic archaeon Pyrococcus furiosus. 
 
12.1 Reflections concerning the origin of life and Davis’ theory 
How the lifeless chemosphere of early Earth transformed into a living biosphere supporting 
thousands of different organisms has puzzled the human race for many years. Different 
theories on the origin of life have been put forward (chapter 3). The events preceding certain 
evolutionary steps might have been very complex and difficult to infer. A unanimous 
explanation of early evolution and evolutionary processes may never be unveiled.  
The reconstruction and characterization of LCA ferredoxin and Ori-ISP is based on a theory 
by B. K. Davis (1999 and 2002), who is a supporter of an autotrophic origin of life situated at 
pyrite surfaces of hydrothermal vents. Thorough analysis of Davis’ evolution theory and his 
phylogenetic analysis of ferredoxins is not within the scope of this thesis. However, some 
issues should be noted.  
Among other important issues which Davis’ theory (section 3.2) does not address are the 
origin of nucleotides, how they first polymerized and the handedness of amino acids. Neither 
does it take into account that some amino acids could have been added to the code and 
eliminated at a later stage in evolution. His theory provides an order of entrance of particular 
amino acids into the genetic code and hereby when they entered proteins. This is used when 
analysing the LCA ferredoxin to obtain the sequence of Ori-ISP. 
Ancestral sequences for bacteria and archaea ferredoxins were constructed based on the 
Neighbour-Joining method. This is a distance-based method that provides no probabilities of 
the various residues in the sequences (Felsenstein, 2004). Davis recognises the internal repeat, 
which is a general feature of ferredoxins (section 2.3.3). To obtain the LCA ferredoxin, Davis 
takes this repeat into account, and hereby he invokes the element of personal choice in the 
resulting sequence since he cannot use probabilities as an argument. To go even further back, 
Davis only takes the residues of the repeat into account and a stage 10 peptide emerges. He 
finds that this peptide has a more ancient residue profile (only three residues have entered 
after stage 5) than extant ferredoxins, and then he argues that this peptide was in fact a stage 5 
protein. Davis then forces mutations in these three positions (section 3.3.3) using the 
argument that the resultant residues were in fact present in the descendant ferredoxins. Again 
Davis has forced the element of personal choice on the sequence.  
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Based on the fact that an internal repeat is present in ferredoxins, it is highly likely that a short 
peptide in fact was the ancestor of ferredoxins, but I find it less likely that this sequence (or 
sequences) is in fact the sequence deduced by Davis. The reconstruction and characterization 
of Ori-ISP will however not prove Davis’ theory, although it will make it more probable and 
thereby support the chemoautotrophic model for the origin of life. 
 
12.2 Model system 
Nonetheless, holo-Ori-ISP alone and in combination with holo-LCA ferredoxin provide a 
model system for learning more about the properties and the factors determining these 
properties of ferredoxins – extant as well as ancient. One interesting finding is the stability of 
the holo-proteins. LCA ferredoxin appears to be much more stable than dimeric Ori-ISP even 
though these proteins are very similar. They differ by the 6-residue insert, the 3-residue C-
terminal tail and three mutations in each of the 23-residue repeats (figure 3.3). It would be 
interesting to produce the stage 10 protein and compare the properties.  
Ori-ISP is believed to have been formed 3.5 billion years ago where the conditions on Earth 
were quite different from today, one of which was the absence of O2. Hence, protection 
against O2 was not necessary under the conditions which prevailed at that time. The 
negatively charged “attachment site” in the N-terminal region of Ori-ISP suggests that it 
might be able to bind to positively charged surfaces. Ori-ISP could have functioned on 
surfaces forming two-dimensional arrays providing directional function. It might have 
functioned in some of the early metabolic cycles as an electron carrier or as a catalytic site. 
Hence, Ori-ISP has plausibly played an important role in the very early stages of the 
development of life. An understanding of this protein and its chemical and biophysical 
properties might help define criteria for surface metabolism and the origin of biological life. 
 
12.3 Ub-Ori-ISP and Ori-ISP 
Cluster reconstitution into Ub-Ori-ISP and HPLC purification of the reaction products 
followed by characterization by analytical gel filtration and UV-vis spectrophotometry were 
successfully accomplished in anaerobic chambers (chapter 7). 
When FeCl3 was used as iron source, a monomeric [4Fe-4S]2+ protein was eluted at low 
conductivities while a dimeric [3Fe-4S]1+ protein or a protein containing two different clusters 
or multiple cluster types was eluted at higher conductivities. When Fe(II) was used as the iron 
source, only monomeric species were obtained. [4Fe-4S]2+ protein was found to elute at low 
conductivity, while the reduced form, containing a [4Fe-4S]1+ cluster, was found to elute at a 
higher conductivity. 
A procedure for obtaining proteolytic cleavage of the Ub-Ori-ISP fusion protein followed by 
cluster reconstitution into Ori-ISP was developed. When using FeCl3 as an iron source the 
obtained products were comparable to those obtained for Ub-Ori-ISP. The method has 
however not been optimized. 
The cluster reconstitution reaction was optimized outside the anaerobic chamber using the 
Ar/N2 flushing for obtaining anaerobic conditions. Much higher stability of the products was 
found when cluster reconstitution was performed inside the anaerobic chambers. The Ori-ISP 
system appears quite flexible concerning formation of monomers, dimers and the type of 
cluster obtained. Therefore the cluster reconstitution reaction should be further optimized to 
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control the outcome of reaction. Reaction times, molar excess of DTT, iron and sulfide are 
parameters that can be varied. In this connection the effects of iron source should also be 
investigated further. 
It was found that even though purification and characterization was performed inside the 
anaerobic chambers degradation of the FeS cluster did seem to happen. Investigations into 
further stabilization of holo-protein should be performed. This might include addition of 
reducing agents and/or addition of glycerol to purification buffers. 
Using a column with a higher resolution power during purification might be advantageous in 
exploring different species of the poorly resolved peaks that were found between main peaks. 
To gain knowledge on the properties of the FeS cluster(s) (resulting spin, localization and 
delocalization patterns), EPR and Mössbauer spectroscopic studies should be performed on 
the obtained species. The redox properties of the holo-protein are also important in 
understanding what functions this protein could have undertaken. These properties can be 
investigated by cyclic voltammetry. The surface binding properties and organization of Ori-
ISP can be studied using in situ scanning tunnelling microscopic techniques. Structural 
information is also important in order to understand the properties of the protein. However 
these may be difficult to obtain. Nuclear Magnetic Resonance analysis may provide some 
insight into solution structures. Crystallization of the holo-Ori-ISP may prove difficult due to 
the high flexibility of the protein and cluster degradation.  
 
12.4 Ub-LCA and LCA ferredoxin 
Two approaches for obtaining holo-LCA ferredoxin were investigated (chapter 10). In the 
first approach holo-Ub-LCA ferredoxin was expressed by E. coli cells, then the protein was 
purified and finally the Ub-fusion was cleaved off by YUH1 followed by further purification. 
The second approach was that holo-LCA ferredoxin was purified directly from E. coli cells 
co-expressing holo-Ub-LCA ferredoxin and the Ub-protease, UBP1.  
The yields of purified holo-LCA ferredoxin obtained from either of the two methods were 
comparable, but very low. This was partly due to a low level of holo-protein expression in the 
E. coli cells and also due to low activity of YUH1 and UBP1 under the investigated 
conditions. Further, the first approach was much more time consuming than the second. 
Protein expression from the E. coli cells should be optimized to provide a higher yield of 
holo-protein. If the second approach for obtaining LCA ferredoxin is to be pursued further, 
then it should be investigated if the activity of UBP1 could be enhanced during the induction 
period (in vivo). If the first approach is to be pursued further, then in vitro cleavage of Ub-
LCA ferredoxin using YUH1 should be optimized. It should be considered if it would be 
advantageous to express and purify UBP1 for in vitro cleavage.  
Based on the obtained results the second approach is presently preferred. However, an 
alternative approach is to construct a third E. coli strain only expressing LCA ferredoxin. 
Even though stability tests have not been performed, holo-LCA ferredoxin does appear to be 
sensitive towards O2. However, holo-LCA ferredoxin is far more stable than holo-Ori-ISP.  
Based on UV-vis spectrophotometric analysis it was found that both of the holo-proteins, Ub-
LCA and LCA ferredoxin, contained at least one [4Fe-4S]2+ cluster. To gain further 
knowledge on the LCA ferredoxin, it should be analysed employing the techniques suggested 
for Ori-ISP (section 12.3). The three-dimensional structure should be determined, which 
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could be obtained by crystallizing the protein followed by X-ray diffraction analysis. Finally 
the properties of holo-LCA ferredoxin should be compared to contemporary ferredoxins and 
those of holo-Ori-ISP.  
 
12.5 Pyrococcus furiosus [4Fe-4S] ferredoxin 
The [4Fe-4S]2+ ferredoxin from P. furiosus was crystallized (chapter 11). However, the 
obtained needles need to be optimized before they are suitable for diffraction experiments. It 
was found that addition of salts appeared to advance crystal formation. Therefore, the effects 
of various salts should be further investigated. It may also prove advantageous to perform 
additive screening. It was argued (chapter 11) that the difficulties in crystallizing the 
ferredoxin may arise because of oxidation of the [4Fe-4S] cluster to a [3Fe-4S] cluster. It 
would be interesting to test the effects of adding a reducing agent and Fe(II) to the protein 
prior to performing crystallization trials. Temperature did also appear to be an important 
parameter for crystal growth, which needs to be further investigated. Finally, changing the 
buffer system and making some changes in the purification procedure may also change the 
crystallization properties of the enzyme. 
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Appendix one 
 
 
 
A.1 Calibration curve for 13/31 Superdex 75 HR column 
A calibration curve was determined for the 13/31 Superdex 75 HR column as described in the 
handbook, Gel Filtration, Principles and Methods. For calibration, the Low Molecular Weight 
Gel Filtration Calibration Kit (GE Healthcare, Amersham Biosciences) was applied. 
The curve was prepared by plotting Kav for the standard proteins as a function of log Mw. Kav 
is defined as: 
 
Kav = 
ot
oe
VV
VV
−
−                                                                                                                     (A.1.1) 
 
Vo = column void volume = elution volume for Blue Dextran 2000 
Vt = total bed volume 
Ve = elution volume of the protein 
 
Vt was determined from the dimensions of the column; 
Vt = 31 cm · π · (0.65 cm)2 = 41.15 ml 
 
Vo and Ve values were determined as described in the following. Three samples containing 
the known standards (all dissolved in 20 mM Tris/HCl, 0.15 M NaCl pH 8.0) were prepared 
for analysis on the gel filtration column: 
 
1) 1.0 mg/ml Blue Dextran 2000 
2) 5.2 mg/ml Ovalbumin, 5.0 mg/ml Ribonuclease A 
3) 4.8 mg/ml Chymotrypsinogen A, 5.7 mg/ml Albumin  
 
250 μl of each of the three solutions were loaded onto the 20 mM Tris/HCl, 0.15 M NaCl pH 
8.0 equilibrated column using a linear flow rate of 0.3 cm/min (chromatograms not shown). 
The volume of elution was determined for each of the five compounds and Kav values were 
calculated (presented in table A.1.1). Kav was plotted as a function of log Mw as presented in 
figure A.1.1 and a trend line was determined and presented in the figure. The R2 value is not 
that good (the closer to one, the better the fit) and the calibration curve should be used with 
caution.  
An approximate molecular weight can be determined for eluting species by first determining 
the volume of elution, then calculating Kav and finally use the equation for the trend line to 
calculate the molecular weight. 
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Table A.1.1 Elution points and Kav values for standards. 
 V0 / ml Ve / ml Mw / kDa Kav 
Blue Dextran 2000 7.86    
Ribonuclease A  13.63 13.7 0.17 
Chymotrypsinogen A  12.56 25.0 0.14 
Ovalbumin  10.52 43.0 0.08 
Albumin  9.64 67.0 0.05 
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Figure A.1.1 Calibration curve for 13/31 Superdex 75 HR column. The trend line and the R-squared value is 
also shown. 
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Appendix two 
 
 
 
A.2 Set up for crystallization of holo-Ub-Ori-ISP 
Two experiments were set up for optimizing the most promising conditions obtained from the 
commercially available screens (chapter 8). Experiment 1 and 2 investigate the effects of 
ammonium sulphate and MPD, respectively. A third experiment was set up and it is a home 
made version of The Solubility Tool Kit (Molecular Dimensions) which applies the 
Hofmeiser series for testing the effects of different salts on solubility (Collins, 2004; Riès-
Kautt and Ducruix, 1997). Here pH 8.0 was employed since this is the pH in which the 
protein was purified and known to be somewhat stable.   
In each experiment the hanging drop vapour diffusion method was applied and the drop was 
equilibrated over 500 ml of reservoir solution. All drops were set up using 1 μl of protein 
solution and 1 μl of reservoir solution. The protein concentration was 100 mg/ml and the 
temperature during set up and storage was 20 ± 1ºC. 
 
Experiment 1: 
Number Precipitant Salt / additive Buffer 
1 2.0 M (NH4)2SO4  100 mM MES pH 6.5 
2 2.0 M (NH4)2SO4  100 mM HEPES pH 7.0 
3 2.0 M (NH4)2SO4  100 mM HEPES pH 7.5 
4 2.0 M (NH4)2SO4  100 mM Tris/HCl pH 8.0 
5 2.0 M (NH4)2SO4  100 mM Tris/HCl pH 8.5 
6 2.2 M (NH4)2SO4  100 mM MES pH 6.5 
7 2.2 M (NH4)2SO4  100 mM HEPES pH 7.0 
8 2.2 M (NH4)2SO4  100 mM HEPES pH 7.5 
9 2.2 M (NH4)2SO4  100 mM Tris/HCl pH 8.0 
10 2.2 M (NH4)2SO4  100 mM Tris/HCl pH 8.5 
11 2.4 M (NH4)2SO4  100 mM MES pH 6.5 
12 2.4 M (NH4)2SO4  100 mM HEPES pH 7.0 
13 2.4 M (NH4)2SO4  100 mM HEPES pH 7.5 
14 2.4 M (NH4)2SO4  100 mM Tris/HCl pH 8.0 
15 2.4 M (NH4)2SO4  100 mM Tris/HCl pH 8.5 
16 2.6 M (NH4)2SO4  100 mM MES pH 6.5 
17 2.6 M (NH4)2SO4  100 mM HEPES pH 7.0 
18 2.6 M (NH4)2SO4  100 mM HEPES pH 7.5 
19 2.6 M (NH4)2SO4  100 mM Tris/HCl pH 8.0 
20 2.6 M (NH4)2SO4  100 mM Tris/HCl pH 8.5 
21 2.8 M (NH4)2SO4  100 mM MES pH 6.5 
22 2.8 M (NH4)2SO4  100 mM HEPES pH 7.0 
23 2.8 M (NH4)2SO4  100 mM HEPES pH 7.5 
24 2.8 M (NH4)2SO4  100 mM Tris/HCl pH 8.0 
25 2.8 M (NH4)2SO4  100 mM Tris/HCl pH 8.5 
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26 3.0 M (NH4)2SO4  100 mM MES pH 6.5 
27 3.0 M (NH4)2SO4  100 mM HEPES pH 7.0 
28 3.0 M (NH4)2SO4  100 mM HEPES pH 7.5 
29 3.0 M (NH4)2SO4  100 mM Tris/HCl pH 8.0 
30 3.0 M (NH4)2SO4  100 mM Tris/HCl pH 8.5 
31 2.0 M (NH4)2SO4 2 % PEG 400 100 mM MES pH 6.5 
32 2.0 M (NH4)2SO4 2 % PEG 400 100 mM HEPES pH 7.5 
33 2.0 M (NH4)2SO4 2 % PEG 400 100 mM Tris/HCl pH 8.5 
34 2.5 M (NH4)2SO4 200 mM Li2SO4 100 mM HEPES pH 7.5 
35 2.5 M (NH4)2SO4 200 mM MgSO4 100 mM HEPES pH 7.5 
36 2.5 M (NH4)2SO4 200 mM MgCl2 100 mM HEPES pH 7.5 
 
Experiment 2: 
Number Precipitant Salt / additive Buffer 
1 40 % MPD  100 mM HEPES pH 7.0 
2 40 % MPD  100 mM HEPES pH 7.5 
3 40 % MPD  100 mM Tris/HCl pH 8.0 
4 40 % MPD  100 mM Tris/HCl pH 8.5 
5 45 % MPD  100 mM HEPES pH 7.0 
6 45 % MPD  100 mM HEPES pH 7.5 
7 45 % MPD  100 mM Tris/HCl pH 8.0 
8 45 % MPD  100 mM Tris/HCl pH 8.5 
9 50 % MPD  100 mM HEPES pH 7.0 
10 50 % MPD  100 mM HEPES pH 7.5 
11 50 % MPD  100 mM Tris/HCl pH 8.0 
12 50 % MPD  100 mM Tris/HCl pH 8.5 
13 55 % MPD  100 mM HEPES pH 7.0 
14 55 % MPD  100 mM HEPES pH 7.5 
15 55 % MPD  100 mM Tris/HCl pH 8.0 
16 55 % MPD  100 mM Tris/HCl pH 8.5 
17 60 % MPD  100 mM HEPES pH 7.0 
18 60 % MPD  100 mM HEPES pH 7.5 
19 60 % MPD  100 mM Tris/HCl pH 8.0 
20 60 % MPD  100 mM Tris/HCl pH 8.5 
21 45 % MPD 200 mM MgCl2 100 mM Tris/HCl pH 8.0 
22 50 % MPD 200 mM MgCl2 100 mM Tris/HCl pH 8.0 
23 50 % MPD 200 mM Li2SO4 100 mM Tris/HCl pH 8.0 
24 50 % MPD 200 mM MgSO4 100 mM Tris/HCl pH 8.0 
25 50 % MPD 200 mM CaCl2 100 mM Tris/HCl pH 8.0 
26 55 % MPD 200 mM MgCl2 100 mM Tris/HCl pH 8.0 
 
Experiment 3: 
Number Precipitant Salt / additive Buffer 
1 2.3 M (NH4)2SO4  100 mM Tris/HCl pH 8.0 
2 2.6 M (NH4)2SO4  100 mM Tris/HCl pH 8.0 
3 2.9 M (NH4)2SO4  100 mM Tris/HCl pH 8.0 
4 3.2 M (NH4)2SO4  100 mM Tris/HCl pH 8.0 
5 1.4 M (NH4)-citrate  Adjusted to pH 8.0 
6 1.7 M (NH4)-citrate  Adjusted to pH 8.0 
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7 2.0 M (NH4)-citrate  Adjusted to pH 8.0 
8 2.3 M (NH4)-citrate  Adjusted to pH 8.0 
9 2.0 M Na-acetate  Adjusted to pH 8.0 
10 2.5 M Na-acetate  Adjusted to pH 8.0 
11 3.0 M Na-acetate  Adjusted to pH 8.0 
12 3.5 M Na-acetate  Adjusted to pH 8.0 
13 1.2 M Mg SO4  100 mM Tris/HCl pH 8.0 
14 1.4 M Mg SO4  100 mM Tris/HCl pH 8.0 
15 1.6 M Mg SO4  100 mM Tris/HCl pH 8.0 
16 1.8 M Mg SO4  100 mM Tris/HCl pH 8.0 
17 1.2 M CaCl2  100 mM Tris/HCl pH 8.0 
18 1.4 M CaCl2  100 mM Tris/HCl pH 8.0 
19 1.6 M CaCl2  100 mM Tris/HCl pH 8.0 
20 1.8 M CaCl2  100 mM Tris/HCl pH 8.0 
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Appendix three 
 
 
 
A.3 Chromatograms for large scale purification of Ub-
LCA ferredoxin 
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This appendix presents typical chromatograms obtained for large scale purification of Ub-
LCA ferredoxin as described in section 10.1.3. The chromatograms are from purifications on 
the 50/7 Q Sepharose Fast Flow column (figure A.3.1), the HiLoad 16/60 Superdex 75 prep 
  
 
 
 
 
 
 
 
 
 
 
 
 Figure A.3.1 Chromatogram for purification of Ub-LCA ferredoxin on the 50/7 Q Sepharose Fast Flow 
column. The collected fraction is indicated with a black box. The blue, red and pink lines indicate the 
absorbance at 236 nm, 280 nm and 390 nm, respectively. The brown and the green lines indicate the 
conductivity and the NaCl gradient, respectively. The concentration of NaCl can be read from the 
conductivity axis employing the unit 10-2 M. 
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 Figure A.3.2 Chromatogram for purification of Ub-LCA ferredoxin on the HiLoad 16/60 Superdex 75 prep 
grade column. The collected fraction is indicated with a black box. The blue, red and the pink lines indicate 
the absorbance at 236 nm, 280 nm and 390 nm, respectively. 
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grade column (figure A.3.2) and the 16/10 Source 30Q column (figure A.3.3). The purity of 
the obtained product, Ub-LCA ferredoxin, was tested by SDS-PAGE and the results are 
presented in figure A.3.4. The obtained results are discussed in chapter 10. 
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Figure A.3.3 Chromatogram for purification of Ub-LCA ferredoxin on the 16/10 Source 30Q column. The 
collected fraction is indicated with a black box. The blue, red and pink lines indicate the absorbance at 
236 nm, 280 nm and 390 nm, respectively. The brown and the green lines indicate the conductivity and the 
NaCl gradient, respectively. The concentration of NaCl can be read from the conductivity axis employing the 
unit 10-2 M. 
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 Figure A.3.4 Purity of Ub-LCA ferredoxin tested by SDS-PAGE. Lane 1: 5 μl of 2.3 mg/ml LCA. Lane 2: 
Marker, 1 μl.  
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Appendix four 
 
 
 
A.4 Crystallization of P.  furiosus [4Fe-4S] ferredoxin 
This appendix presents conditions used for screening and optimizing crystallization of P. 
furiosus [4Fe-4S] ferredoxin (elaborated from chapter 11). In each of the outlined trials, the 
hanging drop vapour diffusion method was applied and each drop was equilibrated over  
500 ml of reservoir solution. Observations made for each experiment are also outlined using 
the following abbreviations: 
 
P1 Slight precipitate 
P2  Moderate precipitate 
P3 Heavy precipitate 
F Phase separation 
D Denaturation 
S Skin covering the drop 
N Needles  
K Quasi-crystalline material 
 
A.4.1 Screening 
A home made version of The Solubility Tool Kit (Molecular Dimensions) which applies the 
Hofmeiser series for testing the effects of different salts on solubility (Collins, 2004; Riès-
Kautt and Ducruix, 1997) was set up. The set up was performed in an anaerobic chamber 
(section 4.2.1). The temperature during set up and storage was 20 ± 1ºC. 1 μl of protein stock 
solution (15.0 mg/ml) was mixed with 1 μl of reservoir solution. 
 
No. Precipitant Buffer Observations 
1 2.3 M (NH4)2SO4 100 mM Tris/HCl pH 8.0  
2 2.6 M (NH4)2SO4 100 mM Tris/HCl pH 8.0 P1 
3 2.9 M (NH4)2SO4 100 mM Tris/HCl pH 8.0 P1 
4 3.2 M (NH4)2SO4 100 mM Tris/HCl pH 8.0 P2 
5 1.4 M (NH4)-citrate Adjusted to pH 8.0 P1 
6 1.7 M (NH4)-citrate Adjusted to pH 8.0 P2 
7 2.0 M (NH4)-citrate Adjusted to pH 8.0 P2 
8 2.3 M (NH4)-citrate Adjusted to pH 8.0 P2 
9 2.0 M Na-acetate Adjusted to pH 8.0  
10 2.5 M Na-acetate Adjusted to pH 8.0  
11 3.0 M Na-acetate Adjusted to pH 8.0  
12 3.5 M Na-acetate Adjusted to pH 8.0  
13 1.2 M Mg SO4 100 mM Tris/HCl pH 8.0  
14 1.4 M Mg SO4 100 mM Tris/HCl pH 8.0  
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15 1.6 M Mg SO4 100 mM Tris/HCl pH 8.0  
16 1.8 M Mg SO4 100 mM Tris/HCl pH 8.0  
17 1.2 M CaCl2 100 mM Tris/HCl pH 8.0  
18 1.4 M CaCl2 100 mM Tris/HCl pH 8.0  
19 1.6 M CaCl2 100 mM Tris/HCl pH 8.0  
20 1.8 M CaCl2 100 mM Tris/HCl pH 8.0  
 
A.4.2 Initial optimization 
These trials were performed in an anaerobic chamber (section 4.2.1). The temperature during 
set up and storage was 20 ± 1ºC.  
 
Trial 1: 
1 μl of protein stock solution (15.0 mg/ml) was mixed with 1 μl of reservoir solution. 
No. Precipitant Buffer Observations 
1 1.8 M (NH4)2SO4 0.1 M Na acetate/HCl pH 4.0 P3, S, D 
2 2.0 M (NH4)2SO4 0.1 M Na acetate/HCl pH 4.0 P3, S, D 
3 2.2 M (NH4)2SO4 0.1 M Na acetate/HCl pH 4.0 P3, S, D 
4 2.4 M (NH4)2SO4 0.1 M Na acetate/HCl pH 4.0 P3, S, D 
5 1.8 M (NH4)2SO4 0.1 M Na acetate/HCl pH 4.6 P3, S 
6 2.0 M (NH4)2SO4 0.1 M Na acetate/HCl pH 4.6 P3, S 
7 2.2 M (NH4)2SO4 0.1 M Na acetate/HCl pH 4.6 P3, S 
8 2.4 M (NH4)2SO4 0.1 M Na acetate/HCl pH 4.6 P3, S 
9 1.8 M (NH4)2SO4 0.1 M Na acetate/HCl pH 5.0 P2 
10 2.0 M (NH4)2SO4 0.1 M Na acetate/HCl pH 5.0 P2 
11 2.2 M (NH4)2SO4 0.1 M Na acetate/HCl pH 5.0 P2, S 
12 2.4 M (NH4)2SO4 0.1 M Na acetate/HCl pH 5.0 P2, S 
13 1.8 M (NH4)2SO4 0.1 M Na acetate/HCl pH 6.0 P1 
14 2.0 M (NH4)2SO4 0.1 M Na acetate/HCl pH 6.0 P1 
15 2.2 M (NH4)2SO4 0.1 M Na acetate/HCl pH 6.0 P1 
16 2.4 M (NH4)2SO4 0.1 M Na acetate/HCl pH 6.0 P1 
 
Trial 2: 
1 μl of protein stock solution was mixed with 1 μl of reservoir solution. Two different protein 
stock concentrations (Conc. presented as mg/ml) were used. 
No. Conc. Precipitant Additive Buffer Observations 
1 15 1.6 M (NH4)2SO4 2 % PEG 400 0.1 M Na acetate/HCl pH 4.6 P2, S 
2 15 1.8 M (NH4)2SO4 2 % PEG 400 0.1 M Na acetate/HCl pH 4.6 P2 
3 15 2.0 M (NH4)2SO4 2 % PEG 400 0.1 M Na acetate/HCl pH 4.6 P3 
4 15 2.2 M (NH4)2SO4 2 % PEG 400 0.1 M Na acetate/HCl pH 4.6 P3, F 
5 15 1.6 M (NH4)2SO4 2 % PEG 400 0.1 M Na acetate/HCl pH 5.0 P1 
6 15 1.8 M (NH4)2SO4 2 % PEG 400 0.1 M Na acetate/HCl pH 5.0 P2 
7 15 2.0 M (NH4)2SO4 2 % PEG 400 0.1 M Na acetate/HCl pH 5.0 P2 
8 15 2.2 M (NH4)2SO4 2 % PEG 400 0.1 M Na acetate/HCl pH 5.0 P2 
9 15 1.6 M (NH4)2SO4 2 % PEG 400 0.1 M Na acetate/HCl pH 6.0  
10 15 1.8 M (NH4)2SO4 2 % PEG 400 0.1 M Na acetate/HCl pH 6.0 P1 
11 15 2.0 M (NH4)2SO4 2 % PEG 400 0.1 M Na acetate/HCl pH 6.0 P1 
12 15 2.2 M (NH4)2SO4 2 % PEG 400 0.1 M Na acetate/HCl pH 6.0 P2 
13 15 1.6 M (NH4)2SO4 2 % PEG 400 0.1 M HEPES pH 7.5  
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14 15 1.8 M (NH4)2SO4 2 % PEG 400 0.1 M HEPES pH 7.5  
15 15 2.0 M (NH4)2SO4 2 % PEG 400 0.1 M HEPES pH 7.5 P1 
16 15 2.2 M (NH4)2SO4 2 % PEG 400 0.1 M HEPES pH 7.5 P1 
17* 15 1.8 M (NH4)2SO4 2 % PEG 400 0.1 M Na acetate/HCl pH 4.6 P2 
18* 15 1.8 M (NH4)2SO4 2 % PEG 400 0.1 M Na acetate/HCl pH 5.0 P2 
19* 15 1.8 M (NH4)2SO4 2 % PEG 400 0.1 M Na acetate/HCl pH 6.0 P1 
20* 15 1.8 M (NH4)2SO4 2 % PEG 400 0.1 M HEPES pH 7.5 P1 
21* 15 / 20 Crystal Screen I (Hampton Research) no. 47 + 2 % PEG 400 P3 / P3 
22 15 / 20 Crystal Screen I (Hampton Research) no. 47 + 2 % PEG 400 P3 / P3 
23* 15 / 20 Crystal Screen I (Hampton Research) no. 47 P3, N / P3, N 
24 15 / 20 Crystal Screen I (Hampton Research) no. 47 P3, N / P3, N 
* Seeding from drop containing needles; obtained using Crystal Screen I condition no. 47 (Hampton Research) 
during screening. 
 
Trial 3: 
2 μl of protein stock solution was mixed with 2 μl of reservoir solution. Two different protein 
stock concentrations 15.0 mg/ml and 20.0 mg/ml were tested for each condition. 
Observations made at: No. Precipitant Buffer 
15 mg/ml 20 mg/ml 
1 1.8 M (NH4)2SO4 150 mM Na acetate/HCl pH 4.6 P3, S P3, S 
2 1.8 M (NH4)2SO4 100 mM Na acetate/HCl pH 4.6 P3, S P3, S, N 
3 1.8 M (NH4)2SO4 50 mM Na acetate/HCl pH 4.6 P3, S P3, S, N 
4 1.8 M (NH4)2SO4 150 mM Na acetate/HCl pH 5.0 P2 P3, S 
5 1.8 M (NH4)2SO4 100 mM Na acetate/HCl pH 5.0 P2, N P3, S 
6 1.8 M (NH4)2SO4 50 mM Na acetate/HCl pH 5.0 P2,  P3, S 
7 1.8 M (NH4)2SO4 150 mM Na acetate/HCl pH 6.0 P1 P2 
8 1.8 M (NH4)2SO4 100 mM Na acetate/HCl pH 6.0 P1 P2 
9 1.8 M (NH4)2SO4 50 mM Na acetate/HCl pH 6.0 P1 P2 
10 2.0 M (NH4)2SO4 150 mM Na acetate/HCl pH 4.6 P3, S P3, S 
11 2.0 M (NH4)2SO4 100 mM Na acetate/HCl pH 4.6 P3, S P3, S, N 
12 2.0 M (NH4)2SO4 50 mM Na acetate/HCl pH 4.6 P3, S P3, S 
13 2.0 M (NH4)2SO4 150 mM Na acetate/HCl pH 5.0 P2 P3, S 
14 2.0 M (NH4)2SO4 100 mM Na acetate/HCl pH 5.0 P2 P3, S 
15 2.0 M (NH4)2SO4 50 mM Na acetate/HCl pH 5.0 P2 P3, S 
16 2.0 M (NH4)2SO4 150 mM Na acetate/HCl pH 6.0 P1 P2 
17  2.0 M (NH4)2SO4 100 mM Na acetate/HCl pH 6.0 P1 P2 
18 2.0 M (NH4)2SO4 50 mM Na acetate/HCl pH 6.0 P1 P2 
 
Trial 4: 
The first 24 conditions of Additive Screen (Hampton Research) were tested using the 
conditions at which needles had appeared during screening. 2 μl of protein stock solution  
(15.0 mg/ml) was mixed with 2.5 μl of reservoir solution and 0.5 μl of the additive. 
Reservoir solution No. 
Precipitant Buffer 
Additive (concentrations prior to mixing) Observations 
1 2.0 M (NH4)2SO4 0.1 M Na acetate/ 
HCl pH 4.6 
0.1 M Barium chloride dihydrate P3 
2 Do Do 0.1 M Cadmium chloride hydrate P3, N 
3 Do Do 0.1 M Calcium chloride dihydrate P3 
4 Do Do 0.1 M Cobalt(II) chloride hexahydrate P3 
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5 Do Do 0.1 M Copper(II) chloride dihydrate P3, S 
6 Do Do 0.1 M Magnesium chloride hexahydrate P3 
7 Do Do 0.1 M Manganese(II) chloride tetrahydrate P3 
8 Do Do 0.1 M Strontium chloride hexahydrate P3 
9 Do Do 0.1 M Yttrium(III) chloride hexahydrate P3, N 
10 Do Do 0.1 M Zinc chloride P3, N 
11 Do Do 0.1 M Iron(III) chloride hexahydrate P3 
12 Do Do 0.1 M Nickel(II) chloride hexahydrate P3 
13 Do Do 0.1 M Chromium(III) chloride hexahydrate P3 
14 Do Do 0.1 M Praseodymium(III) acetate hydrate P3 
15 Do Do 1.0 M Ammonium sulfate P3, N 
16 Do Do 1.0 M Potassium chloride P3, N 
17 Do Do 1.0 M Lithium chloride P3, S, N 
18 Do Do 2.0 M Sodium chloride P3 
19 Do Do 0.5 M Sodium fluoride P3, N 
20 Do Do 1.0 M Sodium iodide P3, F 
21 Do Do 2.0 M Sodium thiocyanate P3 
22 Do Do 1.0 M Potassium sodium tartrate tetrahydrate P3 
23 Do Do 1.0 M Sodium citrate tribasic dihydrate P3, N 
24 Do Do 1.0 M Cecium chloride P3 
 
A.4.3 Further optimization 
These trials were performed in an anaerobic chamber (section 4.2.2) at room temperature. A 
protein stock concentration of 23.5 mg/ml was applied. During set up, mixing of protein 
solution and reservoir solution was performed at three different volume ratios 
(protein:reservoir); 1:1 (total drop volume of 3 μl), 1:2 (total drop volume of 3 μl) and 1:3 
(total drop volume of 4 μl). Not all three ratios were applied in each trial. 
 
Trial 5: 
Observations made at protein to reservoir volume: No. Precipitant Buffer 
1:2 1:1 
1 1.6 M (NH4)2SO4 0.1 M Na acetate/HCl pH 4.0 P2, N P3, K 
2 1.8 M (NH4)2SO4 0.1 M Na acetate/HCl pH 4.0 P2 P3, F, K 
3 2.0 M (NH4)2SO4 0.1 M Na acetate/HCl pH 4.0 P3, S P3, F, K, S 
4 2.2 M (NH4)2SO4 0.1 M Na acetate/HCl pH 4.0 P3, S, K P3, F, K, S, D 
5 1.6 M (NH4)2SO4 0.1 M Na acetate/HCl pH 4.6 P1 P 
6 1.8 M (NH4)2SO4 0.1 M Na acetate/HCl pH 4.6 P1 P2 
7 2.0 M (NH4)2SO4 0.1 M Na acetate/HCl pH 4.6 P2, K, S, F P3, K, F, S 
8 2.2 M (NH4)2SO4 0.1 M Na acetate/HCl pH 4.6 P3, F P3, K, F, S 
9 1.6 M (NH4)2SO4 0.1 M Na acetate/HCl pH 5.0   
10 1.8 M (NH4)2SO4 0.1 M Na acetate/HCl pH 5.0 P1 P1 
11 2.0 M (NH4)2SO4 0.1 M Na acetate/HCl pH 5.0 P2 P2 
12 2.2 M (NH4)2SO4 0.1 M Na acetate/HCl pH 5.0 P3 P3 
13 1.6 M (NH4)2SO4 0.1 M Na acetate/HCl pH 6.0   
14 1.8 M (NH4)2SO4 0.1 M Na acetate/HCl pH 6.0   
15 2.0 M (NH4)2SO4 0.1 M Na acetate/HCl pH 6.0 P1 P1 
16 2.2 M (NH4)2SO4 0.1 M Na acetate/HCl pH 6.0 P1 P1 
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Trial 6: 
Observations made at protein to reservoir volume: No. Precipitant Buffer 
1:3 1:2 1:1 
1 1.2 M (NH4)2SO4 0.1 M Na acetate/HCl pH 4.0  P1 P2, S 
2 1.4 M (NH4)2SO4 0.1 M Na acetate/HCl pH 4.0 P1, N P2, N P3, N F, K 
3 1.5 M (NH4)2SO4 0.1 M Na acetate/HCl pH 4.0 P1, N P2, N P3, N, F, K 
4 1.6 M (NH4)2SO4 0.1 M Na acetate/HCl pH 4.0 P2, N P2, N, K P3, F, K 
5 1.7 M (NH4)2SO4 0.1 M Na acetate/HCl pH 4.0 P2 P2, K P3, F, K 
6 1.8 M (NH4)2SO4 0.1 M Na acetate/HCl pH 4.0 P2 P2, K P3, F, K 
7 1.9 M (NH4)2SO4 0.1 M Na acetate/HCl pH 4.0 P2 P2, K, F P3, F, K 
8 2.0 M (NH4)2SO4 0.1 M Na acetate/HCl pH 4.0 P3, K P3, K, F P3, F, K 
9 1.2 M (NH4)2SO4 0.1 M Na acetate/HCl pH 4.6   P1 
10 1.4 M (NH4)2SO4 0.1 M Na acetate/HCl pH 4.6  P1 P1 
11 1.5 M (NH4)2SO4 0.1 M Na acetate/HCl pH 4.6 P1 P1 P1 
12 1.6 M (NH4)2SO4 0.1 M Na acetate/HCl pH 4.6 P1 P1 P1 
13 1.7 M (NH4)2SO4 0.1 M Na acetate/HCl pH 4.6 P1 P1 P2 
14 1.8 M (NH4)2SO4 0.1 M Na acetate/HCl pH 4.6 P2 P2 P3, F, K 
15 1.9 M (NH4)2SO4 0.1 M Na acetate/HCl pH 4.6 P2 P2 P3, F, K 
16 2.0 M (NH4)2SO4 0.1 M Na acetate/HCl pH 4.6 P2 P3, F, K P3 
 
Trial 7: 
Observations made at protein to 
reservoir volume: 
No. Precipitant Buffer Additive 
1:2 1:1 
1 2.0 M (NH4)2SO4 0.1 M Na 
acetate/HCl pH 4.6 
0.2 M Li2SO4 P2, F, K, N P3, F, K, N 
2 2.0 M (NH4)2SO4 Do 10 mM ZnCl2 P2, N, K P3, F 
3 2.0 M (NH4)2SO4 Do 10 mM Zn acetate P2 P3 
4 2.0 M (NH4)2SO4 Do 10 mM Mg acetate P2 P3 
5 2.0 M (NH4)2SO4 Do 0.2 M (NH4)H2PO4 P3, F, K, N P3, F, D 
6 2.0 M (NH4)2SO4 Do 10 mM MgCl2 P2 P3 
7 2.0 M (NH4)2SO4 Do 0.2 M NH4 acetate P2 P3 
8 1.8 M (NH4)2SO4 Do 0.2 M Li2SO4 P2, N P3, F, K 
9 1.8 M (NH4)2SO4 Do 10 mM ZnCl2 P1 P2 
10 1.8 M (NH4)2SO4 Do 10 mM Zn acetate P1 P2 
11 1.8 M (NH4)2SO4 Do 10 mM Mg acetate P1 P2 
12 1.8 M (NH4)2SO4 Do 0.2 M (NH4)H2PO4 P2, F, K, D P2, F, D 
13 1.8 M (NH4)2SO4 Do 10 mM MgCl2 P1 P2 
14 1.8 M (NH4)2SO4 Do 0.2 M NH4 acetate P1 P2 
 
Trial 8: 
Observations made at protein to 
reservoir volume: 
No
. 
Precipitant Buffer: 
100 mM Na acetate  
Additive 
1:3 1:2 1:1 
1 1.2 M (NH4)2SO4 pH 4.0 0.2 M Li2SO4 P2, N P3, N P3, N, F, K 
2 1.4 M (NH4)2SO4 pH 4.0 0.2 M Li2SO4 P2, N P3, N P3, F, K 
3 1.6 M (NH4)2SO4 pH 4.0 0.2 M Li2SO4 P2 P3, D P3, F, K, D 
4 1.8 M (NH4)2SO4 pH 4.0 0.2 M Li2SO4 P2 P3, F, K, D P3, F, K, D 
5 2.0 M (NH4)2SO4 pH 4.0 0.2 M Li2SO4 P2 P3, F, K, D P3, F, K, D 
6 2.2 M (NH4)2SO4 pH 4.0 0.2 M Li2SO4 P3, D P3, D P3, F, D 
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7 1.2 M (NH4)2SO4 pH 4.6 0.2 M Li2SO4  P P 
8 1.4 M (NH4)2SO4 pH 4.6 0.2 M Li2SO4 P1 P1 P1 
9 1.6 M (NH4)2SO4 pH 4.6 0.2 M Li2SO4 P1 P1 P2 
10 1.8 M (NH4)2SO4 pH 4.6 0.2 M Li2SO4 P1 P2, N, F, K P3, N, F, K 
11 2.0 M (NH4)2SO4 pH 4.6 0.2 M Li2SO4 P2 P2, F, K P3, F 
12 2.2 M (NH4)2SO4 pH 4.6 0.2 M Li2SO4 P3 P3, F, D P3, F, D 
13 1.2 M (NH4)2SO4 pH 4.0 0.2 M (NH4)H2PO4 P1 P2, N P3, N, K 
14 1.4 M (NH4)2SO4 pH 4.0 0.2 M (NH4)H2PO4 P2, N P2, F, K P3, F, K 
15 1.6 M (NH4)2SO4 pH 4.0 0.2 M (NH4)H2PO4 P2, N P2, F, K P3, F, K 
16 1.8 M (NH4)2SO4 pH 4.0 0.2 M (NH4)H2PO4 P2, D P3, D P3, F, K, D 
17 2.0 M (NH4)2SO4 pH 4.0 0.2 M (NH4)H2PO4 P2, D P3, F, K, D P3, F 
18 2.2 M (NH4)2SO4 pH 4.0 0.2 M (NH4)H2PO4 P3, D P3, K, F, D P3, F, D 
19 1.2 M (NH4)2SO4 pH 4.6 0.2 M (NH4)H2PO4 P1 P1 P1 
20 1.4 M (NH4)2SO4 pH 4.6 0.2 M (NH4)H2PO4 P1 P1 P1 
21 1.6 M (NH4)2SO4 pH 4.6 0.2 M (NH4)H2PO4 P1 P1 P2 
22 1.8 M (NH4)2SO4 pH 4.6 0.2 M (NH4)H2PO4 P2, N P2, F, K P3 F, K ,D 
23 2.0 M (NH4)2SO4 pH 4.6 0.2 M (NH4)H2PO4 P2, F P3, F P3, F, D 
24 2.2 M (NH4)2SO4 pH 4.6 0.2 M (NH4)H2PO4 P3, D P3, F, D P3, F, D 
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Chapter one 
 
 
 
1 Introduction 
The second part of this dissertation concerns crystallization of the bifunctional enzyme dCTP 
deaminase:dUTPase from Mycobacterium tuberculosis (M. tuberculosis). This enzyme is 
involved in the reaction pathway for biosynthesis of the nucleotide dTTP and catalyses the 
conversion of dCTP to dUMP (Helt et al., 2008). dCTP deaminase:dUTPase belongs to a 
family of enzymes also including two other members; the monofunctional dCTPdeaminase 
and dUTPase (Johansson et. al, 2003 and 2005). 
Studying this enzyme family will provide an understanding of the evolutionary relations 
between the dUTPases and the dCTP deaminases, which will contribute to explain 
evolutionary relations between different organisms and the flow of genetic information. Also, 
studies of enzymes involved in pathways for biosynthesis of dTTP might provide clues 
concerning the evolution of DNA, e.g. clues as to how DNA evolved to contain thymidylate 
instead of deoxyuridylate. Finally, tuberculosis continues to be a worldwide problem and 
characterizing dCTP deaminase:dUTPase from M. tuberculosis might lead to a new potential 
drug target. 
I learned about ongoing research on M. tuberculosis dCTP deaminase:dUTPase from my 
supervisor, Associate Professor, Pernille Harris, who had been contacted by Associate 
Professor, Martin Willemoës (Department of Biology, University of Copenhagen). I accepted 
the task of trying to crystallize this enzyme. The goal was to determine the structure of the 
enzyme as an apo-enzyme and also in complex with the inhibitor, dTTP, and a substrate 
analogue, α,β-imido dUTP. 
 
1.1 Outline of part II 
Chapter 2 provides an introduction to the enzyme family including dCTP deaminase, dCTP 
deaminase:dUTPase and dUTPase. Also included is a description of the biosynthesis of the 
deoxynucleotides used for incorporation into DNA and tuberculosis treatment aimed at the 
nucleotide biosynthesis. Chapter 3 describes crystallization trials, data collection and structure 
determination. The structures of the apo-enzyme and the enzyme in complex with dTTP are 
presented and compared. These are further discussed in relation to other members of the 
enzyme family and implications concerning the dTTP inhibition mode and hydrolysis 
mechanism are discussed. Finally chapter 4 gives an outlook discussing further experiments 
based on the results presented in this part of the dissertation.   
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Chapter two 
 
 
 
2 dCTP deaminases, dUTPases and nucleotide synthesis 
 
2.1 The deoxyribonucleotide synthesis 
The building blocks from which DNA is synthesized are the deoxyribonucleotides, dCTP, 
dATP, dGTP and dTTP. Except for dTTP all of these are synthesized from the corresponding 
ribonucleotides by the action of ribonucleotide reductase at the diphosphate level (see figure 
2.1). This enzyme reduces the 2'-hydroxyl group to a hydrogen atom. The ribonucleotide UDP 
is also reduced by ribonucleotide reductase but, the product dUDP is not used for 
incorporation into DNA. The reason for not including urasil in DNA is probably that cytosine 
in DNA can deaminate spontaneously yielding urasil. This deamination is mutagenic since 
urasil pairs with adenine instead of guanine. The cell contains a repair system in which it 
recognises uracil (it recognises the missing methyl group compared to thymine) and cuts it out 
of the sequence. If DNA contained urasil there would be no way of correcting the 
spontaneous deamination of cytosine (Berg et al., 2002).    
 
2.2 Synthesis of dTTP 
DNA contains thymine and the corresponding deoxyribonucleotide used for incorporation 
into DNA is dTTP. In all organisms dUMP is the origin of dTTP. dUMP is methylated by 
thymidylate synthetase to yield dTMP, which is further phosphorylated in two steps by the 
action of dTMP kinase and nucleoside diphosphate kinase to yield dTTP (see figure 2.1) 
(Myllykallio et al., 2002; Neuhard and Kelln, 1996).  
There are two ways dUMP can be synthesized. A minor part of dUMP is obtained from 
reduction of UDP to dUDP by the action of ribonucleotide reductase, which is further 
phosphorylated to dUTP and then hydrolysed (reaction 2 figure 2.1) to dUMP by dUTPase 
(Bianchi et al., 1987; Møllgaard and Neuhard, 1978; Neuhard and Thomassen, 1971). The 
major supply of dUMP originates from deamination of a cytosine deoxyribonucleotide (see 
fig 2.1). In Gram-positive bacteria and eukaryotes dUMP is obtained directly from dCMP by 
the action of dCMP deaminases (reaction 4 figure 2.1), which are zinc-containing metallo-
enzymes (Almog et al., 2004; Weiner et al., 1993). In Gram-negative bacteria and some 
achaea dUMP is obtained from dCTP, which is deaminated and dephosphorylated. In E. coli 
and Salmonella typhimurium (S. typhimurium) this happens in two consecutive steps where 
dCTP is deaminated (reaction 1 figure 2.1) by dCTP deaminase to generate dUTP, which is 
further hydrolysed (reaction 2 figure 2.1) by dUTPase to generate dUMP (Johansson et al., 
2003; Neuhard and Nygaard, 1987). However, it was found a few years back that in the 
hyperthermophilic archeon Methanocaldococcus jannaschii (M. jannaschii), one enzyme, 
dCTP deaminase:dUTPase, carries out both functions in one active site (reaction 3 figure 2.1) 
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(Björnberg et al., 2003; Li et al., 2003). In both cases the deamination occurs without the aid 
of a metal ion (Johansson et al., 2003 and 2005). Until very recently the M. jannaschii 
enzyme was the only reported enzyme to carry out both functions, but now, a second 
dCTPdeaminase:dUTPase from the bacteria M. tuberculosis has been discovered. This is 
interesting as it demonstrates that the bifunctional enzyme can be found outside the archaean 
kingdom (Helt et al., 2008).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.1 Overview of synthesis of deoxyribonucleotides used for incorporation into DNA. dGTP, dATP 
and dCTP are obtained directly at the diphosphate level from reduction of the corresponding oxynucleotides. 
dTTP is synthesised from dUMP via three enzymatic reactions. The synthesis of dUMP is dependent on the 
organism (see text). Solid arrows indicate enzymatic reactions while dotted arrows indicate how a particular 
nucleotide affects the reaction to which the arrow points. Activators are indicated with (+) while inhibitors 
are indicated with (-). Reaction 1 is carried out by dCTP deaminase, reaction 2 is carried out by dUTPase, 
reaction 3 is carried out by the bifunctional dCTP deaminase:dUTPase and reaction 4 is carried out by dCMP 
deaminase. The figure was created by Associate Professor Martin Willemoës (Department of Biology, 
University of Copenhagen) and presented with permission. 
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dTTP inhibits dCTP deminases and dCTP deaminase:dUTPases by binding in the active site 
(Johansson et al., 2007,) while, dUTPases only show negligible affinity towards dTTP 
(Climie et al., 1994; Nord et al., 1997). dTTP also acts as an inhibitor of dCMP deaminases, 
where it binds in an allosteric site in competition with the activator, dCTP (Almog et al., 
2004) (see figure 2.1). Enzymes having dCTP deaminase activity are probably regulated by 
dTTP to avoid initiation of dCTP breakdown to dUMP in the presence of excess dTTP.  
 
2.3 dCTP deaminases and dUTPases 
dCTP deaminases, dUTPases and the bifunctional dCTPdeaminase:dUTPase belong to the 
same superfamily and they are all homo-trimers in their active form (Chan et al., 2004; 
Johansson et al., 2003 and 2005) (dUTPases can also be found as monomers or dimers, 
Gonzáles et al., 2001). The dCTP deaminases and the bifunctional enzymes share the highest 
structural similarity. However, all enzymes share an almost identical core structure and three 
active sites are contained in the active trimer. Figure 2.2 presents representative crystal 
structures of the three types of enzymes.  
A C E
B D F
 
 Figure 2.2 Ribbon views of dCTP deaminase and dUTPase crystal structures. A and B) Structure of E. coli 
dCTP deaminase-dUTP complex (PDB ID: 1XS1, Johansson et al., 2005). C and D) Structure of M. 
jannaschii E145A dCTP deaminase:dUTPase-α,β-imido dUTP complex (PDB ID: 2HXD, Siggaard et al., 
2008). E and F) Structure of M. tuberculosis dUTPase-α,β-imido dUTP complex (PDB ID: 1SIX, Chan et al., 
2004). The structures are viewed along the threefold axis (A, C and E) and perpendicular to the threefold axis 
(B, D and F).  The subunits in each of the three trimeric structures are shown in pink, cyan and green and in 
each structure the nucleotides are presented in ball and stick. The figure was prepared in PyMOL (DeLano 
W. L., 2002). 
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In the enzymes having dCTP deaminase activity the active site is composed of residues from 
two subunits and the C-terminal folds back upon the enzyme generating a lid covering the 
active site (Johansson et al., 2005; Helt et al., 2008; Siggaard et al., 2008). In dUTPases the 
active site is composed of residues from all three monomers as a result of the C-terminal 
reaching across the trimer and interacting with the γ-phosphate of the nucleotide placed in a 
pocket between the two other subunits (figure 2.2) (Chan et al., 2004).  
Figure 2.3 shows a schematic view of the reactions these enzymes catalyse and points out the 
differences between the nucleotides. Whether the reactions in the bifunctional enzyme are 
concerted or happen in two consecutive steps have not yet been resolved. The dUTP 
analogue, α,β-imido dUTP, is an often used nucleotide in imitating the interactions between 
the substrate and enzyme in dUTPase. The dUTP analogue and the inhibitor, dTTP, of 
enzymes having dCTP deaminase activity are also shown in figure 2.3. 
 
 
 
 
 
 
 
 
 
 
Figure 2.3 Schematic views of the reactions catalysed by the enzymes and differences in nucleotides. Upper 
part of the figure: dCTP deaminase catalyses the deamination of dCTP to yield dUTP and ammonia (the 
change indicated by the blue arrows). dUTP is then hydrolysed by dUTPase to yield dUMP and 
pyrophosphate. The bifunctional enzyme dCTP deaminase:dUTPase catalyses both of these reactions in one 
active site. Lower part of the figure: The inhibitor of dCTP deaminase and dCTPdeaminase:dUTPase, dTTP, 
only differs from dUTP by a single methyl group (indicated by pink arrow). In the dUTP analogue, α,β-imido 
dUTP, the α,β-bridging oxygen has been replaced with an imido group (green arrow) rendering the 
nucleotide non-hydrolysable by the mono-functional dUTPase. 
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The members of this enzyme family are non-metalloenzymes as opposed to dCMP 
deaminases (see section 2.2). The deamination of dCTP therefore happens by means of a 
different mechanism. However, for the reaction to take place dCTP deaminases and dUTPases 
require a magnesium ion (Neuhard, 1978; Shao et al., 1997), which has no catalytic effect but 
is coordinated to the phosphate moiety, rendering the true substrates dCTP·Mg2+ and 
dUTP·Mg2+, respectively, and the true inhibitor of the enzymes with dCTP deaminase 
function dTTP·Mg2+ (Johansson et al., 2007).  
Mutational analyses have been performed on enzymes from the family in order to establish 
which residues play key roles in the enzymatic reactions. These are outlined in section 3.2.6. 
Based on mutational analyses, obtained crystal structures and structure based sequence 
alignments, mechanisms for the deamination of dCTP (Johansson et al., 2005) and hydrolysis 
of dUTP (Chan et al., 2004) have been suggested and they are presented and discussed in 
section 3.2.6.2. 
Identification of residues common to this group of enzymes and residues specific for the 
deaminase activity or the hydrolysis activity will be of great value in predicting the function 
of new enzymes belonging to this family just based on sequence searches. The more new 
enzymes that are determined to belong to this family the stronger the evidence will be for how 
this group of enzymes evolved and the connection between dCTPdeaminases and dUTPases. 
 
2.4 Cooperativity in the active trimer 
Kinetic studies on S. typhimurium and E. coli dCTP deaminase have revealed cooperativity of 
substrate binding and that dTTP inhibition happens by a non-trivial competition between 
substrate and inhibitor for binding to the same site (Beck et al., 1975; Johanson et al., 2007). 
Structural studies on E. coli dCTP deaminase have shown the enzyme capable of adopting 
two different conformations in the active site dependent on the bound nucleotide. The part of 
the active site that undergoes conformational changes is found close to the threefold axis of 
the homo-trimer rendering the two conformations mutually exclusive (see figure 2.4). The 
side chains of two residues from neighbouring subunits are likely to clash unless all three 
subunits are found in the same conformation (elaborated in section 3.2.7) (Johanson et al., 
2007). The same phenomenon has been observed in the M. tuberculosis dCTP 
deaminase:dUTPase (discussed in section 3.2.7) while dTTP inhibition in the M. jannaschii 
bifunctional enzyme is suggested to be of simple competition with dCTP for binding in the 
active site. dUTPases kinetic studies have not indicated any signs of cooperativity (Larsson et 
al., 1996; Nord et al., 1997). 
 
2.5 The importance of dUTPases 
dUTP is a toxic nucleotide in the cell. dUTP and dTTP differ only by a single methyl group 
(see figure 2.3) and therefore dUTP can readily be accepted by DNA-polymerase instead of 
dTTP and incorporated into DNA. The DNA repair system will correct the misincorporation. 
However, when the concentration of dUTP is high, inducing excessive incorporation of uracil 
into DNA, the repair system goes into a deleterious cycle of multiple excisions leading to 
multiple strand breakage causing the cell to die. This process is termed thymineless cell death. 
Consequently dUTPase is an essential enzyme not only required for synthesis of dTTP, but 
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also for keeping a vital low ratio of dUTP:dTTP, hence maintaining the integrity of the 
genomic DNA (Richards et al., 1984; Gadsden et al., 1993). 
The trimeric dUTPases are not regulated by dTTP and they show extremely low affinity for 
dTTP (section 2.2). The reason for this selectivity against dTTP and nucleotides meant for 
incorporation into RNA is probably to avoid hydrolysis of non-lethal nucleotides at the 
expense of eliminating the highly toxic dUTP. As a consequence the nucleotide binding site 
has evolved to only recognise the uracil base (Chan et al., 2004; Johanson et al. 2007). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.4 Active and inactive conformation of E. coli dCTP deaminase. Close-up of residues 120-124 from 
superposition of the E. coli dCTP daminase-dUTP complex structure (green, PDB ID:1XS1, Johansson et al., 
2005) and E138A-dTTP complex structure (pink, PDB ID: 2J4Q, Johansson et al., 2007). The backbone is 
shown in ribbon view while the side chains of Val-122 and Thr-123 in all three subunits in the two structures 
are shown in sticks. Nucleotides are (shown in ball and stick) presented in standard atom colours. However, 
carbon is shown in colours corresponding to the colour of the matching enzyme. Mg2+ is shown in grey. The 
superposition is viewed along the three-fold axis. The E138A dTTP complex structure is found in the 
inactive conformation while the dUTP complex structure is found in the active conformation. It is evident 
that Val and Thr from neighbouring subunits will clash unless all subunits in the trimer are found in the same 
conformation (Johansson et al., 2007). The figure was prepared in PyMOL (DeLano W. L., 2002) in a similar 
mode as presented by Johansson et al. (2007). 
 
2.6 Tuberculosis treatment aimed at the nucleotide synthesis 
Tuberculosis continues to be a burden in developing as well as developed countries, infecting 
and killing millions of people worldwide every year. Tuberculosis is also a major cause of 
death among people infected with HIV/AIDS. Multi-drug resistant strains are a growing 
problem and new drug targets are therefore necessary (World Health Organization). 
Microorganisms like M. tuberculosis need an abundant supply of nucleotides for the DNA 
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synthesis in the rapidly dividing cells. Therefore, drugs aimed at enzymes involved in 
nucleotide synthesis are a growing area of research. 
A used approach in cancer treatment is to target enzymes of the thymidylate biosynthesis 
(Barabás et al., 2004), and inhibition of dUTPases has also been considered as a potential 
target for inhibiting cancer growth and viral replication (McIntosh and Hanes, 1997; Grässer 
et al., 2001; Ladner, 2001). 
Now, dUTPase has also been considered a drug target in the battle against tuberculosis. 
Human and M. tuberculosis dUTPases share 34 % sequence identity, which have to be taken 
into consideration when designing an inhibitor. Since the active sites of these two enzymes 
only show minor differences, a drug designed to inhibit M. tuberculosis dUTPase could easily 
inhibit the human form. The more different the considered enzymes are, the easier it is to 
design a species specific drug. In this connection knowing the structures of each enzyme is a 
key factor (Chan et al., 2004).  
The emergence of the bifunctional enzyme dCTP deaminase:dUTPase from M. tuberculosis  
yields a potential new drug target since this enzyme is not found in eukaryotes (Helt et al., 
2008). Obtaining the crystal structure of the enzyme and knowing how the enzyme is 
inhibited by dTTP is a necessary step in order to synthesize a drug targeting the bifunctional 
enzyme. The crystal structure of M. tuberculosis dCTP deaminase:dUTPase and the dTTP 
inhibition mode are presented and discussed in chapter 3 and have also been published (Helt 
et al., 2008).  
 
2.7 M. tuberculosis dCTP deaminase:dUTPase 
The enzyme was found in a database search for probable bifunctional enzymes. The primary 
sequence of dCTP deaminase:dUTPase from M. tuberculosis is composed of 190 amino acid 
residues corresponding to a molecular weight of 20.9 kDa for each subunit in the trimeric 
enzyme (Helt et al., 2008). The enzyme was expressed as a recombinant enzyme in E. coli 
and purified using standard purification techniques. Kinetic experiments has proved the 
enzyme to have both dCTPdeaminase and dUTPase activity with equal affinity towards dCTP 
and dUTP (Helt et al., 2008). This contrasts findings for the bifunctional enzyme from M. 
jannaschii, which has a lower affinity for dUTP compared to dCTP (Björnberg et al., 2003). 
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Chapter three 
 
 
 
3 Crystal structure of dCTP deaminase dUTPase 
 
3.1 Experimental 
 
3.1.1 Crystallization 
Enzyme used for crystallization trials, was generously supplied by Associate Professor Martin 
Willemoës (Department of Biology, University of Copenhagen). The enzyme was provided in 
two stock concentrations; 1.9 mg/ml and 4.3 mg/ml in 50 mM HEPES (4-(2-Hydroxy-
ethyl)piperazine-1-ethanesulfonic acid) pH 6.8, 2 mM DTT, and kept at -20 ºC for storage. 
Initial screening using commercially available screens was not performed. dCTP 
deaminase:dUTPase from M. tuberculosis bears a close resemblance to dCTP deaminase from 
E. coli which has previously been crystallized (Johansson et al., 2005). Consequently, initial 
screening was performed using the E. coli dCTP deaminase crystallization conditions  
(5-8 mg/ml enzyme, 5 mM dCTP or dUTP, 20 mM MgCl2 in 50 mM HEPES pH 7.5 mixed 
with reservoir solution; 28-30 % (v/v) PEG 400, 0.2 M MgCl2 in 0.1M HEPES pH 7.5) as a 
starting point. In all experiments the hanging drop vapour diffusion method was applied and 
the drop was equilibrated over 1 ml of reservoir solution. The concentration of enzyme was 
lowered compared to the E. coli conditions as it otherwise precipitated when concentrations 
above 4.3 mg/ml were attempted. 
Crystallization trials attempting to crystallize the apo-enzyme, the enzyme in complex with 
inhibitor, dTTP, and the enzyme in complex with substrate analogue, α,β-imido dUTP, were 
all begun by testing PEG 400 (20 to 40 %) against MgCl2 concentration (50 to 200 mM).  
 
3.1.1.1 Crystallization of dCTP deaminase:dUTPase in the presence of 
dTTP 
All the conditions for crystallization experiments are described in appendix A.1. Just prior to 
setting up each experiment, the enzyme solution was mixed with dTTP (100 mM stock 
solution) and MgCl2 (2 M stock solution) to obtain suitable concentrations and kept at 0ºC 
during set up. 
The crystal used for structure determination of dCTP deaminase:dUTPase in complex with its 
inhibitor, dTTP, was crystallized at 15ºC (appendix A.1, plate A3 number C6). 4 μl of enzyme 
solution containing 1.8 mg/ml enzyme, 20 mM MgCl2, 5 mM dTTP, 50 mM HEPES pH 6.8 
was mixed with 2 μl of reservoir solution, 45 % PEG 400, 200 mM MgCl2, 100 mM HEPES 
pH 7.5, and allowed to equilibrate. Crystals appeared within one day and grew to a size of 
0.11 × 0.05 × 0.05 mm in four days. After 10 days crystals were harvested and cryocooled for 
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storage and data collection, they were transferred directly from the crystallization drop to 
liquid nitrogen and kept herein for several weeks until data-collection. 
 
3.1.1.2 Crystallization of apo-dCTP deaminase:dUTPase 
All the conditions for crystallization experiments are described in appendix A.2. In the first 
experiment the enzyme was mixed with MgCl2 (2 M stock solution) just prior to set up. In 
each experiment the enzyme was kept at 0ºC during set up. 
The crystal used for structure determination of apo-dCTP deaminase:dUTPase was 
crystallized at 4ºC (appendix A.2, plate B5 number C6). 2 μl of enzyme stock solution 
containing 1.9 mg/ml enzyme, 50 mM HEPES pH 6.8 was mixed with 2 μl of reservoir 
solution, 20 % PEG 8000, 50 mM MgCl2, 100 mM HEPES pH 7.5, and allowed to 
equilibrate. Micro-crystals and precipitation appeared after one day and after six weeks one 
crystal had grown to the size of 0.06 × 0.03 × 0.03 mm. The crystal was cryocooled for 
storage and data collection, it was transferred from the crystallization drop and soaked in a 
cryo-solution containing 75 % reservoir solution and 25 % PEG 400 for ca. ten seconds. The 
diffraction-properties were tested and the crystal was annealed (the cryo-stream was blocked) 
for five seconds. Diffraction properties were tested again and since the diffraction limit was 
about 4 Å a dataset was not collected. The crystal was stored in liquid nitrogen for several 
months and at a later synchrotron trip a complete dataset was collected (section 3.1.2).  
 
3.1.1.3 Crystallization of dCTP deaminase:dUTPase in the presence of α,β-
imido dUTP 
All the conditions for crystallization experiments are described in appendix A.3. Just prior to 
setting up each experiment, the enzyme was mixed with α,β-imido dUTP (10 mM stock 
solution) and MgCl2 (2 M stock solution) to obtain suitable concentrations and kept at 0ºC 
during set up. 
The crystal used for structure determination of dCTP deaminase:dUTPase in complex with 
substrate-analogue, α,β-imido dUTP, was crystallized at 4ºC (appendix A.3, plate C2 number 
A5). 2.4 μl of enzyme solution containing 1.6 mg/ml, 17 mM MgCl2, 1.7 mM α,β-imido 
dUTP, 50 mM HEPES pH 6.8 was mixed with 2 μl of reservoir solution, 30 % PEG 400,  
200 mM MgCl2, 100 mM HEPES pH 7.5, and allowed to equilibrate. Crystalline precipitation 
appeared after one day and after one month tiny crystals had appeared and grown to the size 
of 0.04 × 0.04 × 0.02 mm. After four months crystals were harvested and cryocooled for 
storage and data collection, they were transferred directly from the crystallization drop to 
liquid nitrogen and kept herein until data-collection. 
It was also attempted to soak α,β-imido dUTP into crystals of apo-enzyme. 0.5 μl of a 10 mM 
α,β-imido dUTP solution was added to a crystallization drop containing crystals of apo-
enzyme (appendix A.2, plate B4 number D2). After one hour another 0.5 μl was added and 
after a total two hours crystals were harvested and cryocooled. To another drop containing 
crystals of apo-enzyme (appendix A.2, plate B3 number D1) 1 μl of the 10 mM α,β-imido 
dUTP solution was added and crystals were harvested and cryocooled after two weeks. In 
both cases crystals were transferred directly from the crystallization drop to liquid nitrogen 
and kept herein until the diffraction properties could be tested. 
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3.1.2 Data collection and processing 
Diffraction properties of crystals were tested at MaxLab (Lund, Sweden) beamline 9-11-3 and 
at ESRF (Grenoble, France) beamline ID14-3. Diffraction data were collected at the ESRF 
using a wavelength and temperature of 0.931 Å and 100 K, respectively. Data were collected 
from 0º to 180º using 1º increments. The diffracting properties of several crystals were tested 
before finding those suitable for data collection. Four trips to the ESRF were made and the 
data set for the apo-enzyme was collected by Managing Laboratory Technician Flemming 
Hansen (Department of Chemistry, University of Copenhagen) while the two others were 
collected by the author. 
The diffraction data were indexed, integrated, scaled and merged using XDS and 
XSCALE (Kabsch, 1993). Details on data collection, processing and statistics are presented in 
table 3.1. 
 
Table 3.1 Data collection, processing and statistics a. 
 dCTP deaminase:dUTPase-
dTTP complex 
Apo-dCTP 
deaminase:dUTPase 
dCTP 
deaminase:dUTPase 
crystallized with α,β-
imido dUTP 
Synchrotron source  ESRF ID14-3 ESRF ID14-3 ESRF ID14-3 
Detector ADSC Quantum 4 ADSC Quantum 4 ADSC Quantum 4 
Data collection 
temperature (K) 
100 100 100 
Wavelength (Å) 0.931 0.931 0.931 
Resolution limits (Å) 19.6 - 2.0 (2.1 - 2.0) 19.9 - 2.5 (2.8 - 2.5) 20.0 - 3.0 (3.5-3.0) 
    
No. of reflections 247,075 (33,274) 118,238 (33,612) 234,584 (85,651) 
No. of unique 
reflections 
22,235 (2,973) 32,512 (9,296) 42,308 (15,761) 
Data redundancy 11.1 (11.2) 3.6 (3.6) 5.5 (5.4) 
Completeness (%) 98.1 (97.8) 99.1 (99.0) 99.5 (99.9) 
Rmerge (%)b 15.9 (59.5) 19.3 (55.1) 31.1 (63.7) 
Mean I/σ(I) 15.01 (4.46) 6.81 (2.24) 5.43 (2.56) 
Space group R32 P21 R3 (hexagonal settings) 
Unit-cell parameters 
(Å,º) 
a = b = c = 82.640 
α = β = γ = 70.750 
a = 62.800, b = 96.700,  
c = 78.00,  
α = γ = 90.0, β = 97.700 
a = b = 97.700,  
c = 596.300 
α = γ = 90.0, β = 120.0 
Matthews coefficient, 
VM (Å3/Da) 
1.95 1.87 2.19 
Solvent content (%) 36.83 34.42 43.79 
a values in parenthesis are for the outermost resolution shell. 
b Rmerge = Σ|I —〈I〉|/ΣI, where I is observed intensity and 〈I〉  is average intensity obtained from multiple 
observations of symmetry related reflections. 
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3.1.3 Structure determination and refinement 
 
3.1.3.1 dCTP deaminase:dUTPase in complex with dTTP 
The crystal structure of dCTP deaminase:dUTPase in complex with dTTP was solved by 
molecular replacement. Due to the high resemblance of M. tuberculosis dCTP 
deaminase:dUTPase to M. jannaschii dCTP deaminase:dUTPase and E. coli dCTP deaminase 
(see section 3.2.6) both were tested as search models for molecular replacement. Using the 
peptide chain of the M. jannaschii structure (PDB ID: 1OGH, Johansson et al., 2003) no 
solution could be obtained. However, using the peptide chain of the E. coli dCTP deaminase 
structure (PDB ID: 1XS1, Johansson et al., 2005) a solution was found. Molecular 
replacement was performed by MOLREP (Vagin and Teplyakov, 1997) from the CCP4 
program suite (Collaborative Computational Project, Number 4, 1994) and a solution was 
obtained in space group R32 with two molecules (A and B) per asymmetric unit. Multiple 
rounds of model building in the σA-weighted 2Fobs-Fcalc and Fobs-Fcalc electron density map 
and refinement were carried out using the programs WinCoot (Emsley and Cowtan, 2004) and 
REFMAC5 (Murshudov et al., 1997, from the CCP4 program suite), respectively. Refinement 
progress was observed by the development in the R- and Rfree-factor based on 5 % 
independent reflections. In both subunits residues 1-189 could be modelled and non-
crystallographic symmetry was imposed on residues 1-112 and 118-180 during refinement. 
During refinement clear density for dTTP coordinated to Mg2+ appeared in both subunits. At 
the end of the refinement process a total of 169 water molecules were added to the model 
using the automated ARP/wARP (Lamzin et al., 2001) procedure in REFMAC5 and inspected 
manually in WinCoot. Also, density corresponding to three PEG fragments appeared in the 
model. Finally, the model was validated using WHAT IF (Vriend, 1990) and PROCHECK 
(Laskowski et al., 1993). Refinement statistics are presented in table 3.2.  
 
3.1.3.2 Apo-dCTP deaminase:dUTPase 
The crystal structure of apo-dCTP deaminase:dUTPase from M. tuberculosis was solved by 
molecular replacement using the peptide chain A of the enzyme in complex with dTTP (see 
section 3.1.3.1) as a search model. A solution was found in space group P21 with six 
molecules (A, B, C, D, E and F) per asymmetric unit. Model building and refinement was 
carried out as described (section 3.1.3.1). In the six subunits residues 1 to 161 (A), 159 (B, C, 
E), 160 (D), 158 (F) could be modelled and non-crystallographic symmetry was imposed on 
residues 1-55 and 75-158 during refinement. 120 water molecules and seven PEG fragments 
were added to the model during refinement and it was finally validated as described (section 
3.1.3.1). Refinement statistics are presented in table 3.2.  
 
3.1.3.3 dCTP deaminase:dUTPase crystallized in the presence of α,β-imido 
dUTP 
The crystal structure of the enzyme crystallized in contact with α,β-imido dUTP was solved 
by molecular replacement using the peptide chain A of the enzyme in complex with dTTP 
(see section 3.1.3.1) as a search model. A solution was found in space group R3 (hexagonal 
setting) with 12 molecules (A, B, C, D, E, F, G, H, I, J, K and L) per asymmetric unit. Model  
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building and refinement was carried out as described (section 3.1.3.1). Non-crystallographic 
symmetry was imposed on residues 1-110, 119-161 and 178-183 during refinement. In all 12 
subunits residues 1-161 could be modelled while residue 162 could be modelled in ten 
subunits and in subunit A, residue 163 could also be modelled. A part of the C-terminal could 
be modelled in all subunits, the shortest stretch (residue 177 to 184) found in subunit L and 
the longest stretch (residue 173 to 187) found in subunit C. In none of the 12 subunits density 
corresponding to the nucleotide, α,β-imido dUTP, was visible. However, in subunits B and G 
density corresponding to the triphosphoryl moiety of the nucleotide appeared in the model 
and in subunits A, D, E, H, J and K density corresponding to mono-phosphate appeared. Six 
water molecules were added to the model and it was validated using PROCHECK (Laskowski 
et al., 1993). Refinement statistics are presented in table 3.2. 
  
Table 3.2 Refinement statistics. 
 dCTP 
deaminase:dUTPase-
dTTP complex 
Apo-dCTP 
deaminase:dUTPase 
dCTP 
deaminase:dUTPase 
crystallized with α,β-
imido dUTP 
No. of reflections in working 
set 
21,122 30,888 40,242 
No. of reflections in test set 1,113 1,624 2,224 
R (%)a 16.13 22.82 25.66 
Rfree (%)b 21.70 29.48 31.37 
Molecules in asymmetric unit 
(asu) 
2 6 12 
No. of water molecules in asu 169 120 6 
No of PEG molecules in asu 3 7 0 
Rmsd bond length (Å) 0.010 0.011 - 
Rmsd angles (º) 1.39 1.56 - 
Rmsd dihedral angles (º) 1.81 2.45 - 
Average B factor, main chain 
A/B/… (Å2) 
15.9/15.0 19.1/19.1/18.3/19.7/19.4/ 
19.5 
29.0 (average, all chains) 
Average B factor, side chain 
A/B/… (Å2) 
18.3/17.4 19.6/19.7/19.0/20.5/20.0/ 
20.1 
31.6 (average, all chains) 
Average B factor, protein 
A/B/… (Å2) 
17.1/16.2 19.5/19.4/18.7/20.1/19.7/ 
19.8 
30.2 (average, all chains) 
Rmsd B factor, main chain 
A/B/… (Å2) 
1.37/1.43 0.50/0.52/0.47/0.53/0.51/ 
0.51 
0.82 (average, all chains) 
Rmsd B factor, side chain 
A/B/… (Å2) 
1.81/1.80 0.55/0.53/0.55/0.54/0.54/ 
0.53 
0.96 (average, all chains) 
Average B factor, water 
molecules (Å2) 
21.6 11.7 3.6 
Avarage B factor, dTTP A/B 
(Å2) 
14.3/13.0 - - 
B factor, Mg A/B (Å2) 9.8/7.7 - - 
Avarage B factor, PEG (Å2) 33.4 25.0 - 
a R = Σwork||Fobs|— k|Fcalc||/Σwork Fobs.  
b Rfree = Σtest||Fobs|— k|Fcalc||/Σtest Fobs, where Fobs and Fcalc are observed and calculated structure factors, 
respectively, k is the scale factor, and the sums are the overall reflections in the working set and test set, 
respectively. 
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3.1.4 PDB code entries 
The coordinates and structure factors have been deposited in the Protein Data Bank with 
accession codes 2QLP and 2QXX for the apo-enzyme and the enzyme-dTTP complex, 
respectively. The structure of the enzyme in complex with the substrate analogue has not been 
published. 
 
3.2 Results and discussion  
 
3.2.1 Crystallization 
 
3.2.1.1 Crystallization of dCTP deaminase:dUTPase in the presence of 
dTTP 
From the first experiment (appendix A.1, plate A1) rod shaped crystal appeared. It was clear 
that the higher the PEG concentration in the reservoir solution the larger the crystals. 20 % 
PEG 400 yielded clear drops. 25-30 % PEG 400 produced crystalline precipitation within one 
week. 35 % PEG produced crystalline precipitation from which needles grew within one 
week. 40 % PEG 400 produced micro crystals within two days and within one week rod 
shaped crystals and crystalline precipitation appeared when the MgCl2 concentration was 
between 100 and 200 mM; the largest crystals appearing in 150 mM MgCl2, having an 
approximate size of 0.10 × 0.02 × 0.02 mm (figure 3.1 A). One of these diffracted to 2.4 Å 
In the second experiment (appendix A.1, plate A2) the PEG 400 concentration interval was 
raised to 35-55 % and also the MgCl2 concentration interval was raised to 100-250 mM. The 
experiment was set up at room temperature as the first experiment, but precipitation was 
observed in all drops just after set up with no change over time. I was puzzled but led to 
believe that the crystallization conditions were dependent on temperature.  
 
A B C
Figure 3.1 Crystals of dCTP deaminase dUTPase crystallized in the presence of dTTP. Conditions from 
which each of the crystals was grown are found in appendix A.1. A) Plate A1 number C5. The crystal is ca. 
100 μm long. B and C) Plate A3 number C6. The largest crystals are ca. 110 μm long. 
Therefore in experiment three (appendix A.1, plate A3), the same conditions were set up as in 
the first experiment. However, the plate was set up on ice and stored at 15ºC. Within one day 
micro crystals appeared in all drops. Within four days some of the crystals had grow in some 
of the drops. The crystallization pattern was not the same as observed in the first experiment, 
but this might be due to the change in set up and storage temperature. The most beautiful 
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crystals appeared in 35 % PEG 400, 150-250 mM MgCl2 and 40 % PEG 400,  
200 mM MgCl2 (0.1 × 0.01 × 0.01 mm), while the largest in 45 % PEG 400, 200 mM MgCl2, 
the volume of enzyme solution in the crystallization drop was twice that of the reservoir 
solution (0.11 × 0.05 × 0.05 mm) (figure 3.1 B and C). One of these was used to collect data 
to 2.0 Å.  
In the fourth and fifth experiment (appendix A.1, plates A4 and A5) it was tried to reproduce 
the results and further optimize by lowering the temperature to 4ºC. However, only crystalline 
precipitation and smaller crystals were found.  
 
3.2.1.2 Crystallization of apo-dCTP deaminase:dUTPase 
From the first experiment (appendix A.2, plate B1) crystals appeared at a MgCl2 
concentration of 50 mM in the reservoir solution and at all examined PEG 400 concentrations. 
These crystals were the shape of long (100 μm) thick needles, the largest ones present at PEG 
concentrations of 25 % (figure 3.2 A). A PEG 400 concentration of 20 % also yielded some 
very small crystals the shape of “hexagonal tents”. The diffracting properties of some of the 
needles were tested, but none diffracted.  
A second experiment (appendix A.2, plate B2) was set up to optimize these conditions, but 
precipitation was observed in all drops just after set up with no change over time. This was 
believed to be due to high temperatures (see section 3.2.1.1).  
Two experiments were set up at 4ºC and 15ºC, respectively (identical except for temperature, 
appendix A.2 plates B3 and B4). At 4ºC plate-like crystals appeared when the PEG 
concentration in the reservoir was 25 % and the MgCl2 concentration was either 0 or 50 mM 
(figure 3.2 D to F shows crystals obtained at 50 mM MgCl2). The largest crystals (0.1 × 0.07 
× 0.02 mm) were found when the volume of enzyme solution in the crystallization drop was 
twice the volume of the reservoir solution. At 15ºC crystals were also found at a reservoir 
concentration of 25 % PEG 400, but only when the volume of enzyme solution in the 
crystallization drop was twice the volume of the reservoir solution. Plate-like crystals 
comparable to those obtained at 4ºC were also found at 15ºC, but “hexagonal tent”-shaped 
crystals also appeared (0.06 × 0.03 × 0.03 mm) (figure 3.2 B and C). The diffracting 
properties of some of the crystals were tested, but none diffracted.  
It was decided to test if raising the PEG 400 concentration and also raising the concentration 
of the enzyme would yield better crystals (appendix A2 plate B5). However, this only 
produced precipitation and micro crystals. PEG 1000, PEG 4000 and PEG 8000 were also 
tested in combination with 50 mM MgCl2. After one day precipitation and microcrystalline 
material was found in all drops. But after one month a few crystals (figure 3.2 G to I) 
appeared in one drop equilibrated over reservoir solution containing 20 % PEG 8000 and 50 
mM MgCl2. After six weeks the crystals had increased in size and the largest was 0.06 × 0.03 
× 0.03 mm. When the diffraction properties were tested at first, high mosaicity and low 
resolution (about 4 Å) was observed. After annealing the crystal (section 3.1.1.2) low 
mosaicity was observed but the resolution remained low. Since this was the only diffracting 
crystal it was saved. After several months the diffraction properties were tested once more and 
surprisingly enough the resolution had improved markedly and a data set could be collected to 
2.5 Å.  
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Figure 3.2 Crystals of apo-dCTP deaminase dUTPase. Conditions from which each of the crystals was 
grown are found in appendix A.2. A) Plate B1 number A2. The crystals are ca. 100 μm long. B) Plate B4 
number D2. The diameter is ca. 30 μm. C) Plate B4 number A2. On the longest axis the crystals are ca. 
60 μm. D) Plate B3 number D1. The largest crystals are ca. 80 μm long. E and F) Plate B3 number D2. The 
largest crystals are ca. 100 μm long. G, H and I) Plate B5 number C6. In each panel a bar indicates the size of 
the crystal. The crystal shown in G was used for data collection. 
 
3.2.1.3 Crystallization of dCTP deaminase:dUTPase in the presence of α,β-
imido dUTP 
From the first experiment (appendix A.3, plate C1) only precipitation was observed, which 
was believed to be an effect of temperature (section 3.2.1.1). 
In the second and third experiment (identical except for temperature, appendix A.3, plates C2 
and C3) the temperature was lowered to 4ºC and 15ºC, respectively. At 15ºC only crystalline 
precipitation was observed while small crystals grew from the crystalline precipitation at 4ºC 
when the volume of enzyme solution in the crystallization drop was twice the volume of the 
reservoir solution. Crystals also appeared in the drop set up with 2.4 μl enzyme solution and  
2 μl of reservoir solution containing 30 % PEG 400, 200 mM MgCl2 (figure 3.3). The largest 
of the crystals grew to a size of 0.04 × 0.04 × 0.02 mm and this was used to collect data to  
3 Å. Three more experiments were set up (appendix A.3, plates C4, C5 and C6) to optimize 
the conditions and test other PEGs as precipitants, but only micro crystals and precipitation 
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appeared. Soaking apo-crystals in α,β-imido dUTP did not yield diffracting crystals and 
attempts to anneal crystals resulted in breakdown of the crystal.  
 
A B C 
Figure 3.3 Crystals of dCTP deaminase dUTPase crystallized in the presence of α,β-imido dUTP. All 
crystals are from plate C2 number A5 (appendix A.3). The crystals are ca 40 μm on the longest axis. The 
crystal shown in B was used for data collection. 
 
3.2.1.4 Comments on crystallization 
Getting the enzyme to form crystals seems to be fairly easy, but it is difficult to get the 
crystals to grow to a size suitable for diffraction. Comparing diffracting properties of the 
obtained crystals to crystal size and the state of the crystallization drop, it is clear that the 
larger the crystal the better the diffraction. Also, diffracting crystals were found to either grow 
from crystalline precipitation or be present in drops with a considerable amount of 
precipitation.  
The reason for poor diffraction and difficulty in obtaining large crystals especially observed in 
crystals of apo-enzyme and crystals crystallized in the presence α,β-imido dUTP might be due 
to disordered regions in the enzyme and difficulties in binding of α,β-imido dUTP (see 
sections 3.2.3 and 3.2.5).  
 
3.2.2 The model of the dCTP deaminase:dUTPase-dTTP complex  
The crystal structure was solved in space group R32 with two subunits, A and B, in the 
asymmetric unit. In both subunits residues 1-189 could be modelled leaving only one residue 
un-modelled. dTTP coordinated to one magnesium ion was found to be present in both A and 
B. The Ramachandran plot (figure 3.4) produced by PROCHECK shows that 89.4 % of the 
residues are found in the most favoured regions while 10.3 % of the residues are in the 
additional allowed regions. 0.3 % of the residues corresponding to one residue, Asn-185 A, 
are found in the generously allowed regions. The precise spatial position of this residue is 
questionable due to lack of electron density. The backbone of each chain fits nicely into the 
σA-weighted 2Fobs-Fcalc electron density map except for residue Ile-187-A, which is barely 
visible. Also a few residues show weak side chain density: Asp-68-B, Arg-166-B and Asn-
187-A. There is slight evidence from the Fobs-Fcalc electron density map that Ile-32 (not 
shown) and Thr-114 (figure 3.5) from both chains are present in more than one conformation 
(rotation around Cα-Cβ bond). However, imposing double conformation onto these residues 
does not improve the quality of the model and has not been included. 
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Figure 3.4 Ramachandran plot and plot statistics (produced by PROCHECK, Laskowski et al., 1993) of the 
M. tuberculosis dCTP deaminase:dUTPase-dTTP complex structure. 
 
 
 
 
 
 Thr-114 
 
 
 
 
 
 
 
 
 
 
 Figure 3.5 Electron density map presenting Thr-114 and the surrounding residues from subunit A of the M. 
tuberculosis dCTP deaminase:dUTPase-dTTP complex structure. The blue mesh represents the 2Fobs-Fcalc 
map contoured at 1 σ. The green (positive) and red (negative) mesh represent the Fobs-Fcalc map contoured at 
3 σ. There is slight evidence that Thr-114 is found in two conformations. The figure was prepared using 
WinCoot (Emsley and Cowtan, 2004). 
 
 
 
 
The Cα atoms of each subunit can be superposed with a root mean square deviation (rmsd) of 
0.22 Å while all residues of each subunit can be superposed with a rmsd value of 0.39 Å. 
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The threefold crystallographic symmetry generates two independent homotrimers of A and B 
subunits, respectively (see figure 3.6). The height of each trimer along the threefold axis is 
about 45 Å, while the diameter of the trimer perpendicular to the threefold axis is about 50 Å. 
 
 
A B 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
C  
D 
 
 
 
 
 
 
 
 
 
 
 
 
 Figure 3.6 Ribbon views of the structure of M. tuberculosis dCTP deaminase:dUTPase-dTTP complex. The 
asymmetric unit contains two subunits (panel A), A and B, shown in green and pale green, respectively. The 
threefold symmetry-axis (black arrow) generates two homotrimers stacked on top of each other (panel B). In 
the trimer generated of three A subunits each subunit is shown in green, pink and cyan, respectively. In the 
trimer generated of three B subunits each subunit is shown in pale green, pale pink and pale cyan, 
respectively. Panels C and D show the A-trimer perpendicular to the threefold axis and viewed along the 
threefold axis, respectively. The N- and C-terminals are shown in blue and red, respectively. In each panel 
dTTP is shown in yellow in ball and stick and Mg2+ is shown in grey. The figure was prepared with PyMOL 
(DeLano W. L., 2002).  
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Each subunit of M. tuberculosis dCTP deaminase:dUTPase is composed of 13 β-strands (β1- 
β13), two α-helices (α1-α2) and one 310-helix (γ1) (see figure 3.7). Several turns and loops are 
present in the structure. The β-strands are arranged in four anti-parallel β-sheets (the position 
of a single string in the sheet is indicated by the order): S1 (β1, β7 and β10), S2 (β2, β13 and 
β8), S3 (β4, β3, β6, β11 and β9) and S4 (β5 and β12). The structure of each subunit has a core 
of β-sheets flanked by α-helices. β-strings 6 and 10 almost extends into strings 7 and 11 
respectively. This generates a core structure of a distorted β-barrel, which is common to 
enzymes having dCTP deaminase activity (Johansson et al., 2005). 
  
 
 
 β12 
α2  β5 
 β9 
 β6 
 
β3 β4 β11  
γ1  β2 
 
 
 
β13  
β8  
 α1 β7 β1 
 β10 
 
 
Figure 3.7 Secondary structure of M. tuberculosis dCTP deaminase:dUTPase. Ribbon view of subunit A of 
the M. tuberculosis dCTP deaminase:dUTPase-dTTP complex structure where helices are shown in cyan, 
while the four β-sheets are displayed in four different shades of blue. The inhibitor, dTTP, in complex with 
magnesium (grey) is shown in yellow in ball and stick. The figure was prepared in PyMOL (DeLano W. L., 
2002). 
 
Assembling the trimer also generates three active sites common to the enzyme family (see 
section 2.3). Each active site is found in a pocket between two monomers. The C-terminal 
folds back upon the active site like a lid rendering the nucleotide almost completely shielded 
from the solvent (see figure 3.8).  
The nucleotide present in the active site shows an extensive hydrogen bonding network with 
the surroundings which is shown in figure 3.9. The 2Fobs-Fcalc electron density map 
demonstrating the nucleotide is also presented in the figure. Since the active site is composed 
of residues from neighboring subunits, residues from one of the two are marked with asterisk 
(e.g. Ala*) in the following description. The numbering of water molecules are those from 
subunit A. The positions of the water molecules in subunit B are equivalent however, the 
numbers differ. 
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From the thymidine moiety O2, N3 and O4 form hydrogen bonds. O2 forms hydrogen bonds 
with Arg*-106, Gln-174 and Thr-127. N3 forms one hydrogen bond to Thr-127 while O4 
forms hydrogen bonds to water molecules 51 and 66. Water 66 also forms a hydrogen bond to 
Glu-129 and Ser-113. Further, water molecule 51 is hydrogen bonded to Ala-115 and Glu-
129. Also, Glu-129 is hydrogen bonded to water molecule 15, which is further hydrogen 
bonded to Ser*-102. Ser*-102 is also hydrogen bonded to Arg*-106 and it is placed directly 
above the pyrimidine plane, which is supported by Ile-126 on the other side. 
 
A B 
 
 
 
 
 Figure 3.8 Active site architecture of M. tuberculosis dCTP deaminase:dUTPase-dTTP complex. dTTP is 
bound in the active site pocket between two of the three subunits in the active trimer. The two subunits are 
shown in ribbon view in pink and green, respectively. dTTP and Mg2+ are shown in ball and stick (yellow 
and grey). The C-terminal folds as a lid covering the active site pocket (A) and when the surfaces of both 
subunits are generated (B) it is evident that the nucleotide is almost completely shielded from solvent only 
exposed to the solvent by means of a narrow channel. The figure was prepared with PyMOL (DeLano W. L., 
2002). 
 
 
 
 
 
 
The deoxy-ribosyl moiety is only supported by one hydrogen bond which is O3 bound to 
Asp-119 and the deoxy-ribosyl moiety is placed in a hydrophobic cleft in a way so that C2 is 
pointing between Ile-118 and Phe-122. At the same time Asp-119 forms two hydrogen bonds 
to water molecule 72. Also, the deoxy-ribosyl moiety is supported by Tyr-162 and Tyr-171. 
The nucleotide is resting on a hydrophobic surface generated by residues Ile-118, Phe-122, 
Ile-126, Tyr-162 and Tyr-171. 
The triphosphoryl moiety of the nucleotide acts as a tri-dentate ligand and is coordinated to a 
magnesium ion via O1, O2 and O3 from α-, β-, γ-phosphoryl, respectively. Mg2+ is also 
coordinated by water molecules 60, 65 and 166 generating an octahedral coordination sphere. 
O1 from the α-phosphoryl is further hydrogen bonded to water molecules 60, 65 and 72 while 
O2 is hydrogen bonded to Ser*-102 and Gln*-148. From the β-phosphoryl, O2 is further 
hydrogen bonded to water molecules 60 and 116 and Lys-101 while O1 is hydrogen bonded 
to Ser*-103. From the γ-phosphoryl, O3 is further hydrogen bonded to water molecules 53, 65 
and 116 while O2 is bound to Tyr-162 and Lys-170. O1 is hydrogen bonded to Lys-170 and 
water molecule 163. 
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 A 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
B  
 
 
 
 
 
 
 
 
 
 
 
 
 
 Fig 3.9 The inhibitor and the surrounding residues in the M. tuberculosis dCTP deaminase:dUTPase-dTTP 
complex structure. A) Electron density maps presenting the nucleotide in subunit A. The blue mesh 
represents the 2Fobs-Fcalc map contoured at 1 σ and the green mesh represents the positive Fobs-Fcalc map 
contoured at 3 σ. B) Schematic view of the hydrogen bonding network surrounding dTTP. The active site is 
composed of residues from two subunits in the trimer. Residues without asterisk (e.g. Ala) are from the first 
subunit while residues marked with asterisk (e.g. Ala*) are from the second subunit. The dotted lines 
represent hydrogen bonds between atoms. Panel A was prepared in WinCoot (Emsley and Cowtan, 2004). 
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3.2.3 The model of the apo-dCTP deaminase:dUTPase   
The structure of the apo-enzyme was solved in space group P21 with six molecules (A, B, C, 
D, E and F) in the asymmetric unit. The structure of the asymmetric unit is that of two 
homotrimers (as presented for the enzyme-dTTP complex structure in figure 3.6 B). However, 
as evident from the electron density map each subunit is missing approximately 30 residues in 
the C-terminal. The Ramachandran plot (figure 3.10) produced by PROCHECK shows that 
89.7 % of the residues are found in the most favoured regions while 9.2 % of the residues are 
found in the additional allowed regions. 0.4 % of the residues corresponding to residues Glu-
59-F and His-112-A, E, are found in the generously allowed regions. Finally, 0.8 % of the 
residues are found in the disallowed regions corresponding to Thr-114 (A to F). The backbone 
of each chain fits nicely into the σA-weighted 2Fobs-Fcalc electron density map, but a few 
residues show weak side chain density: Leu-26-B, Arg-47-A,C, Gln-56-A,E, Asp-58-A,C, 
Glu-59-C,F, Asp-68-D and Ser-158-B. From the Ramachandran plot Glu-59-F is found in the 
generously allowed region, but the precise spatial position of this residue is questionable due 
to the lack of electron density. His-112-A,E are also in the generously allowed region and Thr 
114 (A to F) are in the disallowed region. These residues are found in the active site and 
involved in rearrangements upon binding of the inhibitor (se section 3.2.4) and inspection of 
the 2Fobs-Fcalc electron density map shows an excellent fit between spatial arrangement and 
electron density (not shown). The Cα atoms of each subunit can be superposed with rmsd 
values ranging from 0.15 Å to 0.25 Å, while all atoms in the subunits can be superposed with 
rmsd values ranging from 0.50 Å to 0.62 Å. 
 
Figure 3.10 Ramachandran plot and plot statistics (produced by PROCHECK, Laskowski et al., 1993) of the 
M. tuberculosis apo-dCTP deaminase:dUTPase structure. 
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3.2.4 Comparison of the structures of the apo-enzyme and the enzyme-
dTTP complex 
The overall fold of the apo-dCTP deaminase:dUTPase structure is the same as for the 
structure with the inhibitor bound (see section 3.2.2) and the structural elements are preserved 
(inspected in WinCoot, Emsley and Cowtan, 2004). Superposing monomers from each of the 
two structures it is apparent that six of the PEG fragments (all but number three in the 
structure file) from the apo-structure superpose with a part of the C-terminal (residues 177-
179) from the dTTP complex structure (figure 3.11). This indicates that these PEG fragments 
could be wrongly modelled into the electron density and that the electron densities in these 
parts of the 2Fobs-Fcalc electron density map may represent a short stretch of the C-terminal 
backbone. These PEG fragments have not been replaced with amino acids since no side chain 
density is visible in the 2Fobs-Fcalc and Fobs-Fcalc electron density map.  
 
 
 
 
 
 
 
 
 
 
Figure 3.11 Position of PEG fragments in the apo-enzyme structure. Superposing the apo-enzyme structure 
(green) with the enzyme-dTTP complex structure (pink) shows that some of the PEG fragments from the 
apo-enzyme structure superpose with residues 177-179 from the C-terminal of the enzyme-dTTP complex 
(only one of six corresponding superpositions is shown). The figure was prepared in PyMOL (DeLano W. L., 
2002). 
 
In figure 3.12 subunit A from the structure of the apo-enzyme has been superposed with 
subunit A from the structure of the enzyme with the inhibitor bound. The Cα atoms of the 
subunits from the apo-structure and those of the enzyme-dTTP complex structure can be 
superposed with rmsd values ranging from 0.97 Å to 1.03 Å, while all atoms in the subunits 
can be superposed with rmsd values ranging from 1.35 Å to 1.46 Å. Comparing the two 
structures two major differences are apparent and these are described in the following sections 
(3.2.4.1 and 3.2.4.2).  
 
3.2.4.1 Closing of the binding pocket 
The first difference is that upon binding of the inhibitor, the C-terminal folds back on the 
enzyme generating a lid almost covering the binding pocket (see figure 3.12). Four residues 
from the C-terminal are involved in binding to the inhibitor either directly (Tyr-162 and Lys-
170) or via water molecules (Ala-167 and Ser-169), see section 3.2.2. The structure of the 
apo-enzyme on the other hand has a disordered C-terminal. The inhibitor is actually a dTTP-
Mg2+ complex and the magnesium ion appears to play an important role in positioning the tri-
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phophoryl moiety correctly in the active site. It also plays an important role in the hydrogen-
bonding network surrounding the nucleotide hereby also in closing the lid of the active site on 
top of the nucleotide. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.12 Comparison of the apo- and the dTTP-complex structures of M. tuberculosis dCTP 
deaminase:dUTPase. Ribbon view of superimposed subunits of the M. tuberculosis dCTP deaminase:dUTP-
ase apo-form (green) and dTTP-complex (pink) with dTTP and Mg2+ shown in ball and stick (yellow and 
grey). The solid black arrow points to the C-terminal, which is only visible in the dTTP complex. The dotted 
arrow points to changes in the active site induced by binding of dTTP. The blue arrow represents the position 
of the threefold axis. The figure was prepared in PyMOL (DeLano W. L., 2002). 
 
From a superposition (not shown) of the M. tuberculosis dCTP deaminase:dUTPase-dTTP 
complex structure with the E. coli dCTP deaminase structures when the enzyme is in contact 
with dCTP (PDB ID: 1XS4, E138A, Johansson et al., 2005) or dUTP (PDB ID: 1XS1, 
Johansson et al., 2005) an almost identical closing of the C-terminal lid is observed. This is 
also observed from a superposition with the M. jannaschii E145A dCTP deaminase:dUTPase-
α,β-imido dUTP complex structure (PDB ID: 2HXD, Siggaard et al., 2008.). These findings 
strongly indicate that the observed C-terminal fold is also present when the substrate dCTP 
binds to M. tuberculosis dCTP deaminase:dUTPase and probably also during the enzymatic 
reactions. An intriguing difference is that the E. coli E138A dCTP deaminase-dTTP complex 
structure (PDB ID: 2J4Q, Johansson et al., 2007) does not have an ordered C-terminal. 
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3.2.4.2 Conformational changes of residues 110-117 
A B
Ile-118 
DC 
Gly- His- 
Thr-111  Phe- 116 112 Leu-109  117  
Ala-115 
Ser- Thr- Leu-110 113 114 
E F
The second difference is in the binding pocket in the region where the thymidine moiety binds 
(figure 3.12). Figure 3.13 shows a close-up of the residues 109-118 from the superposition of 
the apo-enzyme and the enzyme in complex with the inhibitor. The situation is shown from 
two different angles. Upon binding dTTP, a major change is apparent in this stretch. Due to 
steric hindrance in accommodating the methyl group of the thymidine moiety, Gly-116 is 
  
Figure 3.13 Structural changes induced by binding of the inhibitor, dTTP. Close-up of residues 109-118 
from a superposition of the apo-structure (green) and dTTP-complex structure (pink), the residues are shown 
as sticks. The situation is shown from two different directions (A and B). The nucleotide and Mg2+ are shown 
in ball and stick (yellow and grey). To outline the changes, this residue stretch is also shown for each the two 
structures; C and D presents the apo-structure while E and F presents the dTTP-complex structure. Panels A, 
C, E are from one direction and B, D, F are from the second direction. In all panels the residues are (from 
left) Leu-109, Leu-110, Thr-111, His-112, Ser-113, Thr-114, Ala-115, Gly-116, Phe-117 and Ile-118 as 
shown in C. The figure was prepared with PyMOL (DeLano W. L., 2002). 
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pushed away. In the C-terminal direction this causes a shift in Phe-117 while Ile-118 has 
almost the same position. In the N-terminal direction binding of dTTP can almost be 
described as a wave-effect in the backbone. The side-chain position of Ala-115 is changed by 
2.8 Å and it is now close to the α-phosphoryl of the nucleotide. Thr-114 is also shifted 
markedly and Ser-113 and His-112 almost switch positions. Thr-111 changes position 
slightly, while Leu-110 is pushed backwards due to the new position of His-112. Finally, 
almost no change is observed in Leu-109. The hydrogen bonding network in this stretch (109-
118) changes as a consequence of the conformational changes. The structure of the apo-
enzyme has a smaller number of hydrogen bonds, but this might be due to the lower 
resolution and few water molecules in the structure. In the trimer structure of the apo-enzyme 
no hydrogen bonds are found between separate monomers in this region. However, in the 
trimer structure of the enzyme-dTTP complex interactions between Thr-111 and Thr-114 in 
separate monomers causes a connection between all three monomers in this region.  
The impact these structural changes have on the trimer and the regulation of enzyme activity 
is presented and discussed in section 3.2.7. 
 
3.2.5 The model of dCTP deaminase:dUTPase crystallized in the presence 
of α,β-imido dUTP 
The structure of the M. tuberculosis dCTP deaminase:dUTPase crystallized in the presence of 
α,β-imido dUTP was solved in spacegroup R3 with 12 subunits in the asymmetric unit. Due to 
the poor resolution (3 Å) and the high number of subunits in the asymmetric unit every single 
residue was not individually examined. During refinement emphasis was made to refine 
subunits A to D and residues in the vicinity of the active site in all subunits. Even though the 
model is poor, some conclusions can still be made.   
The Ramachandran plot (figure 3.14) produced by PROCHECK shows that 85.2 % of the 
residues are found in the most favoured regions while 12.7 % of the residues are found in the 
additional allowed regions. 1.2 % of the residues are found in the generously allowed regions 
while 0.8 % of the residues are found in the disallowed regions. From the plot it is obvious 
that the residues 110-115 are those which are dominating the generously allowed and 
disallowed regions. This is interesting since these residues are found in the active site and 
they are observed to change conformation upon binding of nucleotide (see section 3.2.4.2).     
In all subunits the backbone of each chain fits nicely into the σA-weighted 2Fobs-Fcalc electron 
density map. In none of the subunits the entire C-terminal could be modelled as it could in the 
enzyme-dTTP complex structure (see section 3.2.2). However, 7 to 15 of the C-terminal 
residues could be modelled in the subunits. This contrasts the apo-structure (see sections 
3.2.3. and 3.2.4), in which none of the C-terminal residues could be convincingly modelled. 
In two out of the 12 subunits the triphosphoryl moiety of α,β-imido dUTP could be modelled. 
Comparing subunits A to D with subunits A from the apo- and dTTP-complex structures 
differences are apparent in the region 112 to 116 (figure 3.15). This new structure does not 
resemble either of the apo- or dTTP-complex structures. In this structure the region 112-116 
appears as if it is pushed into the active site and residues 114 and 115 are seen to overlap with 
the nucleotide of the dTTP-complex structure.   
These findings indicate that the α,β-imido dUTP is partially bound in some of the subunits 
and the lid found to cover the active site (see section 3.2.2) is partially closed on top of the 
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active site. However, since it was very difficult to obtain crystals when α,β-imido dUTP was 
present in solution it might be that the nucleotide is not able to bind in the active site. Since 
dTTP binds very convincingly in the enzyme (see figure 3.9 A) only two factors can be 
responsible for this. The first is the methyl group of dTTP, not present in dUTP (figure 2.3). 
Since dUMP is the product, the uridine moiety might show lower binding capability in the 
active site than the thymidine moiety. However, kinetic results indicate that the enzyme has 
equal affinity for dCTP and dUTP (Helt et al., 2008). The second is the replacement of 
 Figure 3.14 Ramachandran plot and plot statistics (produced by PROCHECK, Laskowski et al., 1993) of the 
M. tuberculosis dCTP deaminase:dUTPase structure obtained from crystals grown in the presence of α,β-
imido dUTP. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.15 Differences in the binding pocket. Superposition of subunit A from the dTTP-complex structure 
(pink), subunit A from the apo structure (green) and subunits A to D from the structure obtained when the 
enzyme was crystallized in contact with α,β-imido dUTP (four shades of cyan). The backbone of residue 110 
to 117 of each subunit is shown and dTTP from the dTTP-complex structure is also shown in ball and stick. 
The backbones of the subunits from the structure obtained from crystallizing the enzyme with α,β-imido 
dUTP are seen to overlap with dTTP. The figure was prepared with PyMOL (DeLano W. L., 2002). 
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the α,β-bridging oxygen with an imido group. In dUTPases α,β-imido dUTP is found to bind 
correctly in the active site and it is not hydrolysed (Chan et al., 2004). In the substrate 
analogue O3 of α-phosphoryl is replaced by NH, which changes the direction of a possible 
hydrogen bond. This might prove unfavorable for nucleotide binding in the bifunctional 
enzymes since there are differences in the active site (see section 3.2.6.2). Another possibility 
is that α,β-imido dUTP is not resistant to hydrolysis in the bifunctional enzymes (nothing has 
yet been published on this matter). In this connection it is worth noting that the native enzyme 
in contact with α,β-imido dUTP has not been crystallized, neither from E. coli dCTP 
deaminase nor from M. jannaschii dCTP deaminase:dUTPase. 
 
3.2.6 Structural comparisons with other members of the enzyme family  
Structures of two dCTPdeaminase:dUTPases have now been solved, namely those of M. 
jannaschii (Johansson et al., 2003; Siggaard et. al., 2008) and M. tuberculosis (Helt et al., 
2008). Structures of only one dCTP deaminase have been solved, which is that of E. coli 
(Johansson et al., 2005 and 2007). Several structures of dUTPases have been solved. 
Mutational analyses have been performed on some of the enzymes from the family to 
establish which residues play key roles in the enzymatic reactions (Barabás et al., 2004; Chan 
et al., 2004; Johansson et al., 2003, 2005 and 2007). From the E. coli dCTP deaminase the 
mutations E138A, E138Q, R115A (Johansson et al., 2005), H121A and V122G (Johansson et 
al., 2007) were found to inactivate the enzyme. From the M. jannaschii bifunctional enzyme it 
was found that the D135N mutant was inactive concerning both functions while the E145Q 
was an inactive deaminase but retained 25 % of the dUTPase activity (Johansson et al., 2003). 
The glutamate found at position 138 in the E. coli enzyme corresponds to the glutamates 
found in position 145 in the M. jannaschii enzyme and in position 129 in the M. tuberculosis  
bifunctional enzyme (figure 3.16 A). The residues E138, R115 and H121 from the E. coli 
enzyme are conserved in corresponding positions in enzymes having dCTP deaminase activity 
(figure 3.16 A) and E138 and R115 are suggested to participate in the deamination reaction 
(see section 3.2.6.2 and Johansson et al., 2005). From E. coli dUTPase the mutation D90N 
rendered the enzyme inactive (Barabás et al., 2004). The E. coli residue D90 corresponds to 
M. jannaschii D135 and M. tuberculosis D119 (bifunctional enzyme). It is conserved in all 
members of the family (figure 3.16) and believed to play a key role in positioning the 
nucleotide correctly in the active site (Chan et al., 2004). 
Throughout the remaining part of chapter 3, amino acid numbers will refer to M. tuberculosis 
dCTP deaminase:dUTPase unless otherwise stated. 
 
3.2.6.1 Overall structure 
Figure 3.16 A shows a structure based sequence alignment of the M. tuberculosis dCTP 
deaminase:dUTPase-dTTP complex structure, the M. jannaschii E145A dCTP deaminase: 
dUTPase-α,β-imido dUTP complex structure (PDB ID: 2HXD, Siggaard et. al., 2008, the 
mutation has been excluded in the alignment) and the E. coli dCTP deaminase-dUTP complex 
structure (PDB ID: 1XS1, Johansson et al., 2005). Figure 3.17 shows a superposition of 
subunit A from each of the three structures. From the figures it is apparent that there is a very 
high structural similarity and the overall fold is almost conserved. There are minor 
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                                                      * 
1- Bifunc  M. tube   MLLSDRDLRAEISSGRLGIDPFDD-TLVQPSSIDVRLDCLFRVFNN-TRYTHIDPA---- 54   
  
 
A 
2- Bifunc  M. jann   MILSDKDIIDYVTSKRIIIKPFNK-DFVGPCSYDVTLGDEFIIY-DD---EVYDLS---- 51    
3- dCTPdeam E. coli  MRLCDRDIEAWLDEGRLSINPRPPVERINGATVDVRLGNKFRTF-RGHTAAFIDLSGPKD 59   
 
                                                                             * 
 
 
1- Bifunc  M. tube   -KQ--QDELTS-LVQPVDGEPFVLHPG-----------------------EFVLGSTLEL 87   
2- Bifunc  M. jann   -KE--L-N-YK-RIKI--KNSILVCPLNYNLTEEKINYFKEKYNVDYVVEGGVLGTTNEY 103  
 
3- dCTPdeam E. coli  EVSAALDRVMSDEIVLDEGEAFYLHPG-----------------------ELALAVTLES 96    
 
                                   § 
 
                                   #                §  
                                   *   #        #  **    *    # 
1- Bifunc  M. tube   FTLPDNLAGRLEGKSSLGRLGLLTHSTAGFIDPGFSGHITLELSNVANLPITLWPGMKIG 147  
 
2- Bifunc  M. jann   IELPNDISAQYQGRSSLGRVFLTSHQTAGWIDAGFKGKITLEIVAFDK-PVILYKNQRIG 162  
 
3- dCTPdeam E. coli  VTLPADLVGWLDGRSSLARLGLMVHVTAHRIDPGWSGCIVLEFYNSGKLPLALRPGMLIG 156  
 
 
                     § 
 
1- Bifunc  M. tube   QLCMLRLTSPSEHPYG-SSRAGSKYQGQRGPTPSRSYQNFIRST 190  
2- Bifunc  M. jann   QLIFSKLLSPADVGYSERK--TSKYAYQKSVMPSLIHLDNHKKD 204  
 
3- dCTPdeam E. coli  ALSFEPLSGPAVRPYNRRE--DAKYRNQQGAVASRIDKD----- 193  
 
  
 
 
 
 
                                                               *
B 
1- Bifunc  M. tube  MLLSDRDLRAEISSGRLGIDP-----------FDDTLVQPSSIDVRLDCLFRVFNNTRYT 49   
 
2- dUTPase M. tube  ------------MSTTLAIVRLDPG----LPLPSRAHDGDAGVDLYSAE----------- 33   
 
3- dUTPase E. coli  ------------MMKKIDVKILDPRVGKEFPLPTYATSGSAGLDLRACLN---------- 38   
4- dUTPase Human    --------------MQLRFARLSEHA---T-APTRGSARAAGYDLYSAY----------- 31   
 
5- dUTPase EIAV     ---------------MLAYQG--------TQIKEK-RDEDAGFDLCVPY----------- 25   
 
6- dUTPase FIV      ----------------MIIEG--------DGILDK-RSEDAGYDLLAAK----------- 24   
 
 
                                                                         § 
 
                                                                         # 
                                                      *                  *   # 
 
1- Bifunc  M. tube  HIDPAKQQDELTSLVQPVDGEPFVLHPGEFVLGSTLELFTLPD-NLAGRLEGKSSLGRL- 107  
 
2- dUTPase M. tube  ---------------------DVELAPGRRALVRTGVAVAVPF-GMVGLVHPRSGLATRV 71   
3- dUTPase E. coli  --------------------DAVELAPGDTTLVPTGLAIHIADPSLAAMMLPRSGLGHKH 78   
 
4- dUTPase Human    ---------------------DYTIPPMEKAVVKTDIQIALPS-GCYGRVAPRSGLAAKH 69   
 
5- dUTPase EIAV     ---------------------DIMIPVSDTKIIPTDVKIQVPP-NSFGWVTGKSSMAKQ- 62   
6- dUTPase FIV      ---------------------EIHLLPGEVKVIPTGVKLMLPK-GYWGLIIGKSSIGSK- 61   
 
 
 
                               §                       
                           #  **    *    #                   § 
 
1- Bifunc  M. tube  GLLTHSTAGFIDPGFSGHITLELSNVA-NLPITLWPGMKIGQLCMLRLTSPSEHPYGSSR 166  
 
2- dUTPase M. tube  GLSIVNSPGTIDAGYRGEIKVALINLDPAAPIVVHRGDRIAQLLVQRVELVELVEVSSFD 131  
3- dUTPase E. coli  GIVLGNLVGLIDSDYQGQLMISVWNRG-QDSFTIQPGERIAQMIFVPVVQAEFNLVEDFD 137  
 
4- dUTPase Human    FIDVG--AGVIDEDYRGNVGVVLFNFG-KEKFEVKKGDRIAQLICERIFYPEIEEVQALD 126  
 
5- dUTPase EIAV     GLLIN--GGIIDEGYTGEIQVICTNIG-KSNIKLIEGQKFAQLIILQHHSNSRQPWDENK 119  
6- dUTPase FIV      GLDVL--GGVIDEGYRGEIGVIMINVS-RKSITLMERQKIAQLIILPCKHEVLEQGKVVM 118  
 
 
 
 
1- Bifunc  M. tube  AGSKYQGQRGPTPSRSYQNFIRST 190  
 
2- dUTPase M. tube  EAGLASTSRGDGGHGSSGGHASL- 154  
 
3- dUTPase E. coli  A-----TDRGEGGFGHSGRQ---- 152  
4- dUTPase Human    D-----TERGSGGFGSTGKN---- 141  
 
5- dUTPase EIAV     I-----SQRGDKGFGSTGVF---- 134  
 
6- dUTPase FIV      D-----SERGDNGYGSTGVFSSW- 136  
 
(Figure 3.16: figure legend found on the next page)  
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Figure 3.16 Structure-based sequence alignments. A) M. tuberculosis dCTP deaminase:dUTPase-dTTP 
complex compared to M. jannaschii E145A dCTP deaminase:dUTPase-α,β-imido dUTP complex (PDB ID: 
2HXD, Siggaard et. al., 2008, the mutation was not included) and E. coli dCTPdeaminase-dUTP complex 
(PDB ID: 1XS1, Johansson et al., 2005). B) M. tuberculosis dCTP deaminase:dUTPase-dTTP complex 
compared to M. tuberculosis dUTPase-α,β-imido dUTP complex (PDB ID: 1SIX, Chan et al., 2004), E. coli 
dUTPase-α,β-imido dUTP complex (PDB ID: 1RN8, Barabas et al., 2004), dUTPase-dUDP complex from 
human (PDB ID: 1Q5H, Mol et al., 1996), dUTPase from equine infectious anaemia virus (EIAV, PDB ID: 
1DUN, Dauter et al., 1999) and dUTPase-dUMP complex from feline immunodeficiency virus (FIV, PDB 
ID: 1F7N, Prasad et al., 2000). 
In both panels six residues conserved in all eight examined structures are marked above the alignment 
with *. Residues believed to play an active part the deamination reaction are marked with #, while residues 
believed to play an active part the hydrolysis are marked with §. The structure-based sequence alignments 
were prepared with INDONESIA (Madsen et al., 2002), manually inspected in WinCoot (Emsley and 
Cowtan, 2004) and corrected in BioEdit (Hall, Ibis Biosciences). 
 
differences in the position, lengths and presence of β-strings within the three structures. 
However, the central core with the distorted β-barrel is preserved. α-helices found in the M. 
tuberculosis dCTP deaminase:dUTPase-dTTP complex structure are also present in the other 
structures. Both the E. coli dCTP deaminase and the M. jannaschii dCTP deaminase:dUTPase 
structures contain an α-helix which is not present in M. tuberculosis dCTP 
deaminase:dUTPase structure, but these helices are not found in corresponding positions. The 
extra helix found in E. coli dCTP deaminase is present in a region where both of the 
bifunctional enzymes show no secondary structural elements. In this region the E. coli 
structure shows 8 and 12 residue inserts compared to the M. tuberculosis and the M. 
jannaschii dCTP deaminase:dUTPase structures, respectively. M. jannaschii dCTP 
deaminase:dUTPase contain a 23-residue stretch not present in the other enzymes. The stretch 
containing the α-helix is present as a bulge in the “bottom” of the subunit. It is probably due 
to this stretch that the M. jannaschii dCTP deaminase:dUTPase structure could not perform as 
a search model in solving the structure of M. tuberculosis dCTP deaminase:dUTPase (see 
section 3.1.3.1). When superposing the structures of the bifunctional enzymes the bulge in the 
M. jannaschii structure clashes with neighbouring subunits from the M. tuberculosis structure 
(results not shown). From the structural sequence alignment it is clear that 46 residues are 
identical within the three structures. Comparing the structures two on two; M. tuberculosis vs. 
E. coli, M. tuberculosis vs. M. jannaschii and E. coli vs. M. jannaschii, show an additional 34, 
17 and 14 identical residues, respectively. This indicates that the bifunctional enzyme from M. 
tuberculosis is more closely related to the dCTP deaminase from E. coli than to the 
bifunctional enzyme from M. jannaschii. 
The M. tuberculosis dCTP deaminase:dUTPase also shows a high resemblance to dUTPases. 
Figure 3.18 shows a superposition of one subunit from each of the two structures; the M. 
tuberculosis dCTP deaminase:dUTPase-dTTP complex and the M. tuberculosis dUTPase-α,β-
imido dUTP complex (PDB ID: 1SIX, Chan et al., 2004). Figure 3.16 B shows a structure 
based sequence alignment between the bifunctional enzyme and five dUTPases. The enzymes 
share an almost identical core structure from residue Pro-71 to Thr-155. Only few residues 
from the N-terminal of M. tuberculosis dCTP deaminase:dUTPase, Pro-29 to Cys-38, 
superpose well with the N-terminal of the dUTPases. Also, M. tuberculosis dCTP 
deaminase:dUTPase contains a 30-residue stretch not found in the dUTPases. The structure of 
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the C-terminal differs markedly because the C-terminal of dUTPases reaches across the trimer 
so that the active site is composed of residues from all three monomers (Chan et al., 2004).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.17 Comparison of enzymes having dCTP deaminase activity. Ribbon view of superimposed 
subunits of M. tuberculosis dCTP deaminase:dUTPase-dTTP complex (pink), M. jannaschii E145A dCTP 
deaminase:dUTPase-α,β-imido dUTP complex (lime, PDB ID: 2HXD, Siggaard et. al., 2008) and E. coli 
dCTP deaminase-dUTP complex (cyan, PDB ID: 1XS1, Johansson et al., 2005). The enzymes share the same 
overall fold. The solid black arrow indicates an α-helix only found in the E. coli enzyme, while the dotted 
arrow indicates an α-helix only found in the M. jannaschii enzyme. The position of threefold symmetry-axis 
is indicated by the blue arrow. Nucleotides are (shown in ball and stick) presented in standard atom colours. 
However, carbon is shown in colours corresponding to the colour of the matching enzyme. Mg2+ is shown in 
grey. The N- and C-terminals are shown in blue and red, respectively. The figure was prepared using PyMOL 
(DeLano W. L., 2002). 
 
 
 
 
 
 
 
 
 
3.2.6.2 Active site 
As seen in figures 3.17 and 3.18 the position of the active site is conserved within the 
examined structures. There is a high degree of conservations in the residues constituting the 
active sites and their corresponding positions. It is furthermore seen that the position of the 
nucleotides is almost invariant in the enzyme-nucleotide complex structures. 
Comparing all the examined structures (figure 3.16 A and B) it is clear that only six residues 
(Asp-33, Thr-84, Ser-102, Ile-118, Asp-119 and Gly-124) are strictly conserved not only in 
the sequence, but also in spatial arrangement (results not shown). This proves that these 
residues are crucial for correct binding of the nucleotide and active site architecture and they 
are indeed all found in vicinity of the active site. Ser-102 and Ile-118 are stacking with the 
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pyrimidine ring on either side while Thr-84 is involved in correct positioning of Ile-118. Asp-
119 hydrogen bonds with the deoxyribosyl moiety while Asp-33 hydrogen bonds to water 
molecules coordinated to Mg2+. Gly-124 is squeezed in between two hydrophobic residues 
one of which is involved in supporting the nucleotide, leaving no room for a side chain. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Figure 3.18 Comparison of the bifunctional enzyme and dUTPase. Ribbon view of superimposed subunits of 
M. tuberculosis dCTP deaminase:dUTPase-dTTP complex (pink) and M. tuberculosis dUTPase-α,β-imido 
dUTP complex (orange, PDB ID: 1SIX, Chan et al., 2004). Nucleotides are (shown in ball and stick) 
presented in standard atom colours. However, carbon is shown in colours corresponding to the colour of the 
matching enzyme. N-and C- terminals are presented in blue and cyan, respectively. Mg2+ is shown in grey.  
The blue arrow represents the position of the threefold axis. The figure was prepared using PyMOL (DeLano 
W. L., 2002). 
 
 
 
 
 
 
The hydrophobic surface on which the nucleotide rests (see section 3.2.2) is completely 
conserved in the bifunctional enzymes while in the E. coli dCTP deaminase structure four out 
of the five residues are conserved compared to the bifunctional enzymes. A conservative 
substitution (F to W) has taken place in the residue corresponding to position 122. Comparing 
the dUTPases to the bifunctional enzymes, the hydrophobic surface is conserved but, 
conservative substitutions are present in all positions except for Ile-118 (figure 3.16 B).  
Residues from the M. tuberculosis dCTP deaminase:dUTPase-dTTP complex structure 
directly involved in hydrogen bonding to the thymidine moiety of the nucleotide (Arg-106, 
Thr-127 and Gln-174) are conserved in the bifunctional enzymes while Thr is substituted with 
Val in the E. coli dCTP deaminase. Several residues found very close to the pyrimidine 
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moiety are conserved in all the examined enzymes having dCTP deaminase activity. The 
same degree of conservation is not observed in the dUTPases (comparing figure 16 A and B), 
consistent with no dCTP deaminase activity. 
Two mechanisms for the deamination of dCTP in E. coli dCTP deaminase have been 
suggested (Johansson et al., 2005). In both mechanisms the same residues are considered to 
play a part in the reaction and the central point is activation of a water molecule to attack C4 
in the pymidine ring. The side chains of residues corresponding to Ser-102, Arg-106 and Glu-
129 and the backbone O of Ala-115 are believed to play an active part in the reaction. All four 
residues are conserved in the examined enzymes having dCTP deaminase activity. This 
conservation together with fact that Arg, Ala and Glu are not conserved in the monofunctional 
dUTPases (see figure 3.16 B) brings evidence to the suggested mechanisms and it is 
reasonable to suggest that the deamination reaction happens by means of the same mechanism 
in enzymes having dCTP deaminase function. 
Residues from the M. tuberculosis dCTP deaminase:dUTPase-dTTP complex structure 
directly involved in hydrogen bonding to the phosphoryl part of the nucleotide are Lys-101, 
Ser-102, Ser-103, Gln-148, Tyr-162 and Lys-170. The serines, Tyr-162 and Lys-170 are 
conserved in the three enzymes having dCTP deaminase activity. In both M. jannaschii dCTP 
deaminase:dUTPase and E. coli dCTP deaminase Lys-101 is substituted with arginine. Gln-
148 is conserved in M. jannaschii dCTP deaminase:dUTPase while it is substituted with 
alanine in E. coli dCTP deaminase (see figure 3.16 A). In the dUTPase structures Ser-102 and 
Gln-148 are strictly conserved. Lys-101 is found to be either lysine or arginine while Ser-103 
is found to be either serine or glycine. In all dUTPases an arginine is found in the position of 
Tyr-162 while no residue is visible in the position corresponding to Lys-170.  
From the active site comparisons it is clear that M. tuberculosis dCTP deaminase:dUTPase is 
more closely related to M. jannaschii dCTP deaminase:dUTPase than to E. coli dCTP 
deaminase even though the opposite was the case when comparing the overall sequence (see 
section 3.2.6.1) 
A mechanism for the hydrolysis of dUTP in dUTPase has been suggested (Chan et al., 2004) 
directly involving three residues corresponding to Ser-102, Asp-119 and Gln-148, which are 
strictly conserved in all examined dUTPases and the bifunctional enzymes from M. 
tuberculosis and M. jannaschii. The reaction involves nucleophilic attack on α-phosphoryl by 
an activated water molecule held in place by the side chains of aspartic acid and glutamine. 
During the reaction the leaving group, pyrophosphate, is supported by the side chain of serine. 
In E. coli dCTP deaminase glutamine is substituted with alanine and at the same time an 
arginine side chain (Arg-126, E. coli numbering) occupies the position of the nucleophilic 
water molecule (Johansson et al., 2005). In all the examined enzymes Gly-116 is conserved 
except in E. coli dCTP deaminase where a histidine (His-125 E. coli numbering) is present. A 
structural comparison (figure 3.19) between the E. coli dCTP deaminase-dUTP complex 
(PDB ID: 1XS1, Johansson et al., 2005) and the M. tuberculosis apo-dCTP 
deaminase:dUTPase shows that the histidine side chain would clash with the bulky side chain 
of residue 97 (Trp-106 E. coli numbering), which explains why this side chain is found in 
another conformation. The new position of the side chain corresponding to residue 97 would 
clash with the bulky side chain of residue 117 (Arg-126, E. coli numbering), which explains 
why this side chain in the E. coli enzyme is directed into the active site. Most likely, the 
 - 202 -
Part II                                                                  Crystal structure of dCTP deaminase:dUTPase 
glycine at position 116 is a fingerprint residue for the group of bifunctional enzymes amongst 
dCTP deaminases. 
 
 
 
 
 
 
 
 
 
 
 
 
 Figure 3.19 Mono-functionality of E. coli dCTP deaminase. A superposition of the E. coli dCTPdeaminase-
dUTP complex (cyan, PDB ID: 1XS1, Johansson et al., 2005) and the M. tuberculosis apo-dCTP 
deaminase:dUTPase (green) shows that the side chain of His-125 (E. coli) sets of a domino effect positioning 
the side chain of Arg-126 (E. coli) into the active site pushing away the water molecule which performs the 
nucleophilic attack (green, present in the apo-structure, see section 3.2.8). Nucleotide and side chains (shown 
in ball and stick) are presented in standard atom colours. However, carbon is shown in colours corresponding 
to the colour of the matching enzyme. Mg2+ is shown in grey. The figure was prepared in PyMOL (DeLano 
W. L., 2002). 
 
 
 
 
 
 
 
 
3.2.7 dTTP regulation of enzyme activity 
As discussed in section 3.2.4.2 major structural rearrangements are observed in the region 
110-117 upon binding of the inhibitor in M. tuberculosis dCTP deaminase:dUTPase. These 
residues are found very close to the threefold axis and consequently, binding of one dTTP 
molecule in the trimer causes changes in the neighbouring binding pocket (see figure 3.20). 
Upon binding of a dTTP molecule in one of the three active sites, the position of His-112 is 
shifted, which causes the side chain to push the side chain of Leu-110 backwards. To avoid a 
clash, Thr-114 from the second binding pocket has to change position. This changes the 
conformation in the second subunit probably leaving the binding pocket more susceptible to 
binding of a second dTTP molecule. Unless all three subunits of the trimer are in the same 
conformation Leu-110 and Thr-114 of neighbouring subunits are expected to clash. 
Consequently, these two residues mediate a “switch” between the apo- and the inhibited 
conformation. These findings are in agreement with recently reported findings from the E. 
coli dCTP deaminase (Johansson et al., 2007), where dTTP regulation of E. coli dCTP 
deaminase has been shown to involve the transition of the enzyme between two 
conformations (active and inactive) in a concerted mechanism as described in section 2.4. The 
enzyme is in an active conformation when complexed to dCTP or dUTP and in an inactive 
conformation when complexed to dTTP. The conformational change is mediated by amino 
acid residues Val-122 and Thr-123 (E. coli numbering), situated close to the threefold axis in 
the center of the trimer, and the interaction of this region with the additional 5-methyl group 
of dTTP compared to dCTP and dUTP (figure 2.4). Thr-114 in M. tuberculosis dCTP 
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deaminase:dUTPase corresponds to Thr-123 in E. coli dCTP deaminase and threonine is also 
found in the corresponding position in M. jannaschii dCTP deaminase:dUTPase (figure 3.16 
A). The inactive conformation of M. tuberculosis dCTP deaminase:dUTPase is found when 
the enzyme is inhibited by dTTP, but is the apo-form of the enzyme then found in an active 
conformation? Comparing the position of the nucleotide and the backbone of residues 109-
118 from the M. tuberculosis dCTP deaminase:dUTPase-dTTP complex structure and the 
apo-enzyme structure to the corresponding residues (118-127) from the E. coli dCTP 
deaminase-dUTP complex structure (PDB ID: 1XS1, Johansson et al., 2005) it is seen, that 
the position of the nucleotide is almost identical (see figure 3.21). The E. coli dCTP 
deaminase structure has a much higher resemblance to the apo-dCTP deaminase:dUTPase 
structure (rmsd values 1.14 Å from comparison of main chain atoms in the 10-residue stretch) 
than to the dCTP deaminase:dUTPase-dTTP complex structure (rmsd values 2.03 Å from 
comparison of main chain atoms in the 10-residue stretch). Therefore it is a reasonable 
assumption that the apo-conformation of dCTP deaminase:dUTPase is the active confor-
mation, which is more susceptible to substrate than inhibitor. 
A B
 
  
 
 
 
 
 
The inactive conformation might be able to accommodate dCTP and dUTP. However, the 
reaction cannot take place due to non-optimal conditions (discussed in section 3.2.8). Since 
the same conformation (active or inactive) must be present in all three subunits of the trimer it 
is plausible to assume that dTTP could be found in one of the active sites while the two others 
might be occupied by dCTP. This might explain the observed kinetic data indicating a non-
Figure 3.20 Changes in the trimer of M. tuberculosis dCTP deaminase:dUTPase as a consequence of dTTP 
Binding. Cα-trace of residues 109-118 in all three subunits from superposition of the apo-form of M. 
tuberculosis dCTP deaminase:dUTPase (three shades of green) and the dTTP-complex (three shades of 
pink). In all subunits the side chain of residues Leu-110, His-112 and Thr-114 are shown. A) The 
superposition viewed along the threefold axis. B) Same situation as in A, but sideways view. In both panels 
residues from one subunit are labelled. Panels were prepared with PyMOL (DeLano W. L., 2002). 
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competitive mechanism, where increasing the substrate concentration cannot fully reduce the 
dTTP inhibition (Helt et al., 2008). 
 
 
 
 
 
 
 
 
 
 Figure 3.21 Active and inactive conformation of M. tuberculosis dCTP deaminase:dUTPase. Ribbon view of 
residues 109-118 from superposition of subunits from the M. tuberculosis dCTP deaminase:dUTPase apo-
structure (green) and dTTP-complex structure (pink) with the E. coli dCTP deaminase-dUTP complex 
structure (cyan, PDB ID: 1XS1, Johansson et al., 2005). Nucleotides are presented in standard atom colours. 
However, carbon is shown in colours corresponding to the colour of the matching enzyme. Mg2+ is shown in 
grey. Of the two tuberculosis structures, the apo-structure more closely resembles the E. coli structure. 
Consequently it is believed that the apo-structure is in an active conformation while the dTTP complex 
structure is in an inactive conformation. The figure was prepared using PyMOL (DeLano W. L., 2002). 
 
 
 
 
 
 
 
3.2.8 Why dTTP is not hydrolysed by dCTP deaminase:dUTPase 
dCTP deaminase:dUTPase is able to hydrolyse dCTP and dUTP, but not dTTP, which acts as 
an inhibitor. The reason must originate in the difference between dUTP and dTTP and the 
consequent differences imposed on the structure of the enzyme-nucleotide complex. dTTP 
only differs from dUTP by the methyl group, which is bound to C5 of the pyrimidine ring.  
Figure 3.22 shows the active sites from a superposition of the four structures: M. tuberculosis 
dCTP deaminase:dUTPase-dTTP complex, M. tuberculosis apo-dCTP deaminase:dUTPase, 
M. jannaschii E145A dCTP deaminase:dUTPase-α,β-imido dUTP complex (Siggaard et. al., 
2008) and M. tuberculosis dUTPase-α,β-imido dUTP complex (PDB ID: 1SIX, Chan et al., 
2004). From the figure it is seen that the position of the nucleotides in the enzyme-nucleotide 
structures is almost invariant. Consequently, it must be structural changes in the enzyme 
associated with the presence of the methyl group of dTTP that causes the enzyme to be 
inactive towards dTTP. Residues believed to participate in the hydrolysis reaction are the 
conserved Ser-102 Asp-119 and Gln-148 (see section 3.2.6.2). From figure 3.22 it is seen that 
these residues superpose well in all four structures. Also, the water molecule suggested to 
perform the nucleophilic attack is present in all structures with the correct angle for the attack 
(indicated with solid black arrow in the figure). Based on the suggested mechanism for 
hydrolysis of dUTP by dUTPase (Chan et al., 2004, section 3.2.6.2), the M. tuberculosis 
dCTP deaminase:dUTPase-dTTP complex should be a competent catalytic complex with the 
ability to hydrolyse dTTP. 
In the M. tuberculosis dCTP deaminase:dUTPase-dTTP complex structure and in the M. 
jannaschii E145A dCTP deaminase:dUTPase-α,β-imido dUTP complex structure a second 
water molecule is found very close to the nucleophilic water molecule (indicated with solid 
blue arrow in the figure). Also, a minor displacement of serine, which supports the leaving 
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group, pyrophosphate, during reaction, is observed in the M. tuberculosis dCTP 
deaminase:dUTPase-dTTP complex structure. The presence of this water molecule and the 
minor displacement of serine do not appear to be factors explaining the lack of reaction.  
Therefore an explanation must be found in the structural changes observed in residues 110-
117 (see section 3.2.4.2) upon binding of dTTP in M. tuberculosis dCTP deaminase:dUTPase. 
This dramatic change is caused by steric reasons due to the methyl group. Due to binding of 
dTTP Ala-115 changes its position by 2.8 Å and moves closer to and points the side chain 
towards the α-phosphoryl hereby pushing a water molecule aside (water 59, subunit A of the 
apo- M. tuberculosis dCTP deaminase:dUTPase structure). A corresponding water molecule 
(dotted arrow in figure 3.22) is also present in the M. jannaschii E145A dCTP 
deaminase:dUTPase-α,β-imido dUTP complex structure and the M. tuberculosis dUTPase-
α,β-imido dUTP complex structure. A corresponding molecule is not only present in these 
three structures as shown in the figure, but also in the vast majority of dUTPase structures 
deposited in the Protein Data Bank (see table 3.2).  
 
 A B
Gln 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.22 Catalytic complexes for hydrolysis. Close up of the active site (ribbon view) from superposition 
of the M. tuberculosis dCTP deaminase:dUTPase apo-structure (green) and dTTP complex structure (pink), 
the M. jannaschii E145A dCTP deaminase:dUTPase-α,β-imido dUTP complex (cyan, PDB ID: 2HXD, 
Siggaard et. al., 2008) and the M. tuberculosis dUTPase-α,β-imido dUTP complex (orange, PDB ID: 1SIX, 
Chan et al., 2004). From all four structures the side chain of Ser-102 Asp-119 and Gln-148 are shown and 
from the M. tuberculosis dCTP deaminase:dUTPase enzyme the side chain of Ala-115 is also shown. Ribbon 
views of the backbones of the M. tuberculosis enzymes are shown. Nucleotides are presented in standard 
atom colours. However, carbon is shown in colours corresponding to the colour of the matching enzyme. 
Important water molecules are also shown in colours corresponding to the colour of the matching enzyme. 
Mg2+ is shown in grey. The active site is shown from two directions (panels A and B). A solid black arrow 
points to the nucleophilic water molecule while a dotted arrow points to the water molecule which is 
hydrogen bonded to O2 of α-phosphoryl. A solid blue arrow points to a water molecule next to the 
nucleophilic water molecule (found in the bifunctional enzymes). The figure prepared with PyMOL (DeLano 
W. L., 2002). 
Ala 
Asp 
Ser 
Ser Gln 
Ala 
Asp 
 - 206 -
Part II                                                                  Crystal structure of dCTP deaminase:dUTPase 
Table 3.2 Structures examined for including a water molecule corresponding to water 59 from the apo-dCTP 
deaminase:dUTPase structure. In each case subunit A (or the first stated subunit in the pdb-file) was examined 
by superposition with the apo- and the dTTP-complex structures of M. tuberculosis dCTP deaminase:dUTPase. 
Life form /  
virus 
Enzyme PDB ID Resolu-
tion / Å 
Nucleotide Muta-
tion 
 
Corresponding water 
(W number) 
E. coli dCTP 
deaminase 
1XS1 a 
1XS4 a 
1XS6 a 
2J4Q b 
2J4H b 
1.80 
2.53 
2.00 
2.60 
2.70 
dUTP 
dCTP 
dUTP 
dTTP 
dCTP 
- 
E138A 
E138A 
E138A 
H121A 
Yes (W 263) 
Yes (W 165) 
Yes (W 29) 
No (5 H2O in model) 
No H2O in model 
M. jannaschii Bi-
functionel 
1OGH c 
2HXD d 
1.88 
2.30 
- 
α,β-imido dUTP 
- 
E145A 
Yes (W 118, chain B) 
Yes  (W 33) 
E. coli dUTPase 1SEH e 
1SYL e 
1RN8 e 
1RNJ e 
1EUW f 
1EU5 f 
1.47 
1.95 
1.93 
1.70 
1.05 
1.45 
dUMP 
dUTP 
α,β-imido dUTP 
α,β-imido dUTP 
- 
- 
- 
D90N 
- 
D90N 
- 
- 
Yes (W 9) 
Yes (W 7) 
Yes (W 2) 
Yes (W 3) 
Yes (W 228) 
Yes ( W 229) 
Human dUTPase 1Q5U g 
1Q5H g 
2HQU h 
2.00 
2.00 
2.20 
- 
dUDP 
α,β-imido dUTP 
- 
- 
- 
Yes (W 20) 
Yes (W 102) 
Yes (W 5) 
M. tuberculosis dUTPase 1SNF i 
1SLH i 
1MQ7 i 
1SIX i 
1SMC i 
1SM8 i 
1SJN i 
1.85 
3.00 
1.95 
1.30 
2.10 
2.90 
1.80 
dUMP 
dUDP 
- 
α,β-imido dUTP 
dUTP 
dUTP (Cr3+) 
α,β-imido dUTP 
- 
- 
- 
- 
- 
- 
- 
Yes (W 107) 
Yes  (W 537) 
Yes (W 57) 
Yes (W 304) 
Yes (W 204) 
No 
Yes (W 26) 
EIAV dUTPase 1DUN j 
1DUC j 
1.90 
2.05 
- 
dUDP (Sr2+) 
- 
- 
No 
Yes (W 5) 
FIV dUTPase 1DUT k 
1F7Q l 
1F7P l 
1F7N l 
1F7R l 
1F7O l 
1F7K l 
1F7D l 
1.90 
2.26 
2.30 
2.20 
2.50 
2.20 
2.20 
1.40 
- 
dUTP 
dUDP 
dUMP 
dUDP 
- 
dUMP 
- 
- 
- 
- 
- 
- 
- 
- 
- 
Yes (W 36) 
Yes (W 612) 
Yes (W 632) 
No 
Yes (W 225) 
No  
No 
No 
a Johansson et al., 2005; b Johansson et al., 2007; c Johansson et al., 2003; d Siggaard et. al., 2008; e Barabás et 
al., 2004; f Gonzáles et al., 2001; g Mol et al., 1996; h Varga et al., 2007; i Chan et al.,2004; j Dauter et al., 1999; 
k Prasad et al., 1996; l Prasad et al., 2000. 
 
A water molecule in this position makes a hydrogen bond to O2 of the α-phosphoryl and has 
not previous been considered to play a part in the suggested mechanism of dUTPase. Since 
the structure of M. tuberculosis dCTP deaminase:dUTPase in complex with dTTP represents 
what is best described with the current knowledge as a catalytic complex for hydrolysis of the 
nucleotide, this suggests that a water molecule at the position of water 59 (apo-structure) is 
essential for the reaction to proceed. Due to its position it cannot play the part of an attacking 
nucleophile. The hydrolysis reaction probably happens as suggested (Chan et al., 2004). 
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However, the water molecule is necessary for stabilizing the transition state by attracting 
electron density from α-phosphoryl, hereby leaving the phosphorous atom more susceptible 
for nucleophilic attack. If the water molecule is not present and the side chain of the 
hydrophobic residue alanine is pointing towards O2 (the distance is 3.1 Å), the effect is 
reversed and electrons pushed towards the phosphorous atom. This raises the activation 
energy of the reaction, rendering it too high for the hydrolysis to take place. This explains 
why dTTP is not hydrolysed but acts as an inhibitor in enzymes having dCTP deaminase 
activity. 
 
3.3 Conclusion 
M. tuberculosis dCTP deaminase:dUTPase has been crystallized as an apo-enzyme and an 
enzyme-dTTP complex and data were collected to 2.4 Å and 2.0 Å, respectively. Each crystal 
structure was solved using molecular replacement and deposited in the Protein Data Bank. 
The enzyme was also crystallized in the presence of α,β-imido dUTP, data was collected to 
3.0 Å and the structure was solved using molecular replacement. The quality of the model was 
poor and α,β-imido dUTP did not appear in the model. 
Major changes in the conformation of the active site and ordering of the C-terminal were 
apparent upon binding of the inhibitor, dTTP. The inhibition mode of dTTP explaining 
previously obtained kinetic data has been inferred. Also, it has been explained why dTTP is 
not hydrolysed by the enzyme, this gives new insight into the reaction mechanism of 
bifunctional dCTP deaminase:dUTPases as well as monofunctional dUTPases. 
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Chapter four 
 
 
 
4 Concluding remarks and outlook 
One of the greater perspectives of the second part of this thesis is to find the evolutionary 
connection between dCTP deaminases, dUTPases and the bifunctional enzymes based on 
sequence analysis and to survey the flow of genetic information. In this connection 
determining functionality based only on sequence is a powerful tool saving numerous of 
hours spent in the laboratory. 
A second perspective of this project is to learn how DNA evolved and how and when dTTP 
became one of the nucleotides used for incorporation into DNA. dTTP is not synthesized by 
equivalent paths in all organisms and studying these different paths might help in answering 
evolutionary questions. 
A third perspective is the appearance of a possible drug target in the battle against 
tuberculosis since the bifunctional enzyme is not found in eukaryotes. 
 
4.1 Key residues and mutational analysis 
Several residues have previously been identified as being important for the deamination 
reaction, the hydrolysis reaction and correct binding of the nucleotide in the active site 
(section 3.2.6). The monofunctional dUTPases are easy to distinguish from dCTPdeaminase 
and the bifunctional enzymes since the primary sequence is shorter and they do not contain 
the conserved residues believed to participate in the deamination reaction. Distinguishing the 
dCTP deaminases from the bifunctional enzymes is not an easy task and more 
monofunctional and bifunctional enzymes have to be identified (from kinetic experiments) 
before certain conclusions may be drawn. Some of the known dCTP deaminases might prove 
to be bifunctional since they have probably not been tested for dUTPase activity. However, a 
few conclusions can be drawn from comparing the E. coli dCTP deaminase to the bifunctional 
enzymes from M. tuberculosis and M. jannaschii. A glutamine is believed to participate in 
positioning of the nucleophilic water molecule (Chan et al., 2004) for the hydrolysis. In the E. 
coli enzyme an alanine (residue 157) is found in this position. At the same time an arginine 
side chain is positioned where the nucleophilic water should be (Johansson et al., 2005), 
probably due to a domino effect caused by a histidine (residue 125). In the position 
corresponding to this histidine a glycine is present in the bifunctional enzymes and dUTPases 
examined in this thesis. Besides the residues already believed to participate in the hydrolysis 
reaction this glycine is speculated to be a key residue in distinguishing between mono- and 
bifunctionality (section 3.2.6.2). 
It would be interesting to include the mutations A157Q and H125G in the E. coli dCTP 
deaminase and examine if this would render the enzyme bifunctional. Mutational studies 
should also be performed on the bifunctional enzymes to investigate the effects of mutations 
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on residues assumed to participate in the enzymatic reactions. The effect of C-terminal 
closure on the reactions should also be investigated e.g. by producing the particular enzyme 
lacking the C-terminal. 
 
4.2 The transition state of hydrolysis 
In section 3.2.8 it was argued that the reason for the impaired hydrolysis of dTTP was the 
absence of a water molecule, which otherwise made a hydrogen bond to O2 of α-phosphate, 
and the presence of the Ala-115 side chain in a corresponding position.  
One way to gain insight into the hydrolysis reaction, the importance of the water molecule 
and the transition state would be to mimic the transition state. AlF3 is widely used in 
mimicking the transition state in hydrolysis or phosphorylation of nucleotides in enzymatic 
reactions (Delbaere et al., 2004; Gorrell et al., 2005; Ostermann et al., 2000; Xu et al.1997). 
In dUTPases the α-phosphorous atom is attacked by the activated nucleophilic water 
molecule, consequently AlF3 would have to play the part of the α-phosphoryl group. To 
obtain a transition state model complex one would have to crystallize the enzyme in contact 
with 2’,5’-dideoxyuridine, AlF3, pyrophosphate and magnesium.    
Another way to gain insight into the mechanism of hydrolysis and inhibition would be to 
perform theoretical calculations concerning the ground states and probable transitions states 
of the nucleotides when bound in the enzyme. Hereby one could infer the importance of water 
molecules and amino acid residues present in the vicinity of the nucleotide. 
 
4.3 Crystallization conditions 
To gain a better insight into the structures, structural changes and reaction mechanisms it 
would be beneficial to have atomic resolution structures. Since it appears to be an easy task to 
crystallize the enzyme but it is difficult to obtain large crystals it may be advantageous to test 
commercially available additive screens. Also, screening for other crystallization conditions 
using commercially available screens may reveal conditions for producing larger and better 
diffracting crystals. Finally, changing the buffer system and making some changes in the 
purification procedure may also change the crystallization properties of the enzyme. 
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Appendix one 
 
 
 
A.1 Crystallization of dCTP deaminase:dUTPase in 
contact with inhibitor, dTTP 
 
A.1.1 Plate A1 
Enzyme solution: 1.8 mg/ml, 5 mM dTTP, 20 mM MgCl2, 50 mM HEPES pH 6.8. 
Temperature: The plate was set up at room temperature and kept at 23ºC. 
2 μl of enzyme solution was mixed with 2 μl of reservoir solution. 
No. Precipitant Salt Buffer 
A1 20 % PEG 400 50 mM MgCl2 100 mM HEPES pH 7.5 
B1 20 % PEG 400 100 mM MgCl2 100 mM HEPES pH 7.5 
C1 20 % PEG 400 150 mM MgCl2 100 mM HEPES pH 7.5 
D1 20 % PEG 400 200 mM MgCl2 100 mM HEPES pH 7.5 
A2 25 % PEG 400 50 mM MgCl2 100 mM HEPES pH 7.5 
B2 25 % PEG 400 100 mM MgCl2 100 mM HEPES pH 7.5 
C2 25 % PEG 400 150 mM MgCl2 100 mM HEPES pH 7.5 
D2 25 % PEG 400 200 mM MgCl2 100 mM HEPES pH 7.5 
A3 30 % PEG 400 50 mM MgCl2 100 mM HEPES pH 7.5 
B3 30 % PEG 400 100 mM MgCl2 100 mM HEPES pH 7.5 
C3 30 % PEG 400 150 mM MgCl2 100 mM HEPES pH 7.5 
D3 30 % PEG 400 200 mM MgCl2 100 mM HEPES pH 7.5 
A4 35 % PEG 400 50 mM MgCl2 100 mM HEPES pH 7.5 
B4 35 % PEG 400 100 mM MgCl2 100 mM HEPES pH 7.5 
C4 35 % PEG 400 150 mM MgCl2 100 mM HEPES pH 7.5 
D4 35 % PEG 400 200 mM MgCl2 100 mM HEPES pH 7.5 
A5 40 % PEG 400 50 mM MgCl2 100 mM HEPES pH 7.5 
B5 40 % PEG 400 100 mM MgCl2 100 mM HEPES pH 7.5 
C5 40 % PEG 400 150 mM MgCl2 100 mM HEPES pH 7.5 
D5 40 % PEG 400 200 mM MgCl2 100 mM HEPES pH 7.5 
 
A.1.2 Plates A2 and A3  
(Same reservoir solutions, but different temperature) 
Enzyme solution: 1.8 mg/ml, 5 mM dTTP, 20 mM MgCl2, 50 mM HEPES pH 6.8. 
Reservoirs A1-D5: 2 μl of enzyme solution was mixed with 2 μl of reservoir solution. 
Reservoirs A6-D6: 4 μl of enzyme solution was mixed with 2 μl of reservoir solution. 
Temperature plate A2: The plate was set up at room temperature and kept at 23ºC. 
Temperature plate A3: The plate was set up on ice and kept at 15 ºC. 
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No. Precipitant Salt Buffer 
A1 35 % PEG 400 100 mM MgCl2 100 mM HEPES pH 7.5 
B1 35 % PEG 400 150 mM MgCl2 100 mM HEPES pH 7.5 
C1 35 % PEG 400 200 mM MgCl2 100 mM HEPES pH 7.5 
D1 35 % PEG 400 250 mM MgCl2 100 mM HEPES pH 7.5 
A2 40 % PEG 400 100 mM MgCl2 100 mM HEPES pH 7.5 
B2 40 % PEG 400 150 mM MgCl2 100 mM HEPES pH 7.5 
C2 40 % PEG 400 200 mM MgCl2 100 mM HEPES pH 7.5 
D2 40 % PEG 400 250 mM MgCl2 100 mM HEPES pH 7.5 
A3 45 % PEG 400 100 mM MgCl2 100 mM HEPES pH 7.5 
B3 45 % PEG 400 150 mM MgCl2 100 mM HEPES pH 7.5 
C3 45 % PEG 400 200 mM MgCl2 100 mM HEPES pH 7.5 
D3 45 % PEG 400 250 mM MgCl2 100 mM HEPES pH 7.5 
A4 50 % PEG 400 100 mM MgCl2 100 mM HEPES pH 7.5 
B4 50 % PEG 400 150 mM MgCl2 100 mM HEPES pH 7.5 
C4 50 % PEG 400 200 mM MgCl2 100 mM HEPES pH 7.5 
D4 50 % PEG 400 250 mM MgCl2 100 mM HEPES pH 7.5 
A5 55 % PEG 400 100 mM MgCl2 100 mM HEPES pH 7.5 
B5 55 % PEG 400 150 mM MgCl2 100 mM HEPES pH 7.5 
C5 55 % PEG 400 200 mM MgCl2 100 mM HEPES pH 7.5 
D5 55 % PEG 400 250 mM MgCl2 100 mM HEPES pH 7.5 
A6 45 % PEG 400 100 mM MgCl2 100 mM HEPES pH 7.5 
B6 45 % PEG 400 150 mM MgCl2 100 mM HEPES pH 7.5 
C6 45 % PEG 400 200 mM MgCl2 100 mM HEPES pH 7.5 
D6 45 % PEG 400 250 mM MgCl2 100 mM HEPES pH 7.5 
 
 
A.1.3 Plates A4 and A5  
(Same reservoir solutions, but different temperature) 
Enzyme solution: 1.8 mg/ml, 5 mM dTTP, 20 mM MgCl2, 50 mM HEPES pH 6.8. 
Reservoirs A3-D3: 2 μl of enzyme solution was mixed with 2 μl of reservoir solution. 
Reservoirs A4-D4: 4 μl of enzyme solution was mixed with 2 μl of reservoir solution. 
Temperature plate A4: The plate was set up on ice and kept at 4ºC. 
Temperature plate A5: The plate was set up on ice and kept at 15ºC. 
No. Precipitant Salt Buffer 
A3 30 % PEG 400                                   200 mM MgCl2 100 mM HEPES pH 7.5 
B3 35 % PEG 400 200 mM MgCl2 100 mM HEPES pH 7.5 
C3 40 % PEG 400 200 mM MgCl2 100 mM HEPES pH 7.5 
D3 35 % PEG 400 250 mM MgCl2 100 mM HEPES pH 7.5 
A4 45 % PEG 400 100 mM MgCl2 100 mM HEPES pH 7.5 
B4 45 % PEG 400 150 mM MgCl2 100 mM HEPES pH 7.5 
C4 45 % PEG 400 200 mM MgCl2 100 mM HEPES pH 7.5 
D4 35 % PEG 400 200 mM MgCl2 100 mM HEPES pH 7.5 
 
 
Part II                                                                                                                             Appendix 
 
 
Appendix two 
 
 
 
A.2 Crystallization of apo-dCTP deaminase:dUTPase 
 
A.2.1 Plate B1 
Enzyme solution: 1.9 mg/ml, 20 mM MgCl2, 50 mM HEPES pH 6.8. 
Temperature: The plate was set up at room temperature and kept at 23ºC. 
2 μl of enzyme solution was mixed with 2 μl of reservoir solution. 
Reservoir solutions are the same as for plate A1 (appendix A.1). 
 
A.2.2 Plate B2 
Enzyme solution: 1.9 mg/ml, 50 mM HEPES pH 6.8. 
Temperature: The plate was set up at room temperature and kept at 23ºC. 
Reservoirs A1-D4: 2 μl of enzyme solution was mixed with 2 μl of reservoir solution. 
Reservoirs A5-D6: 4 μl of enzyme solution was mixed with 2 μl of reservoir solution. 
No. Precipitant Salt Buffer 
A1 15 % PEG 400  100 mM HEPES pH 7.5 
B1 15 % PEG 400 20 mM MgCl2 100 mM HEPES pH 7.5 
C1 15 % PEG 400 50 mM MgCl2 100 mM HEPES pH 7.5 
D1 15 % PEG 400 70 mM MgCl2 100 mM HEPES pH 7.5 
A2 20 % PEG 400  100 mM HEPES pH 7.5 
B2 20 % PEG 400 20 mM MgCl2 100 mM HEPES pH 7.5 
C2 20 % PEG 400 50 mM MgCl2 100 mM HEPES pH 7.5 
D2 20 % PEG 400 70 mM MgCl2 100 mM HEPES pH 7.5 
A3 25 % PEG 400  100 mM HEPES pH 7.5 
B3 25 % PEG 400 20 mM MgCl2 100 mM HEPES pH 7.5 
C3 25 % PEG 400 50 mM MgCl2 100 mM HEPES pH 7.5 
D3 25 % PEG 400 70 mM MgCl2 100 mM HEPES pH 7.5 
A4 30 % PEG 400  100 mM HEPES pH 7.5 
B4 30 % PEG 400 20 mM MgCl2 100 mM HEPES pH 7.5 
C4 30 % PEG 400 50 mM MgCl2 100 mM HEPES pH 7.5 
D4 30 % PEG 400 70 mM MgCl2 100 mM HEPES pH 7.5 
A5 20 % PEG 400  100 mM HEPES pH 7.5 
B5 20 % PEG 400 20 mM MgCl2 100 mM HEPES pH 7.5 
C5 20 % PEG 400 50 mM MgCl2 100 mM HEPES pH 7.5 
D5 20 % PEG 400 70 mM MgCl2 100 mM HEPES pH 7.5 
A6 25 % PEG 400  100 mM HEPES pH 7.5 
B6 25 % PEG 400 20 mM MgCl2 100 mM HEPES pH 7.5 
C6 25 % PEG 400 50 mM MgCl2 100 mM HEPES pH 7.5 
D6 25 % PEG 400 70 mM MgCl2 100 mM HEPES pH 7.5 
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A.2.3 Plates B3 and B4 
Enzyme solution: 1.9 mg/ml, 20 mM MgCl2, 50 mM HEPES pH 6.8. 
Reservoirs A1-D1: 2 μl of enzyme solution was mixed with 2 μl of reservoir solution. 
Reservoirs A2-D2: 4 μl of enzyme solution was mixed with 2 μl of reservoir solution. 
Temperature plate B3: The plate was set up on ice and kept at 4ºC. 
Temperature plate B4: The plate was set up on ice and kept at 15 ºC. 
No. Precipitant Salt Buffer 
A1 25 % PEG 400  100 mM HEPES pH 7.5 
B1 15 % PEG 400 50 mM MgCl2 100 mM HEPES pH 7.5 
C1 20 % PEG 400 50 mM MgCl2 100 mM HEPES pH 7.5 
D1 25 % PEG 400 50 mM MgCl2 100 mM HEPES pH 7.5 
A2 25 % PEG 400  100 mM HEPES pH 7.5 
B2 15 % PEG 400 50 mM MgCl2 100 mM HEPES pH 7.5 
C2 20 % PEG 400 50 mM MgCl2 100 mM HEPES pH 7.5 
D2 25 % PEG 400 50 mM MgCl2 100 mM HEPES pH 7.5 
 
A.2.4 Plate B5 
Enzyme solution 1: 1.9 mg/ml, 50 mM HEPES pH 6.8. 
Enzyme solution 2: 4.3 mg/ml, 50 mM HEPES pH 6.8.  
Reservoirs A1-D1 and A3-D6: 2 μl of enzyme solution was mixed with 2 μl of reservoir solution. 
Reservoirs A2-D2: 4 μl of enzyme solution was mixed with 2 μl of reservoir solution. 
Temperature: The plate was set up in a cold room at 4ºC and kept herein. 
No. Enzyme 
solution 
Precipitant Salt Buffer 
A1 2 20 % PEG 400 50 mM MgCl2 100 mM HEPES pH 7.5 
B1 2 25 % PEG 400 50 mM MgCl2 100 mM HEPES pH 7.5 
C1 2 30 % PEG 400 50 mM MgCl2 100 mM HEPES pH 7.5 
D1 2 35 % PEG 400 50 mM MgCl2 100 mM HEPES pH 7.5 
A2 1 20 % PEG 400  100 mM HEPES pH 7.5 
B2 1 25 % PEG 400  100 mM HEPES pH 7.5 
C2 1 30 % PEG 400  100 mM HEPES pH 7.5 
D2 1 35 % PEG 400  100 mM HEPES pH 7.5 
A3 1 20 % PEG 400  100 mM HEPES pH 7.5 
B3 1 25 % PEG 400  100 mM HEPES pH 7.5 
C3 1 30 % PEG 400  100 mM HEPES pH 7.5 
D3 1 35 % PEG 400  100 mM HEPES pH 7.5 
A4 1 20 % PEG 1000 50 mM MgCl2 100 mM HEPES pH 7.5 
B4 1 25 % PEG 1000 50 mM MgCl2 100 mM HEPES pH 7.5 
C4 1 30 % PEG 1000 50 mM MgCl2 100 mM HEPES pH 7.5 
D4 1 35 % PEG 1000 50 mM MgCl2 100 mM HEPES pH 7.5 
A5 1 15 % PEG 4000 50 mM MgCl2 100 mM HEPES pH 7.5 
B5 1 20 % PEG 4000 50 mM MgCl2 100 mM HEPES pH 7.5 
C5 1 25 % PEG 4000 50 mM MgCl2 100 mM HEPES pH 7.5 
D5 1 30 % PEG 4000 50 mM MgCl2 100 mM HEPES pH 7.5 
A6 1 10 % PEG 8000 50 mM MgCl2 100 mM HEPES pH 7.5 
B6 1 15 % PEG 8000 50 mM MgCl2 100 mM HEPES pH 7.5 
C6 1 20 % PEG 8000 50 mM MgCl2 100 mM HEPES pH 7.5 
D6 1 25 % PEG 8000 50 mM MgCl2 100 mM HEPES pH 7.5 
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Appendix three 
 
 
 
A.3 Crystallization of dCTP deaminase:dUTPase in 
contact with substrate analogue, α,β-imido dUTP 
 
A.3.1 Plate C1 
Enzyme solution: 1.6 mg/ml, 17 mM MgCl2, 1.7 mM α,β-imido dUTP, 50 mM HEPES pH 
6.8. 
Temperature: The plate was set up at room temperature and kept at 23ºC. 
2.4 μl of enzyme solution was mixed with 2 μl of reservoir solution. 
Reservoir solutions are the same as for plate A1 (appendix A.1). 
 
A.3.2 Plates C2 and C3  
(Same reservoir solutions, but different temperature) 
Enzyme solution: 1.6 mg/ml, 17 mM MgCl2, 1.7 mM α,β-imido dUTP, 50 mM HEPES pH 
6.8. 
Reservoirs A5-D5: 2.4 μl of enzyme solution was mixed with 2 μl of reservoir solution. 
Reservoirs A6-D6: 4 μl of enzyme solution was mixed with 2 μl of reservoir solution. 
Temperature plate C2: The plate was set up on ice and kept at 4ºC. 
Temperature plate C3: The plate was set up on ice and kept at 15 ºC. 
No. Precipitant Salt Buffer 
A5 30 % PEG 400                                   200 mM MgCl2 100 mM HEPES pH 7.5 
B5 35 % PEG 400 200 mM MgCl2 100 mM HEPES pH 7.5 
C5 40 % PEG 400 200 mM MgCl2 100 mM HEPES pH 7.5 
D5 35 % PEG 400 250 mM MgCl2 100 mM HEPES pH 7.5 
A6 45 % PEG 400 100 mM MgCl2 100 mM HEPES pH 7.5 
B6 45 % PEG 400 150 mM MgCl2 100 mM HEPES pH 7.5 
C6 45 % PEG 400 200 mM MgCl2 100 mM HEPES pH 7.5 
D6 35 % PEG 400 200 mM MgCl2 100 mM HEPES pH 7.5 
 
A.3.3 Plate C4 
Enzyme solution 1: 1.6 mg/ml, 17 mM MgCl2, 1.7 mM α,β-imido dUTP, 50 mM HEPES pH 
6.8. 
Enzyme solution 2: 1.9 mg/ml, 20 mM MgCl2, 2 mM α,β-imido dUTP, 50 mM HEPES pH 
6.8. 
2.4 μl of enzyme solution 1 was mixed with 2 μl of reservoir solution in all drops except 1D, 
2D and 3D, here 2 μl of enzyme solution 2 was used. 
Temperature: The plate was set up in a cold room at 4ºC and kept herein. 
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No. Precipitant Salt Buffer 
A1 25 % PEG 400 150 mM MgCl2 100 mM HEPES pH 7.5 
B1 30 % PEG 400 150 mM MgCl2 100 mM HEPES pH 7.5 
C1 35 % PEG 400 150 mM MgCl2 100 mM HEPES pH 7.5 
D1 25 % PEG 400 200 mM MgCl2 100 mM HEPES pH 7.5 
A2 25 % PEG 400 200 mM MgCl2 100 mM HEPES pH 7.5 
B2 30 % PEG 400 200 mM MgCl2 100 mM HEPES pH 7.5 
C2 35 % PEG 400 200 mM MgCl2 100 mM HEPES pH 7.5 
D2 30 % PEG 400 200 mM MgCl2 100 mM HEPES pH 7.5 
A3 25 % PEG 400 250 mM MgCl2 100 mM HEPES pH 7.5 
B3 30 % PEG 400 250 mM MgCl2 100 mM HEPES pH 7.5 
C3 35 % PEG 400 250 mM MgCl2 100 mM HEPES pH 7.5 
D3 25 % PEG 400 150 mM MgCl2 100 mM HEPES pH 7.5 
A4 20 % PEG 1000 200 mM MgCl2 100 mM HEPES pH 7.5 
B4 25 % PEG 1000 200 mM MgCl2 100 mM HEPES pH 7.5 
C4 30 % PEG 1000 200 mM MgCl2 100 mM HEPES pH 7.5 
D4 35 % PEG 1000 200 mM MgCl2 100 mM HEPES pH 7.5 
A5 15 % PEG 4000 200 mM MgCl2 100 mM HEPES pH 7.5 
B5 20 % PEG 4000 200 mM MgCl2 100 mM HEPES pH 7.5 
C5 25 % PEG 4000 200 mM MgCl2 100 mM HEPES pH 7.5 
D5 30 % PEG 4000 200 mM MgCl2 100 mM HEPES pH 7.5 
A6 10 % PEG 8000 200 mM MgCl2 100 mM HEPES pH 7.5 
B6 15 % PEG 8000 200 mM MgCl2 100 mM HEPES pH 7.5 
C6 20 % PEG 8000 200 mM MgCl2 100 mM HEPES pH 7.5 
D6 25 % PEG 8000 200 mM MgCl2 100 mM HEPES pH 7.5 
 
A.3.4 Plate C5 
Enzyme solution 1: 1.6 mg/ml, 17 mM MgCl2, 1.7 mM α,β-imido dUTP, 50 mM HEPES pH 
6.8. 
Enzyme solution 2: 1.2 mg/ml, 13 mM MgCl2, 1.3 mM α,β-imido dUTP, 50 mM HEPES pH 
6.8. 
1 μl of enzyme solution 1 was mixed with 1 μl of reservoir solution. 
Temperature: The plate was set up in a cold room at 4ºC and kept herein. 
4D and 5D was seeded from Plate C4, number 1A, using the tip of a needle. 
No. Enzyme  
Solution 
Precipitant Salt Buffer 
A1 1 4 % PEG 8000 200 mM MgCl2 100 mM HEPES pH 7.5 
B1 1 6 % PEG 8000 200 mM MgCl2 100 mM HEPES pH 7.5 
C1 1 8 % PEG 8000 200 mM MgCl2 100 mM HEPES pH 7.5 
D1 1 10 % PEG 8000 200 mM MgCl2 100 mM HEPES pH 7.5 
A2 2 10 % PEG 8000 200 mM MgCl2 100 mM HEPES pH 7.5 
B2 2 15 % PEG 8000 200 mM MgCl2 100 mM HEPES pH 7.5 
A3 1 20 % PEG 400 150 mM MgCl2 100 mM HEPES pH 7.5 
B3 1 25 % PEG 400 150 mM MgCl2 100 mM HEPES pH 7.5 
D3 2 25 % PEG 400 150 mM MgCl2 100 mM HEPES pH 7.5 
A4 1 20 % PEG 400 100 mM MgCl2 100 mM HEPES pH 7.5 
B4 1 25 % PEG 400 100 mM MgCl2 100 mM HEPES pH 7.5 
D4 2 25 % PEG 400 150 mM MgCl2 100 mM HEPES pH 7.5 
A5 2 25 % PEG 400 150 mM MgCl2 100 mM HEPES pH 7.5 
 - 216 -
Part II                                                                                                                             Appendix  
B5 1 25 % PEG 400 150 mM MgSO4 100 mM HEPES pH 7.5 
C5 1 25 % PEG 400 150 mM MgCl2 100 mM HEPES pH 7.0 
D5 1 25 % PEG 400 200 mM MgCl2 100 mM HEPES pH 7.5 
 
A.3.5 Plate C6 
Enzyme solution: 1.9 mg/ml, 200 mM MgCl2, 3 mM α,β-imido dUTP, 50 mM HEPES pH 
6.8. 
2 μl of enzyme solution was mixed with 2 μl of reservoir solution. 
Temperature: The plate was set up in a cold room at 4ºC and kept herein. 
No. Precipitant Salt Buffer 
A4 15 % PEG 400 100 mM MgCl2 100 mM HEPES pH 7.5 
B4 18 % PEG 400 100 mM MgCl2 100 mM HEPES pH 7.5 
C4 21 % PEG 400 100 mM MgCl2 100 mM HEPES pH 7.5 
D4 24 % PEG 400 100 mM MgCl2 100 mM HEPES pH 7.5 
A5 4 % PEG 8000 100 mM MgCl2 100 mM HEPES pH 7.5 
B5 6 % PEG 8000 100 mM MgCl2 100 mM HEPES pH 7.5 
C5 8 % PEG 8000 100 mM MgCl2 100 mM HEPES pH 7.5 
D5 10 % PEG 8000 100 mM MgCl2 100 mM HEPES pH 7.5 
A6 4 % PEG 8000 200 mM MgCl2 100 mM HEPES pH 7.5 
B6 6 % PEG 8000 200 mM MgCl2 100 mM HEPES pH 7.5 
C6 8 % PEG 8000 200 mM MgCl2 100 mM HEPES pH 7.5 
D6 10 % PEG 8000 200 mM MgCl2 100 mM HEPES pH 7.5 
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Appendix four 
 
 
 
A.4 Structural evidence for a concerted bifunctionality in 
dCTP deaminase-dUTPase from Methanocaldococcus 
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Abstract 
The crystal structures of two mutant dCTP deaminase-dUTPases from Methanocaldococcus jannaschii, E145A 
and E145Q, have been determined. The mutant enzymes that are impaired in the deaminase reaction were 
crystallised as a complex with α,β-imido-dUTP or diphosphate, respectively. In the structure of E145Q in 
complex with diphosphate, the diphosphate occupies the same position as the β- and γ-phosphoryls of the 
nucleotide analogue in the E145A complex. Firstly, the C-terminal region that is unresolved in previous 
structures of the apo-form of the enzyme is now in both cases ordered and closes over the active site by 
interacting with the phosphate backbone of the nucleotide or with the diphosphate. In both complexes a 
magnesium ion is readily observed to complex with all three phosphoryls in the nucleotide complex or with the 
diphosphate. A water molecule that is likely to be involved in the nucleotidyl diphosphorylase reaction is 
observed in the E145A:α,β-imido-dUTP complex. This water molecule is held in place by Asp135, a residue 
positioned similarly as the catalytic acid in the monofunctional trimeric dUTPase. Based on a comparison of the 
active site between the bifunctional enzyme and the monofunctional family members, dCTP deaminase and 
dUTPase, we may suggest that the reaction mechanisms are the same. Furthermore, the conformation of side 
chains involved in the deaminase reaction is similar in the nucleotide and diphosphate complexes indicating a 
concerted re-arrangement, or induced fit, of the active site promoted by the interactions between the enzyme and 
the β- and γ-phosphoryls of the bound nucleotide. 
 
Introduction 
The formation of dUMP de novo, the precursor of dTTP, occurs in general via two pathways; one by which UDP 
is reduced to dUDP by ribonucleotide reductase and further phosphorylated to dUTP and hydrolysed to dUMP 
and diphosphate by dUTPase, and a second, where dUMP is generated by the deamination of a cytosine deoxy-
 - 218 -
Part II                                                                                                                             Appendix  
ribonucleotide. Whereas the dUMP obtained from reduction of UDP is considered a minor supplement,  the 
deamination of a cytosine deoxy-ribonucleotide generally provides up to 50-80% of the dUMP used for dTTP 
synthesis 1-3. In eukaryotes 4-6 and Gram-positive bacteria like Bacillus subtilis 1 the deamination of dCMP 
directly to dUMP is catalysed by the zinc containing enzyme dCMP deaminase 7. In other organisms the 
deamination occurs at the level of  dCTP as in the Gram-negative bacteria Salmonella typhimurium 2,8,9 and 
Escherichia coli 10,11. The product dUTP then gets cleaved by dUTPase to dUMP. Alternatively as it was 
discovered in the archaea Methanocaldococcus jannaschii 12-15 and recently in Mycobacterium tuberculosis 16, a 
bifunctional enzyme (dCTP deaminase-dUTPase) simultaneously deaminates and cleaves dCTP to release 
dUMP. The enzymes constituting the dCTP dependent dUMP forming pathways; dCTP deaminase and trimeric 
dUTPase, or the bifunctional enzyme are all three members of a structural family of trimeric enzymes that share 
a common fold for the subunit 17. 
Others and we have previously published the structure of the apo-form of the M. jannaschii dCTP deaminase-
dUTPase 13,14. In addition, we have published the structures of the E. coli dCTP deaminase 17 and recently the M. 
tuberculosis bifunctional enzyme 16. We have undertaken an investigation of both the catalytic mechanism of the 
unusual metal-ion independent deamination reaction carried out by these enzymes18 and the mechanism by 
which dTTP regulates the activity 16,19. The bifunctional enzyme is quite unusual in that it simultaneously 
modifies a substrate at two different and distant positions within the same molecule. In this work we are 
addressing the structural properties behind the mechanism by which the bifunctional dCTP deaminase-dUTPase 
coordinates the deamination and triphosphate cleavage reactions. 
 
Results and Discussion 
 
Crystallization and structure determination 
Earlier attempts to crystallize wild type dCTP deaminase-dUTPase with substrate analogues or inhibitors have 
failed, therefore, two mutant enzymes, E145A and E145Q, impaired in the deaminase reaction15 were produced. 
Crystallization experiments of these two mutant enzymes with dCTP, dUTP, dTTP or the intermediate product 
analogue α,β-imido-dUTP resulted in well-diffracting crystals of E145A in complex with α,β-imido-dUTP and 
Mg2+ and of E145Q in complex with diphosphate and Mg2+. dCTP was used in the latter co-crystallisation 
experiment, and the observation that one of the two products was bound demonstrates that the E145Q mutant is 
able to cleave dCTP by way of the dUTPase half-reaction 15. The E145Q structure revealed 30% of the enzyme 
in a E145Q:PPi complex and 70% of the enzyme in the apo form. 
 
The overall fold of the M. Jannaschii dCTP deaminase-dUTPase trimer 
The overall fold of the dCTP deaminase-dUTPase mutant enzymes in complex with either nucleotide or 
diphosphate was very similar to previously published structures. The C-terminal region appears to fold back over 
the active site to form two 310-helices - not only in the presence of nucleotide - but also in the presence of 
diphosphate.  Figure 1A shows a superposition of the structure of the M. jannaschii enzyme apo-form 13,16 and 
the complexes of mutant M. jannaschii enzymes described in this work. Also included in this Figure are 
structures previously published of bifunctional 16 and monofunctional 17 enzyme family members in complex 
with nucleotides. As can be seen, the formation of the complexes results in an almost identical ordered C-
terminal region that closes as a lid over the active site.  
 
The active site 
Figure 2 provides a detailed picture of the binding of α,β-imido-dUTP and PPi to the E145A and E145Q mutant 
enzymes, respectively. In the structure of the E145A:α,β-imido-dUTP complex, the magnesium ion was 
octahedrally coordinated to the α-, β- and γ-phosphoryls as well as to three water molecules. There was clear 
electron density for both the nucleotide as well as the magnesium ion in the structure (Figure 2a). As mentioned, 
the C-terminal region was found to close over the active site and only the last five amino acid residues were 
unidentifiable in the electron density maps. The γ-phosphoryl of the bound nucleotide formed hydrogen bonds 
with Tyr177 and Lys184 from the C-terminal region. The β-phosphoryl group was hydrogen bonded to Arg117 
and Ser119, whereas Ser118 and the two water molecules, wat33 and wat87, were hydrogen bond partners for 
the α-phosphoryl group (Figure 2b). Also, in addition to a hydrogen bond to Thr143, O2 in the uracil moiety of 
α,β-imido-dUTP was interacting with the C-terminal region through a hydrogen bond to the side chain of 
Gln188 (Figure 2b). Asp135 (OD2) formed a hydrogen bond to O3’ of the deoxy-ribose ring. The other oxygen 
of the carboxylate group OD1 was only interacting with the water molecules wat87 and wat12 (Figure 2b). There 
were also noteworthy hydrophobic interactions between the nucleotide and the enzyme. The aromatic side chain 
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of Phe138 was stacking with the deoxy-ribosyl moiety and Ile142 interacted with the pyrimidine ring of α,β-
imido-dUTP (Figure 2a).  
The structure refinement revealed that the crystals of E145Q in complex with PPi contained the protein in two 
conformations; one similar to the structure determined previously with no ligand and a disordered C-terminal 
region 13, and one resembling the active site structure of the E145A:α,β-imido-dUTP complex (Figure 2 and 3). 
To describe this static disorder the side chains of Tyr43, Tyr56 and residues in the segment His128 to Trp133 
were modelled in double conformations (Figure 2c and 3). The closure of the active site by the C-terminal region 
involved a hydrogen bond between the backbone amide of Ser194 and Tyr43 and the interaction between side 
chains of Lys184 and Tyr177 (Figure 2c) and the diphosphate. 
In Figure 3, the side chain position of His128 and Trp133 in the wild type dCTP deaminase-dUTPase without 
ligand bound (1OGH) is compared to the structures of E145A and E145Q with bound ligand. In the structure of 
the apo-form of the wild type enzyme His128 was hydrogen bonded to Asp125, but upon binding of nucleotide 
as represented by the E145A structure, the imidazole ring was turned away from the active site. The position of 
His128 in the apo-form structure would be likely to cause a steric hindrance for nucleotide binding. Also, the 
side chain of Arg122 changed its position upon nucleotide or diphosphate binding to the active site. In both the 
nucleotide and diphosphate complex the side chain of Arg122 was facing towards Phe138 and formed a 
hydrogen bond to OE1 of Gln188 and the OG1 of Thr143 that also interacted with the nucleotide (Figure 2a and 
c). 
 
The dCTP deaminase reaction 
The catalytic mechanism for the deamination of dCTP catalyzed by dCTP deaminase-dUTPase is likely to be 
identical to that of E. coli dCTP deaminase as suggested by Johansson et al. 17,18. The position of active site 
residues involved in the deamination reaction as observed in the E145A:α,β-imido-dUTP complex, and those of 
E. coli dCTP deaminase in complex with dUTP superimpose well. As predicted, Glu145 in dCTP deaminase-
dUTPase occupied a position equivalent to Glu138 that earlier was shown to be central to catalysis in the 
monofunctional E. coli dCTP deaminase 17,18. Interestingly, these residues are found in the same conformation in 
the E145Q: PPi complex.  
 
The dUTPase reaction 
The E145Q mutant enzyme, although impaired in deaminase activity, has been reported to be a functional 
dUTPase and as apparent from the crystal complex, can cleave dCTP 15. The nucleotidyl diphosphorylase 
reaction is likely to be mediated by Asp135 of which the OD1 may activate wat87 through proton abstraction to 
make a nucleophilic attack on the α-phosphate of the substrate. The Asp135 of the M. jannaschii dCTP 
deaminase-dUTPase is in a similar position as the catalytic aspartic acid residue identified in trimeric dUTPases 
20-22.  
A similar orientation of the active site residues was recently observed in the dTTP inhibited form of M. 
tuberculosis dCTP deaminase-dUTPase 16. The inhibition of the bifunctional M. tuberculosis enzyme by dTTP is 
explained by a rearrangement of residues 109-118 (residues 125-134 in the M. jannaschii enzyme). This 
rearrangement occurs to accommodate the additional methyl group of the thymine moiety of dTTP. As a result, 
Ala115 of the M. tuberculosis enzyme (Ala131 in the  M. jannaschii enzyme) moves to expel a water molecule 
corresponding to wat33 in the M. jannaschii  complex (Figure 2b). This water molecule which would otherwise 
hydrogen bond to the α-phosphate, is suggested to be crucial for the catalysis of the nucleotidyl diphosphorylase 
reaction 16. The structure of the E145A:α,β-imido-dUTP complex lends support to this hypothesis: when 
superposing the E145A:α,β-imido-dUTP complex with the M. tuberculosis dCTP deaminase-dUTPase:dTTP 
complex, the nucleotides are found in identical positions. The hydrogen bond patterns between the enzyme and 
the triphosphates are similar and the only notable difference is the position of Ala115 in the M. tuberculosis 
enzyme complex that takes the place of that occupied by wat33  in the M. jannaschii enzyme (Figure 4). In the 
structure of the E145Q:PPi complex no water molecule corresponding to Wat33 was found although the position 
of Ala131 made room for it. Although the resolution to 2.6 Å of the E145Q:PPi complex of course imposed a 
limititation on the search for water molecules in the structure, the lack of an α-phosphoryl in this complex that 
otherwise coordinates to Wat33 is likely to explain its absence (Figure 4). 
 
Conclusions 
In the structures determined in the present work the nucleotide as well as the diphosphate could easily be 
positioned based on the electron densities alone (Figure 2a and 2c). The structures of these two complexes 
revealed large differences when compared to the to the previously solved structure of the apo-form M. jannaschii 
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dCTP deaminase-dUTPase with changes in the positions of amino acyl side chains in the active site and the 
ordering of the previously unresolved C-terminal region.  
As mentioned, each reaction catalysed by dCTP deaminase-dUTPase is likely to occur via the same mechanism 
as that previously proposed for the monofunctional dCTP deaminase 17,18 and trimeric dUTPase 20,21. However, 
the present work provides a new and important insight into the mechanism by which the bifunctional enzyme 
coordinates the simultaneous deamination and diphosphorylase reaction of dCTP. The imidazole ring of His128 
points into the active site in the apo-form of the enzyme, much like what is seen in the dTTP inhibited forms of 
E. coli dCTP deaminase 19 and M. tuberculosis dCTP deaminase-dUTPase 16. The observation that both His 128 
and Trp133 move out of the active site to avoid steric hindrance of binding of the nucleobase moiety of the 
substrate suggests an induced fit mechanism for the binding of nucleotide to the enzyme (Figure 3). Also, the 
E145Q:PPi complex was found to exist in two conformations: one resembling the apo-form and one where in 
addition to an ordered C-terminal region, the residues from His128 to Trp133 had adapted a similar 
conformation as in the nucleotide complex of E145A (Figure 2c and 3). 
Pre-steady state kinetics of the E. coli dCTP deaminase revealed a time-lag in the progress curve of product 
formation that was increased by the presence of dTTP 19. This lag was interpreted to represent a structural 
rearrangement of the same region as discussed above (His121 to His124 in the E. coli dCTP deaminase) from an 
inactive conformation to an active conformation in order to be able to bind the substrate 19. We therefore suggest 
that the E145Q:PPi complex demonstrates the likely existence of a concerted structural response of the active site 
in the bifunctional enzyme that accompanies nucleotide binding and which combines optimal positioning of 
catalytic residues for both the deaminase and the dUTPase “half-reactions”. A mechanism that judged from the 
structure of the E145Q:PPi complex appears to depend, at least in part, on the interaction between the enzyme 
and the β- and γ-phosphates of the substrate. 
  
Materials and Methods 
 
Crystallisation of proteins 
The plasmid based on the pET-3a vector (Novagen) used for overproduction of the M. jannaschii dCTP 
deaminase-dUTPase has been described previously 12. Mutations were introduced using the quick-change site-
directed mutagenesis system (Stratagene) according to the supplier’s recommendations and using the deoxy-
oligonucleotides D145A5-3, GGAAAAATAACCTTGGCGATTGTTGCTTTCGAT; D145A3-5, ATCGAAAG-
CAACAATCGCCAAGGTTATTTTTCC; D145N5-3, GGAAAAATAACCTTGCAGATTGTTGCTTTCGAT; 
D145N3-5, ATCGAAAGCAACAATCTGCAAGGTTATTTTTCC. Protein was produced and purified as 
previously described 12. Crystals were obtained by the hanging drop, vapour-diffusion method with 2 µL protein 
solution, 2 µL mother liquor and 1 mL reservoir volume at room temperature. The PEG/ION screen (Hampton 
Research) was used for crystallisation of both mutant proteins. Crystals of E145A  were grown from a solution 
of 2 mg mL-1 protein, 20 mM Tris-HCl, pH 8.5, 20 mM magnesium chloride and 3 mM α,β-imido-dUTP and 
reservoir solution of 0.2 M di-potassium hydrogen phosphate and 20 % PEG3350. Crystals of E145Q were 
grown from a solution of 2 mg mL-1 protein, 20 mM Tris-HCl, pH 8.5, 20 mM magnesium chloride and 5 mM 
dCTP and reservoir solution of  0.2 M tri-potassium citrate and 20 % PEG3350. 
 
Diffraction data collection 
Diffraction data from were collected at the ESRF (Grenoble, France), beam line ID23-1. 25 % ethylene glycol 
mixed with mother liquor was used for cryo protection. The crystals of the E145A variant and E145Q variant 
diffracted to 2.55 and 2.3 Å resolution, respectively. The diffraction data from crystals of E145Q were auto 
indexed and integrated using Denzo and scaled with Scalepack 23. The diffraction data from crystals of E145A 
were integrated using MOSFLM 24  and scaled using Scala 25. Both crystals belonged to space group I432 with 
one protein chain in the asymmetric unit giving a Matthews coefficient of 4.44 Å3/Da, corresponding to a water 
content of approximately 72 %. Details on data collection, processing and statistics are summarized in Table 1.  
 
Structure determination and refinement 
The structures of mutant enzymes were  determined using the molecular replacement technique as implemented 
in the program AMoRe 26 with the previously determined structure of dCTP deaminase-dUTPase in the space 
group P213 as the search model (Protein Data Bank code entry: 1OGH, chain A). All water molecules were 
removed from the model before commencing with molecular replacement. Refinement and model building was 
carried out using Refmac5 27 and O 28.  In the E145A structure residues 1 to 199 were modelled and clear 
electron density for α,β-imido-dUTP was seen.  121 water molecules were furthermore included in the model. In 
the E145Q structure residues 1 to 199 were modelled and density for PPi was seen. 71 water molecules were 
included. Tyr43 and Tyr56 were found in alternate positions and modelled as such. Furthermore, residues 128 to 
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133 were also found in alternate positions. 70% were in a conformation similar to the structure found in the apo-
enzyme, 1OGH, and 30% were in a conformation similar to the one found in the E145A  complex structure. The 
PPi and the C-terminal region were modelled with B-factors of about 70 Å2 as compared to about 30 Å2 to the 
neighbouring atoms. They were therefore given an occupancy of 0.3, assuming that binding of PPi was the 
prerequisite necessary for an ordered C-terminal and the rearrangement of residues 128-133. The quality of the 
structures was checked using WHATIF 29 and PROCHECK 30. Refinement statistics are summarized in Table 1. 
 
Protein Data Bank accession codes 
The atomic coordinates and structure factors have been deposited in the Protein Data Bank with the PDB ID 
codes 2HXD and 2HXE.  
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Enzyme:ligand E145A:α,β-imido- dUTP E145Q:PPi 
Resolution range (Å) 25 - 2.3 25 - 2.3 
 (2.42 - 2.30)a (2.69 - 2.62)a 
Rmerge (%)b 8.9 (43.2)a 10.1 (43.4)a 
Space group I432 I432 
Cell dimensions a,b,c (Å) 171.5 171.6 
<I>/σ(I) 14.4 (3.0)a 26.8 (5.4)a 
Completeness (%) 96.4 (98.9)a 100.0 (100.0)a 
Total no. of reflections 80,955 178,848 
No. of unique reflections 18,566 14,787 
Monomers in asymmetric unit 1 1 
Total no. of reflections 17,636 12,631 
No. of reflections (working set) 16,712 11,995 
No. of reflections (test set) 924 636 
No. of protein atoms 1756 1756 
No. of water molecules 122 72 
Rfactor (%)c 17.8 (26.4)a 18.5 (23.0)a 
Rfree (%)d 22.1 (35.3)a 22.8 (28.0)a 
Average Bfactor (Å) 27.1 35.1 
Average Bfactor protein atoms (Å) 30.1 38.3 
Average Bfactor nucleotide or PPi and Mg2+ 
(Å) 
33.1 64.7 
Average Bfactor water atoms (Å) 35.4 36.3 
Bond length rmsde from ideal (Å) 0.022 0.021 
Bond angle rmsde from ideal (deg.) 1.84 1.74 
Ramachandran plot   
Most favoured regions (%) 89.9 92.1 
Additional allowed regions (%) 9.0 7.9 
Generously allowed regions (%) 1.1 0 
Disallowed regions (%) 0 0 
 
Figure legends 
 
Figure 1. Structural comparison of subunits of the bifunctional dCTP deaminase-dUTPase from M. jannaschii 
and M. tuberculosis and the monofunctional E. coli dCTP deaminase. The colour coding is as follows; M. 
jannaschii apo-form (yellow), M. jannaschii E145Q:PPi complex (cyan), M. jannaschii E145A:α,β-imido-dUTP 
complex (green), E. coli dCTP deaminase-dUTP complex (purple) (Protein Data Bank entry 1XS1) and the M. 
tuberculosis dCTP deaminase-dUTPase:dTTP complex (pink) (Protein Data Bank entry 2QXX). The nucleotides 
and the diphosphate are in standard colouring. The magnesium ions are in dark grey. The N-and C-terminals of 
the subunits are as indicated. The apo-form of the M. jannaschii enzyme has an unresolved C-terminal region for 
which reason only the last residue with clear electron density has been modelled. Panels were prepared using 
PyMol (DeLano Scientific). 
 
Figure 2.  Views of the active site of the E145A:α,β-imido-dUTP complex  and the E145Q:PPi complex. (a), 
Close up stereo picture of the E145A:α,β-imido-dUTP complex. The orange and blue amino acid residues are 
contributed by two different subunits in the trimer. (b), Schematic view of the active site architecture of the 
E145A:α,β-imido-dUTP complex. Amino acid residues in black and blue are contributed by two different 
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subunits in the trimer, Asp135 is coloured in red to indicate its double appearance. (c), Close up stereo picture of 
the E145Q:PPi complex. Colouring of amino acid residues is as above. In panel a and c the displayed 2Fobs – Fcalc 
difference electron density maps are contoured at 1.0 σ level at a distance of 1.0 Å around the nucleotide, the 
diphosphate and the magnesium ions. The Figure was prepared using MOLSCRIPT 31 and Raster3D 32. 
 
Figure 3. Stereo view of the amino acid residues in double conformations in the crystal structure of E145Q:PPi 
complex (shown in yellow and blue) compared to wild-type dCTP deaminase-dUTPase structure with no ligand 
bound (shown in red) and  the E145A:α,β-imido-dUTP complex (shown in green). The amino acid residues 
were superimposed using default parameters in the program O 28. The Figure was prepared using MOLSCRIPT 
31 and Raster3D 32. 
 
Figure 4. Two different views, A and B,  of an overlay of the active site around the bound ligands in the 
E145A:α,β-imido-dUTP (green) and E145Q:PPi (yellow) complexes and the M. tuberculosis bifunctional 
enzyme in complex with dTTP (purple, PDB accession code 2QXX). The E145Q:PPi complex is represented by 
two structures, one with no diphosphate bound similar to the apo-form (1OGH) and one with diphosphate bound 
similar to the E145A:α,β-imido-dUTP  complex (see text). The spheres coloured as the complexes represent 
important water molecules. Black spheres represent magnesium ions. The solid arrow points to the proposed 
catalytic water molecule that attacks the α-phosphoryl in the dUTPase half-reaction 20 (see text). The dotted 
arrow points to the newly identified water molecule proposed to also play an important role in catalysis of the 
dUTPase half-reaction 16. The side chain of Ala115 of the M. tuberculosis enzyme, indicated in bold, (Ala131 in 
M. jannaschii) that plays a role in the dTTP is compared to the position of the homologues residue, Ala131, in 
M. jannaschii. Panels were prepared using PyMol (DeLano Scientific). 
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